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Abstract
BACKGROUND: Vitamin D deficiency is becoming a worldwide public health 
concern as it increases the risk of many diseases and disorders. Little is known 
about the health outcomes of such deficiency in the South Asian population, in 
which it is more pronounced. The aim of this thesis was therefore to investigate the 
ethnic differences between South Asians and Caucasians with regard to the effect 
of vitamin D status on osteoporosis and cardiovascular disease risk. Furthermore, 
the study aimed to determine the extent of the problem and the genetic or social 
reasons behind it.
METHODS: The research involved three sub-projects; the first of which undertook 
further analysis of the data from the original Vitamin D, Food Intake, Nutrition and 
Exposure to Sunlight in Southern England (D-FINES) study. Subjects from D- 
FINES were then re- invited to take part in the second part of this research, which 
measured volumetric bone density of the tibia and radius as using 
(pQCT)estimates of bone health. General health and biomarkers of cardiovascular 
disease and osteoporosis were assessed by standard clinical biochemical blood 
assays. The final stage utilised an interventional study design to test the efficiency 
of vitamin D production in both ethnic groups following controlled exposure to 
ultraviolet (UV) radiation.
RESULTS: In general, South Asian women had significantly lower vitamin D status, 
HDL cholesterol and insulin sensitivity; significant higher BMI, insulin level, insulin 
resistance and beta cell function compared to Caucasian women. All of these 
undesirable biochemical indicators put South Asian women at higher risk of 
cardiovascular disease. South Asian women also had lower bone areas in all sites 
measured; and lower cortical bone thickness and volumetric bone density at some 
sites of tibial bone. All of these bone parameters indicate lower bone strength 
among South Asian women compared to Caucasian women; leading to a higher 
risk of osteoporosis long- term. Despite consistently lower vitamin D levels in South 
Asian women they were shown to synthesise vitamin D just as efficiently as 
Caucasians when exposed to the same dose of UV. Interestingly, the baseline 
level of vitamin D rather than ethnicity influenced the amount of UV needed to 
reach equal serum concentrations. This novel finding indicated no effect of skin
tone on the production of vitamin D and identified that length of exposure was the 
critical factor. Inferences made from data collected on UV skin exposure behaviour 
of the two groups suggested that the main reason for predominant vitamin D 
deficiency in south Asians is their tendency to avoid sunlight for fear of tanning.
CONCLUSION: More research and public health messages to the South Asian 
population are urgently required to reduce cardiovascular and osteoporosis risk 
factors. This could be achieved by a number of ways
1. Encouraging more widespread use of vitamin supplements
2. Educating on the health benefits of safe UV exposure to increase their 
vitamin D status.
3. Encouraging a vitamin D rich diet
Furthermore the association between vitamin D, bone health indices and lipid 
profiles warrant additional research in both groups.
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1.1. Introduction:
Vitamin D is essential for human health, being recognised within the last two decades to be not 
only important for bone-health, but also important in reducing the risk o f  many chronic diseases 
including heart disease, diabetes, infectious diseases, and cancer (Lappe, 2011). Vitamin D is 
known as the ‘sunshine vitamin’, because the human skin produces it when exposed to ultraviolet 
B (UVB) radiation. It was previously believed that only the elderly were at high risk o f vitamin D 
deficiency, since they have lower rate o f skin synthesis, as well as reduced skin exposure, (report 
by F AO/WHO expert consultation), however, it has been found that anyone not exposed to an 
adequate amount o f sunlight or does not intentionally consume at least lOOOIU o f vitamin D, is at 
high risk o f vitamin D deficiency (Holick, 2004). Due to the recent trends in modem times to 
spend more time indoors and to consume an unbalanced diet, people have become more prone to 
vitamin D deficiency, resulting in a global epidemic, associated with many diseases and 
disorders. Moreover, obtaining the adequate amount o f vitamin D is becoming more difficult 
owing to multiple environmental, cultural and personal factors.
1.2. Brief introduction to vitamin D
1.2.1. Vitamin D pharmacology
Vitamin D is the most important member o f the fat-soluble secosteroids; a chemical group similar 
to the steroid group o f hormones but with a broken ring structure. Vitamin D has two major 
physiologically relevant forms, which are vitamin D2 (ergocalciferol) and vitamin D3 
(cholecalciferol), refer to figure 1 . 1
HO'" HO'"
Figure 1.1 Chemical composition o f vitamin D2 (on the left) and vitamin D3 (on the right)
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Following exposure to sunlight or an artificial radiation source, vitamin D 3 is synthesised (Chel 
et ah, 1998). In humans, vitamin D can only be synthesized via a photochemical process in the 
skin, or must alternatively be obtained through the ingestion o f pre-formed vitamin D in food. 
Both o f these forms, whether synthesised or ingested have the same biological activity (Holick, 
2004). However, solely relying on vitamin D intake in the diet is insufficient due low levels o f 
vitamin D available in many food sources. However, diet sources can be essential when skin 
production o f vitamin D is limited (Francis, 2008). In addition, the foods that are rich in vitamin 
D include offal (organ meats), shellfish, and oily fatty foods, which are often considered to be 
unacceptable in the modem diet. For these reasons among others, it is quite difficult to obtain 
400IU/ day o f vitamin D fi*om a normal diet.
In efforts to overcome the above-mentioned limitations, staple foods including milk, flour, and 
margarine are artificially fortified with vitamin D2 in most developed countries. There is also a 
large variety o f vitamin supplement tablets available over the counter. Some types o f mushroom, 
when exposed to sufficient light, provide enhanced amount o f vitamin D, and improving the 
vitamin D status that was not different than vitamin D supplements (Urbain et al., 2011). Despite 
this, animal-based sources o f vitamin D are still considered to be important sources, since the 
ealcitriol form of the vitamin is the most abundant final active metabolite. This is o f importance 
given that ealcitriol has been found be more potent on a molar basis than cholecalciferol (Trang 
et al., 1998). Aside fi-om food sources, it is believed that the major source o f vitamin D is 
sunlight, with human skin producing vitamin D3 when exposed specifically to UVB.
1.2.2. The discovery o f vitamin D
Vitamin D was discovered by historical accident, when rickets was a world public health and was
predominant in England where sunlight levels are low throughout much o f the year (Silva, 2007).
An historical overview of the discoveiy o f vitamin D by Rajakumar et al. (2008) stated that in
1920, the British scientist, Edward Mellanby, discovered vitamin D by introducing cod liver oil
as a treatment for rickets. He wrote "The action o f fats in rickets is due to a vitamin or accessory
food factor which they contain, probably identical to the fat-soluble vitamin". Following this,
McCollum, from the United States o f America (USA) demonstrated that even when the vitamin
A content fi-om cod liver oil was destroyed, the oil still maintained its anti-rachitic properties. He
named the active component o f the oil vitamin D. Steenbock and Black then went on to
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demonstrate that rickets could be treated with UV irradiation o f food, in particular non- 
saponifiable lipids (Rajakumar et ah, 2007). Clinical investigations discovered that rickets could 
be cured directly with sunlight or artificial UV exposure, suggesting that what subsequently 
became known as vitamin D, could be formed in vivo by irradiation (Bikle, 2009).
1.2.3. Forms o f vitamin D
Many forms o f vitamin D have been identified vitamin Di-vitamin D5 but the most common ones 
are vitamin D2 and D 3 . Vitamin D, written without subscript numbers refers to D2 or D3 types, or 
both; collectively known as calciferol. The five forms o f vitamin D all contain steroid rings in 
which one o f the bonds in the steroid rings is broken. These compounds have been called 
secosteroids in order to distinguish them from the steroid class o f hormones. The structural and 
pharmacological differences between each o f the forms result mainly from only slight changes in 
their chemical structure. For example, the difference between vitamin D 2 and vitamin D3 is the 
presence o f a double bond between carbons 22 and 23, and methyl group on carbon 24 o f D2 that 
is absent in D3 .
Vitamin D2 was chemically characterised for the first time in 1932, followed by the structural 
characterisation o f vitamin D3 in 1936. Furthermore, it was established that vitamin D 3 is formed 
fi-om the ultraviolet irradiation o f 7-dehydrocholestro 1 (Figure 1.2). Vitamin D2 is derivative o f 
ergosterol (a membrane sterol) produced by some organisms such as phytoplankton, 
invertebrates, and fungi in response to UV irradiation, but not by land plants or vertebrates.
1.2.4. Vitamin D synthesis - production in the skin
Vitamin D3 is synthesised in the skin when 7-dehydrocho lestro 1 (a derivative o f cholesterol) is 
irradiated by ultraviolet B (UVB) o f the appropriate wavelength. The reaction involves the 6 - 
electrons in a conrotatoiy manner in an electrocyclic reaction resulting pre-vitamin D3 (pre-Ü3), 
which is isomerised to vitamin D3 . (Figure 1.2).
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Figure 1.2 The production of vitamin D3 from 7-dehydrocholesterol in the epidermis
In epidemiis, 7-dehydrocholestrol is converted to vitamin D 3 .  Sunlight (UVB) breaks the B ring 
o f the cholesterol to form pre-Dg, and then it goes to thermal rearrangement to fonu D 3 .  
FoiTnation ofpre D3 to lumisterob and tachysterob in case of continues irradiation, but in the 
dark, can be reverted back to pre D3
© Taken from (Bikle, 2009)
Within a few hours, the rearrangement o f pre-D3 is induced by a heat-dependent process. The 
newly-fonued vitamin D3 is absorbed into the bloodstream (Gibney, 2002). Continued irradiation 
o f pre-Ü3 leads to the reversible formation o f lumisterob and tachysterob, both o f which can 
revert back to pre-Ds in the dark. This process occurs in the thick epidenuis layer o f the human 
skin, in particular in the two innermost strata, the stratum basale and stratum spinosum (Figure 
1.3)
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Figure 1.3: Layers of the epithelial skin layer
Epidermal strata of the skin, vitamin D production is greatest in the stratum basale and stratum 
spinosum (colored purple)
© Taken from New World Encyclopedia
Vitamin D production requires UVB radiation o f wavelengths between 270-300nm, with peak 
synthesis occurring between 295 and 297nm (Armas et ah, 2007). These wavelengths are present 
in sunlight when the UV index is greater than three. The UV index is the UV intensity reaching 
the earth at a given point (measured in W/m“ ), and ranges from 0 to 10, corresponding to night­
time and midday sun with a clear sky, respectively. Both the UV index and total amount o f UVB 
that human skin is exposed to are affected by the ozone layer, clouds and winds. Tanning lamps 
produce primarily ultraviolet A (UVA), but typically produce between 4%-l 0% of their total UV 
emission as UVB.
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1.2.5. Vitamin D metabolism
Whether from the diet or made in the skin, vitamin D3 is absorbed in micelle form, becomes 
incorporated into chylomicrons and is transported by the lymphatic system into the venous 
circulation. Vitamin D in the circulation is bound to the vitamin D binding protein (globulin) and 
is carried to liver, where it is hydroxylated at position C-25 (upper right of the molecule) to form 
25-hydroxycholecalciferol (calcidiol or 25(0H)D), known as pro-hormone. This fonu is the main 
storage form of vitamin D (see figure 1.4), formed by the hepatic enzyme 25-hydroxylase (25- 
OHase).
Figure 1.4 Conversion of cholecalciferol to calcidiol
As well as being the main storage fonu, 25(OH)D is also the major circulating fonu o f vitamin D, 
used by clinicians to measure vitamin D status. It is well know that serum 25-hydroxyvitamin D 
is best predictor o f vitamin D status in the human body. A normal level o f serum 25-OHD is 
estimated to be 50 nmol/1 or higher (Gomez-Alonso et al., 2003). Vitamin D metabolites are 
stored in the liver and fat cells until needed, and is then released into the plasma where it binds to 
globulin for transport. 25(OH)D is biologically inactive and must be converted to the active form 
within cells. In the kidney, 25(OH)D is hydroxylated at the 1-a position (lower right o f the 
molecule) to form calcitriol; 1,25-dihydroxycholecalciferol (l,25(OH)2D) as shown in figure 1.5. 
This conversion is catalysed by the enzyme 25-hydroxyvitamin D3 1 -alpha-hydroxylase. 
Calcidiol can also be hydroxylated, but the reaction catalysed by 24-hydroxlase yields, an 
apparently inactive metabolite, 24, 25-dihydroxyvitamin D (24-hydroxycalcidiol).
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Figure 1.5 Conversion of calcidiol to calcitriol
The systematic activation of vitamin D plays an important role in maintaining bone and muscle 
health by regulating calcium homeostasis (Holick, 2008b). Other tissues and organs such as the 
prostate gland, breasts, colon, lungs, and immune cells, including monocytes and macrophages, 
can also activate 25(OH)D to l,25(OH)2D. This local production of l,25(OH)2D facilitates the 
specific regulation of cell growth and controls immune fimction, as well as affecting most genes 
responsible for health (see figure 1.6). Calcitriol also acts locally as a cytokine, defending the 
body against microbial invaders (Edfeldt et al., 2010). In addition, the Vitamin D Receptor 
(VDR) is present in the cells of most tissues, including the endothelium, vascular smooth muscle, 
and myocardium is responsive to l,25(OH)2D. Circulatoiy l,25(OH)2D, being lipophilic, 
diffuses across the cell membrane and enters the nucleus where it binds to the VDR. VDR is a 
member o f the ligand-activated nuclear transcription factors, (nuclear transcription factors) that 
are capable o f altering gene function and inducing protein synthesis in response to chemical 
stimulus (Lee et ah, 2008).
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Figure 1.6 Sources of Vitamin D and its physiological role
© Taken from Holick, 2008
1.3. Osteoporosis and bone overview
Osteoporosis is a so-called ‘silent disease’ because no clinical symptoms are recognized, instead, 
this skeletal disorder occurs progressively, and is characterised by reduced skeletal mass, 
deterioration o f bone micro-architectural properties and reduced bone strength (Gcnant ct ah,
2011) (please refer to figure 1.7). The main consequence o f osteoporosis is the increase risk o f 
bone fracture which mostly develops via an imbalance o f two process; the resorption o f old or 
damaged bone and the formation o f new bone (Horowitz et ah, 2010).
5#
1 1
Figure 1.7 Micrograph scan images of 4mm thick lumbar vertebrae from
(A) a young person and (b) an elderly person, presenting the reduction in bone mass and loss of 
bone micro-structure
©Taken from (Compston and Rosen, 2009)
Osteoporosis risk increases with age and is more common in women (Warburton et ah, 2007). 
Oestrogen deficiency after menopause is correlated with rapid bone loss; while in men, the 
decrease in testosterone has a comparable but lesser effect. Figure 1. 8  summarises the main risk 
factors for developing osteoporosis. In general, bone loss occurs when bone resorption outstrips 
bone formation, eventually reducing bone strength to the point where even mild trauma results in 
a bone fracture. Osteoporosis is more prevalent in industrialised countries (Compston and Rosen, 
2009). According to the National Osteoporosis Society (2011), in the UK more than two million 
women are thought to have osteoporosis. At the age o f 50, about 2 in 100 women have 
osteoporosis and this rises to 1 in 4 women at the age of 80. Over a third o f women and one in 
five men in the UK suffer one or more bone fractures as a result of osteoporosis in their lifetime 
(National Osteoporosis Society, 2011).
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Figure 1.8 Risk factors o f osteoporosis (Horowitz et al., 2010)
Based on epidemiological studies, peak bone mass (PBM) is the major determinant of 
osteoporosis fracture risk. It has been estimated that a 10% increase in PBM, corresponding to 
one standard deviation, would reduce the risk o f osteoporosis fracture by 50% (Burckhardt et ah, 
2001). Indicating that having higher bone mass during the mid age (by age o f 30) time would 
decrease the risk o f fracture caused by osteoporosis.
1.3.1. Bone quality and strength
1.3.1.1. Bone metabolism
There are two types o f bone: cortical bone, the dense outer area (80% o f the skeleton) and 
trabecular bone, the spongy central area (20% of the skeleton) (Gurr, 2001). Trabecular bone is 
organized into trabeculae, which form linear connecting strands that are essential for structural 
bone integrity, and is predominant in the hip and pelvic bone (flat bone). Cortical bone is 
organized into osteons, organized around a central haversian canal in a ring-like structure. This 
type of bone is more commonly found in the tibia and radius. In mature bone (adult frilly formed
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bone), bone growth and modelling is replaced by a process o f repair called remodelling (Figure 
1.9). Worn parts o f bone are resorbed by miiltinucleate cells called osteoclasts (in a process called 
resorption), while new cells called osteoblasts rebuild excavation holes with strong new bone (in 
a process called bone fondation). Bone cell activity can be measured using biochemical markers; 
blood levels o f alkaline phosphatase and osteocalcin reflect fomiation; urinary hydroxyproline, 
deoxypyridinoline and pyridinoline indicate resorption (Favus, 1999). This bone remodelling (or 
bone metabolism) is a lifelong process, whereby the reshaping or replacement o f bone occurs 
following injuries such as fractures or in response to frrnctional demands of mechanical loading 
(Gurr, 2001).
(a) Quiescence - (b) Resorption (d) Formationtq  Reversal
MematopoiPtK Mesenchymal 
stem  cellstem  celiA ctiv â t o n
Pre-osteoclast Monocyte Pre-osteoblasis
m
O c o b a tMacmphaye
Ostpocfast
90-130 days
Figure 1.9 Bone remodelling a balanced process where (a) Quiescence: is resting state where the 
bone surface is covered with flattened lining cells (b) Resolution : is the process whereby 
osteoclasts remove old bone cells (c) Reversal: is the preparation stage for new osteoblasts to 
begin building bone and (d) Formation: osteoblasts synthesize matrix to replace re sorbed bone.
©Taken from (Compston and Rosen, 2009)
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1.3.1.2. Biochemical markers o f  bone turnover:
Products o f collagen breakdown or bone cell degradation reflect rates o f bone turnover. These are 
non-diagnostic tools but are significantly reduced during anti-resorptive therapy and may be used 
to determine responsiveness to treatment (Favus, 1999). Bone activity can be assessed by 
measuring levels o f biochemical markers in the blood.
Markers o f resorption; N-terminal and C-terminal cross-linked telopeptide o f type I collagen 
(NTx, CTx), urinary deoxypyridinoline and pyridinoline, and serum tartrate- resistant acid 
phosphatase.
Markers o f formation: serum bone- specific alkaline phosphate, serum osteocalcin, and serum 
type - 1  pro-collagen peptides
1.3.1.3. Measuring and assessing bone strength
The endpoint used to evaluate bone strength is bone fi-acture (Njeh, 1999). Loss o f bone mineral 
mass or alteration o f the micro-architecture are not the only causes o f fi^acture, falls occurring as a 
result o f  imbalance, inappropriate protective response or muscle weakness also contribute 
(Rizzoli, 2004). However, BMD is the major determinant o f bone strength and measures o f BMD 
at the proximal femur and lumbar spine regions are used to diagnose osteoporosis by applying 
criteria established by the World Health Organisation (WHO) in 1994 (Compston and Rosen,
2009). BMD predicts roughly 66-74% o f bone strength variance and is not a volumetric (mass 
per volume) but an areal density (mass per area) measure (Rizzoli, 2010). BMD corresponds to 
the bone mineral content and bone scanned area and thus this variable integrates not only the 
amount o f mineral but also the bone dimensions. That BMD is highly predictive o f bone strength 
can be partially explained by the integration o f bone size into this measurement. Other important 
factors that determine bone strength are bone geometry dimensions such as external diameter and 
cortical thickness (figure 1 .1 0 )
22
Original cross-section
t  Cortical thickness: 
bending resistance 
increased by 6.7%
f  Outer diarnet' 
bending resistan 
increased by 70
f  Cortical thickness and outer diameter: 
bending resistance increased by ?55%
i|
Figure 1.10 Cortical thickness and outer diameter as predictors o f bone strength
(a) The external diameter of bone and cortical thickness are key components to increase the 
resistance to flexion; expansion o f the outer diameter and bone thickness is associated with 
increased bone strength (b) Importance o f bone micro-architecture to bone strength; a small 
increase in bone mass that affects trabecular structure has little effect on BMD but improves bone 
strength greatly.
©Taken from (Rizzoli, 2004)
Mechanical studies have suggested that increasing the diameter o f a bone cylinder greatly 
increase its resistance to flexion. The outer diameter o f long bone may predict up to 55% o f bone 
strength variance. Increasing in cortical thickness also improves bone strength and considered the 
least important factor (Ammann and Rizzoli, 2003). Bone mineralization and bone tissue quality 
may also be implicated to bone strength, as is trabecular bone shape and structure (figure 1 .1 1 ). 
Sex hormone deficiency also alters the connectivity o f trabecular bone structure, by decreasing 
trabeculae number, increasing trabeculae separation, and by modification o f trabeculae shape 
tfom rods to plates, all o f which decrease bone strength. Bone re-modelling results in
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modification of major determinants o f bone strength including mass and cortical thickness. 
Osteoporosis fracture results from decreases in BMD, changes in micro-architecture or geometry, 
which may be influenced by nutrition, exercise, dmgs and hormones.
PlrtCi^ixv
(a) (b )
Figure 1.11 Trabecular connectivity, shape and structure as bone strength determinants
(a) The form o f trabeculae (plates or rods) to be evaluated; important in detennining the 
mechanical properties o f the trabecular bone (b) Dimensions o f bone play an important role in 
bone strength, e.g. it is easier to crush rectangular structure than it is to crush a cylindrical 
structure o f identical mass.
©Taken from (Rizzoli, 2004)
Several methods can be used to evaluate bone strength at different parts o f the skeleton. In figure 
1.12, a schematic representation o f these methods are shown. In figure 1.12 (a) the strength o f the 
vertebral body or proximal tibia is measured by compression; in (b) the strength o f the midshaft 
tibia or long bones (tibia, femur or humerus) is measured by bending at 3 or 4 points.
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Figure 1.12 Bone strength tests
(a) compression and (b) three-point bending (a) compression o f the vertebral body or o f proximal 
tibia (b) three-point bending test o f long bones, usually measured by detennining the stress on the 
bone.
©Taken from (Rizzoli, 2004)
1.3.2. Osteoporosis fractures
Fragility fractures are more common in the vertebral column, hips, ribs and wrists and are 
associated with an enonnous healthcare burden. The estimated number o f fractures attributed to 
osteoporosis is 250,000 in the UK and 1 in 3 women and 1 in 5 men over 80 will suffer from a 
hip fracture. For women, the hospital cost o f all osteoporosis fractures exceeds that o f stroke and 
myocardial infarction (see figure 1.13).
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Figure 1.13 Hospitalization cost o f common diseases versus bone fracture
©Adapted from (Compston and Rosen, 2009)
The most common fracture type in the UK is hip fracture (60,000 cases per year), followed by 
radius fracture (50,0000 eases per year) and the incidence in women and men increases after age 
45 and 76 respectively. The cause o f osteoporosis fracture is by major or minor trauma. BMD is 
used to predict fracture risk and studies in postmenopausal women have shown that for each 1 SD 
decrease in BMD, there is 2-3 fold increase in fracture risk (Trémollieres et al., 2010). 
Interestingly, bone density at the wrist, spine calcaneus or hip is related to hip fracture risk 
(Figure 1.14).
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Figure 1.14 BMD versus hip fracture risk
Bone mineral density at hip followed by wrist and spine calcaneus is the highest risk related to 
h ip fracture
©Taken from (Compston and Rosen, 2009)
Even though BMD and fracture risk are strongly inversely associated and the relationship is 
highly predictive, other bone mechanical factors are also important for defining bone strength, 
which determines fracture risk. Such determinants are difficult to assess clinically and are often 
referred to as qualitative risk factors. These include rate o f bone turnover, trabecular connectivity, 
cortical and trabecular thickness, bone shape and the structural model index (a measure o f plate 
consistency of bone). Recent studies have measured bone density using pQCT and magnetic 
resonance imaging (MRI). It is clear that with low BMD, less force is necessary to cause a 
fracture whereas for other factors such as structure, shape and geometry, the relationship to 
fracture risk is more difficult to define.
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1.3.3. Diagnosis of osteoporosis
Since osteoporosis is characterized by low bone mass and bone density, the key way to diagnose 
osteoporosis is through quantifying BMD. There are variety o f methods to assess bone density 
including quantitative ultrasound, quantitative computed tomography and DXA. Based on 
historical studies, DXA is considered the ‘gold standard’ for diagnosis that has been used in 
major clinical trials. DXA is a fast and accurate, non-invasive method that measures bone density 
at several skeletal sites such as the spine, hips and wrist (see figure 1.15). A drawback o f DXA is 
that it is associated with a two-dimensional estiiuate o f bone density and cannot provide a true 
volumetric measure.
Figure 1.15 Example o f a DXA machine
A patient lies on the couch with their hips and knees flexed to flatten the lumbar spine. 
©Taken from (Compston and Rosen, 2009)
PQCT is another way to analyse bone strength and can predict fracture risk but cannot diagnose 
osteoporosis due to poor correlation with BMD measurements. As such, there are no standardized 
population-based studies available. However, pQCT measurements can be use till in providing 
additional specific volumetric bone density detail.
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According to WHO diagnostic guidelines, osteoporosis is present when BMD is less than or 
equal 2.5 SD below that o f a young adults reference population, and is translated into a T-score. 
The WHO has established the following diagnostic guidelines (Smith et al., 2009).
• T-score 1.0 or greater is normal
• T-score between 1.0 and 2.5 is low bone mass or osteopenia
• T score 2.5 or below is osteoporosis
Other diagnostic parameters like clinical history and physical examinations could also be 
included to determine the presence o f osteoporosis.
Standard laboratory tests including serum calcium, albumin, alkaline phosphatase, creatinine, full 
blood count (FBC), and erythrocyte sedimentation rate (ESR) are also useful in determining the 
presence o f osteoporosis. More specialised tests can also be performed, such as 25(OH)D3 
measurement and the 24-hour urinary calcium test (Horowitz et al., 2010). Markers o f bone 
turnover can also be predictors o f future bone loss rates and fracture risk. Conventional X-rays 
and more advaneed imaging techniques may be also helpful to reveal previous fractures or to 
confirm the presence o f a suspected fracture.
1.4. CVD overview
CVD is a broad term used to describe any disease that involves the heart or blood vessels, 
including arteries and veins. CVD is the number one cause o f death in the UK and in Wales, 
causing 170,000 deaths in 2008 (around one third o f all deaths) (Scarborough et al., 2010).
The most common form o f CVD is coronary heart disease (CED), whieh occurs when the 
coronary arteries become narrowed by gradual build up o f fatty material (atheroma) on the vessel 
wall (Poulter, 2003). In the UK, around half (46%) o f all deaths are caused by CHD and 28% are 
as a result o f stroke, (cerebrovascular disease) which is caused by blockage o f any blood vessels 
supplying the brain (Scarborough et al., 2010). The two main forms o f CHD are heart attack (also 
known as myocardial infarction [Ml]) and angina. Ischaemic heart disease (IHD) is a type o f 
heart disease that is characterized by reduced blood supply to the cardiac muscle, which may
29
progress to heart failure (also called congestive heart failure), which is caused by the inability of 
the heart to supply or pump sufficient amounts o f blood around the body.
According to the British Heart Foundation Statistics Database (2010), roughly a quarter o f deaths 
amongst south Asian populations living in the UK are attributed to CHD. Only 15% o f Caucasian 
deaths on the other hand are a result o f CHD. However, the estimated incidence rates o f Ml in 
Scotland is higher than in south Asians o f both genders (Chaturvedi, 2003).
1.4.1. CVD risk factors
It is well known that an undesirable lipoprotein profile (i.e. high total cholesterol, LDL 
cholesterol and triglyceride level, and low HDL cholesterol) is associated with an increased risk 
o f CVD (Warburton et al., 2007). A recent, large randomised clinical trial showed the efficacy o f 
statins to increase HDL and decrease LDL and thus have a beneficial impact on lowering the risk 
of atherosclerosis and CVD (Nicholls et al., 2011). Cardiovascular risk factors, including 
undesirable lipid profiles are summarized in figure 1.16.
Risk factors o f Cardiovascular disease
M odifiable N on-m odifiable
• High LDL ch o le s te ro l  
•High b lood  p r e s s u re
• Sm ok ing
•Low HDL c h o le s te ro l  
•Lack o f  exerc ise  
• D ia b e te s  a n d  g lu co se  
in to le ra n c e  
•Left v e n t r i c u la r  
h y p e r t ro p h y  
•Centra l  o b e s i ty  
• H o m o c y s te in e  
•High c lo t t ing  fa c to r s  
•Oral  c o n t r a c e p t iv e s
•Age
•Sex
•Family h is to ry  
•G e n e t ic s  
•Birth w e ig h t
Figure 1.16 Risk factors o f CVD
(Poulter, 2003)
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1.4.2. Insulin resistance (IR) and cardiovascular disease risk
It has been noted that a group o f factors such as elevated insulin, glucose intolerance, central 
obesity (measured by waist to hip ratio), and fasting triglyceride (TAG) levels also contribute to 
heart disease. These factors are also well known features o f IR syndrome, which is a metabolic 
disturbance that includes hyperinsulinaemia and hyperglycaemia (Chaturvedi, 2003). The 
relationship between glucose and insulin reflects the balance between hepatic glucose output and 
insulin secretions, which are maintained by a feedback loop between the liver and p -cells in the 
pancreas (Wallace et al., 2004). Direct and indirect methods o f varying complexity are currently 
employed for the purpose o f quantifying IR and sensitivity. Some methods rely on steady-state 
analysis o f glucose and insulin, whereas others rely on dynamic testing. Direct methods for 
measuring insulin sensitivity in humans are relatively complex. The hyperinsulinaemic 
euglycemic glucose clamp and the insulin suppression test directly assess insulin-mediated 
glucose utilization under steady-state conditions and are both labour and time intensive. Another 
method that is less complex and indirect relies on a minimal model analysis o f frequently 
sampled intravenous glucose tolerance tests. Finally, simple surrogate indexes for insulin 
sensitivity/resistance are available (e.g., QUICKI, HOMA, Matusda index) that are derived from 
blood insulin and glucose concentrations under fasting conditions (steady-state) or after an oral 
glucose load (dynamic) (Muniyappa et al., 2008).
1.4.3. Homeostatic model assessment (HOMA)
Homeostatic model assessment is a method for assessing IR, steady-state P-cell function (%B) 
and insulin sensitivity (%S) (Bilous and Donnelly, 2010). Basal fasting glucose and insulin range 
from 1-25 mmol/1 for glucose and 1-2,200 pmoFl for insulin. The output o f HOMA gives normal 
p-cell function and insulin sensitivity expressed as a percentage, where 100% is normal. Figure 
1.17 represent the H0M A2, the updated version showing the variation o f P-cell ftmction in 
relation to insulin sensitivity. IR is presented as a reciprocal o f HOMA IR, where 1 is normal. 
Equations applied in HOMA are as follows:
HOMA IR = (FPIX  FPG)/22.5 
HOMA %B = (20 X FPI)/(FPG-3.5)
31
Where FPI is fasting plasma insulin coneentration (mU/1), and FPG is fasting plasma glucose 
(mmol/1)
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Figure 1.17 HOMA2
The updated version. A computer model (1996) represents the variations in hepatic and 
peripheral glucose resistance 
© Taken from (Wallace et ah, 2004).
Wallace and colleagues (2004) reported that HOMA has become widely used as a clinical and 
epidemiological tool and can yield valuable data. Plasma glucose <2.5 mmol/1 represents either 
hypoglycaemia, which is not steady-state or a problem with the assay; neither outcome should be 
included in the model. The outcome of the HOMA model can be used between populations (with 
the proviso that glucose and insulin assays are comparable) or for investigating longitudinal 
changes. HOMA can be used to indicate whether reduced insulin sensitivity or P-cell failure 
predominates in IR. This model has been tested and compared with a number o f well-validated 
models used to measure IR and P-cell function, and has been shown to correlate well.
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1.5. Vitamin D and health
1.5.1. Vitamin D and general health
Vitamin D plays many important roles in the human body, maintaining the general health o f 
organ systems. Vitamin D is important for bone health, where it regulates the calcium and 
phosphorus levels in the blood by promoting their absorption from food in the intestine. Vitamin 
D also promotes absorption o f these minerals in the kidney, which enables normal mineralization, 
growth and remodelling o f bone, and prevention of hypocalcaemic tetany. Indeed, recent studies 
have shown a significant link between vitamin D and multiple chronic diseases, such as 
osteoporosis, cancer, diabetes and cardiovascular disease (Holick, 2004). Most tissues and cells 
in the body have a vitamin D receptor (VDR), which is testimony to vitamin D ’s essential role in 
human health. Studies have suggested that more than 200 different genes may be directly or 
indirectly regulated by vitamin D, through interaction with the VDR (Holick, 2008c). For 
example, the vitamin is involved in the regulation o f cell the proliferation, differentiation and 
apoptosis, processes that involve the regulation o f multiple genes. Wu-Wong(2009) have 
reviewed preclinical and clinical studies to investigate the involvement o f VDR in cardiovascular 
function. He founded that VDR plays an important role in regulating cardiovascular function and 
VDR agonists can potentially useful to treat cardiovascular disease (Wu-Wong, 2009).
1.5.2. Vitamin D and bone health
Vitamin D prevents rickets in children and osteomalacia in adults, and, together with calcium, 
helps to protect older adults from osteoporosis. The most important role o f vitamin D is to 
maintain bone calcium balance by promoting calcium absorption in the intestine. Vitamin D also 
promotes matrix formation by increasing osteoclastic activity and maintains calcium and 
phosphate metabolism (Lanham-New, 2008). Vitamin D then induces synthesis o f a calcium- 
binding protein in intestinal epithelial cells that faeilitates efficient absorption o f calcium into 
blood.
Parathyroid hormone (PTH), indirectly stimulates the absorption o f calcium from the small 
intestine by stimulating the production o f the active form o f vitamin D in the kidney. When 
ionized calcium levels are decreased in the plasma, PTH is secreted to increase calcium in the 
kidney, gut and bone. In the kidney, PTH increases the tubular reabsorption o f calcium, decreases
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the tubular reabsorption o f phosphate and bicarbonate, and stimulates the conversion o f 25(OH)D 
to 1, 25(OH)D. In bone, PTH promotes the secretion o f calcium and phosphate into blood (refer 
to figure 1.18). The ability of PTH to control calcium and phosphate is mediated solely by 
l,25(OH)D. Active vitamin D is also important in regulating the transcription o f vitamin D- 
dependent genes coding for calcium-transporting protein and bone matrix proteins. Maintaining 
blood calcium and phosphate levels within the nomial range is critical for normal bone 
mineralisation, muscle contraction, nerve conduction and general cellular fimction in all cells of 
the body.
Low blood
PTH
V  C alcitrio l
Bone
Figure 1.18 The effect of vitamin D on calcium homeostasis
Calcidiol, 25(OH)D; Calcitriol, l,25(OH)D act to increase blood concentrations o f calcium; 
generated through the activity o f parathyroid hormone within the kidney. Vitamin D facilitates 
absorption o f calcium from the small intestine. In concert with parathyroid hormone, vitamin D 
also enhances fluxes o f calcium out of bone.
Taken from (Jones and DeLuca, 1988)
1.5.3, Vitamin D and CVD
Vitamin D regulates vitamin-D-binding proteins including some calcium-binding proteins, which
are responsible for carrying calcium in the bloodstream and protecting cells from the damaging
effects o f free calcium. When vitamin D levels are insufficient, levels of serum calcium become
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too high and may contribute to calcification o f arteries and potentially, atherosclerosis. Recent 
epidemiological studies have indicated that insufficient 25(OH)D levels have been documented in 
patients with myocardial infarction, stroke, heart failure, diabetic CVD diseases and peripheral 
arterial disease (Lee et ak, 2008).
1.5.4. Vitamin D and diabetes
There is a strong association with vitamin D deficiency and the incidence o f diabetes. This 
relationship is partly due to the availability o f vitamin D receptors in both beta (P) cells in the 
pancreas and in the immune cells involved in lalpha,25-dihydroxyvitamin D3 formation. Vitamin 
D deficiency has been shown to impair insulin synthesis and secretion in humans and in animal 
models o f diabetes, suggesting a role in the development o f type 2 diabetes. The Third National 
Health and Nutrition Examination Survey, in the US, also found an inverse association between 
vitamin D status and diabetes, suggesting the involvement o f insulin resistance (IR) (Scragg et 
ak, 2004). Furthermore, epidemiological studies suggest a link between vitamin D deficiency in 
early life and the subsequent onset o f type 1 diabetes. For some populations, type 1 diabetes is 
associated with certain polymorphisms within the vitamin D receptor gene (Mathieu & 
Badenhoop, 2005) . A very recent systematic review has found individuals with the highest 
vitamin D status (>62.5 nmol/1) had a 43% lower risk o f developing type 2 diabetes compared 
with those in the lowest group (<35 nmol/1), suggesting a major role o f  vitamin D status in the 
development o f type 2 diabetes (Mitri et ak, 2011).
1.5.5. Vitamin D and other chronic diseases
In a meta-analysis o f controlled trials o f vitamin D supplementation, mortality was found to be 
7% higher in those with a poor vitamin D status than those with vitamin D levels in the normal 
range (Autier and Gandini, 2007). Other studies have associated low levels o f vitamin D with an 
increased risk o f chronic diseases. In a clinical study o f 1179 women aged >55 years reported 
that women taking daily vitamin D supplements had a lower overall cancer incidence after 4 
years (Lappe et ak, 2007). The International Association for Research o f Cancer (2008) also 
reported that increased risks o f colorectal cancer and colorectal adenoma are associated with low 
concentrations o f vitamin D. Finally, there is a proposed link between low vitamin D status and
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inflammatoiy diseases such as multiple sclerosis and rheumatoid arthritis (Ruxton and 
Derbyshire, 2009).
1.6. Vitamin D classification
1.6.1.25(OH)D analysis
Serum 25(OH)Ds is the most useful marker for assessing individual vitamin D status (Vogeser,
2010). Wallace and colleagues, (2010) detailed the main methods o f measuring 25(OH)D, which 
are briefly summarised here. These methods included the competitive immunoassay and a 
method based on chromatographic separation (liquid chromatography; LC or high performance 
liquid chromatography; HPLC) followed by non-immunological direct detection by mass 
spectrometry ( LC-MS/MS) (Wallace et ak, 2004). Few studies have tested the accuracy or the 
validity o f  such 25(OH)D analysis methods. The main reason for the lack o f methodology 
comparisons was the absence o f a 25(OH)D reference standard until recently (Vogeser, 2010) 
Commercially, the immunoassay method is an automated protein-binding assay (based on the use 
o f vitamin D binding protein for antibodies) for quantification o f 25(OH)D that enables 
convenient, high throughput analysis in a routine setting (Vogeser, 2010). On the other hand, 
chromatographic separation requires an extraction step to release 25(OH)D from its binding 
proteins, (85% o f 25(OH)D is protein-bound) and this can be subject to variable co-precipitation 
(Wootton, 2005). This method requires normal-phase separation followed by reverse-phase 
separation. The most common methods o f quantification use liquid-liquid or liquid-solid pre­
sample cleanup with UV detection after column separation (Wootton, 2005).
HPLC and LC-MS/MS methods require more expensive equipment and qualified technicians to 
use them. Chromatography run-times are considerably longer than the time taken to perform an 
immunoassay. Especially if  the latter are performed on automated platforms. For HPLC and LC- 
MS/MS methods, extraction and procedural losses of25(OH)D are corrected for by inclusion o f  
an internal standard. This correction factor may account for higher 25(OH)D results when 
compared with those obtained by immunoassay. In general, the precision o f immunoassays,
HPLC and LC-MS/MS are comparable and can all sufficiently identify severe vitamin D 
deficiency (Wallace et ak, 2004). HPLC has been compared with other vitamin D analysis 
methods in terms o f accuracy and precision with a commercially available radioimmunoassay
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(RIA) and electrochemiluminescence immunoassay, and acceptable correlations were observed 
(Jafri et al., 2011). LC-MS/MS is also a reliable method, as demonstrated by van den Ouweland 
and colleagues (2 0 1 0 ), who concluded that it was a reliable and robust method to measure 
25(0H)D3 and 25(OH)D2 (van den Ouweland et al., 2010). Furthermore, LC-MS/MS enables 
more reliable analysis o f 25(OH)D concentrations in comparison with protein binding assays, and 
the ability to co-quantify the major circulating metabolites; 25(OH)D3 and 25(OH)D2 
simultaneously is also relevant advantage o f LC-MS/MS (Vogeser, 2010). Shah and colleagues 
(2 0 1 1 ) conducted a study to test the accuracy o f chromatographic methods to identify and 
quantify 25(OH)D3 and 25(OH)D2 in a mixture containing isomers (epimers and isobars). The 
study found that LC-MS/MS is a reliable, reproductive method that can accurately detect 
25(0H)D3 and 25(OH)D2 independently o f co-eluting epimers and isobars and is able to 
circumvent other instrumental analytical interference (Shah et al., 2011).
1.6.2. Recommended vitamin D levels and diagnosis o f deficieney
The clinical marker used to measure vitamin D status is the serum concentration o f 25(OH)D. 
According to the Rank Forum on Vitamin D, (University o f Surrey, 2009), it is desirable for all 
people to have 25(OH)D levels above 25 nmoFl, but higher concentrations o f 75 nmol/1 may be 
required for beneficial Vitamin D-related health outcomes to take effect. Dawson-Hughes and 
colleagues suggested optimal level between 50-80 nmol/1 for bone fi*acture prevention, and 
suggested average intake o f 800-1OOOIU per day o f vitamin D 3 to reach serum level o f 75 nmol/1 
(Dawson-Hughes et ak, 2005). UK Dietaiy Reference Values (DRVs) for vitamin D are targeted 
only at specific populations, namely children and groups o f adults considered ‘at risk’, with the 
expectation that the general population synthesises enough vitamin D through exposure to 
sunlight (SACN, 2007), (See table 1.1). Lanham-New, (2008) highlighted the importance o f re­
defining vitamin D requirements in the UK, since there is evidence o f extensive vitamin D 
hypovitaminosis in those that are not typically considered as at risk.
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Table 1.1 UK Dietary Reference Values (DRV) for vitamin D
Age group/status DRV (micrograms/day)
0  to 6  months 8.5
7 to 12 months 7.0
1 to 3 years 7.0
3 to 50 —
Men and women aged 50 years plus 1 0 . 0
Pregnancy and lactation 1 0 . 0
Adapted from Update on Vitamin D, SACN 2007
The Institute o f Medicine (2011) issued the dietary reference intakes for vitamin D (Table 1.2), 
superseding the previously reported Adequate Intake. These recommendations were made 
regardless o f the vitamin D synthesised in the skin and were intended for North American 
populations with adequate calcium intakes.
Table 1.2 References intake o f vitamin D among age groups
Age Reference intake for vitamin D
0 - 1 2  months **
Pregnant/lactating 600 lU/day
1-70 years of age 600 lU/day (15 pg equivalent)
71+years of age 800 lU/day
Adapted from Dietary Reference Intakes for Calcium and Vitamin D, Institute of Medicine (2011)
The most widely used classification o f vitamin D status, and the one that is used in this research 
which considers vitamin D status in terms o f deficiency, insufficiency, hypovitaminosis, 
adequacy, and toxicity. In this classification system, vitamin D insufficiency is associated with 
disturbances in normal calcium homeostasis, as manifested by a mild elevation in PTH and /or a 
low 25(OH)D level without overt clinical disease. Deficiency, on the other hand, is defined as a 
lack o f the active vitamin D metabolite, calcitriol, in its target cells. An optimal amount o f 
circulating 25(OH)D is necessary to satisfy the tissue’s requirement to produce an adequate
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amount o f calcitriol. When vitamin D deficiency occurs, severe clinical symptoms such as 
rickets, osteomalacia, myopathy, severe secondary hyperparathyroidism (serum PTH >65 pg/ml), 
and calcium mal-absorption are possible (Zittermann, 2006). There is no clear-cut separation 
between these status divisions, but rather 25(OH)D levels are a continuum, ranging from severe 
deficiency, to vitamin D toxicity. Table 1.3 outlines the proposed staging o f vitamin D status 
described herein, with regard to the 25(OH)D concentration.
Table 1.3 Suggested terminology to describe vitamin D status according to circulating 
25(OBT)D concentration
Stages of vitamin D status Serum 25(OH)D
concentrations (nmol/1)
Severe deficiency <12.5
Deficiency 12.5-25
Insufficiency >25-50
Hypovitaminosis D >50-70 to 100
Adequacy 70-100 to 250
Toxicity >250
To convert values for 25(OH)D to ng/ml, divide by 2.50.
Adapted from Zittermann, 2006
1.6.3. Vitamin D Toxicity
No overdoses o f vitamin D have been reported from exposure to UV light. This is because human 
skin has a limited capacity to form the precursor, 7-dehydrocholesterol and has limited capacity 
to take up cholecalciferol. Thus, prolonged exposure to sunlight produces only inactive 
compounds. A recent study reported that no toxicity occurred when subjects received 20,000 
lU/day o f vitamin D or had serum 25(OH)D levels o f  less than 200 ng/mL over an extended
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period (Heaney, 2008). Vitamin D toxicity is however observed when plasma concentrations o f 
calcium are also elevated. This can lead to raised blood pressure and calcification o f  soft tissue 
including the kidneys, heart, lungs, and blood vessel walls. Safe upper limits for dietaiy vitamin 
D have been calculated (see table 1.4) which should pose no risk o f vitamin D-associated adverse 
health effects, even in the event o f raised calcium (Ross et al., 2011). It important to note that 
although acute vitamin D overdose is not associated with toxicity in the absence o f high calcium 
levels, the long-term effects o f vitamin D overdose is not known.
Table 1.4 Upper limits of vitamin D according to age group
Age/Status Upper limit of 
vitamin D (lU)
0 - 6  months of age 1 0 0 0
6 - 1 2  months of age 1500
1-3 years of age 2500
4-8 years of age 3000
9-71+years of age 4000
Pregnant/lactating 4000
Adapted from the Institute of Medicine (2010)
1.7. Prevalence o f vitamin D deficiency
Globally, vitamin D status is a cause for concern and it is now recognized that more than 50% o f 
the world's population is at risk o f vitamin D deficiency (Holick, 2008b). McKenna (1992) 
summarised a large number o f studies from North America and Europe looking at vitamin D 
status up to the end o f the last century. This review o f the historical data indicated that healthy, 
elderly people had a mean 25(OH)D level in the range designated as ‘insufficient’ throughout the 
whole year. The review also showed that the majority o f institutionalised subjects had 25(OH)D 
levels in the range indicating deficiency.
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1.7.1. Factors affecting vitamin D status
Many factors can affect the status o f vitamin D, and an important one is the effect o f age. A 
possible explanation for reduced vitamin D levels in the elderly is an age-dependent decrease in 
the epidermal concentrations o f pro-vitamin D3 (7-dehydrocholestero 1). Aging can decrease the 
capacity o f the skin to produce pre-vitamin D3 by greater than two-fold (MacLaughlin and 
Holick, 1985). Recognition o f this decline could have significant consequences for the elderly 
who infrequently expose more than a small area o f skin to sunlight and who largely depend on 
this exposure for their vitamin D nutritional needs.
Later studies have also shown that the mean o f 25(OH)D level among European children and 
young adults in the winter can be as much as half the levels that they are in the summer time 
(Zittermann et al., 2003). These results provide evidence that seasons affect vitamin D status. 
Bolland et al. (2008) investigated the effects o f seasonal variation of 25(OH)D on diagnosis o f 
vitamin D insufficiency. The research group reported that the 25(OH)D levels required to ensure 
25(OH)D levels >50 nmol/L throughout the year varied substantially by season (in the summer, 
levels could be at least 60-75 nmol/L).
‘D-FINES’, The Vitamin D, Food Intake, Nutrition and Exposure to Sunlight in Southern 
England study (2009) also found a significant association between latitude and vitamin D status 
in addition to seasonal variation, where populations who live in northern Britain have a lower 
average vitamin D status, than those living in the south. This finding was supported by The 
Multiple Sclerosis Resources Centre, (2009) who stated that “The (vitamin D) deficiency is twice 
as common among the Scots as it is amongst the English” . Some research has suggested that 
limited or no vitamin D is produced in the skin from October to April at latitudes above 45°, 
primarily due to the limited availability o f UVB radiation as shown in figure 1.19.
This finding can be also explained by the impact o f the solar elevation angle and atmospheric 
conditions (including clouds, ozone, surface reflection, and aerosols). In reality, the UVB 
availability and so the vitamin D production dose is immensely variable even at one location, 
primary due to such atmospheric conditions.
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Figure 1.19 Latitude lines in the globe
The red line represents the 45° latitude. The UK is located northerly o f this line. Latitude is 
defined by world atlas as the angular distance, in degrees, minutes, and seconds o f a point north 
or south of the Equator.
© Adapted from world atlas
A European study demonstrated clear geographical differences in vitamin D status in elderly 
patients from different countries. Mean 25(OH)D concentrations during winter were found to 
range between 22 nmol/1 in an elderly, Greek population, and 46 nmol/1 in an elderly, 
Scandinavian population, which correspond to insufficiency or even deficiency classifications 
(Vanderwielen et al., 1995). The vitamin D levels reported can be explained by different latitude, 
dietaiy and lifestyle habits between the two European countries. For example, elderly people 
living in Scandinavia and southem Europe seem to consume different quantities of fatty fish have 
different frequencies o f sun exposure and the use o f vitamin D supplements (Lips, 2007). Even 
though solar UVB is the major source o f vitamin D, dietary intake can also affect vitamin D 
status, especially if people consume rich, vitamin D sources such as cod liver oil, salmon, 
fortified breakfast cereal, and bovine liver. However, diet alone cannot sustain a blood level of 
25(OH)D of >30 ng/ml (>75 nmol/1) (Holick, 2007).
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It is suggested that for every 100 lU ingested, (this amount being available in one serving o f 
fortified food), the 25(OH) will only be increased by 1 ng/ml (2.5 nmol/1) (Lappe, 2011). It is 
also known that at least 1000-2000 lU o f  vitamin D per day is required to sustain a blood level o f 
25(OH)D o f >30 ng/ml (>75 nmol/1). It is therefore suggested that it is not possible to achieve 
the optimal serum 25(OH)D level from a normal diet (Holick, 2008c), but rather from a 
combination o f dietary intake and UVB exposure. Holick (2004) estimate that, in order to 
produce the amount o f vitamin D considered optimal, there is a human need to expose 25% o f the 
body to 25% o f the Minimal Erythemal Dose (MED) in midday solar radiation, 2-3 times a week, 
at all times o f the year. MED is defined as the minimum amount o f UVB that produces light skin 
redness, 24 hours after exposure. Holick provides a practical example that one would need to 
expose 25% o f the body to middy solar radiation for 15 minutes, 2-3 times a week, during 
summer, to produce the amount o f vitamin D considered optimal.
In addition, Webb and Engelsen (2006) considered that skin type was an important factor to 
consider when calculating the time o f exposure necessary to achieve optimal synthesis o f vitamin 
D. (see table 1.5 for skin type and description). They estimated that at the UK latitude o f 54°, 
successful vitamin D production in skin type 11 would require approximately seven minutes’ sun 
exposure time, at noon, during the summer (June-September) (see table 1.6 for more detail) 
(Webb and Engelsen, 2006). It has been confirmed by multiple studies that melanin in the skin 
absorbs UV light and the darker the skin is, the more time is required to produce similar amount 
o f vitamin D compared to lighter skin tones (Holick, 2008a). In addition, there are other factors 
that interfere with vitamin D synthesis, sueh as the applieation o f sunscreen and barrier items 
such as glass and clothing. Pre-menopausal women living in a sunny but socially conservative 
countries, like Turkey, can have 25(OH)D levels in the deficiency range, if  women traditionally 
veil most o f their bodies (Alagol et al., 2000). Findings from worldwide studies therefore 
indicate that, whilst reaching the optimal level o f vitamin D is critical for health, there are 
significant barriers to aehieving this and multiple factors affecting an individual’s vitamin D 
status (Zittermann, 2006).
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Table 1.5 Skin type descriptions
Skin type Reaction to sunlight Skin colour
I Always bums, never tans Pale, Fair, Freekles
n Usually bums, sometimes tans Fair
ni May bum, usually tans Light Brown
IV Rarely bums, always tans Olive brown
V Moderate constitutional pigmentation Brown
VI Marked constitutional pigmentation Blaek
Adapted from (Gilchrest, 2008)
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Table 1.6 Sun exposure time (in minutes) for vitamin D production as a function of latitude, 
date, time, and skin type
S k i n  t y p e  b y  l a t i t u d e 2 1  D e c e m b e r
1 2 0 0 h  
2 1  M a r c h 2 1  J u n e
1 1 . 5 ° N
I 6 3 4
I I 7 4 4
ni 8 5 5
I V 1 3 7 8
V 1 7 1 0 1 0
V I 28 1 6 1 6
29"N
I 1 6 5 3
I I 2 0 6 4
I I I 2 3 7 5
I V 3 5 1 0 7
V 4 8 1 4 1 0
V I 8 5 2 3 1 6
4 2 . 5 ° N
I 7 0 8 4
I I 9 4 1 0 5
ni 1 2 7 1 2 6
I V NA 1 9 8
V NA 2 5 1 1
V I NA 4 1 1 9
62.5°
I NA 4 4 7
n NA 5 5 9
I I I NA 6 7 1 1
rv NA 1 0 6 1 6
V NA 1 6 3 2 1
V I NA NA 3 6
Adapted from Webb & Engelsen ( 2005)A11 calculations are based on clear sky conditions. Times are related to local 
solar time. NA signify that an SDD was not available.
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1.8. Vitamin D Status in the UK population
A study analyzing the vitamin D concentration in a cohort o f multi-cultural outpatients, residing 
in the UK showed a low 25(OH)D eoneentration (i.e. <10 mierogram/L (<25 nmol/1)), in the 
range defined as vitamin D defieieney, in one in eight Caucasians, one in four blaek Afro- 
Caribbeans and one in three Asians (Ford et al., 2006). Table 1.7 shows the vitamin D status in 
Caucasian and Asian adults, as assessed by eross-seetional studies. From the listed studies, the 
mean o f vitamin D status among all groups is 45 nmol/1. The vitamin D status among Caueasians 
is 65.53 nmoFl, ranging fi-om 57.4 to 75.6 nmol/1, and is elassified as hypovitaminosis D. 
However, the vitamin D status among Asians is 26.26 nmol/1, with a range o f  18.0 to 34.9 nmol/1 
and is classified as deficient, or insuffieient depending on which end o f the range is being 
assessed.
Table 1.7 Vitamin D status in UK Caucasian and Asian adults from cross-sectional studies
R e f e r e n c e
l o c a t i o n
R e f e r e n c e C a u c a s i a n A s i a n
B i r m i n g h a m ( F o r d  e t  a l . ,  2 0 0 6 ) n 3 1 7 ( l - 9 2 y r s 9 & ( 5 ' ) n 2 5 1  ( 2 - 8 7  y r s  $  &
A n n  C l i n  B i o c h e m ;  4 3 ;  4 6 8 -  
4 7 3
5 7 . 4 0  n m o F L
d ' )
3 4 . 9 4  n m o F L
G r e a t e r ( R o y  e t  a l . ,  2 0 0 7 ) n 7 8  ( 1 8 - 3 6  y r s ? )
M a n c h e s t e r
B o n e  4 0 : 2 0 0 - 2 0 4 1 9 . 7  n m o l / L
G r e a t e r ( M a c f a r l a n e  e t  a l . ,  2 0 0 5 ) n  1 0 5 3  ( 1 8 - 7 5  y r s  ? ) n  2 0 8 2  ( 1 8 - 7 5  y r s ? )
M a n c h e s t e r
A n n  R h e u m  D i s  6 4 : 1 2 1 7 -  
1 2 1 9
6 3 . 6  n m o l / L 1 8 . 0  n m o F L
L e i c e s t e r ( B r o o k e - W a v e l l  e t  a l ,  2 0 0 8 ) n  2 3  ( 5 5 - 6 5  y r s  $ ) n  2 4  ( 5 5 - 6 5  y r s  ? )
A n n  H u m  B i o l  3 5  ( 4 ) :  3 8 6 -  
3 9 3
7 5 . 6  n m o F L 3 2 . 4  n m o l / L
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A study in the UK examined vitamin D concentrations with the aim o f illustrating the effects o f 
season, gender and ethnic group. The population was subjected to distributuion analysis, and 
revealed a marked difference in 25(OH)D3 levels between Asian and non-Asian asymptomatic 
adult subjects, during both seasons. The majority o f Asians o f both genders were 25,(OH)D3 
deficient (winter 94%, summer 82%) (Pal et al., 2003). Results from the D-FINES study 
indicated that on average for the year, 65% of Asians and 5.8% o f Caucasians had vitamin D 
status <25 nmol/1, depending on the season (Lanham-New et al., 2011). Expressed another way, 
the mean serum 25(OH)D is 54.88 nmol/1 among Caucasians and 24.38 nmol/1 among Asians, 
which is again insufficient and deficient, respectively. In the winter, which is assumed to be the 
period o f lowest serum vitamin D during the year, Caucasians had a mean level o f 43 . 8  nmoFl, 
which is insufficient and Asians had a mean level o f  22.1 nmol/1, which is severely deficient, 
therefore supporting the assumption. In the summer, the levels o f serum vitamin D were 68.0 
nmol/1 among Caucasians and 28.6 nmol/1 among Asians. The outcome o f this data confirms the 
fact that the UK population, (especially the Asian population), is at risk o f  low vitamin D status 
and therefore at high risk o f vitamin D related health problems. Vitamin D deficiency/ 
insufficiency was especially associated with conditions such as bone diseases, different types o f 
cancer, multiple sclerosis, diabetes and cardiovascular disease.
1.8.1 Factors affecting Vitamin D Status in the UK
Among members o f the UK population, low vitamin D status is common due to a number o f 
factors. One o f the most important is that sun exposure significantly affects the population’s daily 
production o f vitamin D. In the winter, solar UVB radiation is insufficient to maintain 
recommended vitamin D levels, which augments the issue that there is already little sunlight 
available in Northern areas, i.e. above 45° (the latitude o f London is 52° N) even in the other 
seasons. It is suggested that a limited amount or no vitamin D at all, is produced in skin from 
October to April at latitudes above 45°, owing to the reduced zenith angle o f  the sun (Thieden, 
2008).
Vitamin D deficiency is associated with many health problems that are more prevalent within 
certain UK population groups such as South Asians, post-menopausal women, the elderly,
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pregnant women, and children (Ladhani et ah, 2004). The South Asian population, 
encompassing people from countries such as Bangladesh, India, Sri Lanka and Pakistan, is the 
largest ethnic group living in the UK. Based on UK, CENSUS-DATA (CENSUS-DATA, 1993), 
South Asian contributing 4.0% to the 7.9% o f the UK population described as ethnic minorities. 
Many studies have indicated an elevated risk o f low vitamin D status among UK-based Asians 
(Ford et al., 2006, Peacey et al., 2004).
The average dietaiy intake o f vitamin D among the Asian population in 2004 was reported to be 
0.96 pg per 2000 kcal (Sevak et al., 2004), whereas the recommended daily allowance (RDA) is 
5pg. However, other factors exert a much greater effect on vitamin D status in the Asian 
population compared with diet. For example, Asians have highly pigmented skin and a cultural 
predilection to avoid direct sun exposure (McCarty, 2009). This may explain why Asian Indians 
have a veiy poor vitamin D status even in UV-drenched India (Arya et al., 2004). In this 
population, 66.3% were determined to be vitamin D deficient, with 25-(OH)D concentration <15 
ng/ml. Another study investigated the average body surface exposure among Asians and 
indicated that approximately 1 0 % o f body surface was exposed in winter (face and hands only), 
increasing to 20% in summer (McCarty, 2009). Most Asians, especially women, dress modestly 
covering 80% or more o f their body, putting them at higher risk o f vitamin D deficiency 
compared with Western women.
1.9. Justification for this research
The direct effect o f vitamin D status on skeletal health has long been established and the impact it 
has on diseases such as diabetes, multiple sclerosis and heart disease have all been reported In 
the UK some sub-populations are more at risk o f deficiency than others, with Asian females 
being identified as the most at risk. Despite this, little is currently known about the bone mineral 
density o f  this group, or the association o f their vitamin D status to disease risk. The capacity o f 
the skin o f Asian females to synthesise vitamin D compared with the skin o f a Caucasian female 
also requires further investigation. This PhD project will investigate more details information 
about vitamin D status and other health implication in regard to ethnic differences among UK 
population.
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1.10 Aims and Objectives o f the research program
1.10.1 Study 1: To investigate the effect o f low vitamin D status on markers o f cardiovascular
health in the D-FINES study population: Ethnic Influences
Objectives:
• To re-analyse the D-FINES data to assess the relationship between vitamin D and lipid 
profile, insulin and glucose levels.
• To examine the association between summer vitamin D status and serum lipid profiles, 
(including tricacylglycerol [TAG], low-density lipoprotein [LDL], high-density 
lipoprotein [HDL]) insulin, and fasted blood glucose levels, and investigate if there are 
any ethnic differences.
• To investigate the association o f serum lipid profiles and insulin levels, with specific 
25(OH)D cut-off values.
1.10.2 Study 2: To elucidate the relationship between bone health (calcium metabolism and bone
resorption) and cardiovascular disease risk in the D-FINES study population
Objectives:
• To re-analyse D-FINES to define the relationship between bone health and lipid profile
• To investigate the association between serum lipid profiles and insulin levels, with bone 
health (bone quality, bone mineral density [BMD], and bone resorption) and determine if  
ethnic differences exist.
• To examine the association between BMD and lipid measures according to lipid profiles 
and insulin cut-off separated, stratified by ethnicity.
1.10.3 Study 3: To describe the interaction between vitamin D, ethnicity, bone health and
lifestyle among pre-menopausal women.
Objectives:
•  To write a study protocol and obtain ethical approval from the NHS and The University o f
Surrey (UK) ethics committee.
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• To invite women from the D-FINES survey to take part in the new study to be conducted in 
the summer o f 2010. Invitation will be by post, presentation meetings, and telephone.
To arrange appointments to meet the subjects for a consultation (1.5 hour per person)
To measure volumetric bone density, take blood samples, and other health and nutrition and 
health parameters including anthropometric measurement, dietary intake, physical activity 
level, and disease history.
To assess whether differences in cortical and trabecular volumetric bone density at the radius 
and tibia exist between South Asian and Caucasian women.
To assess whether there are differences in muscle function (grip strength, sit to walk test, and 
muscle ratio) between South Asian and Caucasian women.
To assess whether there are differences in intentional UVB exposure behaviours between 
South Asian and Caucasian women.
To determine if women with the most bone pain or with the most muscle pain also have a 
lower bone density at the forearm and tibia.
To assess the relationship between bone pain and vitamin D status.
To investigate the association between UVB exposure and vitamin D status, and to assess 
whether this is related to ethnicity.
To assess the relationship between volumetric bone density, muscle function and vitamin D 
status among Asian and Caucasian pre-menopausal women.
To explore whether levels o f physical activity, grip strength, and bone pain are associated 
with tibia and radius estimates o f bone strength, cortical density, or total bone area.
1.10.4 Study 4: To investigate the differences in vitamin D production in Caucasian and Asian 
post-menopausal women in response to UVB exposure under controlled conditions.
Objectives:
• To write a study protocol and obtain ethical approval from the NHS and the University o f 
Surrey (UK) ethics committee for the study to be conducted in the winter o f 2010.
• To recruit female volunteers between the ages o f48-65 years old, who give consent to 
take part in the study.
• To arrange multiple appointments and visits for groups o f six subjects per visit.
50
To collect fasted blood samples during the visits pre- and post- sun bed sessions and to 
measure other related variables such as anthropometric measurements.
To investigate the differences in vitamin D production between Asian and Caucasian post­
menopausal women in response to a defined controlled UVB exposure.
To determine the percentage change in 25(OH)D in response to defined controlled UVB 
exposure.
To investigate if  any changes occur in the lipid, glucose and insulin levels following UV 
exposure from three sun bed sessions (over a 14 days period) and to determine if  this 
differs between ethnic groups.
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CHAPTER 2
EFFECT OF LOW VITAMIN D STATUS ON MARKERS OF 
CARDIOVASCULAR HEALTH IN THE D-FINES STUDY POPULATION:
ETHNIC INFLUENCES
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2.1. INTRODUCTION
Cutaneously synthesised or orally ingested vitamin D is metabolized by a hepatic hydroxylase 
into 25(OH)D and by renal la-hydroxylase to the hormone 1,25-dihydroxyvitamin D (calcitriol), 
which is under the control o f parathyroid hormone (PTH). It is recognized that variety o f tissues 
and cells in the body have vitamin D receptors (VDRs), including osteoblasts, myocytes, 
cardiomyocytes, pancreatic B-cells, vascular endothelial cells, neurons, colonocytes, and immune 
cells (Zittermann, 2006). These cells thus respond to the active l,25(OH)D form o f vitamin D, 
which is a potent regulator o f cellular growth, in both normal and cancerous cells. In addition, 
studies have suggested that upwards o f 2 0 0  different genes may be directly, or indirectly, 
regulated by vitamin D through the VDR. Recent studies have shown a significant link between 
vitamin D status and chronic diseases, such as osteoporosis, cancer, diabetes and cardiovascular 
disease (Holick, 2004).
Epidemiological studies report that the rate o f coronary heart disease, diabetes, and hypertension, 
and vitamin D deficiency, increase in proportion to increased distance from the equator (Holick, 
2004), with the former mentioned diseases a likely consequence o f vitamin D status. For 
example, recent studies have shown a significant link between vitamin D levels and 
cardiovascular-disease risk and events (Michos and Melamed, 2008). Moreover, deficient or 
insufficient 25(OH)D levels have been documented in patients with myocardial infarction, stroke, 
heart failure, diabetic cardiovascular diseases and peripheral arterial disease (Lee et al., 2008). In 
one study, (Poole et al., 2006) the semm 25(OH)D levels o f 44 patients admitted to an acute 
stroke unit with first-ever stroke, were compared with those measured in 96 healthy, ambulant 
elderly subjects, eveiy two months for one year. The study found a significant relationship 
between serum 25(OH)D levels and the incidence o f acute stroke, where 77% o f stroke patients 
had serum 25(OH)D <50 nmol/1, compared to the mean 62 nmol/1 in healthy subjects. In 
addition, according to (Scragg et al., 1990), patients with myocardial infarction (MI) had a 
significantly lower (p<0.05) mean level o f 25(OH)D, than age- and sex-matched controls. This 
difference was stated to be “particularly apparent in winter and spring, although the decrease in 
MI risk associated with a raised level o f vitamin D3 is seen in all seasons o f  the year.”
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Another recent study that followed large sample o f adults with no histoiy o f cardiovascular 
disease (CVD) for 7.3 years found that vitamin D status was independently and inversely 
associated with CVD rate (Ginde et al., 2009). In a similar study, Wang and colleagues (2008) 
followed more than 1700 patients who were without CVD for an average o f 5.4 years. They 
found that individuals with 25(OH)D <15 ng/mL (<37.5 nmol/1) had an incidence o f 
cardiovascular events with a hazard ratio o f 1.62 (95% confidence interval 1.11 to 2.2.36, 
p=0.01), compared to subjects with 25(OH)D >15 ng/mL (>37.5 nmol/1) (Wang et al., 2008). In 
addition, the Third National Health and Nutrition Examination Survey (Kendrick et al., 2009) 
between 2001-2004, examined the burden o f  CVD using serum 25(OH)D levels and prevalence 
o f hypovitaminosis D. After controlling for demographic, lifestyle, and clinical characteristics, 
logistic regression was used to assess the relationship between three categories o f vitamin D 
status and CVD risk. The three categories o f  25(OH)D level were >30, 20 to 29, and <20 ng/ml; 
>75, 50-72.5 and <50 nmol/1, and hypovitaminosis D was defined as vitamin D <30 ng/ml (<75 
nmol/1). The burden o f CVD increased in the lower 25(OH)D categories, with 5.3%, 6.7% and 
7.3% having coronary heart disease; 1.5%, 2.4%, and 3.2% having heart failure; 2.5%, 2.0%, and 
3.2% having stroke; and 3.6%, 5.0%, and 7.7% having peripheral arterial disease respectively 
(Kim et al., 2008).
A recent review (Perez-Lopez, 2009) reported a strong association between poor vitamin D status 
and multiple heart disease risk factors such as lipoprotein level, hypertension, and increased PTH 
level. In addition, vitamin D deficiency may predispose to diabetes, metabolic syndrome, left 
ventricular hypertrophy, and chronic vascular inflammation, all o f which are known risk factors 
for CVD. More specifically, vitamin D deficiency activates the rennin-angiotensin-aldosterone 
system and can therefore prdispose to hypertension and left ventricular hypertrophy (Lee et al., 
2008). Consequential increases in PTH may mediate many o f the detrimental CV effects 
responsible for increasing insulin resistance, hypertension, and inflammation. Martins et al. 
(2007) studied the association between serum levels o f 25(OH)D and selected cardiovascular 
disease risk factors in adults in the US (7186 male and 7902 female). The study found that mean 
25(OH)D levels were lower in participants with obesity, hypertension, and diabetes mellitus and 
in those with high semm triglyceride levels. The adjusted prevalence o f obesity (OR, 2.29), 
hypertension (OR, 1.30), and diabetes mellitus (OR, 1.98) and high semm triglyceride level (OR,
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1.47) were significantly higher in the first versus the fourth quartile o f serum 25(OH)D levels 
(p<0.001 for all). Such correlations between serum 25(OH)D and risk factors o f CVD do not 
prove that 25(OH)D is a mediator o f the associated risk; for most o f these correlations, alternative 
explanations can be posited.
To establish a causative relationship between vitamin D status and CVD risk, controlled 
interventional studies are required, involving administration o f optimally effective doses o f 
vitamin D. For example, Zittermann and colleagues, (2009) followed healthy, overweight 
subjects (n=200) for one year, who received 83.3 pg/d (3332IU) cholecalciferol and adhered to a 
weight reduction programme. Mean 25(OH)D and calcitriol concentrations increased by 55.5 
nmol/1 and 40.0 pmol/1, respectively, by the end o f the year and were significantly higher than in 
the placebo group. There was a significant decrease in serum PTH concentrations (p=0.014), and 
triglyceride levels (p-<0.001). These effects were independent o f the loss o f body weight, fat 
mass and gender. In addition, (Schleithoff et al., 2006) randomly administered 123 patients with 
congestive heart failure (CHF), either vitamin D 50 pg/d plus calcium 50 mg/d, or placebo plus 
calcium 500 mg/d.. Over nine months, vitamin D supplementation significantly increased 
median 25(OH)D levels (p=0.001) while significantly decreasing PTH (p=0.03) . The systolic 
and diastolic blood pressures were slightly decreased by the end o f the study, demonstrating a 
clear therapeutic advantage.
Increased exposure to sunlight has been purported to be protective against CVD. This hypothesis
was tested by (Vik et ak, 1979) and (Lund et al., 1978). The hypothesis could explain (in part)
the observation that in winter, there is an increase in coronary heart disease (CHD) mortality and
morbidity. The original hypothesis focused on direct sunlight exposure, but it would now appear
that the observed relationships are actually mediated by vitamin D levels that are increased and
adjusted after exposure to sunlight. The hypothesis is also consistent with data showing a direct
relationship between latitude and CHD mortality and morbidity, where the prevalence o f vitamin
D deficiency increases in proportion to the geographical distance from the equator (Elford et al.,
1989). The reason for this is because o f the increased atmospheric filtering o f UVB radiation
caused by oblique angles o f the sun’s rays at a higher latitude. In addition, the association
between age and CHD can be explained by vitamin D status, since older people generally have
lower 25(OH)D levels in comparison to younger people. This happens due to the decreased
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capacity o f elderly skin to produce vitamin D3. Moreover, CHD mortality and morbidity rates 
are increased among ethnic groups with a darker skin colour, compared to white skin, and more 
specifically for Asians living in Britain (Fox and Shapiro, 1988). People with darker skin require 
proportionally more sun exposure to synthesise equal amounts o f vitamin D, compared to people 
with a lighter skin colour. Modem behaviour may further pre-dispose the populace to low 
vitamin D levels, owing to indoor lifestyles together with the use o f sunscreens and sun- 
avoidance, all which o f  minimize the direct exposure o f the skin to sunlight.
In this respect, the UK population is a cause for concern as a result o f  its high latitude, along with 
the other multiple factors that minimize sun exposure. At particular risk is the large. South Asian 
population who, because o f their dark skin colour, largely covered skin and minimum exposure 
time to the sun, are unlikely to be achieving optimal vitamin D synthesis. A recent review 
(McCarty, 2009) has warned o f the high risk o f insulin resistance, obesity, diabetes and CHD 
among Asian Indians. It is hypothesised that this is primarily due to poor vitamin D status and 
the resulting up-regulation o f PTH in this sub-group. Investigation o f the association o f vitamin 
D concentration with CVD and diabetes risk has so far been insufficient, more specifically among 
ethnic groups. The aim o f this study was to examine the association between 25(OH)D 
concentration and CVD and diabetes risk factors, as defined by semm lipid profiles, [serum 
triglyceride (TAG), low and high density lipoprotein (LDL, HDL respectively)], and insulin 
levels. This investigation has been done through examining the D-FINES data that have been 
collected between year 2006-2008.
2.2. OBJECTIVES
• Extract relevant data from the large D-FINES clinical trial database.
• Examine if there is any association o f 25(OH)D level with lipids, insulin and glucose levels 
fi'om the summer D-FINES da ta , adjusting for potential confounders.
• Examine the 25(OH)D tertiles, quartiles and cut-off values.
• Quantify insulin resistance, beta cell, and insulin sensitivity function in both ethnic groups 
using the homeostatic model assessment (HOMA) and investigate if there is an association 
with vitamin D concentrations.
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2.3. SUBJECTS AND METHODS
Data o f the original D-FINES study were collected by the D-FIENS team between 2006 and2008. 
A brief summary o f the method is explained below. However, the D-FINES II study data, 
conducted during the summer o f 2010 was collected and measured by this project investigator as 
it is explained in detail in chapter 4.
2.3.1. Screening
For recruitment o f Caucasians, the study targeted GP Surgeries covering each o f the six 
Deprivation Scores (previously defined). Asian women were recruited via local Asian 
organisations including; the Woking Asian Women’s Association (WAWA); Khidmat Group, 
Woking; the Islamic Resource Centre in Kingston (IRC); the Islamic Society in Surrey and the 
Thornton Heath Asian Women’s Network. A number o f talks were conducted to help women 
understand the purpose and importance o f the study. A total o f 348 participants enrolled in the 
original D-FINES study, including 270 Caucasians and 78 Asian women living in Southem 
England. Participants received an information sheet by post and signed individual consent forms 
before being allowed to participate in the study. Individual appointments were made, with each 
subject undertaking four assessment visits between 2006 to 2007 and once more in spring 2008. 
One visit needed each season to do the measurements where it took place in the clinical 
investigation Unit (CIU). In addition to a range o f bone health, dietary and anthropometric 
measurements, fasted blood samples for vitamin D were taken, and lipid profiles were analysed.
2.3.2. Ethics
This study was approved by South-West Surrey Local Research Ethics Committee (SWSLREC) 
on 29* March 2006 (06/Ql909/1). Ethical approval fi'om the University of Surrey Ethics 
Committee was received on 7* April 2006 (EC/2006/19/SBMS). Ethical approval from NHS was 
also received on 29* March 2006 (06/Q l909/1 ).
2 .3 3 .25(OH)D biochemistry
Whilst Vitamin D levels were analysed for each season, for the purpose o f this study, only 
summer Vitamin D has been included in the current analysis. Measurement o f Vitamin D was 
undertaken in collaboration with Dr Jacqueline Berry from the Vitamin D Group at the 
University o f Manchester lab where it is registered in vitamin D External Quality Assessment
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Scheme (DEQAS). Serum 25(OH)D was measured using the manual enzyme immunoassay kit 
(Immunodiagnostic Systems Ltd, Bolton, Tyne and Wear, UK). The vitamin D CV was 46.19% 
and the measuring range o f the vitamin D was between 11.40 and 164.50 nmol/1.
2.3.4. Plasma lipid and lipoprotein profile
Lipids were measured using a colorimetric method in Nutrition Lab, University o f Surrey. LDL 
was calculated using the formula LDL = Total cholesterol - (Triglycerides levels /  5 + HDL 
levels). The LDL, HDL, total cholesterol and TAG CV were 30.95%, 27.59%, 23.50% and 
54.76% respectively. Insulin was measured using a kit from Millipore (HI-14K), which 
specifically measures human insulin by radioimmunoassay methodology. Glucose was analysed 
by colorimetry using the Mira test in Postgraduate Medical School (PGMS), Diabetes and 
Endocrinology Lab. Insulin and glucose CV were 42.75% and 27.19% respectively.
2.3.5 HOMA model
The HOMA calculator Microsoft Excel spreadsheet. University o f Oxford (Diabetes Trails Unit, 
2004) have been downloaded and was used to estimate the insulin resistance (IR), beta cell 
function (%B) and insulin sensitivity (%S) using fasting glucose and insulin levels. The %B, %S 
and IR CV were 35.97%, 50.00%, and 52.45% respectively.
2.3.6 Statistical analysis
Data was analysed using PASW Statistic Version 18 (SPSS Inc. Chicago, US 2008). Variables 
were checked for normality using KoImogorov-Smirnov (K-S) test. Spearman correlation and 
Pearson correlation statistics were applied where HDL, cholesterol and LDL were normally 
distributed. Equal tertiles, quartiles and cut-off groups o f specific range were studied for 
differences in 25(OH)D concentration, univariate analysis o f variance, (ANOVA) using BMI as 
covariant and post- hoc testing with the Scheffe test.
2.4 RESULTS
2.4.1 Anthropometric and biochemistry analysis
As shown in table 2.1 below, Caucasian women were found to be significantly taller, and slightly 
heavier than Asian women. However, Asian women had a significantly higher BMI than 
Caucasian group (p<0.01). As discussed in the introduction o f this report, there is continuing
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debate regarding an optimal level o f serum vitamin D. However, there is evidence suggesting 
that levels o f circulating 25(OH)D below 25nmol/l, represent deficiency; below 50nmol/l 
represents insufficiency; and above 75nmol/l is optimal. The average vitamin D status among the 
groups studied is certainly below the optimal cut-off. The semm 25(OH)D results from this 
study indicate that the mean serum vitamin D level was significantly lower in Asian women 
(29.17 nmol/1), compared to Caucasian women (67.43 nmol/1; t = 14.93, P<0.0001).
TAG, HDL, cholesterol and insulin are significantly different between the ethnic groups, where 
TAG and insulin are lower among Caucasians, and HDL and cholesterol are higher among 
Caucasians compared to Asians. Mean values o f LDL and glucose however were not 
significantly different between the ethnic groups.
Table 2.1: Descriptive data o f anthropometric values, and biochemistry measurements 
separated by ethnic groups
C ,  n Mean[SD] Median[IQR] A, n Mean[SD] Median PQR]
B M I 2 7 9 25.75[4.13]** 2521[5.62] 92 26.63[5.17] 25.81 [7.51]
w e i g h t  ( k g ) 2 7 9 68.94[11.01] 67.60[14.40] 92 65.44[12.46] 64.00[15.20]
h e i g h t ( m ) 2 7 9 1.64[0.06T**‘’ 1.64[0.08] 92 1.57[0.06] 1.58[0.06]
2 5 ( O H ) D  i n  n m o l / 1 2 7 8 67.43 [23.68] 64.50[28.00f 92 29.17[14.28] 23.90[15.30]
T A G  i n  m m o l / 1 2 2 8 1.06[0.48] 0.97[0.59]*** 64 1.30[0.53] 1.19[0.66]
H D L  i n  m m o l / 1 2 2 8 1.65[0.47T**^ 1.63 [0.57] 64 1.45[0.34] 1.42[0.39]
C h o l e s t e r o l  i n  m m o l / 1 2 2 8 5.04[1.32f*^ 5.10[1.65] 64 4.73[0.87] 4.75[1.15]
I n s u l i n  i n  m U / 1 1 9 7 12.08[4.66] 11.40[5.36]****’ 57 15.85[6.04] 14.70[7.30]
L D L  i n  m m o l / 1 2 2 8 3.18[1.11] 3.12[1.37] 64 3.03 [0.78] 3.08[1.13]
G l u c o s e  i n  m m o P l 2 2 5 5.58[0.53] 5.52[0.62] 63 5.65[0.79] 5.48[0.60]
C=Caucasian, A=Asian 
***p<0.001, **p<0.01, *p<0.05
“ Normally distributed analysed by t test, not- normally distributed analysed by Mann-Witney U
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Ethnicity E thnicity
E thn icity
Figure 2.1 Boxplots of lipid profile and insulin levels for Caucasian and Asian groups
T h e  d a t a ,  p r e s e n t e d  a s  b o x p l o t s  a b o v e  ( F i g u r e  2 . 1 ) ,  s h o w  t h e  r a n g e  o f  T A G ,  H D L ,  c h o l e s t e r o l  
a n d  i n s u l i n  l e v e l s  f o r  C a u c a s i a n  a n d  A s i a n  w o m e n  i n c l u d e d  i n  t h e  s t u d y .  O u t l i e r s  w e r e  r e m o v e d  
( a b o v e  2  S D ’ s  f r o m  t h e  m e a n ) .  T h e  s p r e a d  o f  t h e  c h o l e s t e r o l  d a t a  f o r  A s i a n  w o m e n  w a s  n o t  a s  
w i d e  a s  f o r  C a u c a s i a n s ,  w h e r e a s  t h e  s p r e a d  o f  t h e  d a t a  i n  t h e  o t h e r  b o x  p l o t s  f o r  l i p i d s  a n d  i n s u l i n  
w e r e  q u i t e  e q u a l  b e t w e e n  C a u c a s i a n  a n d  A s i a n  g r o u p s .
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2.4.2 Comparing subjects’ measurements to the standard cut-off
The National Cholesterol Education Program (NCEP) has published definitions regarding normal 
and high lipid values. These were endorsed by the American Heart Association (AHA) and other 
health organisations and are displayed in Table 2.2 for comparison with the mean values o f lipid 
and insulin levels among Caucasian and Asian groups. Triglyceride levels are “normal” among 
Caucasians and Asians; total cholesterol is “desirable” among Caucasians and Asians; HDL is 
categorized as “high”, considered “desirable” among Caucasians, and “low” considered 
“undesirable” among Asians. However, among both groups, LDL is above the “optimum” level.
Table 2.2 Cut-offs for blood lipid values in mmol/L compared to the study results
B l o o d  l i p i d C u t - o f f  v a l u e s S t u d y  r e s u l t s  ( m e a n  [ S D ] )
m m o l / L
C a u c a s i a n s A s i a n s
T r i g l y c e r i d e
n o r m a l 1 . 7 1 . 0 6 [ 0 . 4 8 ] 1 . 3 0 [ 0 . 5 3 ]
b o r d e r l i n e  h i g h 1 . 7 - 2 . 2
h i g h 2 . 2 - 5 . 6
v e r y  h i g h >  5 . 6
T o t a l  c h o l e s t e r o l
d e s i r a b l e < 5 . 1 5 . 0 4 1 1 . 3 2 ] 4 . 7 3 1 0 . 8 7 ]
b o r d e r l i n e  h i g h 5 . 1  - 6 . 1
h i g h > 6 . 1
H D L  c h o l e s t e r o l
l o w  ( u n d e s i r a b l e ) <  1 . 0 1 . 6 5 [ 0 . 4 7 ] 1 . 4 5 [ 0 . 3 4 ]
h i g h  ( d e s i r a b l e ) >  1 . 5
L D L  c h o l e s t e r o l
o p t i m a l <  2 . 6 3 . 1 8 [ 1 . 1 1 ] 3 . 0 3  [ 0 . 7 8 ]
n e a r / a b o v e  o p t i m u m 2 . 6 - 3 . 3
b o r d e r l i n e  h i g h 3 . 3  - 4 . 1
h i g h 4 . 1  - 4 . 8
v e r y  h i g h 4 . 8
Adapted from American Heart Association, 2009
The results for insulin are shown in Table 2.3 with a comparison to the mean insulin values 
recommended for both ethnic groups. It can be seen that insulin is “elevated” among both ethnic 
groups when compared to standard cut-off values.
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Table 2.3 Cut-offs for blood iusuliu values iu mmol/1 compared to the study results
S u g g e s t e d  t e r m  o f  
b l o o d  i n s u l i n
Low
Normal
Elevated-
hyperinsulinema
C u t - o f f  v a l u e s  S t u d y  r e s u l t s  -  m e a n  v a l u e s  
m U / l [ S D ]
m U / 1
C a u c a s i a n A s i a n
< 5
5 - 1 5
> 1 5
12.08[4.66] 15.85[6.04]
N o r m a l  r a n g e  r e f e r e n c e  f r o m  R I A  k i t - m i l i p o r e -  h u m a n  i n s u l i n  s p e c i f i c  b o o k l e t ,  2 0 0 9
I n s u l i n  m e a n  o f  C a u c a s i a n  s u b j e c t s  w a s  i n  t h e  n o r m a l  r a n g e  b u t  a m o n g  S o u t h  A s i a n  s u b j e c t s  w a s  c o n s i d e r e d  
e l e v a t e d  o r  h y p e r i n s u l i n e m a .
2.4.3 Association between 25(OH)D, lipid profile, iusuliu and glucose
The data in table 2.4 below shows correlation values between 25(OH)D and selected lipid 
profiles. TAG is significantly negatively correlated with 25(OH)D among Caucasian women 
(p<0.001) but not Asian women. There is a trend towards a negative correlation between 
cholesterol and 25(OH)D values in both Caucasian and Asian women (p=0.06, p<0.07). LDL is 
significantly negatively correlated with 25(OH)D levels among Caucasian and Asian women 
(p<0.01 for both). HDL was positively correlated with 25(OH)D but the significant relationship 
only appeared after adjusting for BMI. There were no significant correlation between insulin and 
glucose levels with 25 (OH) in both ethnic groups but no significant relationships were apparent 
(data not shown). All significant relationships remained as such after adjustment for BMI.
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Table 2.4 Spearman Correlation relations between 25(OH)D and lipid profile
Spearman correlation Pearson correlation
Values 111 mmol/L Caucasian Asian Caucasian Asian
TAG (mmol/I) -0.23*** (-0.19**) -0.10 -0.23*** -0.10
n
HDL (mmol/I) 0.06 0.05 0.10 0.15(0.31*)
1------------- — -------- 222
Cholesterol -0.14* -0.20 -0.13 -0.23 (-0.32*)
(mmol/1) n 61 222
LDL (mmol/1) -0.16**(-0.15*) -0.24 -0.16**(-0.15*) -0.33**(-0.47*’ --;
n 61
***p<0.001, **p<0.01, *p<0.05; QPartial correlation adjusted for BMI
HDL, Cholesterol and LDL were normally distributed data where TAG was not normally distributed
The significant relationships detailed in Table 2.4 are presented graphically in Figure 2.2 
(Caucasian women) and 2.3 (Asian women) below. Among Caucasian women, there is a 
significant, negative, linear relation between serum vitamin D level and triglyceride level 
(p<0.001), total cholesterol (p<0.05), and LDL (p<0.01). Among Asian women, another 
significant, negative relation exists between serum vitamin D level and LDL and cholesterol 
level (p<0.01) after adjustment for BMI values. Outliers were excluded from the group, where an 
extreme value appeared 2 SD above the mean.
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--0 .2 3
p<0.001
M ean v a lue  o f TAG
-=-0.13
p<0.06
M ean v a lu e  o fc h o le s tro l
--0 .1 6
p<0.01
M ean v a lue  o f LDL
Figure 2.2 Scatterplots of TAG, Cholesterol and LDL against 25(OH)D in Caucasian 
women
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= -0.23 r=-0.33
p<0.01
M ean v a lu e  o f  ch o le s tro l M ean v a lu e  o f  LDL
Figure 2.3 Scatterplots o f cholesterol and LDL against 25(OH)D in Asian women
2.4.4 Lipid profiles and insulin levels stratified by 25(OH)D groups
Samples were grouped as fertiles or quartiles for each ethnic group by 25(OH)D, see Table 2.5. 
There was a significant difference between the lowest TAG, cholesterol, and LDL tertiles and 
quartiles in the Caucasian group. No significant differences between HDL, glucose and insulin 
groups were observed, and there were no significant differences among Asian tertiles or quartiles. 
Figure 2.4 below shows that high levels o f TAG, cholesterol and LDL are associated with the 
lowest tertile o f 25(OH)D and that low levels o f TAG, cholesterol and LDL are associated with 
highest tertile o f 25(OH)D.
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Table 2.5 Equal tertiles and quartiles for 25(OH)D values against lipid profiles, insulin and 
glucose levels among Caucasian and Asian groups
XI T2 T3 Ql Q2 Q3 Q4
TAG C 1.15"(0.54) 1.09(0.43) 0.93"(0.39) 1.18X0.56) 1.09(0.41) 1.02(0.44) 0.95X0.42)
(mmol/L)
A 1.39(0.58) 1.27(0.51) 1.35(0.61) 1.32(0.48) 1.43(0.65) 1.20(0.36) 1.34(0.64)
Cholesterol C 5.30 (^1.50) 5.18(1.25) 4.66'’(1.14) 5.49X1.53) 4.90(1.22) 5.09(1.23) 4.70X1.22)
(mmol/L)
A 4.94(0.84) 4.74(0.82) 425(0.89) 4.84(0.89) 4.81(0.85) 4.91(0.68) 4.30(0.93)
LDL C 3.39 (^1.17) 3.27(1.07) 2.89\0.92) 3.51X1.21) 3.08(1.04) 3.26(0.97) 2.89X1.00)
(mmol/L
A 3.21(0.67) 3.10(0.64) 2.65(0.85) 3.18(0.69) 3.12(0.64) 3.20(0.63) 2.58(0.87)
HDL C 1.61(0.44) 1.68(0.50) 1.57(0.45) 1.66(0.41) 1.61(0.47) 1.63(0.53) 1.60(0.46)
(mmol/L)
A 1.45(0.36) 1.38(0.34) 1.43(0.40) 1.40(0.30) 1.40(0.43) 1.47(0.26) 1.46(0.40)
Insulin C 11.52(4.53) 12.81(4.45) 11.95(4.69) 11.14(4.39) 12.46(4.53) 12.89(4.52) 11.93(4.79)
(mU/L)
A 16.62(528) 15.93(8:02) 15.33(3.92) 16.61(5.58) 16.48(7.50) 1528(6.66) 15.33(4.06)
Glucose C 5.55(0.53) 5.60(0.54) 529(0.57) 5.56(0.50) 5.50(0.53) 5.67(0.55) 5.58(0.61)
A 5.63(0.93) 5.63(0.52) 5.56(0.78) 5.83(0.90) 5.47(0.71) 5.59(0.45) 5.58(0.80)
Cells within a row with different superscript letters are significantly different; () SD
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Figure 2.4 TAG, cholesterol and LDL levels against 25(OH)D tertiles by ethnicity
Bars with different superscript letters are significantly different
Sub-groups were analysed separately based on the four categories o f vitamin D status outlined 
previously. CVD risk variables were then compared across these four categories, to further 
investigate any association between these factors (see table 2,6). It should be noted that there are 
no Caucasians with vitamin D levels <25nmol/l and no Asian subjects in the group with levels > 
75nmol/l.
Mean TAG levels were significantly different between subjects with insufficient and optimal
vitamin D status, and between inadequate and optimal vitamin D value. The highest 25(OH)D
levels were found to be associated with the lowest TAG. Means o f cholesterol were also
significantly different between inadequate and optimal 25(OH)D values within the Caucasian
group, and another significant difference was observed between deficient and inadequate
individuals in the Asian group. There was also a significant difference in mean LDL between
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s u b j e c t s  w i t h  i n a d e q u a t e  a n d  o p t i m a l  v i t a m i n  D  s t a t u s  a m o n g  C a u c a s i a n s ,  w h e r e  o p t i m a l  s t a t u s  i s  
a s s o c i a t e d  w i t h  t h e  l o w e s t  L D L  l e v e l s ,  a l t h o u g h  n o t  b e t w e e n  t h e  h i g h e s t  a n d  l o w e s t  o f  v i t a m i n  D  
l e v e l s .  F o r  L D L ,  t h e r e  w a s  n o  s i g n i f i c a n c e  d i f f e r e n c e  o b s e r v e d  b e t w e e n  t h e  v i t a m i n  d e f i c i e n t  
g r o u p  a n d  t h e  i n a d e q u a t e  g r o u p ,  o r  b e t w e e n  t h e  i n s u f f i c i e n t  a n d  i n a d e q u a t e  g r o u p s ,  i n  A s i a n s .  
I n s u l i n  l e v e l s  a g a i n  s h o w e d  a  s t e p w i s e  r e d u c t i o n  w i t h  i n c r e a s i n g  v i t a m i n  D  s t a t u s ,  b u t  d i f f e r e n c e s  
w e r e  n o t  s i g n i f i c a n t  b e t w e e n  t h e  g r o u p s .  N o  s i g n i f i c a n t  d i f f e r e n c e s  f o r  H D L  n o r  g l u c o s e  l e v e l s  
w i t h i n  a n y  o f  t h e  g r o u p i n g s  o f  2 5 ( O H ) D  w e r e  a p p a r e n t  i n  e i t h e r  e t h n i c  g r o u p .
Table 2.6 Cut off values of 25(OH)D against lipid profile, insulin and glucose levels
< 2 5  n m o F l 2 5 - 4 0  n m o l / 1 4 0 - 7 5  n m o F I > 7 5  n m o F l
A 34
TAG (mmol/L) C — 1 . 3 1 ( 0 . 6 1 ) » 1 . 1 0 ( 0 . 4 7 ) » 0^93(01^)''
A  1 1 . 3 5 ( 0 . 4 7 ) 1 . 1 8 ( 0 . 6 7 )
Cholesterol (mmol/L) C - 5 . 0 3 ( 1 . 5 5 ) 5 . 2 6 ( 1 . 3 5 ) » 4 . 6 5 ( 1 . 1 4 ) k
V1 . 8 #  8 4 ) " " 4 . 7 5 ( 0 . 6 7 ) 4 . 1 5 * 1 ( 1 . 0 7 )
LDL (mmoFL c - 3.10(1.29) 3 . 3 5 ( 1 . 0 9 ) » 2 . 8 8 ( 0 . 9 2 ) ' '
1 ^ T Ô 9 X ô ^ ) "
^ . 5 # l 9 ^
HDL (mmol/L) c — 1.64(0.48) 1 . 6 5 ( 0 . 4 7 ) 1.57(0.45)
A 1 : 4 2 ( 0 . 3 5 ) H.3 9 ( 0 . 3 4 ) 1 . 4 2 ( 0 . 4 5 )
Insulin (mU/L) C — 9 . 7 6 ( 4 . 1 6 ) 1 2 . 4 7 ( 4 . 5 2 ) 1 1 . 9 2 ( 4 . 7 0 )
A 1 6 . 4 7 ( 6 . 7 0 ) 14.90(5.46) 1 6 . 3 9 ( 4 . 1 4 )
Glucose C — 5 . 4 6 ( 0 . 4 7 ) 5 . 5 8 ( 0 . 5 4 ) 5 . 6 0 ( 0 . 5 8 )
A 5 . 6 2 ( 0 . 8 1 ) 5 . 7 6 ( 0 . 6 4 ) 5 . 3 4 ( 0 . 7 9 ) "T
Cells within a row with different superscript letters are significantly different
F i g u r e  2 . 5  s h o w s  t h a t  t h e  m o s t  c o n s i s t e n t  r e l a t i o n s h i p  b e t w e e n  v i t a m i n  D  s t a t u s  a n d  C V D  r i s k  
m a r k e r s  across b o t h  e t h n i c  g r o u p s  i s  f o r  c h o l e s t e r o l  a n d  L D L ,  w i t h  n e g a t i v e ,  l i n e a r  r e l a t i o n s h i p s  
a s  i n d i c a t e d  b y  t h e  p r e v i o u s  c o r r e l a t i o n  a n a l y s i s .  T h e  p a t t e r n s  a r e  l e s s  c o n s i s t e n t  f o r  t h e  o t h e r  
m a r k e r s ,  a l t h o u g h  a  g e n e r a l  t r e n d  o f  i n c r e a s i n g  C V D  r i s k  w i t h  w o r s e n i n g  v i t a m i n  D  s t a t u s  c a n  
b e  s e e n .
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Figure 2.5 lipid profile, insulin and glucose against eut off vaines of 25(OH)D separated by 
ethnicity
Bars with different superscript letters are significantly different
Among Caucasian group, there was a difference in TAB between Caucasian subjects with insufficient and 
inadequate status and between subjects with insufficient and optimal. There was a difference in total cholesterol 
mean between subjects with inadequate and optimal. Another difference in LDL mean between subjects with 
inadequate and optimal. Among South Asian subjects difference lies in cholesterol between deficient and inadequate 
quartiles and another significant lies in LDL mean between deficient and inadequate and between insulficient and 
inadequate quartiles. No significant difference in HDL, insulin and Glucose quartiles.
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2.4.5 HOMA calculation and its relation to 25(OH)D
Table 2,7 below shows the %B, %S and IR means (SD) for both ethnic groups. Caucasians are 
shown to have significantly lower beta cell function, higher insulin sensitivity, and lower insulin 
resistance (p<0.05, P<0,001, p<0.001 respectively) than the Asian group.
Table 2.7 %B, %S and IR means by ethnicity
C a u c a s i a n A s i a n
b e t a  c e l l  f u n c t i o n  ( % B ) 1 0 3 . 1 8 ( 3 3 . 4 8 ) * 1 2 1 . 0 2 ( 5 0 . 6 8 )
i n s u l i n  s e n s i t i v i t y  ( % S ) 7 2 . 0 6 ( 3 5 . 2 4 ) * * * 5 4 . 1 2 ( 2 5 . 1 6 )
I R 1 . 6 5 ( 0 . 6 9 ) * * * 2 2 9 ( 1 . 4 2 )
^ p < 0 .0 0 1 , * * p < 0 .0 1 ,  * p < 0 . 0 5 ,  Variables were n o t  n o r m a l l y  d i s t r i b u t e d  a n a l y s e d  b y  M a n n - W i t n e y  U
Using Spearman correlations between 25(OH)D and HOMA variables, 25(OH)D was not 
significantly correlated with any o f the HOMA parameters as shown below in table 2.8.
Table 2.8 Spearman correlations (r values), between HOMA values and 25(OH)D in 
Caucasian and Asian women from the D-FINES study
C a u c a s i a n A s i a n
n = 1 8 1 n = 4 9
H O M A  % B - 0 . 0 6 ( 0 . 4 4 ) 0 . 1 2 ( 0 . 4 1 )
H O M A  % S 0 . 0 8 ( 0 . 3 1 ) 0 . 2 4 ( 0 . 1 0 )
H O M A I R - 0 . 0 8 ( 0 . 3 0 ) - 0 . 2 4 ( 0 . 1 0 )
( ):p  values
2.5 DISCUSSION AND CONCLUSIONS
One o f the most important findings o f this analysis is that the Asian population has a biochemical 
profile that puts them at risk o f multiple, chronic diseases. Their BMI is high enough to be
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classified as overweight, their 25(OH)D concentration is low enough to be classified as 
insufficient and their blood insulin is elevated. A study conducted recently highlighted that the 
Asian population is at high risk o f  insulin resistance, obesity and CVD, primarily due to low 
serum vitamin D, combined with other risk factors that contribute to poor health, such as 
hypertension and high BMI (McCarty, 2009). Elevated, adverse markers o f  cardiovascular health 
measured herein, confirm a higher risk o f CVD in the Asian population. Blunting o f 25(OH)D 
levels, i.e. severe vitamin D deficiency, has been previously noted in Asian women with a 
25(OH)D level <25 nmol/1 (depending on the season). This may explain the lack o f association 
between 25(OH)D and markers o f  cardiovascular health among Asian group, in some o f the 
analyses. However, 25(OH)D is strongly negatively correlated with cholesterol and LDL among 
Caucasian groups, which is the expected relationship.
Previous research has attempted to investigate the relationship between 25(OH)D and lipid 
profiles in South Asian subjects, although the results have been far from conclusive. One such 
study looked at 170 healthy, Bangladeshi adults, including 69 men and 101 women fi*om east 
London. A multiple regression analysis showed that 25(OH)D concentration was a predictor o f 
increasing, fasting lipid concentrations, and only triglyceride levels were significantly, negatively 
correlated with 25(OH)D (John et al., 2005). In contrast, our findings agree with Auwerx and 
colleagues (1992) those fi*om another study, which reported a positive correlation between serum 
25(OH)D and HDL levels (p<0.05 in men and p< 0.005 in women); this relationship was 
independent o f serum calcium levels.
A similar study found that the baseline serum 25(OH)D o f non-diabetic subjects was inversely
associated with insulin level, after a 10-year follow-up (Forouhi et al., 2008). The association
remained significant even after adjustment for age, gender, smoking, BMI, season, PTH, calcium,
physical activity, and social class. Our findings showed some differences between 25(OH)D
tertiles and quartiles when compared to TAG, cholesterol and LDL levels within the Caucasian
group. This finding is not in agreement with another study that also investigated lipid and insulin
levels according to serum 25(OH)D cut-off groups. There, significant differences in mean insulin
levels between 25(OH)D cut-offs were reported, but not in the mean total cholesterol or HDL
(Forouhi et al., 2008). Some significant differences were observed in the Asian group when
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25(OH)D levels were defined by the four physiological-status categories (deficient, 
insuffleient,etc.) and significant associations were seen with cholesterol and LDL. Even though 
there were few direct significant relationships between lipid levels and 25(OH)D when looking 
at the tertiles, quartiles and even the defined 25(OH)D cut off groups, a general trend could be 
observed. Overall, the relationships were in the expected direction, where increases in 25(OH)D 
were related to decreases in TAG, cholesterol, LDL, insulin and glucose and increases in HDL.
The strength o f the present study is its prospective nature. We believe that through careful cohort 
selection and timing, the data were free from bias caused by seasonal or social economic class 
variation. However, one o f the weaknesses o f  the study is the insufficient number o f Asian 
subjects with high 250HD concentrations. In this cohort, there was a large difference between 
serum 250HD levels between Caucasian and Asian women, where most Asian subjects fell into 
the insufficient categories and Caucasian subjects were classified as hypovitaminosis. This 
difference made it difficult to compare the lipid, insulin and glucose levels in the vitamin D sub­
groups. A useful measurement to be incorporated into future research would be to look at blood 
pressure as a risk factor o f CVD and investigate its association with the 25(OH)D concentration 
to get a complete picture o f the most prevalent CVD risk factor.
In conclusion, the findings o f this current study are a cause for concern and warrant further 
investigation. More research is required, incorporating a larger cohort with a wider range o f 
vitamin D levels to explain the role o f vitamin D in mediating the risk o f  CVD. This could be 
achieved by employing specifically designed, prospective studies and double-blind, randomised 
controlled intervention trials o f the effect o f vitamin D supplementation on CVD risk.
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CHAPTERS
ASSOCIATION BETWEEN BONE HEALTH AND CARDIOVASCULAR 
DISEASE RISK: EVIDENCE OF A LINK IN THE D-FINES STUDY
POPULATION
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3.1 INTRODUCTION
3.1.1 General background
Osteoporosis and bone health have been linked to atherosclerosis, suggesting a strong association 
between serum lipid and bone health indices (Buizert et ak, 2009). As confirmation o f  this, early 
experimental studies have suggested that serum cholesterol may be a common pathogenic factor 
in the development o f bone loss and osteoporosis (Makovey et ak, 2009, Adami et ak, 2004). 
Lipid and bone metabolism have recently been linked in several ways, which further sheds light 
on the interaction between the two (Hernandez et ak). One possible mechanism is that adipocytes 
and osteoblasts share a common progenitor from the stromal cells in bone marrow, where a large 
degree o f plasticity exists (Rosen and Klibanski, 2009). This relationship may explain the fact 
that age-related bone loss is accompanied by an increase in marrow adipose tissue, which 
requires a therapeutic approach to prevent the decline in osteoblastic activity in ageing.
According to Parhami et a l,  2002, the products o f the cholesterol biosynthesis pathway are 
important for the development o f marrow stromal cells into fimctional osteoblastic cells, which 
are then capable o f forming a mineralized matrix (Parhami et ak, 2002).
The role o f the low-density lipoprotein receptor-related protein 5 (LRP5) gene in the regulation 
o f bone mass and fi-acture risk has recently been elucidated. The loss o f functionality o f  the LRP5 
due to a mutation has been identified in patients with reduced bone mass and skeletal fragility 
(Kubota et ak, 2009) Recently, large-scale studies have shown that LRP5 variants are 
consistently associated witii BMD and fracture risk (van Meurs et ak, 2008). Mutation in LRP6 , 
which is a related homolog o f LRP5, en-codes a co-receptor involved in Wnt signaling (a 
network o f proteins involved in embiyogenesis) pathway, which in turn has been shown to be 
genetically linked to early coronary disease, metabolic syndrome, osteoporosis and fracture 
(Mani et ak, 2007). These interactions provide an alternative explanation o f the link between lipid 
and bone metabolism.
Moreover, several lipid-based dmgs, such as hormone replacement therapies, statins, and amino 
bisphosphates have been shown to play a role in both bone and lipid metabolism. Statin and 
amino bisphosphates in particular have recently been proven to not only affect the synthesis o f 
cholesterol, but also to regulate bone cell proliferation and osteoclast apoptosis (Majima et ak,
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2007). The statins, pitavastatin and atorvastatin have been suggested to have potential beneficial 
effects on bone metabolism, primarily by reducing bone resorption, indicated by lowering o f 
serum N-telopeptide o f type I collagen NTx, which acts as a bone turnover marker. These effects 
were significantly observed following three months o f statin treatment o f hypercholesterolemia 
patients (Majima et al., 2008). Other observational studies suggest that statins can significantly 
reduce the risk o f fracture and increase bone density (Edwards et ak, 2000). A further possible 
pathophysiological association between lipids and bone metabolism is the presence o f several 
common receptors in both osteocytes and endovascular lining cells. These include the cytokine 
receptor, osteoprotegerin; receptor activator of nuclear factor kB  (RANK) and receptor activator 
ofNE-xB ligand (RANKL), that appear to play important roles in both systems.
3.1.2 Serum Lipids and osteoporotic fracture
Vertebral fracture is known to be the most common type o f osteoporotic fracture and can occur 
early in the natural history o f  osteoporosis. In Turkish studies, they examining fractures in 
postmenopausal women. Total Cholesterol (TC) level was identified as the most prominent factor 
affecting the vertebral fracture risk. It is estimated that an increase o f TC by 1 mg/dl will 
decrease the risk o f vertebrae fracture by 2.2% (Sivas et ak, 2009). Other lipid values were also 
found to be at higher levels among patients with vertebral fracture than those without vertebral 
fractures. In addition to this, Hernandez and colleagues conducted similar research in men and 
found no association between high cholesterol level and prevalent vertebral fracture but did find 
an association with low TC and LDL levels with prevalent non-vertebral fractures. (Hernandez et 
ak). Yamaguchi et ak, also found that TAG level but not other lipid levels were significantly 
lower in women with vertebral fractures than with those without fractures (Yamaguchi et ak, 
2002).
3.1.3 Serum lipids and bone turnover
Few studies have investigated the association between increased bone turnover and increases in
serum cholesterol and lipids levels. One study however, (Majima et ak, 2008) measured the
serum bone-specific alkaline phosphate (BAP) enzyme and serum NTx along with serum lipids in
281 hypercholesterolaemia patients and compared them to 267 control subjects. This study found
that hypercholesterolaemia patients had significant higher BAP than the control group in women
only, and significantly higher NTx than in males and female controls in. In addition, BAP and
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NTx were negatively correlated with HDL in men; and positively correlated with both TC and 
LDL in women. Conversely, another study, (Tanko et ak, 2003) involving a large group o f 
postmenopausal women (n=340) showed no significant correlation between semm cholesterol 
and changes in bone tumover estimated using semm osteocalcin (r=0.05, p=0.31) and C 
telopeptides o f type I collagen (CTx) (r=-0.027, p=0.62) as biomarkers. Due to the limited and 
controversial nature o f these studies, further research is required to elucidate the relationship 
between lipid status and bone tumover.
3.1.4 Serum Lipids and Bone Mineral Density
Several studies have investigated the relationship between semm lipids and bone mineral density 
(BMD) but results have so far been inconsistent and conflicting. Few cross-sectional studies have 
assessed tiie association between lipid level and BMD at selected bone sites and where these do 
exist, they do not tend to support the hypothesis that high levels o f unfavourable lipids are 
associated with low BMD (Buizert et ak, 2009, Solomon et ak, 2005, Adami et ak, 2004, 
Hernandez et ak, Zofkova et ak, 2001). For example, Samelson and colleagues found no 
significant association between total TC level and BMD for any o f the bone sites considered in 
either men (n=450) or women (n=712) between the ages o f young adulthood to middle age. No 
association could be detected even after adjusting for age, smoking, alcohol consumption, BMI, 
blood pressure and oestrogen use (women). This study assessed cholesterol levels over three 
decades and predicted the bone mineral density at the proximal femur (neck, trochanter, and 
Ward’s triangle) and lumbar spine using dual-photon absorptiometry, and at the one-third radial 
shaft and ultradistal radius using single-photon absorptiometry (Samelson et ak, 2004). Another 
cross-sectional and longitudinal investigation o f semm cholesterol and BMD found a significant 
negative association only at baseline, between semm cholesterol and BMD at the lumbar spine 
(Tanko et ak, 2003). This correlation remained even after adjustment for age and BMI. However, 
after an eight year follow-up period, the correlation was lost. The authors suggested that the 
association between spine BMD and semm cholesterol could be explained by the fact that both 
variables are affected by estrogen deficiency rather than by any direct influence o f semm 
cholesterol on osteoblast function (Tanko et ak, 2003).
On the other hand, a few cross sectional studies do provide support for the association between
osteoporosis and CVD with at least one semm lipid measurement being significantly correlated
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with at least one BMD measurement(D'Amelio et al., 2008, Yamaguchi et al., 2002, Makovey et 
al., 2009, Orozco, 2004). In an early postmenopausal group, each decrease o f one SD (0.4 g/cm) 
in bone mineral content was associated with a 2.3 fold increase in the risk o f dying within 17 
years from CVD (95% Cl 1.0 to 5.3; /?<0.05). Similarly, in the late postmenopausal period (age 
70), a decrease in bone mineral content o f one SD below the recommended mean was associated 
with a 1.8-fold increase in the risk o f dying CVD (95% Cl 1.0 to 3.2, p=  0.06). In addition, 
prevalent vertebral compression fracture in the late postmenopausal period was independently 
associated with CVD risk. The author concluded that low bone mass during menopause could be 
a risk factor for increases cardiovascular mortality in later life (von der Recke et ak, 1999). 
Similar findings in relation to osteoporosis fracture, suggested that each 1 SD decrease o f BMD 
in the proximal radius was associated with a 1.7-fold relative risk for stroke death in 
postmenopausal women. Tanko et ak (2003) explained the differences between pre and 
postmenopausal women that may arise in terms o f the effect o f serum lipids on BMD at various 
skeletal sites because o f factors such as hormone status and age.
Table 3.1 (below) summarises the main findings o f the cross-sectional studies investigating the 
relationship between bone quality and lipid profile in female subjects. The overall summary 
indicates an inconsistent relationship between bone quality and lipid profile.
77
Table 3.1 Studies examining the effect of serum lipids on BMD in female participants
A u t h o r s  a n d  
y e a r
S u b j e c t s B o d y  r e g i o n -  
s c a n n e d
M a i n  F i n d i n g
B r o w n b i l l e t  a l . ,
2 0 0 6
U S
1 3 6  P O S T - W f e m o r a l  s h a f t ,  
f e m o r a l  W a r d ' s  
t r i a n g l e ,  t o t a l  b o d y
H i g h e r  l e v e l s  o f  s e r u m  t r i g l y c e r i d e s  a n d  
c h o l e s t e r o l  w e r e  p o s i t i v e l y  a s s o c i a t e d  w i t h  
B M D  a t  v a r i o u s  s k e l e t a l  s i t e s .
C u i  e t  a l . ,  2 0 0 5  
S o u t h  K o r e a
8 6 7  W L S ,  F N ,  r i g h t
t r o c h a n t e r ,  r i g h t  
s h a f t ,  r i g h t  w a r d ’ s  
t r i a n g l e  a n d  
p r o x i m a l  t o t a l  h i p .
L D L  i n v e r s e l y  c o r r e l a t e d  w i t h  h i p  B M D  i n  
P o s t - W  a n d  w i t h  l u m b a r  B M D  i n  P r e  a n d  p o s t -  
W .
T C  a n d  L D L  w e r e  i n v e r s e l y  a s s o c i a t e d  w i t h  
B M D  i n  b o t h  p r e  a n d  P o s t - W  i n  s o m e  s k e l e t a l  
s i t e s .
D ’ A m e l i o  e t  a l .  
2 0 0 8  
I t a l y
1 7 3  i n
m e n o p a u s e  W
N o  a s s o c i a t i o n  b e t w e e n  T C  o r  L D L  w i t h  B M D  
b u t  H D L  w a s  s i g n i f i c a n t l y  h i g h e r  i n  
o s t e o p o r o s i s  p a t i e n t s .
M a k o v e y  e t  a l . ,  
2 0 0 9
A u s t r a l i a
4 9 7  W w h o l e  b o d y ,  L S  
a n d  h i p  s i t e s
H i g h e r  T C  w a s  s i g n i f i c a n t  a s s o c i a t e d  w i t h  
l o w e r  B M D  a t  l u m b a r  s p i n e  a n d  w h o l e  b o d y  
B M D  o n l y  i n  p o s t  W  n o t  t a k i n g  H R T .
O r o z c o  2 0 0 4  
S p a i n
5 2  P O S T - W L u m b a r  a n d  
f e m o r a l
P O S T - W  w i t h  r a i s e d  l i p i d s  h a d  l o w e r  l u m b a r  
a n d  f e m o r a l  B M D  a n d  i n c r e a s e d  r i s k  o f  
o s t e o p e n i a  t h a n  t h o s e  w i t h  n o r m a l  l i p i d  
p r o f i l e s
S i v a s  e t  a l . ,  2 0 0 8  
T u r k e y
1 0 7  P O S T - W L S ,  h i p  a n d  r a d i u s N o  a s s o c i a t i o n  b e t w e e n  s e r u m  l i p i d s  a n d  B M D
S o l o m o n  e t  a l . ,
2 0 0 5
U S
1 3  5 9 2  ,  M  
a n d  W
D E X A  a t  h i p N o  s i g n i f i c a n t  r e l a t i o n s h i p  b e t w e e n  T C ,  L D L ,  
o r  H D L  a n d  B M D
T a n k o  e t  a l . ,  
2 0 0 3
D e n m a r k
3 4 0  P O S T - W L S  a n d  h i p S i g n i f i c a n t  n e g a t i v e  a s s o c i a t i o n  b e t w e e n  T C  
a n d  B M D  a t  L S  b u t  t h i s  a s s o c i a t i o n  w a s  n o t  
o b s e r v e d  a f t e r  8  y e a r s  f o l l o w  u p .
Y a m a g u c h i  e t  
a l . ,  2 0 0 2  
J a p a n
2 1 4  P O S T - W L S ,  F N ,  r a d i u s  a n d  
t o t a l  b o d y
L D L  a n d  H D L  w e r e  i n v e r s e l y  a n d  p o s i t i v e l y  
c o r r e l a t e d  w i t h  b o t h  r a d i u s  a n d  l u m b a r  B M D  
v a l u e s  r e s p e c t i v e l y .
Y i - H s i a n g  e t  a l . ,  
2 0 0 6
7 1 3 7  M ,  4 5 8 5  
P R E - W .  2 2 4 8  
P O S T - W
w h o l e  b o d y  a n d  
t o t a l  h i p  s c a n
S i g n i f i c a n t  n e g a t i v e  c o r r e l a t i o n  b e t w e e n  w h o l e  
b o d y  B M C  a n d  T C ,  T A G  a n d  L D L .  N o  
a s s o c i a t i o n  b e t w e e n  H D L  a n d  B M D .
BMC, bone mineral content; BMD, bone mineral density; HDL, high density lipoprotein; LDL, low density 
lipoprotein; LS, lumbar spine; FN, femoral neck; Post-W, postmenopausal women; Pre-W, premenopausal women; 
TC, total cholesterol; W, women, M, men
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An additional study investigated the influence o f menopausal status, age and hormone 
replacement therapy (HRT) on the relationship between serum cholesterol and BMD. This study 
included 497 females (224 premenopausal and 273 postmenopausal) and found a modest inverse 
relationship between lumbar spine (LS) and whole body BMD and serum TC and LDL levels in 
post-menopausal women and HDL in pre-menopausal women. The investigators concluded that 
HRT use appeared to modify this relationship (Makovey et al., 2009). However, Orozco and 
colleagues (Orozco, 2004) examined postmenopausal women (n=52) with no history o f  HRT, no 
current or past pathology and no treatment that could affect bone or lipid metabolism. This 
research group found that women with hyperlipidaemia, defined as hypercholesterolemia 
(>240mg/dl) or LDL (>160 mg/dl) had lower mean adjusted BMD at lumbar and femoral neck 
regions than those with normal lipid levels. The conclusion o f this study was that hyperlipidaemia 
could be associated with osteoporosis and bone status. Yamaguchi et al. (Yamaguchi et al., 2002) 
also found that plasma LDL and HDL were inversely and positively correlated with both radius 
and lumbar BMD values respectively, even after adjusting for age, years o f menopause, BMI, and 
fat % among postmenopausal women.
In summary, although there are some possible associations between the disease processes o f 
atherosclerosis and osteoporosis, the relationship is still unclear. Only a few studies have refuted 
the association between osteoporosis and serum lipids (Tanko et al., 2003, Solomon et al., 2005) 
whilst most o f the studies give mixed findings regarding the precise relationship between serum 
lipid profiles and bone health, including bone mineral density. To date, there no studies have 
looked at the association between bone health and CVD risk factors within an Asian population, 
and more speeifieally in comparison to a Caucasian group. There is also very limited data that 
investigate the ethnic differences regarding bone quality and density in relation to CVD risk 
factors.
This subsidiary study therefore aims to investigate the association between serum lipid profiles 
and insulin levels, with bone quality, BMD and bone tumover between Caucasian and Asian 
subjects. The data o f this projects have been collected by D-FINES team as part o f  the original 
project where bone variables and all other measurement were collected between the two autumn 
and spring seasons in 2006 and 2007 respectively.
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3.2 OBJECTIVES
The objectives o f  this project are as follows:
• Extract relevant data from the larger D-FINES clinical trial database.
• Determine if there is any association o f serum lipids and insulin levels with bone quality and 
BMD, adjusting for potential confounders.
o Investigate if  there are any ethnic differences between Caucasian and Asian groups for 
the above analyses
• Examine the relationship between lipid level quartiles and the significant bone variables 
previously measured.
• Investigate the association between serum lipid and insulin level with bone tumover and 
calcium metabolism.
o Investigate if  there are any ethnic differences between Caucasian and Asian groups for 
the above analyses
• Analyse and compare the associations between semm lipid and bone quality among pre­
menopausal and post-menopausal subgroups.
3.3 SUBJECTS AND METHODS
3.3.1 Screening and subjects
Please refer to chapter 2 for detailed methods relating to subjects and reemitment criteria.
3.3.2 Ethics
Please see chapter 2 for details o f the ethical approval processes.
3.3.3 Biochemical measurements and bone scanning
Measurement o f vitamin D levels and markers o f calcium metabolism was undertaken in 
collaboration with Dr Jacqueline Berry from the vitamin D group at the University o f 
Manchester. Semm 250HD was measured using the manual enzyme immunoassay kit 
(Immunodiagnostie Systems Ltd, Bolton, Tyne and Wear, UK). Semm intact PTH was measured 
using OCTEIA immunoenzymometric assay (Immunodianostic System Ltd, Bolton, Tyne and 
Wear, UK). The PTH CV was 42.98% for the Autumn and 47.245 for the Spring. Lipid blood
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samples were eollected in the autumn o f 2006 and analyzed; please refer to chapter 2  for the 
lipid, insulin and glucose analysis method.
Bone scans were performed in the autumn and spring o f 2006 and 2007 respectively using Dual 
X-ray Absorptiometry DXA scan. Although the measurement o f bone mineral density is a way 
to assess bone quality and diagnose osteoporosis, another way to assess bone health was 
considered in this study. This method involves the use o f quantitative ultrasonic assessment; its 
main evaluated parameters are the speed o f sound and the frequency dependence o f attenuation. 
Broadband Ultrasonic Attenuation (BUA) is a detector o f bone tissue changes, and has become 
the principal index measure in quantitative assessment.
hi the Autumn and Spring o f 2006/2007, all subjects received a lumbar spine (LS), femoral neck 
(FN) and whole body (WB) bone mineral density scan, using Dual X-ray Absorptiometry (DXA). 
This was undertaken in the bone centre within Guildford Nuffield Hospital, in collaboration with 
Dr Richard Gray (consultant Rheumatologist, Royal Surrey County Hospital). The DXA 
machine was a Hologic QDR4500 (Hologielne, USA). Body composition was also assessed in 
subjects using the whole body BMD measurement. In a subset o f subjects, calcaneal bone mass, 
using BUA (dB/MHz) and Velocity o f sound (VOS; m/s) (MeCue Clinical, Southampton) was 
assessed; the co-effieient o f variation o f the DXA machine was <1% and the CV for the BUA 
was <3-4%.
The bone tumover marker, semm CTx was analysed for the assessment o f bone resorption, with 
measurements undertaken on stored blood samples by the Bone Metabolism Group at the 
University o f Sheffield, in collaboration with Professor Richard Eastell. Semm eross-linked C 
telopeptides o f type I collagen (PCTX) was measured by eleetrochemilumineseent immunoassay 
on a Cobas c411 automatic analyser (Roche Diagnostics).
3.3.4 Statistical analysis
Data was analysed using SPSS (SPSS Version 17, SPSS Inc. Chicago, US 2008). Variables were 
cheeked for normality using KoImogorov-Smirnov (K-S) test. Pearson correlations were applied 
to investigate correlations between normally distributed continuous variables. Subjects were 
grouped according to their lipid and insulin levels and between group differences in bone 
measures were analysed using one-way analysis o f variance (ANOVA).
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3.4 RESULTS
3.4.1 Bone quality measurement
Table 3.2 shows the mean bone quality and bone density parameters for autumn and spring 
separated by ethnicity. There were no statistical differences in mean BUA and VOS between 
ethnic groups but Caucasians had slightly lower levels versus Asians in both seasons. BMD in the 
lumber spine LS and femoral neck FN sites were similar in both ethnic groups in both seasons.
Table 3.2 Bone quality and density separated by ethnicity for pre- and post menopausal 
women recruited to the D-FINES study.
E t h n i c i t y N M e a n  [ S D ]
BUA C a u c a s i a n 8 0 7 1 . 4 3 [ 1 5 . 8 5 ]
dB/MHz A s i a n 4 1 7 3 . 1 7 [ 1 4 . 6 5 ]
VOS m/s C a u c a s i a n 8 0 1 6 3 1 . 8 9 [ 3 7 . 8 3 ]
A s i a n 4 1 1 6 4 7 . 9 4 [ 3 5 . 3 8 ]
BMDLS C a u c a s i a n 2 4 4 0 . 9 8 [ 0 . 1 4 ]
a
B g/cm^ A s i a n 6 7 0 . 9 6  [ 0 . 1 3 ]
1 FNBMD C a u c a s i a n 2 4 3 0 . 8 0 [ 0 . 1 1 ]
< g/cm^ A s i a n 6 7 0 . 8 1 [ 0 . 1 1 ]
BUA C a u c a s i a n 4 7 6 9 . 7 7  [ 1 5 . 2 0 ]
dB/MHz A s i a n 1 9 72.89[19.25]
VOS m/s C a u c a s i a n 4 7 1 6 3 1 . 9 7 [ 4 0 . 2 3 ]
A s i a n 1 9 1 6 4 9 . 7 4 [ 3 1 . 9 7 ]
BMDLS C a u c a s i a n 2 1 9 0 . 9 7 [ 0 . 1 5 ]
W) g/cm^ A s i a n 6 1 0 . 9 5 [ 0 . 1 4 ]
.5 FNBMD C a u c a s i a n 2 1 7 0 . 7 9 [ 0 . 1 1 ]
g/cm^ A s i a n 6 1 0 . 7 9 [ 0 . 1 2 ]
BUA, broadband ultrasound attenuation; BMD, bone mineral density; LS, lumbar spine; FN, femoral neck; 
VOS, velocity o f sound
Means compared between ethnic groups by independent t-test, no significant differences identified
BUA and VOS values for both ethnic groups, were within normal reference ranges VOS 
reference range: 1500-1650 m/s; BUA reference range: 60-90 dB/MHz (Njeh, 1999).
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3.4.2 Association between serum lipids and bone quality
Table 3.3 below shows the eorrelations between markers o f CVD and bone measurements 
analysed by ethnicity and season. A number o f significant negative correlations between lipid 
and bone measures were identified, more commonly in the Caucasian group, than in Asian 
women. The majority o f these significant eorrelations remained even after correcting for BMI 
and vitamin D status. For example, LS and FN BMD were associated negatively (p<0.01), with 
cholesterol and LDL in both seasons, in Caucasian women only, even after adjustment for BMI 
and vitamin D status. A significant, negative correlation between BUA, VOS and cholesterol 
level (p<0.05) was also found in autumn only among Caucasian women, but not Asian women. 
The only significant associations reported for insulin were in autumn for FN BMD and spring for 
BUA among Caucasian women only, with the former relationship losing significance after 
adjustment for BMI and vitamin D status. For both populations, there was a significant negative 
correlation (p<0.05) between FN BMD and HDL in autumn only, but these correlations lost 
significance after adjustment for BMI and vitamin D status. Among the Asian group, results in 
spring were significantly positively correlated for FN BMD and TAG, and a significant negative 
correlation between FN BMD and HDL was observed; these two eorrelations remained 
significant after adjustment for BMI and vitamin D status. The only significant association with 
VOS was a negative correlation with cholesterol level (r=-0.27 and r=-0.28, p<0.05, for non 
adjusted and adjusted data respectively) in autumn among the Caucasian women only.
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Table 3.3 Correlation coefficients (r) for the associations between m arkers o f CVD and 
BUA, VOS, FN BMD, and LS BMD in pre-and post m enopausal women recruited to the D 
FINES study, separated  by ethnicity and season
TAG
(mmoFl)
Cholesterol
(mmoFI)
LDL
(mmol/1)
HDL (mmol/1) Insulin
(mU/1)
BUA dB/M Hz
Caucasian -0 . 1 1 -0.24* -0 . 2 2 -0.17 0.19
(n=47)
Asian (n=19) 0.15
(-0.24*)
0 . 0 2 0 . 0 2 -0.05 -0 . 0 2
VOS m/s
Caucasian -0.19 -0.27* -0.23 -0.19 -0.06
a
(n=47)
Asian (n=19) 0.29
(-0.28*)
0.17 0.08 0.17 0 . 0 1
1
LS BMD g/cm^ 
Caucasian -0.04 -0 .2 1 ** -0 .2 1 ** -0.09 0.08
(n=46)
Asian (n=17) 0.17
(-0.19**)
-0.07
(-0 .2 1 **)
-0 . 0 1 -0.19 -0.14
FN BMD g/cm^ 
Caucasian -0.05 -0 .2 1 ** -0.18* -0.15* 0.15*
(n=47)
Asian (n= 17) 0.29* (0.18)
(-0.19**)
0 . 0 1
(-0.19**)
0 . 1 1
(-0.07)
-0.28* (-0 .2 2 )
(-0 .0 2 )
0 . 0 1
BUA dB/M Hz
Caucasian -0.23 -0.19 -0.15 -0.13 0.38*
(n=47)
Asian (n=19) 0.19 -0.03 0 . 0 0 2 -0 . 1 1
(0.35*)
0 . 0 0
VOS m/s
Caucasian -0.30 -0 . 1 1 -0.08 -0.06 0.29
W)S3
(n=47)
Asian (n=19) 0.262 0.03 0.15 -0.27 0 . 2 1
•d LS BMD g/cm^ 
Caucasian -0.04 -0 .2 2 ** -0 .2 2 ** -0.08 0.08
(n # 3 )
Asian (n=18) 0.16
(-0 .2 1 **)
-0.08
(-0 .2 2 **)
-0 . 0 2 -0.19 -0.15
FN BMD g/cm^ 
Caucasian -0.05 -0 .2 2 ** -0.19** -0.13 0 . 1 0
(n=44)
Asian (n=18) 0.32*(0.29*)
(-0 .2 0 **)
-0.05
(-0 .2 0 **)
0.04 -0.28*(-0.27*) 0 . 0 0 2
B U A ,  b r o a d b a n d  u l t r a s o u n d  a t t e n u a t i o n ;  B M D ,  b o n e  m i n e r a l  d e n s i t y ;  L S ,  l u m b a r  s p i n e ;  F N ,  f e m o r a l  n e c k ;  V O S ,  
v e l o c i t y  o f  s o u n d ;  L D L ,  l o w -  d e n s i t y  l i p o p r o t e i n ;  H D L ,  h i g h  d e n s i t y  l i p o p r o t e i n ;  T A G ,  t r i g l y c e r i d e .
*  c o r r e l a t i o n  i s  s i g n i f i c a n t  a t  t h e  0 . 0 5  l e v e l ,  * *  c o r r e l a t i o n  i s  s i g n i f i c a n t  a t  t h e  0 . 0 1  l e v e l
0  p a r t i a l  c o r r e l a t i o n  c o r r e c t e d  f o r  B M I  a n d  v i t a m i n  D  s t a t u s
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3.4.3 BMD measurements according to lipid profiles and insulin cut-off values
Where significant correlations between lipid and insulin values and bone quality measurements 
were identified (see section 3.4.2 above) the data were grouped into quartiles to facilitate further 
analysis. Variables displaying a significant difference in bone markers between quartiles o f 
lipid/insulin levels arc presented as bar graphs in the following section (Figures 3.1-3.3) to 
illustrate the prevalent relationships.
3.4.3.1 Mean bone measurements by total cholesterol quartiles, separated by ethnicity
Cholesterol was grouped into quartiles as follows: <4.30, 4.30-5.05, 5.05-5.79, >5.79. As shown 
in Tabic 3.4, an increase in total cholesterol was associated with lower BUA, VOS, LS, and FN 
BMD levels. In the Caucasian group, differences appeared in LS and FN BMD measurements 
between the lowest and highest quartiles o f cholesterol in both seasons (see Figure 3.1).
Table 3.4 Mean bone measurements according to quartiles o f cholesterol levels for 
Caucasian women enrolled in the D-FINES study.
C h o l e s t e r o l  Q u a r t i l e s
1 2 3 4
( n = 2 6 ) ( n = 1 9 ) ( n = 1 6 ) ( n = 1 8 )
B U A  ( d B / M H z ) 7 4 . 1 7 7 2 . 8 9 7 3 . 7 2 6 4 . 1 1
V O S  ( m / s ) 1 6 4 0 . 9 6 1 6 2 9 . 9 2 1 6 3 4 . 7 2 1 6 1 8 . 1 9
( n = 6 3 ) ( n = 4 5 ) ( n = 5 1 ) ( n = 6 5 )
1 L S  B M D ( g / c m ^ ) 1 . 0 2 " 0 . 9 8 1 . 0 0 0 . 9 4 "1 F N  B M D ( g / c m ^ ) 0 . 8 3 " 0 . 7 9 0 . 8 1 0 . 7 6 "
DX).s
L S  B M D ( g / c m ^ ) 1 . 0 2 " 0 . 9 7 1 . 0 0 0 . 9 3 "
*C
&
F N  B M D ( g / c m ^ ) 0 . 8 2 " 0 . 7 7 0 . 8 1 0 . 7 6 "
1 ,  < 4 . 3 0  m m o l / 1 ;  2 , 4 . 3 0 - 5 . 0 5  m m o l / 1 ;  3 , 5 . 0 5 - 5 . 7 9  m m o l / 1 ;  4 ,  > 5 . 7 9  m m o l / 1
C e l l s  w i t h i n  a  r o w  l a b e l l e d  w i t h  ( a )  s u p e r s c r i p t  l e t t e r s  a r e  s i g n i f i c a n t l y  d i f f e r e n t  t o  ( b )
B U A ,  b r o a d b a n d  u l t r a s o u n d  a t t e n u a t i o n ;  B M D ,  b o n e  m i n e r a l  d e n s i t y ;  L S ,  l u m b a r  s p i n e ;  F N ,  f e m o r a l  n e c k ;  V O S ,  
v e l o c i t y  o f  s o u n d
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Figure 3.1 M ean FN and LS BMD by quartiles o f cholesterol levels for Caucasian women in 
autum n.
Bars labelled with superscript letters (a) are significantly different to (b)
BMD, bone mineral density; LS, lumbar spine; FN, femoral neck.
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3.43.2 Mean bone measures by LDL quartiles, separated by ethnicity
LDL was grouped into quartiles as follows: <2.47, 2.47-3.10, 3.10-3.70, >3.70. As shown in 
Table 3.5, higher levels o f LDL are assoeiated with lower bone density at the FN and LS, as well 
as with BUA and VOS levels. A significant difference appeared for mean BMD levels at LS and 
FN sites between the highest and lowest LDL quartiles, in both seasons among the Caucasian 
population (figure 3.2).
Table 3.5 Quartiles for LDL values against bone measurements among Caucasian group 
L D L  Q u a r t i l e s  a m o n g  C a u c a s i a n s
1
( n = 5 0 )
2
( n = 5 6 )
3
( n = 5 5 )
4
( n = 6 2 )
1
B
<
L S  B M D ( g / c m ^ ) 1 . 0 3 " 0 . 9 9 0 . 9 8 0 . 9 4 "
F N  B M D ( g / c m ^ ) 0 . 8 3 " 0 . 8 1 0 . 7 7 " 0 . 7 8
6X)
1
L S  B M D ( g / c m ^ ) 1 . 0 1 " 0 . 9 9 0 . 9 9 0 . 9 3 "
F N  B M D ( g / c m ^ ) 0 . 8 3 " 0 . 7 9 0 . 7 6 " 0 . 7 7 "
1 , < 2 . 4 7  m m o l / 1 ;  2 , 2 . 4 7 - 3 . 1 0  m m o l / 1 ;  3 ,  3 . 1 0 - 3 . 7 0  m m o l / 1 ;  4 ,  > 3 . 7 0  m m o l / 1  
C e l l s  w i t h i n  a  r o w  l a b e l l e d  w i t h  s u p e r s c r i p t  l e t t e r s  a r e  s i g n i f i c a n t l y  d i f f e r e n t  t o  
B M D ,  b o n e  m i n e r a l  d e n s i t y ;  L S ,  l u m b a r  s p i n e ;  F N ,  f e m o r a l  n e c k ;  L D L ,  l o w  d e n s i t y  l i p o p r o t e i n
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Figure 3.2 M ean FN and LS BMD by LDL level cut-offs among Caucasian women in spring 
and autum n.
Bars labelled with superscript letters (a) are significantly different to (b)
BMD, bone mineral density; LS, lumbar spine; FN, femoral neck; LDL, low density lipoprotein.
3.4.3.S Mean o f bone measures by HDL cut-offs, separated by ethnicity 
As presented in table 3.6, HDL was grouped into the following quartiles: <1.32, 1.32-1.57, 1.57- 
1.88, >1.88. Higher levels o f HDL were associated with a slightly lower mean BMD at FN in 
Asian women in both seasons, but otherwise no differences were observed. In the Caucasian 
group, no significant differences were seen between the lowest and highest HDL quartiles against 
the FN BMD in autumn.
Table 3.6 Quartiles for HDL values against bone measurements
H D L  Q u a r t i l e s
1 2 3 4
( n = 5 1 ) ( n = 5 7 ) ( n = 5 9 ) ( n = 5 6 )
F N B M D  ( g / c m ^ ) -  
C a u c a s i a n
0 . 8 2 0 . 8 2 0 . 8 0 0 . 7 6
g
( n = 2 0 ) ( n = 1 7 ) ( n = 9 ) ( n = 8 )
! F N  B M D ( g / c m ^ ) -  A s i a n 0 . 8 3 0 . 8 1 0 . 7 6 0 . 7 3
• E
F N  B M D ( g / c m ^ ) -  
A s i a n
O j G 0 . 8 1 0 . 7 0 0 . 7 4
1 , < 1 . 3 2 m m o l / 1 ;  2 ,  1 . 3 2 - 1 . 5 7 m m o l / 1 , 3 , 1 . 5 7 - 1 . 8 8 m m o l / 1 , 4 , > 1 . 8 8 m m o f l
B M D ,  b o n e  m i n e r a l  d e n s i t y ;  L S ,  l u m b a r  s p i n e ;  F N ,  f e m o r a l  n e c k ;  H D L ,  h i g h  d e n s i t y  l i p o p r o t e i n
3.4.3.4 Mean bone measures by TAG cut-offs, separated by ethnicity
Table 3.7 presents the TAG quartiles grouped into <0.75, 0.75-1.03, 1.03-1.46, >1.46 categories 
against FN BMD. Among Asian women, there was no significant difference between the quartile 
groups against FN BMD for either season.
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Table 3.7 TAG quartile values against FN bone measurements in Asian women.
TAG Quartiles among Asians
1 2 3 4
( n = 6 ) ( n = 1 3 ) ( n = 1 6 ) ( n = 2 0 )
1
<
F N  B M D ( g / c m ^ ) 0 . 7 0 0 . 7 0 0 . 7 0 0 . 7 0
bx>
1
F N  B M D ( g Z c m ^ ) 0 . 6 9 0 . 7 6 0 . 7 9 0 ^ 3
1 ,  < 0 . 7 5  m m o l / 1 ;  2 , 0 . 7 5 - 1 . 0 3  m m o l / 1 ;  3 , 1 . 0 3 - 1 . 4 6  m m o l / 1 ;  4 ,  > 1 . 4 7  m m o l / 1  
B M D ,  b o n e  m i n e r a l  d e n s i t y ;  L S ,  l u m b a r  s p i n e ;  F N ,  f e m o r a l  n e c k ;  T A G ,  t r i g l y c e r i d e
3.4.3.S Mean bone measures by insulin cut-offs, separated by ethnicity 
Insulin was grouped into the following quartiles: <9.57, 9.57-12.0, 12.0-15.7, >15.7. As 
presented in table 3.8, a high level o f insulin is significantly associated with a high level o f  FN 
BMD in the Caucasian population. There is also a significant difference between for FN BMD in 
insulin quartiles 2 and 4 (figure 3.5). No significant differences between insulin quartiles against 
BUA levels were observed in spring (Table 3.8).
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Table 3.8 Insulin quartile value against FN BMD and BUA measurement among Caucasian
Insulin Quartile among Caucasians
1 2 3 4
( n = 5 5 ) ( n = 5 8 ) ( n = 4 7 ) ( n = 3 4 )
!
F N  B M D ( g / c m ^ ) 0 . 8 0 0 . 7 7 * 0 . 7 9 0 . 8 5 " )
( n = 1 0 ) ( n = 1 9 ) ( n = 6 ) ( n = 7 )
B U A ( d B / M H z ) 6 1 . 7 0 7 2 . 8 4 5 4 . 9 3 7 8 . 0 0
1
%
I ,  < 9 . 5 7  m U / 1 ;  2 , 9 . 5 7 - 1 2 . 0  m U / 1 , 3 ;  1 2 . 0 - 1 5 . 7  m U / 1 , 4 ,  > 1 5 . 7  m U / I
C e l l s  w i t h i n  a  r o w  l a b e l l e d  w i t h  s u p e r s c r i p t  l e t t e r s  ( a )  a r e  s i g n i f i c a n t l y  d i f f e r e n t  t h a n  ( b )
B U A ,  b r o a d b a n d  u l t r a s o u n d  a t t e n u a t i o n ;  B M D ,  b o n e  m i n e r a l  d e n s i t y ;  F N ,  f e m o r a l  n e c k .
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Figure 3.3 FN BMD by insulin level cut-offs in Caucasian women in Autumn and Spring
Bars labelled with t superscript letters (a) are significantly different than (b)
BMD, bone mineral density; FN, femoral neck.
3.4.4 Association between serum lipids and bone quality according to menopause status 
(pre menopausal and post menopausal)
Table 3.9 below shows the correlation between lipids and bone measurements among in the pre­
menopausal sub-group, excluding women from the analysis who stated that they had used HRT 
within the last year o f the study (n=3). The only remaining significant associations after BMI 
adjustment were between TAG and FN BMD in spring (p<0.05). However, the significance o f 
the correlation between TAG and FN BMD in autumn was lost after adjustment for BMI.
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Table 3.9 correlation coefficients for the associations between markers o f CVD and bone 
health (BUA, VOS, FN, and LS) among pre menopausal women, separated by season and 
ethnicity
T A G  ( m m o F l ) C h o l e s t e r o l L D L H D L I n s u l i n
( m m o F l ) ( m m o l / 1 ) ( m m o l / 1 ) ( m U / 1 )
B U A  ( d B / M H z )  
C a u c a s i a n  ( n = 2 5 ) - 0 . 1 8 0 . 0 7 0 . 2 5 - 0 . 1 7 0 . 0 1
A s i a n  ( n = l l ) - 0 . 0 9 0 . 2 3 0 . 1 4 0 . 2 5 - 0 . 4 6
V O S  ( m / s )  
C a u c a s i a n  ( n = 2 5 ) - 0 . 3 0 - 0 . 2 3 - 0 . 0 9 - 0 . 2 9 - 0 . 1 0
A s i a n  ( n = l l ) 0 . 0 2 0 . 0 6 0 . 0 3 0 . 0 7 - 0 . 5 4
L S  ( g / c m ^ )  
C a u c a s i a n  ( n = 7 6 ) - 0 . 0 6 0 . 0 5 0 . 0 8 - 0 . 0 1 - 0 . 0 6
e A s i a n  ( n = 2 1 ) 0 . 4 0 - 0 . 0 2 0 . 0 4 - 0 . 1 9 - 0 . 0 8
j F N  ( g / c m ^ )  C a u c a s i a n  ( n = 7 7 ) - 0 . 0 6 0 . 1 5 3 0 . 1 5 0 . 0 8 0 . 0 4< A s i a n  ( n = 2 1 ) 0 . 5 1  * ( 0 . 3 7 ) 0 . 2 1 0 . 3 4 - 0 . 3 1 0 . 1 0
B U A  ( d B / M H z )  
C a u c a s i a n  ( n = 1 2 ) - 0 . 1 1 - 0 . 0 1 0 . 1 4 - 0 . 3 2 0 . 4 8
A s i a n  ( n = 8 ) - 0 . 0 8 - 0 . 1 9 0 . 1 8 0 . 0 9 - 0 . 5 3
V O S  ( m / s )  
C a u c a s i a n  ( n = 1 2 ) - 0 . 2 9 0 . 0 5 0 . 2 8 - 0 . 4 1 0 . 1 7
A s i a n  ( n = 8 ) 0 . 0 2 0 . 1 8 0 . 3 1 - 0 . 2 6 - 0 . 4 8
L S  ( g / c m ^ )  
C a u c a s i a n  ( n = 7 5 ) - 0 . 0 4 0 . 0 6 0 . 0 9 - 0 . 0 3 - 0 . 0 4
A s i a n  ( n = 2 0 ) 0 . 3 9 0 . 0 3 0 . 0 6 - 0 . 1 5 - 0 . 1 8
F N  ( g / c m ^ )  
C a u c a s i a n  ( n = 7 5 ) - 0 . 0 6 0 . 1 8 0 . 1 5 0 . 1 4 0 . 0 21 A s i a n  ( n = 2 1 ) 0 . 5 8 * * ( 0 . 5 0 * ) 0 . 2 9 0 3 8 - 0 . 2 2 0 . 0 5
* correlation is significant at the 0.05 level, ** correlation is significant at the 0.01 level () partial correlation for BMI
BUA, broadband ultrasound attenuation; BMD, bone mineral density; LS, lumbar spine; FN, femoral neck; VOS, velocity of 
sound; LDL, low- density lipoprotein; HDL, high density lipoprotein; TAG, triglyceride.
Further analyses were undertaken to assess the associations between CVD and bone markers in 
the post-menopausal sub groups. Six subjects were excluded from the analysis due to use o f 
HRT within the last year o f the study. All o f the relationships previously identified as significant 
in the total population (table 3.3) were replicated in the post-menopausal sub group.
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3.4.5 Association between lipid profile and bone metabolism
In Caucasian women, a significant negative association was found between CTx and insulin 
levels in both seasons. In addition, higher Ctx was associated with higher cholesterol and LDL in 
spring. Significant positive correlations were found between PTH and TAG, cholesterol, and 
LDL levels consistently in both seasons. These correlations remained significant after adjustment 
for BMI and vitamin D status.
In the Asian sub-group, the only significant relationship identified was between PTH and TAG in 
the autumn but not in spring, with higher TAG levels associated with lower PTH levels (p<0.05). 
However, this significance was lost after adjustment for BMI and vitamin D.
Table 3.10 Correlations (r) between markers o f CVD, CTx and PTH
T A G
( m m o l / l )
C h o l e s t e r o l
( m m o l / l )
L D L  ( m m o l / l ) H D L
( m m o l / l )
I n s u l i n  ( m U / 1 )
c t x  ( n g m l )  
C a u c a s i a n - 0 . 1 5 0 . 2 3 0 . 2 1 0 . 2 0 - . 5 2 *  * ( - 0 . 4 7 * * )
g
Ç5
( n = 3 5 )
A s i a n  ( n = 2 8 ) - 0 . 0 8 0 . 1 5 0 . 0 9 0 . 2 3 0 . 0 6
Ü
1 P T H  ( p m o H )  C a u c a s i a n 0 . 1 9 * * ( 0 . 1 0 ) 0 . 1 9 * * ( 0 . 2 0 * * ) 0 . 2 3 * * ( 0 . 2 2 * * ) - 0 . 0 4 0 . 0 7
( n = 1 8 8 )  
A s i a n  ( n = 5 5 ) - 0 . 2 6 *  ( - 0 . 2 5 ) 0 . 0 0 1 - 0 . 0 3 0 . 1 5 0 . 0 8
C t x  ( n g m l )  
C a u c a s i a n 0 . 0 2 0 . 3 3 * ( 0 . 3 8 * ) 0 . 3 4 * ( 0 . 4 5 * ) 0 . 1 4 - 0 . 5 6 * * ( - 0 . 5 6 * * )
1 ( n = 3 5 )A s i a n  ( n = 2 8 ) - 0 . 0 7 0 . 2 1 0 . 1 5 0 . 2 5 0 . 1 41 P T H  ( p m o l / I )  
C a u c a s i a n 0 . 1 9 * * ( 0 . 1 0 ) 0 . 2 1 * * ( 0 . 2 1 * * ) 0 . 2 4 * * ( 0 . 2 2 * * ) - 0 . 0 1 0 . 0 9
( n = 1 9 1 )  
A s i a n  ( n = 5 5 ) - 0 . 0 0 4 - 0 . 0 8 - 0 . 0 3 - 0 . 1 3 0 . 1 8
*  c o r r e l a t i o n  i s  s i g n i f i c a n t  a t  t h e  0 . 0 5  l e v e l ,  * *  c o r r e l a t i o n  i s  s i g n i f i c a n t  a t  t h e  0 . 0 1  l e v e l  
0  p a r t i a l  c o r r e l a t i o n  f o r  B M I  a n d  v i t a m i n  D  s t a t u s .
C t x  C  t e l o p e p t i d e s  o f  t y p e  I  c o l l a g e n ;  P T H ,  p a r a t h y r o i d  h o r m o n e ;  L D L ,  l o w -  d e n s i t y  l i p o p r o t e i n ;  H D L ,  h i g h  d e n s i t y  
l i p o p r o t e i n ;  T A G ,  t r i g l y c e r i d e .
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3.5 DISCUSION AND CONCLUSION
The aim o f this study was to investigate the association between bone health and lipid profiles 
and to thus elucidate the underlying mechanism for the association o f osteoporosis and CVD risk. 
These data indicate a link between low bone quality and increased CVD risk in the Caucasian 
population. A high level o f serum lipids, in particular cholesterol and LDL, were associated with 
low bone density at the lumbar spine and femoral neck regions. Results from this current study 
are concordant with the findings o f some previous studies suggesting an association between 
osteoporosis and at least one type o f  lipid as risk factor o f CVD (D'Amelio et al., 2008, 
Yamaguchi et al., 2002, Makovey et al., 2009, Orozco, 2004, Cui et al., 2005, von der Recke et 
al., 1999).
This study specifically indicates a link between higher bone resorption and an increased risk o f  
CVD in the Caucasian population. Few studies have indicated increased bone turnover alongside 
increased serum cholesterol and lipids levels, so this is a somewhat novel finding. However, 
Makovey, et. al. (2009) did report an inverse relationship between total cholesterol and LDL with 
BMD at all measured bone sites in a cohort o f postmenopausal women, thus supporting the 
possibility o f increased bone resorption. Samelson, et al. (2004) on the other hand failed to 
identify a significant correlation between total cholesterol level and BMD at any o f the bone sites 
examined, possibly because a larger, more diverse population and the study was conducted in 
both men (450) and women (712) (Samelson et al., 2004). Researchers had conflicting results 
because their subjects were o f different ages/postmenopausal stages, these equivocal findings 
could be explained by the effects o f age and hormonal changes in the postmenopausal period.
Another cross-sectional, longitudinal study that investigated the association between serum 
cholesterol and BMD found a significant negative association only at study baseline between 
serum cholesterol and BMD at the lumbar spine region (even after adjustment for age and BMI). 
However, the correlation was not observed over the eight year follow-up period. The authors 
suggested that the association between spine BMD and serum cholesterol could be explained by 
the fact that both variables are affected by oestrogen deficiency, rather than the association being 
due to a direct influence o f serum cholesterol on osteoblast function (Tanko et al., 2003).
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The findings o f the current study highlight the importance o f menopausal stage, since most o f the 
significant associations between lipid and / insulin levels, and bone variables were lost when the 
analysis was conducted in pre-menopausal women alone. In fact, all o f  the relationships 
identified in the whole sample analysis appear to have been driven by the post-menopausal sub­
group, indicating that the postmenopausal period is fundamentally involved in this interaction. 
Makovey et al. (2009) studied a much larger cohort o f postmenopausal women and divided them 
into two sub groups; on HRT and without HRT. The study concluded that HRT modified the 
relationship between LS, and whole body BMD with total cholesterol and LDL. The effect o f 
HRT on the relationship between lipid status and bone health was the reason for excluding HRT 
users fi*om the analyses presented here.
The unexpected inverse correlations detected between HDL and FN BMD in both ethnic groups 
were opposed to the findings o f another study reporting a positive correlation between HDL and 
BMD at the and lumbar BMD, after adjustment for multiple covariant (Yamaguchi et al., 2002). 
It might be due to the weak subject numbers or this relationship lost if  adjusted with other 
confounders that this study did not considered in the analysis. However, Yamaguchi and 
colleague (2002) agree with our finding that there was no correlation between TAG levels and 
bone density at any site (Yamaguchi et al., 2 0 0 2 )
Upon examination o f quartiles o f  cholesterol levels against BMD in the Caucasian group, the 
findings were in agreement with those o f Tanko and colleagues (Tanko et ah, 2003). This group 
also reported a significant difference between cholesterol quartiles and LS BMD despite their 
inclusion o f a larger population (n=340) distributed between each o f the quartile (n=85). Herein, 
we found a positive correlation between serum cholesterol and Ctx in the spring but not in the 
autumn. However, Tanko and colleagues did not identify any significant correlations between 
serum cholesterol and changes in bone turnover estimated using serum osteocalcin and Ctx as 
biomarkers (Tanko et al., 2003). These equivocal findings could be explained by the effect o f 
sample size.
The current study did not find an association between either BUA or VOS with HDL, where a 
similar study found an inverse association between these variables (Buizert et al., 2009). It is 
expected to find positive association between BUA and VOS with HDL, where higher number o f
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BUA indicate bone tissue changes and VOS indicate the speed o f sound and the frequency 
dependence o f attenuation. The loss o f  association in this study might due to the weak subject 
numbers.
Positive correlation between PTH and lipid levels (total cholesterol and LDL) was apparent in 
Caucasian group in both seasons, but was not apparent in the Asian population. This is a novel 
finding that has not been investigated by other researchers in the field. It is therefore difficult to 
confirm this finding in light o f other published research, but it is considered a plausible 
relationship given that PTH is raised when 25(OH)D gets lower in blood; inverse associations 
have been shown in studies between 25(OH)D with total cholesterol and LDL (please refer to 
chapter 2).
In the Asian group, FN BMD correlated positively with semm TAG, and correlated inversely 
with HDL after adjustment o f BMI, which oppose to the expected results. This relationship might 
due to a confounder that has not been considered in the analysis. For example, physical activity 
level might be a factor that may explain this relationship. This study did not find a correlation 
between lipid levels or insulin levels with bone metabolism variables among Asians, which may 
be a consequence o f the small sample size analysed.
The strength o f this study is that it is longitudinal in nature and incorporates repeated bone 
measures in autunrn and spring within the same subjects. However, obtainment o f  unequal 
subject numbers within each ethnic sub-group (Caucasian versus Asian) might be one o f the 
study limitations, especially when lipid levels are grouped into quartiles and compared with bone 
quality variables. This is because the numbers in the quartiles in the Asian group become very 
small, making any relationships statistically difficult to detect. In future studies, an easily 
obtainable and important CVD risk factor to obtain data for would be the measurement o f blood 
pressure.
This study indicates a clear negative assoeiation between total cholesterol and LDL levels and 
bone density at FN and LS sites in Caucasian women. This relationship was more specifically 
defined in post-menopausal women, suggesting an important role for female hormones. In 
conclusion, the data indicate that there is a link between CVD risk factors and bone health. 
Larger sample sizes especially in the Asian group would be advantageous in future studies to aid
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the detection o f ethnic differences in this relationship. Investigating the changes in CVD risk 
factors following improvement o f  bone density as part o f  an intervention study would be a key 
strategy for elucidating the relationship between osteoporosis and CVD risk.
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CHAPTER 4
INTERACTION BETWEEN VITAMIN D STATUS, ETHNICITY, BONE 
HEALTH, MUSCLE FUNCTION AND LIFESTYLE
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4.1. INTRODUCTION
4.1.1. Interaction between vitamin D status and bone health
Many diseases and health disorders are associated with vitamin D deficiency, which are more 
prevalent within certain UK sub-populations. The economic implications o f vitamin D deficiency 
are not clearly defined, but Grant and colleagues (2009) estimated that if vitamin D status in 
Western Europe alone could be raised from the classification o f deficient to sufficient, the 
estimated economic burden could be reduced by at least 187,000 million Euros per year (Grant et 
al., 2009). Vitamin D deficiency is therefore o f high public health importance.
Historically, a strong relationship between vitamin D status and bone health has been shown. 
Vitamin D stimulates bone matrix formation and bone maturation, by enhancing osteoclastic 
activity and potentially influencing differentiation o f bone cell precursors (Lanham-New, 2008). 
Studies have reported that a higher 25(OH)D concentration is linked to higher bone mass in 
women of all ages; 25(OH)D higher than 75 nmol/L has been shown to enhance calcium 
absorption fi*om the gut and kidney, suppress PTH elevation, reduce the risks o f  bone loss and 
fractures, and some extra-skeletal diseases (Lee and Jiang, 2008). Conversely, vitamin D 
deficiency may cause osteomalacia, which is generalized by bone pain, muscle aches and muscle 
weakness; symptoms similar to fibromyalgia. Indeed, Danish women who have symptoms o f 
fibromyalgia have been shown to also suffer from vitamin D deficiency and osteomalacia (Glerup 
et al 2000). Vitamin D deficiency can also increase mobilization o f calcium from bone, a process 
that precipitates osteoporosis.
Holick (2002) emphasized the importance o f  an optimal level o f vitamin D during the pre­
menopausal period (Holick, 2002).Meta-analysis studies have highlighted the lack o f  data 
available in pre-menopausal groups with regard to the association between 25(OH)D and bone 
health outcomes (Cranney et al., 2007, Cranney et al., 2008). Most o f the vitamin D/bone health 
research focuses on post-menopausal women and older men. Based on these limited data sets 
there are inconsistent reports regarding the association between low 25(OH)D and some clinical 
outcomes such as bone fracture and performance measurements. However, fair evidence exists 
for an association between change in hip BMD (increased bone loss) and falls (Cranney et al.,
2008).
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One of the groups at highest risk o f vitamin D deficiency in the UK is the Asian population. 
Within this population, the most at risk are children, as their future growth and health is affected. 
One study investigated the vitamin D concentrations o f a large group of two year old children 
(n=600) o f Asian descent. The study found that 34% o f children had values o f vitamin D below 
25 nmol/1, a value considered to indicate deficiency, and 18% had levels below 20 nmol/1 that 
considered severe deficiency(Lawson and Thomas, 1999). Many o f the infants also showed signs 
o f poor diet such as iron deficiency anaemia. It has been suggested by Zipitis (2006), that it is 
more cost-effective to provide supplements to prevent deficiency, than to treat problems caused 
by the deficiency, such as rickets (Zipitis et al., 2006)..
After Asian children, adult Asian females are the next group to be identified as highly at high 
risk o f having low vitamin D status. According to Roy et al. (2007), who determined the 
association between 25(OH)D and BMD in South Asian women, the majority o f women (94%) 
had serum 250HD level <37.50 nmol/l(15 ng/ml), while 26% had evidence o f marked deficiency 
<12.5 nmol/1 (5ng/ml) (Roy et ak, 2007). Another study, comparing the vitamin D status o f South 
Asian and White European women, found that South Asian women had significantly lower serum 
25(OH)D (32.5+/-12.5 versus 75.0+/-17.5 nmol/1; p<0.001) (Datta et. ah, 2002). Since a low 
vitamin D status is more common among Asian women, more health complications and 
associated problems would be expected as a result.
The consequences o f low vitamin D status are minimized during adulthood, since it affects 
largely the young during growth and developmental stages, and the elderly due to decreasing 
bone mass. However, it is important to maintain optimal vitamin D levels throughout life, to 
lower the risk o f adverse effects later on. Whilst recent studies have investigated the association 
between osteoporosis and vitamin D deficiency among elderly women, there is little data on the 
incidence, determinants or metabolic consequences o f vitamin D deficiency in middle aged 
women. A few studies have reported low vitamin D status among pre-menopausal women, in 
particular in relation to bone health. Adami et al. (2009), for example, observed low levels o f 
vitamin D in 608 healthy pre-menopausal women who took part in a European study. Vitamin D 
level was found to be associated with low spine BMD and increased bone alkaline phosphatase as
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a marker o f bone turnover, especially in those who have low level o f vitamin D (Adami et ak,
2009).
4.1.2. Interaction between vitamin D status and muscle function
The roles o f vitamin D on muscle tissue function have been known for many years, and include 
genomic and non-genomic effects. Genomic effects are initiated by binding o f 1,25- 
dihydroxyvitamin D3 (l,25(OH)2D) to its nuclear receptor (vitamin D receptor; VDR), resulting 
in changes in gene transcription and subsequent protein syntiiesis. Non-genomic effects o f 
vitamin D are rapid and mediated through a membrane-bound VDR (Bartoszewska et ak, 2010). 
There remains substantial controversy and debate surrounding genetic variations in the VDR and 
the importance o f VDR polymorphisms in the development o f osteoporosis (Pfeifer et ak, 2002). 
Most recently, VDR polymorphisms have been described to affect muscle function. It is shown 
that a serum 25-hydroxyvitamin D level below 30 nmol/1 decreased muscle strength (Mastaglia et 
ak, 2011). It has been demonstrated that vitamin D supplementation in combination with calcium 
in elderly subjects contributes to the improvement o f neuro-muscular function (Pedrosa and 
Castro, 2005). A recent meta-analysis has concluded that using vitamin D at daily doses o f 800 to 
1,000 lU consistently imparted beneficial effects on bone strength and body balance (Muir and 
Montero-Odasso, 2011).
4.1.3. Ethnic differences in vitamin D status, bone health and muscle function
Research studies have indicated that people o f South Asian descent have a much lower vitamin D 
status compared to that o f a European population, as they exhibit risk factors such as having 
darker pigmented skin and cultural customs limit skin exposure. In addition to these genetic and 
cultural factors, geographical factors like latitude also come into play. For instance those South 
Asians who live in countries o f high latitude are at higher risk than people in the UK. There is a 
lack o f longitudinal studies o f ethnic groups that allow the effect o f seasonal variation on vitamin 
D to be assessed in South Asian populations versus Caucasian groups. Darling and colleagues 
performed a year-long longitudinal study and found that vitamin D deficiency was extremely 
common in South Asian women, where lack o f seasonal changes was observed (Darling et ak,
2010).
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The risk o f being vitamin D defieient with a high risk o f low bone health is increased in Asian 
populations. Cranney et al. (2007) reeommended that additional studies o f vitamin D in relation 
to bone density be undertaken in this population (Cranney et ak, 2007). A previous study also 
showed that a low vitamin D level (<25nmol/l) is associated with widespread pain, and is more 
pronouneed in South Asians (Macfarlane et ak, 2005). Furthennore, Arya et ak (2004) found a 
significant correlation between 25(OH)D deficiency and low bone mineral density at some bodily 
sites in healthy middle aged Asians who were living in India (Arya et ak, 2004). Another study 
investigated these relationships in South Asian women living in the UK and found a positive 
association between serum 25(OH)D and BMD, more speeifieally at the hip and spine regions 
(Roy et ak, 2007).
4.1.4. Assessing bone strength
The most eommon way to measure bone quality and strength is through measuring BMD. BMD 
measures the amount of mineral available per square centimetre o f bone. Bone size and thiekness 
are also important parameters for bone strength (please refer to figure 4.1). For example, wider 
and thicker bone is a stronger than narrower and less thick bone o f similar bone density
S tronger bone W eak er bone
Bone mineral density
More dense Less dense
Bone diameter
Wide N arrow
Cortical shell thickness
Thick Thin
C u rren t M e d ic in e  Or<
Figure 4.1 geometry and strength of bone
Adapted from atlas for osteoporosis
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A few techniques are available for the measurement o f bone mineral density, but the Dual energy 
X-ray Absorptiometry (DXA) scan is most commonly used in research studies. DXA is able to 
assess the bone density but it actually directly measures 2D areal bone mineral density, which 
should be designated as BMD Due to the nature o f the measurement, this method is size 
dependent (Adams, 2009). This is a particular problem if comparing populations with notable 
bone size differences. For instance, herein, the targeted population are Asians, who have a 
smaller bone size compared to Caucasians. In this case DXA might be unreliable and may result 
in underestimation o f  the bone density in the Caucasian group. Studies that have used a non-size 
dependent measures o f bone density suggest a lower BMD in South Asian women compared with 
Caucasian women (Hamson et al., 2003). However, Cundy and colleague found no differences in 
BMD between Indian and European women when bone size was corrected for (Cundy et al., 
1995). In contrast to DXA, Peripheral Quantitative Computed Tomography (pQCT) measures 
true volumetric BMD, designated simply as BMD, and so it is not size-dependent. It also allows 
the assessment o f bone strength and fracture risk beyond the means o f DXA assessments. Bone 
response can be detected by changes in geometry or redistributed mineral mass which could 
impact bone strength and risk o f fracture (Szabo et al. 2010). It is important to understand bone 
geometry and the mechanics by which bone tissue adapts itself in response to the different 
demands that are made on it. Figure 4.2 explains the types o f  loading experienced by bone, and 
how pQCT is able to estimate some o f these bone forces. Forces like fracture load, are measures 
reflecting bone-bending, where tension occurs mainly on the convex side and compression 
occurs on the concave side. The stress strength index (SSI) measures torque, twisting forces, and 
shear stress along the entire length o f bone.
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Figure 4.2 Types of loading experienced by mature bone
A,compression; B, tension; C, bending; and D, torque. Adapted from (Kontulainen, 2002)
PQCT is used to measure the bone density at peripheral sites, specifically the radius and tibia. 
The technique allows for separate measures o f cortical and trabecular bone that give simultaneous 
information on geometric properties, structural parameters and volumetric density, especially for 
appendicular bone (Gluer et al., 1997). Lots o f research assessing bone geometry in different 
population groups exists, but so far only a few have investigated the differences in volumetrie 
bone mineral density (vBMD) among pre-menopausal South Asian women versus Caucasian 
women. It is important to understand Asian bone geometiy to optimize diagnosis and therapy o f 
osteoporosis. One study showed a smaller radial cross sectional area, lower bone mineral content 
(BMC) and vBMD, cortical thickness, and cortieal area compared to European women. These 
differences could not be explained by ethnic differences in body size (Ward et ak, 2007). 
However, Roy and colleagues reported similar vBMD at the radius in young South Asian women 
compared with Caucasian women (Roy et ak, 2005), demonstrating some inconsistencies in the 
published literature.
4.1.5. Justification of the study
Ethnicity is an important issue with respect to vitamin D status and bone health. A debate is 
ongoing as to whether Asians and Caucasians differ in their volumetric bone density and lower 
extremity muscle ftinction, and whether these differences are related to differential vitamin D 
status. Little is also known about the prevalenee o f vitamin D defieiency-related bone pain. In 
this study, a pQCT bone scan, sit to stand tests and bone pain questionnaires are employed as new
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measurements to investigate these issues, along with the other conventionally used parameters. 
This project focuses on pre-menopausal women, testing the interaction between vitamin D, 
vBMD and lifestyle measurements. In addition, this study looks into more detail about UVB 
exposure behaviour (including from sun and artificial sources) in South Asian and Caucasian 
populations including in pre- and post-menopausal women. Furthermore, this study will explore 
the association between UVB exposure and bone health.
4.2. AIM AND OBJECTIVES
The aim o f this project is to investigate the differences in vitamin D concentration, bone health 
and lifestyle between South Asian and Caucasian pre-menopausal women and to test for 
interactions between these variables.
MAIN STUDY
1. To assess whether there are differences between South Asian and Caucasian pre-menopausal 
women in volumetric bone density at the radius and tibia sites.
2. To determine the association between pQCT bone measurements,25(OH)D and PTH levels.
3. To assess whether there are differences between pre-menopausal South Asian and Caucasian 
women in muscle function (grip strength, sit to walk test and muscle pain) and if this 
correlates with 25(OH)D concentration and PTH levels.
4. To assess the differences in bone/muscle pain between pre-menopausal South Asian and 
Caucasian women and to determine if  there is an association between bone pain, serum 
25(OH)D, and vBMD at radial and tibial sites.
5. To investigate differences in cardiovascular risk (lipids and Homeostatic model assessment 
(HOMA) between ethnic groups and to see if  these correlate with vitamin D status.
6. To assess whether there are differences between pre-menopausal South Asian and Caucasian 
women in UVB exposure behaviour, including sunbed use and exposure to sunlight, as well 
as their UV exposure dose (calculating UV absorbed in dosiometers). Behaviour measures 
will then be correlated with vitamin D level to look for a relationship.
7. To assess the longitudinal changes in bone density in a sample o f pre-menopausal South 
Asian and Caucasian women by investigating the association between pQCT measurements 
taken in summer 2010 and the DXA measurements from Autumn and Spring 2006-2007.
106
4.3. METHODS AND MEASURES
In Summer 2010, we aimed to re-invite the original cohort o f the D-FINES study (n=279 
Caucasian women: 144 post-menopausal and 135 pre-menopausal, and n=94 Asian women: 44 
post-menopausal and 50 pre-menopausal) for a repeat measurement o f vitamin D status, UVB 
exposure, nutrient intake, bone density and lifestyle and anthropometric variables. The intention 
of this design was to enable longitudinal analysis o f these variables over a four year period and to 
elucidate the factors affecting change in vitamin D status in the UK, where at present there is a 
lack o f such data. The original D-FINES (vitamin D, Food Intake, Nutrition and Exposure to 
Sunlight in Southern England) study was in 2006-2008, and included a total o f 373 Asian and 
Caucasian women in the Faculty o f Health and Medical Sciences at the University o f Surrey 
(EC/2006/19/SBMS). All women visited the Clinical Investigation Unit (CIU) four times in 
2006-2007 (summer, autumn, winter and spring) and once more in spring 2008. At each CIU 
visit, blood samples were taken for measurements o f vitamin D status and blood biochemistry. 
Physical activity was also assessed by questionnaire and anthropometric variables were 
measured. After each visit, dietary intake o f nutrients was assessed by completion o f a diet diary 
for 4 days, and UVB exposure was determined by the wearing o f dosimeter badges for a week 
and by completing a sun exposure diary for one week. The participants also undertook whole 
body DXA scans at the Nuffield Hospital, Guildford, in autumn and spring to assess bone 
density. Data collected from D-FINES is currently being used to inform public health policy via 
the Food Standards Agency (FSA) who funded the project (FSA project: N05064).
4.3.1. Criteria for participant selection
All women who were willing to return from the original D-FENES cohort were included in the 
study if  they were still eligible. Eligibility is defined as per the original study (see below).
Inclusion criteria:
• Women who have not suffered any condition or taken any medication likely to affect their 
bone metabolism.
o These criteria will be assessed using the health questionnaire, and will apply to 
both the main study and the sub study.
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Exclusion criteria:
• Coronaiy heart disease or has a pacemaker in situ 
Known Type 1 or Type 2 diabetes 
Renal failure or evidence o f renal impairment 
Liver disease 
Gout
Pregnancy- confirmed pregnancy o r planning pregnancy 
Given birth in the previous 3 months and/or currently breastfeeding 
Eating disorders including anorexia or bulimia nervosa 
Obesity o f known cause e.g. Cushings disease 
Alcohol abuse within the last 2 years
Uncontrolled thyroid disease or an abnormal TSH level based on GP opinion 
Respiratoiy disease (except stable asthma)
Treatment for a malignancy 
Rheumatoid arthritis 
Osteoporosis or osteomalacia
• Use o f the following medications:
o Hormone Replacement Therapy (for greater than 6 months) 
o Glucocorticoids
o Weight loss drugs/ preparations including orlistat (Xenical) or sibutramine 
(Reductil)
o Lipid lowering or anti-hypertensive drugs 
o Anti-depressant medication
4.3.2. R ecruitm ent and procedure
Participants were recruited from the original D-FESIES cohort (n=373 women), for whom contact 
details had already been collected by the D-FINES team See table 4.1 for attendance figures 
obtained from the original study. Ethical approval was obtained to re-contact these women 
(please refer to the appendix A for study ethical approval details).
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Table 4.1 Table of attendance during the original D-FINES study
Summer
2006
Autumn
2006
Winter
2006
Spring
2007
Spring
2008
C a u c a s i a n  P o s t - m e n o p a u s a l 1 4 4 1 3 8 1 3 3 1 3 3 8 0
C a u c a s i a n  P r e - m e n o p a u s a l 1 3 5 1 0 9 9 1 9 0 2 8
A s i a n  P o s t  m e n o p a u s a l 4 0 3 8 3 6 3 5 1 3
A s i a n  P r e - m e n o p a u s a l 4 6 3 9 3 5 3 5 9
A l l  C a u c a s i a n 2 7 9 2 4 7 2 2 4 2 2 3 1 0 8
A l l  A s i a n 8 6 7 7 7 1 7 0 2 2
A l l  W o m e n 3 6 5 3 2 4 2 9 5 2 9 3 1 3 0
4.3.3. Participants and study design
Study invitation letters were sent to a total 373 women from the original D-FINES study, with a 
participant information sheet, and the study flyer (see appendix A) and a pre-paid return 
envelope. Women who responded were sent a consent form (see appendix A). A total o f 115 
healthy females took part in the study (42 pre-menopausal, 75 post-menopausal women). Once 
consent forms were received, participants were scheduled for morning appointments at the CIU at 
the University o f Surrey for a blood sample, grip strength test, a timed sit-to-stand test, a pQCT 
bone scan and anthropometric measurements. At this visit women were also asked to self report 
their lifestyle, sun exposure and bone pain using questionnaires developed for this study. Figure 
4.3 provides a summaiy o f the activities undertaken during the main study visit to the CIU. All 
participants received two dosimeter badges (one for week days and one for the weekend), 
instructions on how to use the dosimeters and food diaries (4-day records) to be completed at 
home. Participants were instructed to send these back to the investigators using the freepost 
envelopes provided. (Please refer to appendix A for a copy o f the study protocol and summaiy)
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The protocol fo r individual participants (one tim e vis it 
to  CIU, University o f Surrey)
Breakfas t
b reak
Blood
s a m p le s  (20 
ml) for 
analysis of:
1. Vitamin D
2. PTH
3. Calcium
4. Albumin
About 10 min
A n th ro p o m e t r ic  
m e a s u re  
inc lude  he igh t  
an d  w eigh t ,  grip 
s t r e n g th
About 10 min
pQCT scan  
including 
f o re a rm  a n d  
lo w er  leg
About 30 min
Sit-to 
s t a n d  t e s t
About 10 
min
Filling o u t  
q u e s t io n n a i r e :
1. Lifestyle 
su rvey
2. D ietary  
su rvey  
(op t iona l)
3. B one pain 
survey
4. UVB 
e x p o s u re
^survey
About 20 min
Figure 4.3 Study day protocol with approximate timescales for each task 
4.3.4. Measurements and tools used
4.3.4.L Anthropometries
All subjects were weighed in light clothes and without shoes on dual Seca scales (to the nearest 
two decimal points). Height was measured using a wall-mounted stadiometer, with shoes 
removed (to the nearest 0.1cm). Body mass index (BMI) was calculated using the equation:
BMI (kg/m2) = weight/ [height*height]
Waist and hip circumferences were measured from set points using measuring tape, and rounded 
to the nearest two decimal points. Data measurements were used to calculate the waist to hip 
ratio. Grip strength was measured using the Jamar hand dynamometer (Sammons Preston Rolyan, 
homecraft Ltd.) in kilogram off applied force from the right and left hands to assess muscle 
strength.
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4.3.4.2. Blood biochemistry
A fasted blood sample o f 20 ml was collected for vitamin D and PTH measurements. Blood 
samples were collected by a trained phlebotomist (Mrs Sue Starkey). All samples centrifuged to 
separate serum then were stored at -80°C prior to analysis. Analysis o f all blood samples was 
undertaken on anonymised samples bUnded to the study group. 25(OH)D (nmol/1) was analysed 
by high-performance liquid chromatography (HPLC) in collaboration with Dr Jacqueline Berry 
o f the Manchester laboratory, where it participate in the Super-regional assay scheme. Serum 
PTH was measured on an Immulite 2500 biochemistry analyzer from Diagnostic Products 
Corporation (Los Angeles, CA) and glucose (mmol/l) was measured by ILAB 650. Serum 
insulin was measured using Insulin Specific Millipore HI-14K (mU/1) with a human insulin- 
specific RIA kit provided by Millipore Corporation and Advance Life Science. Lipid profile have 
been assessed by ILAB 650 automated assays o f clinical analyser (mmol/l). Plasma LDL 
cholesterol were calculated using the formula LDL = Total cholesterol - (Triglycerides levels / 5 
+ HDL levels). The HOMA model was used to estimate insulin resistance (IR), beta cell function 
(%B) and insulin sensitivity (%S) using fasting glucose and insulin levels. (Please refer to chapter 
2 for more detail on the HOMA calculator).
4.3.4.3. Bone density measurementpQCT
A Stratec Medizintechnik GmbH XCT2000L bone densitometer scanner (S/N 91343) was 
installed in the CIU at the University o f Surrey in Januaiy 2010. Both UK-wide and local 
radiation regulations have been complied with and all investigators undertook appropriate 
radiation training prior to operating the scanner (please refer to the Appendix A for a copy o f  the 
training certificate). PQCT measurements were taken at two sites o f the radius and three sites o f 
the tibia (non-dominant) site; measuring vBMD, bone geometiy, fracture load and muscle/fat 
measurements. Figure 4.4 provides an example o f the first scanned slide results from the radius 
(please refer to appendix A for more examples o f other scanned slides). The device translate to 
acquire a trans-axial image. The X-ray source (58kV, 180pA) is collimated to produce a narrow 
fan beam with an effective width o f 2.3 mm. The total radiation dose for each scan is less than 2 
micro sieverts (pSv). The pQCT machine was calibrated weekly using a quality control phantom, 
which includes soft tissue equivalent material. The reliability o f  the PQCT machine have been 
tested by repeated measurements (three radius scans and five tibia scan) over the period o f six
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months. CV of selected radius PQCT measurements o f three sites scanned were; 6.25% for bone 
mass, 11.41% for total bone area, and 4.78% for total bone density. CV of seleeted tibia PQCT 
measurements were 0.74% for bone mass, 0.77% for total bone area, and 0.91% for total bne 
density.
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Figure 4.4 Example output o f the pQCT bone scan at the radius
summarizing the measurement reading for each scan site (4% distal radius and 66% diaphyseal 
radius). The scanner also calculated muscle and fat measurements at 66% site, (data not shown in 
this slice).
The bone pQCT measurements were taken at two radius sites; the 4% distal radius and the 66% 
diaphyseal radius, and 3 tibia sites;4% distal tibia, 14% diaphyseal tibia, and 38% tibia mid shaft. 
One extra scan site (at 66%) in the tibia was also performed for fat and muscle measurements. 
Scan sites were automatically set by the pQCT scanner. Figure 4.5 below illustrates the scanned 
sites within the radius and tibia bone.
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Fat, M u scle  an d  b o n e  area  a t 66%
Tibia m id sh a ft 38%
I D iap h ysea l tib ia 14%
Distal tib ia  4%
D iap hysea l radius 66%
D istal rad ius 4%
Figure 4.5 PQCT measurement sites in the radius and tibia
Definitions o f the pQCT seanner parameters are:
Mass: bone mass of a slice o f 1 cm in grams (g)
SSIPOL: polar strength strain indices in mm^. This parameter predicts the torsional bone 
strength, the bending strength with respect to the X or Y axis.
SSIX: strength strain index, the bending strength in respect to X
SSIY: strength strain index, the bending strength in respect to Y
13
Total Area: total bone area in mm^. Cross seetional area o f the bone after the soft tissue has been 
peeled off.
Total Density: total bone density in mg/cm^
Cortical Density: cortical bone density in mg/em^
Cortical Area; cortical bone area in mm^. The area assigned to be purely cortical
Cortical Thickness C2: cortical thickness in the circular ring mode is the difference between the 
outer and the inner radius in mm
PE R I C: periosteal circumference in the circular ring model in mm 
ENDO C: endosteal circumference in the circular ring model in mm
Cortical and Subcortical Area: cortical and subcortical area in mm^; the area between the outer 
bone edge and trabecular area. Subeortieal bone is defined as the area that could not be assigned 
to cortical or trabecular area
Cortical and Subeortieal Density: cortical and subeortieal density in mg/cm^
Trabecular Area: trabecualr area in mm^. Cross sectional area o f the trabecular area after the 
cortical and subeortieal area has been peeled off.
Trabecular Density: trabecular density in mg/c^
4.3.4.4. Muscle function and strength tests
Sit-to-walk (STW) and Sit-to-stand (STS) test were used to assess muscle function and strength. 
Subjects were asked to sit in a comfortable wooden chair with their back in contact with the 
backrest o f the chair and their feet resting on the ground in front o f the chair (standardised 
position). From the initial seated position, subjects were asked to stand (STS) and walk to another 
chair 6 meters directly in front (STW). The time taken to complete both stages o f the test was 
recorded by stopwatch. This test procedure was obtained from published studies (Kerr et al.,
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2004, Kerr et al., 2007). Eaeh eomponent o f this test was measured five times, and an average 
(mean) time was calculated from these readings.
4.3.4.5. Lifestyle and other health measurements
All subjects were asked to complete two short questionnaires that were designed for the purpose 
o f the study to measure bone and muscle pain, and UVB exposure. The bone and muscle pain 
questionnaire was design carefully to locate pain in the body with intensity rated using a scale 
ranging from 0 to 10; 0, no pain to 10,extremely painful. Other questions about healthy living, the 
ability to cany heavy groceries and reaching high objects were also considered. Other health and 
physical activity questionnaires and a food diaiy were used from the original D-FINES study to 
assess general health, lifestyle, and medical histoiy. A UV behaviour questionnaire was also 
designed for the purpose o f the study to assess the sunlight and exposure to artificial sources, the 
skin area exposed and the amount, if any o f sun block used. (Please refer to appendix A for more 
detail on the questionnaires used in this project). A spectrophotometer (CECIL CE Aquarius 
7200 (7000 calibrating series)) with computer software (Data Stream CE 300 series) was used 
estimate the standard erythemal dose (SED) for eaeh subject. Data from food dairy questionnaires 
over four days were collated to estimate the calcium and vitamin D intake, using Win Diet 
software, Robert Gordon, Aberdeen).
4.3.5. Statistical analysis and power
• Differences in vBMD indices and bone pain by ethnicity were assessed via T-tests and 
Mann-Whitney tests as appropriate. Using estimates o f the radius (arm) reported by Ward 
et al., (2007), 12 participants are needed in each group for 80% power in assessing 
difference in mid-shaft radial-cortical vBMD. There is no published quantitative data on 
vitamin D deficiency and bone and muscle pain ratings, so no power calculation could be 
performed for these variables. In addition, the design o f the study involved calling back 
the registered subjects with the initial study.
• Differences in UVB exposure by ethnicity were analysed by frequency analysis.
• Partial correlations (controlling for the significant variable between groups; height and 
weight) were used to assess whether there was a statistically significant correlation 
between vitamin D status, vBMD and bone pain.
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4.3.6. Study Evaluation
4.3.6.1. Benefits to participants
All subjects were offered a summary o f their results, including bone density, dietaiy analysis, and 
vitamin D status sent with a letter after completion o f the study. The importance o f the data 
collected to the scientific community at large was also stressed, particularly with respect to 
establishing whether vitamin D levels in the UK are changing. The importance o f understanding 
social influences o f vitamin D intake in order to produce effective public health campaigns was 
also highlighted. Subjects were reimbursed for all travel expenses.
4.3.6.2. Risks to participants
• PQCT measurements (for assessment o f bone mineral density) were painless and involve 
a very low total radiation dose 3 pSv, which is the equivalent radiation o f l/6th o f a chest 
X-ray). If  the participant moved during the scan it had to be repeated (the total X-ray dose 
in this case would still only reach 6 pSv, which is equivalent to 1/3*^  ^ o f a chest X ray). 
These doses remain less than the doses obtained during one trip- seven hour return 
transatlantic flight (80 pSv). Therefore, the risks/adverse effects likely to occur as a result 
o f the pQCT radiation dose were deemed to be minimal.
• The venipuncture might cause some minor discomfort, although samples were taken by an 
experienced phlebotomist to minimise any adverse effects.
4.3.6.3. Benefits to scientific knowledge and public health policy
This study will be o f benefit to the vitamin D research field and could inform public health 
policies on vitamin D. This work should also help to bridge gaps in knowledge eoneeming bone 
pain, bone density and lower extremity muscle ftmction in Asian and Caucasian individuals. The 
aim was to assess the link between vitamin D status and bone density that could potentially have 
therapeutic implications. It also provides cmcial data on UVB exposure behaviours, in relation to 
vitamin D and bone health in the South Asian population, which has never before been provided 
in the literature. The study aims to give important insights into the sociological influences on 
vitamin D status and related lifestyle behaviours, which could help to inform public policy about 
effective ways to improve vitamin D status.
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4.4. RESULTS
4.4.1. Demographic, anthropometric & functional measurements
Table 4.2 displays the demographic information and functional measurements o f the study 
subjects. A total o f 41 subjects; 22 Caucasian females and 19 Asian females took part in the 
study. Subjects’ ages ranged from 19-48 years old, and were all considered to be premenopausal. 
A few subjects had noticed some signs o f the menopause but had been told by a physician that 
they were not yet considered as menopausal. Caucasian females were significantly taller 
(p<0.001), but slightly thinner than Asian females. Caucasian females had significantly lower 
BMI (p=0.03), and a slightly lower waist to hip ratio than Asian females. Caucasian women were 
also significantly stronger in right hand grip strength (p<0.01)
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Table 4.2 Demographic data and functional measurements for Caucasian and Asian 
females participating in D-FINES II
M e a n  [ S D ]
A g e  ( y e a r s ) C a u c a s i a n ,  n = 2 2 4 0 . 5 5  [ 4 . 8 3 ]
A s i a n ,  n = 1 9 4 4 . 1 6  [ 9 . 7 4 ]
S i t t i n g  h e i g h t  ( c m ) C a u c a s i a n ,  n = 1 8 8 4 . 5 3  [ 2 . 4 5 ] * * *
A s i a n ,  n = 1 6 8 1 . 2 8  [ 2 . 4 7 ] * * *
S t a n d i n g  h e i g h t  ( m ) C a u c a s i a n ,  n = 2 2 1 . 6 7 [ 0 . 0 5 ] * * *
A s i a n ,  n = 1 9 1 . 6 0  [ 0 . 0 5 ] * * *
w e i g h t  ( k g ) C a u c a s i a n ,  n = 2 2 6 7 . 5 9  [ 1 0 . 6 0 ]
A s i a n ,  n = 1 9 7 1 . 1 8  [ 1 3 . 6 9 ]
B M I C a u c a s i a n ,  n = 2 2 2 4 . 5 7  [ 3 . 9 6 ] *
A s i a n ,  n = 1 9 2 7 . 8 5  [ 5 . 6 0 ] *
W a i s t  ( c m ) C a u c a s i a n ,  n = 1 9 8 5 . 4 2  [ 9 . 6 7 ]
A s i a n ,  n = 1 6 9 3 . 0 6  [ 1 3 . 5 6 ]
H i p  ( c m ) C a u c a s i a n ,  n = 1 9 1 0 1 . 7 4  [ 9 . 4 3 ]
A s i a n ,  n = 1 6 1 0 7 . 1 3  [ 1 1 . 1 7 ]
W a i s t  t o  h i p  r a t i o C a u c a s i a n ,  n = 1 9 0 . 8 4  [ 0 . 0 5 ]
A s i a n ,  n = 1 6 0 . 8 7 [ 0 . 0 6 ]
G r i p  s t r e n g t h  r i g h t  h a n d  ( k g  f o r c e ) C a u c a s i a n ,  n = 1 9 2 4 . 9 1  [ 5 . 3 6 ] * *
A s i a n ,  n = 1 6 2 0 . 2 1  [ 5 . 0 3 ] * *
G r i p  s t r e n g t h  r e f t  h a n d  ( k g  f o r c e ) C a u c a s i a n ,  n = 1 9 2 2 . 3 2  [ 5 . 0 3 ] *
A s i a n ,  n = 1 6 1 9 . 0 0  [ 5 . 8 2 ] *
S i t  t o  w a l k  t e s t  ( s e c o n d s ) C a u c a s i a n ,  n = 1 9 6 . 1 7  [ 0 . 7 3 ]
A s i a n ,  n = 1 5 6 . 6 3  [ 0 . 8 1 ]
M u s c l e  p a i n  s c o r e C a u c a s i a n ,  n = l l 1 3 . 0 0 ( 9 . 6 4 ) * *
A s i a n ,  n = 9 3 3 . 7 7 ( 1 9 . 6 9 ) * *
* * *  p < 0 . 0 0 1 ,  * * p < 0 . 0 1 ,  * p < 0 . 0 5
t - t e s t  w a s  a p p l i e d  t o  c h e c k  o n  t h e  d i f f e r e n c e s  b e t w e e n  t h e  e t h n i c  g r o u p
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Vitamin D level was significantly higher in Caucasian than in Asian women (p<0.001, see table 
4,3). 25(OH)D was classified as insufficient for the South Asian group and as hypovitaminosis 
for the Caucasian group. PTH was significantly lower among Caucasian than Asian women
(p<0.01).
Table 4.3 Vitamin D and PTH status among pre-menopausal Caucasian and Asian women
n Mean[SD] Median
[IQR]
T value (p) or 
U value (p)
2 5 ( O H ) D C a u c a s i a n ,  n = 1 8 8 0 . 9 1  [ 2 0 . 0 8 ] 7 3 . 3 0 [ 4 2 . 5 0 ] 8 . 0 9 ( 0 . 0 0 1 ) =
( n m o l / 1 )
A s i a n ,  n = 1 8 3 1 . 5 3 [ 1 6 . 3 2 ] 2 9 . 5 0 [ 1 9 . 0 0 ]
P T H C a u c a s i a n ,  n = 1 0 1 . 9 9 [ 0 . 3 0 ] 2 . 0 0 [ 0 . 6 0 ] 1 9 . 0 0 ( 0 . 0 1 ) ’’
( p m o l / 1 )
A s i a n ,  n =  1 1 3 . 3 2 [ 1 . 1 6 ] 3 . 4 0 [ 2 . 0 0 ]
‘ N o r m a l l y  d i s t r i b u t e d  a n a l y s e d  b y  t  t e s t ; * ’ n o n - n o r m a l l y  d i s t r i b u t e d  a n a l y s e d  b y  M a n n - W i t n e y  U  t e s t
4.4.2. PQCT measurements
4.4.2.I. Radius scan
Table 4.4 lists the pQCT variables measured at the 4% distal radius in healthy pre-menopausal 
Caucasian and Asian women with descriptive statistics o f mass, area and geometry. Also given in 
the table, where applicable, are the statistical significance values for the différences between the 
two ethnic groups for any measured parameter. At the 4% distal radius, Asian women had 
significantly lower bone mass (p<0.05) than Caucasians. Asian women also had significantly 
lower total area, trabecular area, and cortical sub area than Caucasian women (?<0.01 for all). 
The Asian group had a slightly lower total density, trabecular density and cortical sub density 
than Caucasian but these did not reach statistical significance.
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Table 4.4 Bone variables at the 4% distal radius as measured by pQCT for pre menopausal
Asian and Caucasian women.
Ethnicity Caucasian n=22 Asian n=19 t-test (p) or 
Mann-
M e a u [ S D ] M e d i a u [ I Q R ] M e a u [ S D ] M e d i a u [ I Q R ] Whitn^U(P)
M a s s  ( g / c m ) 1 . 1 7 [ 0 . 1 5 ] * 1 . 1 2 [ 0 . 1 9 ] 1 . 0 6 [ 0 . 1 8 ] * 1 . 1 2 [ 0 . 2 5 ] 2 . 1 7 ( 0 . 0 4 ) =
T o t a l  A r e a  
( m m ^ )
3  7 4 . 8 1  [ 4 3 . 2 9 ] * * 3 7 1 . 1 3 [ 8 5 . 5 0 ] 3 4 0 . 9 5 [ 3 7 . 0 0 ] * * 3 4 8 . 7 5 [ 3 6 . 2 5 ] 2 . 6 7 ( 0 . 0 1 ) =
T o t a l  D e n s i t y  
( m g / c m ^ )
3 1 5 . 6 6 [ 4 5 . 3 5 ] 3 0 6 . 6 5 [ 5 5 . 3 6 ] 3 1 2 . 1 4 [ 4 5 . 6 1 ] 3 1 1 . 5 1  [ 6 2 . 2 2 ] 0 . 2 5 ( 0 . 8 1 ) =
T r a b e c u l a r  
A r e a  ( m m ^ )
1 6 8 . 5 1 [ 1 9 . 4 6 ] * * 1 6 6 . 8 8 [ 3 8 . 4 4 ] 1 5 3 . 3 0 [ 1 6 . 6 2 ] * * 1 5 6 . 7 5 [ 1 6 . 2 5 ] 2 . 6 7 ( 0 . 0 1 ) =
T r a b e c u l a r  
D e n s i t y  ( m g / c ^ )
1 7 8 . 9 8 [ 3 5 . 5 4 ] 1 8 0 . 4 5 [ 5 4 . 3 4 ] 1 7 5 . 4 0 [ 3 7 . 2 1 ] 1 6 8 . 5 2 [ 5 5 . 3 6 ] 0 . 3 2 ( 0 . 7 6 ) =
C o r t i c a l  a n d  
S u b e o r t i e a l  
A r e a  ( m m ^ )
2 0 6 . 3 0 [ 2 3 . 8 3 ] * * 2 0 4 . 2 5 [ 4 7 . 0 6 ] 1 8 7 . 6 4 [ 2 0 . 3 8 ] * * 1 9 2 . 0 0 [ 2 0 . 0 0 ] 2 . 6 7 ( 0 . 0 1 ) =
C o r t i c a l  a n d  
s u b e o r t i e a l  
D e n s i t y  
( m g / e m ^ )
4 2 7 . 3 2 [ 6 0 . 0 3 ] 4 2 2 J 3  [ 7 9 . 8 0 ] 4 2 3 . 8 7 [ 6 2 . 4 9 ] 4 2 4 . 8 8 [ 8 1 . 0 0 ] 0 . 1 8 ( 0 . 8 6 ) =
Within a row, cells with identical superscript symbols are significantly different fi’om each other (***p<0.001, 
* * p < 0 . 0 1 ,  * p < 0 . 0 5 )
= Normally distributed analyses by t test; ’’ non-normally distributed analysed by Mann-Witney U test
Table 4.5 displays the descriptive statistics at the 66% diaphyseal non-dominant radius. At this
scan site, Asian women had significantly lower bone mass than Caucasian women. Asians had
slightly lower total area but not significantly so, but they did exhibit a significantly lower cortical
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area (p<0.01) compared with Caucasian women. Asian women also had slightly higher total bone 
density and slightly lower cortical bone density but neither was significant compared with 
Caucasian women.
Table 4.5 Bone and geometric variables at the 66% diaphyseal radius as measured by 
pQCT for pre menopausal Asian and Caucasian women
Ethnicity Caucasian n=22 Asian n=19 t-test (p) or 
Mann-
M e a n [ S D ] M e d i a n [ I Q R ] M e a n [ S D ] M e d i a n [ I Q R ] WhitneyU(P)
M a s s  ( g / c m ) 1 . 1 9 [ 0 . 5 0 ] 1 . 0 7 [ 0 . 1 2 f 1 . 0 0 [ 0 . 2 0 ] 0 . 9 7 [ 0 . 2 4 ] * 1 2 9 . 0 0 ( 0 . 0 4 ) ’’
S S I P O L
( m m ^ )
3 5 7 . 6 3 [ 3 3 9 . 4 5 ] 2 7 9 . 5 1 1 8 0 . 5 6 ] 2 1 8 . 7 1 1 6 7 . 1 4 ] 1 9 1 . 9 1  [ 1 0 4 . 7 3 ] * 1 2 0 . 0 0 ( 0 . 0 2 ) ’’
S S I X ( m m ^ ) 2 1 4 . 8 6 1 2 5 6 . 3 8 ] 1 4 2 . 4 0 1 5 6 . 3 7 ] 1 2 1 . 3 2 [ 3 9 . 1 7 ] 1 0 7 . 5 7 [ 5 9 . 3 0 ] * 1 3 1 . 0 0 ( 0 . 0 4 ) ’’
S S I Y  ( m m ^ ) 2 1 4 . 5 0 1 1 8 4 . 4 0 ] 1 5 4 . 6 6 [ 5 5 . 0 2 ] 1 4 4 . 4 2 1 4 5 . 9 0 ] 1 3 6 . 5 9 [ 6 7 . 8 6 ] * 1 2 8 . 0 0 ( 0 . 0 3 ) ’’
T o t a l  A r e a  
( m m ^ )
1 6 5 . 3 0 1 8 8 . 2 1 ] 1 3 7 . 1 3 [ 4 1 . 6 3 ] 1 3 0 . 7 1  [ 2 2 . 5 6 ] 1 3 4 . 7 5 [ 3 6 . 7 5 ] 1 5 5 . 0 0 ( 0 . 1 6 ) ’’
T o t a l  D e n s i t y  
( m g / c m ^ )
7 4 6 . 6 4 1 8 6 3 3 ] 7 3 9 . 0 1 1 1 1 4 . 7 1 ] 7 6 8 . 8 3 [ 8 5 . 9 2 ] 7 7 3 . 0 0 1 1 1 3 . 8 8 ] - 0 . 8 2 ( 0 . 4 2 )  =
C o r t i c a l  A r e a  
( m m ^ )
8 3 . 4 2 [ 2 9 . 4 9 ] 7 5 . 8 8 [ 1 1 . 2 5 ] 7 2 . 6 1  [ 1 6 . 8 5 ] 6 7 . 7 5 [ 1 5 . 7 5 ] * * 1 4 5 . 5 0 ( 0 . 1 0 ) ’’
C o r t i c a l
D e n s i t y
( m g / c m ^ )
1 1 3 4 . 8 0 1 3 8 . 4 8 ] 1 1 3 6 . 9 6 [ 6 5 . 2 8 ] 1 1 2 6 . 3 5  [ 4 2 . 5 5 ] 1 1 3 3 . 2 2 [ 4 4 . 5 9 ] 1 9 3 . 0 0 ( 0 . 6 8 ) ’’
C o r t i c a l  
t h i c k n e s s  C  
( m m )
2 . 2 1  [ 0 . 3 3 ] 2 . 1 2 [ 0 . 4 3 ] 2 . 1 7 [ 0 . 4 6 ] 2 . 1 2 1 0 . 6 4 0 . 6 4 ] 0 . 3 0 ( 0 . 7 7 )  =
P E R I  C  ( m m ) 4 4 . 5 4 [ 9 . 8 7 ] 4 1 . 5 1  [ 6 . 1 7 ] 4 0 . 3 9  [ 3 . 4 9 ] 4 1 . 1 5 [ 5 . 8 7 ] 1 5 5 . 0 0 ( 0 . 1 6 )
E N D O C
( m m )
3 0 . 6 9 [ 9 . 5 5 ] 2 8 . 3 6 [ 6 . 8 0 ] 2 6 . 7 6  [ 3 . 8 4 ] 2 5 . 9 9 [ 6 . 2 3 ] 1 6 1 . 0 0 ( 0 . 2 1 ) ’’
* * * p < 0 . 0 0 1 ,  * * p < 0 . 0 1 ,  * p < 0 . 0 5
= N o r m a l l y  d i s t r i b u t e d  a n a l y s e s  b y  t  t e s t ;  n o n - n o r m a l l y  d i s t r i b u t e d  a n a l y s e d  b y  M a n n - W i t n e y  U  t e s t
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S S I P O L ,  p o l a r  s t r e n g t h  s t r a i n  i n d i c e s ;  S  S I X ,  s t r e n g t h  s t r a i n  i n d e x ,  t h e  b e n d i n g  s t r e n g t h  i n  r e s p e c t  t o  X ;  S S I Y ,  
s t r e n g t h  s t r a i n  i n d e x ,  t h e  b e n d i n g  s t r e n g t h  i n  r e s p e c t  t o  Y ;  P E R I  C ,  p e r i o s t e a l  c i r c u m f e r e n c e  i n  t h e  c i r c u l a r  r i n g  
m o d e l ;  E N D O  C ,  e n d o s t e a l  c i r c u m f e r e n c e  i n  t h e  c i r c u l a r  r i n g  m o d e l
Table 4.6 below lists other bone geometrical parameters measured at the 66% site. Fracture load 
X and Y were significantly lower (p<0.05) in Asian women compared to Caucasian women.
Table 4.6 Other bone variables and ratios at the 66% radius site as measured by pQCT in 
pre menopausal Asian and Caucasian women
Ethnicity Caucasian n=22 Asian n=19 t-test (p) or 
Mann-
M e a n [ S D ] M e d i a n [ I Q R ] M e a n [ S D ] M e d i a n [ I Q R ] Whitn^U(P)
F r a c t u r e  
L o a d  X  ( N )
7 7 3 . 4 9 [ 9 2 2 . 9 5 ] 5 1 2 . 6 2 [ 2 0 2 . 9 4 ] * 4 3 6 . 7 6 [ 1 4 1 . 0 3 ] 3 8 7 . 2 4 [ 2 1 3 . 5 0 ] * 1 3 1 . 0 0 ( 0 . 0 4 ) ’’
F r a c t u r e  
L o a d  Y  ( N )
7 7 2 . 1 9 [ 6 6 3 . 8 4 ] 5 5 6 . 7 8 [ 1 9 8 . 0 6 ] * 5 1 9 . 9 3 [ 1 6 5 . 2 5 ] 4 9 1 . 7 1  [ 2 4 4 . 2 8 ] * 1 2 8 . 0 0 ( 0 . 0 3 ) ’’
M a s s l  M a s s 2  
R a t i o
1 . 0 7 [ 0 . 2 6 ] 1 . 0 9  [ 0 . 3 1 ] 1 . 0 7 [ 0 . 1 4 ] 1 . 0 6 [ 0 . 1 9 ] - 0 . 0 3 ( 0 . 9 8 ) =
C r t A r e a 2  
T o t  A r e a l  
R a t i o  %
2 2 . 1 9 1 6 . 4 9 ] 2 0 . 3 8 [ 5 . 0 9 ] 2 1 . 3 9 [ 4 . 7 1 ] 2 1 . 0 5 [ 5 . 0 6 ] 2 0 4 . 0 0 ( 0 . 9 0 ) ’’
M a r r o w
D e n s i t y
( m g / c m ^ )
1 8 . 8 0 [ 1 3 . 0 3 ] 1 7 . 6 6  [ 2 0 . 9 3 ] 1 6 . 1 9 [ 1 2 . 7 6 ] 1 5 . 7 1  [ 2 4 . 3 9 ] 0 . 6 5 ( 0 . 5 2 ) =
M a r r o w  A r e a  
( m m ^ )
3 6 . 2 5 [ 1 3 . 3 0 ] 3 6 . 1 3  [ 1 7 . 4 4 ] 3 1 . 4 1  [ 1 4 . 0 2 ] 3 0 . 7 5  [ 1 5 . 7 5 ] 1 . 1 3 ( 0 . 2 6 ) =
* * * p < 0 . 0 0 1 ,  * * p < 0 . 0 1 ,  * p < 0 . 0 5
= N o r m a l l y  d i s t r i b u t e d  a n a l y s e s  b y  t  t e s t ;  n o n - n o r m a l l y  d i s t r i b u t e d  a n a l y s e d  b y  M a n n - W i t n e y  U  t e s t
Measurements o f fat, muscle and bone area were from the 66% radius scan. Table 4.7 lists the 
results o f muscle and fat analysis. There were significant differences between the ethnic groups in 
fat area and the fat to muscle area ratio, with Asian women having higher fat area than the 
Caucasian group (p<0.05). However, mean values o f fat and muscle density was significantly 
lower in the Asian group than they were in Caucasian women (p<0.05).
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Table 4.7 Cross sectional subcutaneous fat and muscle at the radius as measured by PQCT
in pre menopausal Asian and Caucasian women
Ethnicity Caucasian n=22 Asian n=19 t-test (p) or 
Mann-
Mean[SD] Median [IQR] Mean[SD] Median [IQR] WhitneyU(P)
Muscle Total 
Areal (mm^)
3 0 3 2 . 6 1  [ 3 7 0 . 0 0 ] 3 0 1 4 . 8 8 [ 3 4 2 . 4 4 ] 2756.53 [789.84] 2 8 0 8 . 5 0 [ 8 2 3 . 7 5 ] 1 6 8 . 0 0 ( 0 . 2 8 ) ’’
Muscle Total 
Area2 (mm^)
3 2 7 . 1 5 [ 5 4 . 4 7 ] 3 1 6 . 8 8 [ 7 3 . 5 6 ] 2 9 1 . 2 0 [ 5 2 . 7 7 ] * 2 8 7 . 7 5 [ 7 9 . 5 0 ] 2.14(0.04) =
Muscle Total 
Area3 (mm^)
4 4 4 0 . 4 0 [ 6 0 5 . 0 3 ] 4 2 7 0 . 3 8 [ 6 9 3 . 8 1 ] 4 5 7 0 . 6 7 [ 1 4 9 5 . 4 7 ] 4 5 5 8 . 5 0 [ 1 1 6 7 . 2 5 ] 166.00(0.26)’’
Muscle Cortical 
Density 
(mg/cm^)
1 1 4 2 . 9 1  [ 3 3 . 9 1 ] 1 1 4 0 . 0 0 [ 4 9 . 8 3 ] 1 1 3 1 . 9 9 [ 3 7 . 0 5 ] 1 1 4 7 . 0 8 [ 6 5 . 0 8 ] 0.99(033) =
Muscle Area 
(mm^)
2 7 0 5 . 4 7 [ 3 3 9 . 7 5 ] 2 6 7 5 . 2 5  [ 3 4 6 . 5 6 ] 2 4 6 5 . 3 3 [ 7 7 0 . 8 8 ] 2 5 0 4 . 2 5 [ 7 4 7 . 0 0 ] 174.00(0.36)’’
Bone : Muscle 
Area Ratio %
6 . 3 6 [ 0 . 9 0 ] 6 . 4 1  [ 1 . 1 6 ] 5 . 8 7 [ 1 . 7 8 ] 5 . 9 8 [ 1 . 8 3 ] 1 7 3 . 0 0 ( 0 . 3 5 ) ’’
Fat Area (mm^) 1 4 0 7 . 7 8 [ 3 9 5 . 8 7 ] 1 3 8 4 . 8 8 [ 6 0 4 . 3 8 ] 1 8 1 4 . 1 4 [ 1 5 4 1 . 1 6 ] 1 7 3 3 . 0 0 [ 1 1 2 3 . 5 0 ] * 1 1 8 . 0 0 ( 0 . 0 2 ) ’’
Fat : Muscle 
Area Ratio %
5 2 . 3 3 [ 1 4 . 1 0 ] 4 8 . 9 1  [ 2 2 . 2 9 ] 6 1 . 2 0 [ 5 1 . 5 1 ] 64.30[34.64]* 1 3 0 . 0 0 ( 0 . 0 4 ) ’’
Muscle Density 
(mg/cm^)
7 3 . 1 1  [ 7 . 6 5 ] 7 5 . 6 4 [ 4 . 9 4 ] 7 0 . 8 1  [ 1 7 . 3 9 ] 7 5 . 8 7 [ 5 . 9 4 ] 2 0 3 . 0 0 ( 0 . 8 8 ) ’’
Fat + Muscle 
Density 
(mg/cm^)
5 0 . 4 0 [ 8 . 4 0 ] 4 9 . 4 7 [ 1 4 . 3 8 ] 4 0 . 5 2 [ 1 6 . 1 5 ] 4 4 . 0 5  [ 1 1 . 5 6 ] * 1 1 9 . 0 0 ( 0 . 0 2 ) ’’
* * * p < 0 . 0 0 1 ,  * * p < 0 . 0 1 ,  * p < 0 . 0 5
= N o r m a l l y  d i s t r i b u t e d  a n a l y s e s  b y  t  t e s t ; ’’ n o n - n o r m a l l y  d i s t r i b u t e d  a n a l y s e d  b y  M a n n - W i t n e y  U  
1 ,  s c a n  a t  t h e  4 %  s i t e ;  2 ,  s c a n  a t  6 6 %  s i t e
4.4.2.2. Tibia scan
Table 4.8 displays the descriptive statistics ofpQCT-derived density, mass, area and geometry at 
the 4% distal tibia o f the non-dominant site. South Asian women had significantly smaller bone
123
size illustrated by total area, trabecular area, and cortical and subeortieal area (p<0.05) and higher 
density than Caucasian women for total, trabecular,cortical and subeortieal bone at the 4% site.
Table 4.8 Bone variables at the 4% tibia site separated by ethnicity
Ethnicity Caucasian n=21 Asian n=14 t-test (p) or 
Mann-
Mean[SD] Median[IQR] Mean[SD] Median [IQR] WhitneyU(P)
Mass (g/cm) 3 . 2 4 [ 0 . 5 1 ] 3 . 1 8 [ 0 . 3 9 ] 3 . 2 7 [ 0 . 6 5 ] 3 . 1 8 [ 0 . 6 4 ] 1 4 3 . 0 0 ( 0 . 8 9 ) ’’
Total Area 
(mm^)
1 0 7 1 . 2 1  [ 1 4 0 . 6 7 ] 1 0 6 0 . 0 0 [ 1 5 2 . 6 3 ] 957.38[158.65]* 9 1 9 . 8 8 [ 3 1 9 . 4 4 ] 233(0.03)=
Total Density 
(mg/cm^)
3 0 3 . 2 9 [ 3 1 . 7 8 ] 3 0 0 . 2 4 [ 6 2 . 3 0 ] 343.69[53.43]* 3 3 4 . 4 7 [ 8 2 . 3 9 ] -2.55(0.02) =
Trabecular Area 
(mm^)
4 8 1 . 9 0 [ 6 3 . 3 1 ] 4 7 6 . 7 5 [ 6 8 . 7 5 ] 4 3 0 . 7 1  [ 7 1 . 4 2 ] * 4 1 3 . 8 8 [ 1 4 3 . 7 5 ] 2.23(0.03)=
Trabecular
Density
(mg/cm^)
228.72[29.17] 2 2 7 . 8 3  [ 3 4 . 8 9 ] 2 7 2 . 4 8 [ 6 6 . 9 6 ] 2 4 8 . 6 7 [ 9 4 . 2 9 ] * 8 7 . 0 0 ( 0 . 0 4 ) ’’
Cortical and 
Subeortieal Area 
(mm^)
5 8 9 . 3 1  [ 7 7 . 3 7 ] 5 8 3 . 2 5 [ 8 3 . 8 8 ] 5 2 6 . 6 6 [ 8 7 . 2 3 ] * 5 0 6 . 0 0 [ 1 7 5 . 6 9 ] 2 . 2 3 ( 0 . 0 3 )  =
Cortical and 
Subeortieal 
Density 
(mg/cm^)
364.27[39.67] 366.30[72.48] 4 0 1 . 9 2 [ 5 0 . 3 6 ] * 4 0 0 . 1 5  [ 9 6 . 5 7 ] -2.47(0.02) =
* * * p < 0 . 0 0 1 ,  * * p < 0 . 0 1 ,  * p < 0 . 0 5
= N o r m a l l y  d i s t r i b u t e d  a n a l y s e s  b y  t  t e s t ;  ’’ n o n - N o r m a l l y  d i s t r i b u t e d  a n a l y s e d  b y  M a n n - W i t n e y  U
At the 14% diaphyseal tibia, total and cortical density means were significantly lower (P<0.05) in 
South Asian women than Caucasian women. There was a significant difference between the 
cortical thickness o f the bone at the 14% tibia site, where it was lower among Asian women
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(p<0.05). There were no other significant differences in any other bone parameter at this site 
between the ethnic groups, see table 4.9 for more detail.
Table 4.9 Bone variable at the 14% tibia site separated by ethnicity
Ethnicity Caucasian n=21 Asian n=14 t-test (p) or 
Mann-
Mean[SD] Median [IQR] Mean[SD] Median[IQR] WhitneyU(P)
Mass (g/cm) 2 . 3 2 [ 0 . 3 9 ] 2 . 4 2 [ 0 . 4 0 ] 2 . 2 4  [ 0 . 3 7 ] 2 . 2 9 [ 0 . 6 7 ] 1 1 5 . 5 0 ( 0 . 2 9 ) ’’
SSIPOL (mm^) 1 3 3 0 . 3 6 [ 3 2 8 . 6 2 ] 1 4 0 1 . 8 9 [ 2 4 0 . 0 9 ] 1 2 5 0 . 7 6 [ 3 0 5 . 7 5 ] 1 2 4 1 . 3 9 [ 4 9 7 . 1 1 ] 1 0 5 . 0 0 ( 0 . 2 6 ) ’’
SSIX (mm^) 7 1 8 . 7 1  [ 1 6 4 . 7 4 ] 7 4 6 . 4 4 [ 1 3 8 . 9 2 ] 6 7 8 . 9 0 [ 1 6 4 . 8 9 ] 6 7 3 . 6 1  [ 2 7 6 . 3 0 ] 1 1 7 . 0 0 ( 0 . 3 1 ) ’’
SSIY (mm^) 7 8 4 . 6 8 [ 1 9 8 . 9 3 ] 8 1 6 . 1 3 [ 1 8 6 . 2 1 ] 7 5 5 . 9 2 [ 1 8 1 . 7 1 ] 7 7 2 . 6 3  [ 4 0 2 . 9 9 ] 1 3 1 . 0 0 ( 0 . 5 9 ) ’’
Total Area (mm^) 4 2 1 . 8 8 [ 9 2 . 6 3 ] 4 3 5 . 2 5 [ 9 9 . 2 5 ] 4 6 2 . 3 6 [ 8 5 . 6 6 ] 4 6 0 . 7 5 [ 1 2 4 . 1 3 ] 1 1 5 . 0 0 ( 0 . 2 8 ) ’’
Total Density 
(mg/cm^
5 7 1 . 6 4 [ 1 1 7 . 3 7 ] 5 5 6 . 5 9 [ 1 1 2 . 1 5 ] 4 9 5 . 5 7 [ 9 2 . 0 6 ] * 4 9 9 . 9 6 [ 1 0 3 . 5 7 ] 2 . 0 4 ( 0 . 0 5 )  =
Cortical Area 
(mm^)
1 5 6 . 4 5  [ 2 9 . 0 2 ] 1 5 9 . 0 0 [ 3 7 . 2 5 ] 1 3 8 . 3 9 [ 3 5 . 4 3 ] 1 4 2 . 5 0 [ 4 1 . 1 3 ] 1 . 6 5 ( 0 . 1 1 )  =
Cortical Density 
(mg/cm^)
1 1 3 5 . 6 5 [ 2 4 . 5 0 ] 1 1 3 8 . 8 0 [ 2 4 . 0 4 ] 1 0 9 5 . 0 3 [ 6 5 . 5 3 ] 1 1 1  1 . 3 9  [ 6 4 . 7 9 ] * 8 1 . 0 0 ( 0 . 0 3 ) ’’
Cortical thickness 
C (mm)
2 . 4 6 [ 0 . 4 1 ] 2 . 4 7 [ 0 . 6 1 ] 2 . 0 3  [ 0 . 5 8 ] * 2 . 2 2 [ 0 . 5 9 ] 2 . 5 1 ( 0 . 0 2 )  =
PERI C (mm) 7 2 . 1 6 [ 9 . 9 3 ] 7 3 . 9 6 [ 8 . 3 8 ] 7 5 . 9 1  [ 7 . 2 0 ] 7 6 . 0 9 [ 1 0 . 2 6 ] 1 1 5 . 0 0 ( 0 . 2 8 ) ’’
ENDO C (mm) 5 6 . 7 2 [ 1 1 . 1 2 ] 5 9 . 1 6 [ 1 0 . 9 3 ] 6 3 . 1 3 [ 9 . 6 2 ] 6 1 . 6 3 [ 1 3 . 5 0 ] - 1 . 7 6 ( 0 . 0 9 )  =
* * * p < 0 . 0 0 1 ,  * * p < 0 . 0 1 ,  * p < 0 . 0 5
“N o r m a l l y  d i s t r i b u t e d  a n a l y s e s  b y  t  t e s t ;  n o n - n o r m a l l y  d i s t r i b u t e d  a n a l y s e d  b y  M a n n - W i t n e y  U
S S I P O L ,  p o l a r  s t r e n g t h  s t r a i n  i n d i c e s ;  S S I X ,  s t r e n g t h  s t r a i n  i n d e x ,  t h e  b e n d i n g  s t r e n g t h  i n  r e s p e c t  t o  X ;  S S I Y ,  
s t r e n g t h  s t r a i n  i n d e x ,  t h e  b e n d i n g  s t r e n g t h  i n  r e s p e c t  t o  Y ;  P E R I  C ,  p e r i o s t e a l  c i r c u m f e r e n c e  i n  t h e  c i r c u l a r  r i n g  
m o d e l ;  E N D O  C ,  e n d o s t e a l  c i r c u m f e r e n c e  i n  t h e  c i r c u l a r  r i n g  m o d e l
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At the 38% tibia mid shaft, there was a significant difference between ethnic groups in the mean 
total density, where South Asians had a lower total density than Caucasian women (p<0001). 
South Asian women also had a significantly lower mean o f SSIY3 than Caueasian women 
(p<0.05). See table 4.10 for more details on the 38% tibia mid shaft bone variables.
Table 4.10 Bone variables at the 38% tibia site separated by ethnicity
Ethnicity Caucasian n=21 Asian n=14 t-test (p) or 
Mann-
Mean[SD] Median[IQR] Mean[SD] Median[IQR] WhitneyU(P)
Mass (g/cm) 3 . 2 9 [ 0 . 6 7 ] 3 . 4 1  [ 0 . 6 0 ] 3 . 0 1  [ 0 . 5 2 ] 3 . 0 0 [ 0 . 8 1 ] 1 . 3 1 ( 0 . 2 0 )  =
SSIPOL (mm^) 1 4 0 2 . 5 0 [ 3 6 2 . 5 9 ] 1 4 2 5 . 1 7 1 3 7 1 . 0 7 ] 1 1 9 2 . 7 8 [ 3 1 1 . 4 7 ] 1 1 4 7 . 1 0 1 3 5 4 . 3 3 ] 1 . 7 3 ( 0 . 0 9 )  =
SSIX (mm^) 8 7 1 . 0 7 [ 2 1 8 . 5 0 ] 8 8 2 . 6 0 [ 2 4 7 . 8 4 ] 7 9 2 . 8 8 [ 2 2 5 . 8 4 ] 7 9 3 . 3 9 [ 2 9 2 . 5 6 ] 1 0 5 . 0 0 ( 0 . 1 6 ) ’’
SSIY (mm^) 7 7 7 . 2 5 [ 2 1 6 . 8 3 ] 7 7 3 . 1 3 1 1 3 8 . 9 5 ] 6 7 9 . 7 9 1 1 7 7 . 8 8 ] 6 5 4 . 7 2 [ 2 3 4 . 7 6 ] * 8 7 . 0 0 ( 0 . 0 4 ) ’’
Tot Area (mm^) 3 6 6 . 3 3 1 7 4 . 7 7 ] 3 7 3 . 2 5 [ 6 4 . 1 3 ] 3 6 0 . 9 6 1 7 7 . 0 2 ] 3 5 8 . 8 8 1 1 3 4 . 3 8 ] 1 3 2 . 0 0 ( 0 . 6 1 ) ’’
TotDen
(mg/cm^)
9 0 3 . 5 9 1 7 6 . 9 2 ] 9 0 2 . 8 2 [ 1 1 5 . 1 1 ] 8 5 6 . 8 8 [ 8 5 . 1 7 ] * * 8 8 3 . 9 3 [ 1 3 6 . 4 4 ] 1 . 6 9 ( 0 . 1 0 ) =
CrtArea (mm^) 2 5 5 . 6 9 1 5 3 . 9 6 ] 2 6 5 . 0 0 1 5 2 . 7 5 ] 2 3 6 . 2 1  [ 4 8 . 6 1 ] 2 2 5 . 5 0 [ 8 2 . 8 8 ] 1 . 0 9 ( 0 . 2 9 )  =
CrtDen
(mg/cm^)
1 1 7 9 . 8 3 1 1 9 . 3 8 ] 1 1 8 4 . 7 9 [ 2 7 . 5 8 ] 1 1 6 0 . 8 9 1 5 3 . 3 0 ] 1 1 8 2 . 6 5 1 6 0 . 7 4 ] 1 . 2 7 ( 0 . 2 2 )  =
C R T T H K C
(mm)
4 . 8 9 1 0 . 8 5 ] 5 . 1 6 1 0 . 9 1 ] 4 . 4 8 1 0 . 7 8 ] 4 . 3 8 [ 1 . 1 9 ] 1 . 4 4 ( 0 . 1 6 )  =
PERI_C (mm) 6 7 . 3 6 1 8 . 3 4 ] 6 8 . 4 9 [ 5 . 8 8 ] 6 6 . 9 8 [ 7 . 2 9 ] 6 7 . 1 5 [ 1 2 . 3 8 ] 1 3 2 . 0 0 ( 0 . 6 1 ) ’’
E N D O C
(mm)
3 6 . 6 6 [ 6 . 9 9 ] 3 7 . 9 3  [ 6 . 1 7 ] 3  8 . 8 5  [ 7 . 9 4 ] 3 6 . 1 3 [ 1 4 . 6 6 ] - 0 . 8 6 ( 0 . 4 0 )  =
Fracture Load 
X(N)
3 1 3 5 . 8 4 1 7 8 6 . 6 0 ] 3 1 7 7 . 3 7 [ 8 9 2 . 2 3 ] 2 8 5 4 . 3 7 [ 8 1 3 . 0 1 ] 2 8 5 6 . 1 8 [ 1 0 5 3 . 2 0 ] 1 0 5 . 0 0 ( 0 . 1 6 ) ’’
Fracture Load 
Y(N)
2 7 9 8 . 1 1 1 7 8 0 . 5 7 ] 2 7 8 3 . 2 7 1 5 0 0 . 2 4 ] 2 4 4 7 . 2 3  [ 6 4 0 . 3 9 ] 2 3 5 6 . 9 8 [ 8 4 5 . 1 4 ] * 8 7 . 0 0 ( 0 . 0 4 ) ’’
* * * p < 0 . 0 0 1 ,  * * p < 0 . 0 1 ,  * p < 0 . 0 5
= N o r m a l l y  d i s t r i b u t e d  a n a l y s e s  b y  t  t e s t ; ’’ n o n - N o r m a l l y  d i s t r i b u t e d  a n a l y s e d  b y  M a n n - W i t n e y  U  t e s t
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Table 4.11 below summarizes the other bone geometrie variables and other bone ratio details 
measured at the tibia. A signifieant finding was that Asian women had lower bone marrow 
density and bone marrow area than the Caucasian group (p<0.001).
Table 4.11 Other bone variables and ratios for tibia sites separated by ethnicity
Ethnicity Caucasian n=21 Asian n=14 t-test (p) or 
Mann-
Mean[SD] Median [IQR] Mean[SD] Median [IQR] WhitneyU(P)
CrtArea2 Tot 
Area 1 Ratio %
1 4 . 7 7 [ 3 . 0 6 ] 1 4 . 6 7 [ 3 . 3 4 ] 1 4 . 6 0 [ 3 . 7 7 ] 1 4 . 7 7 [ 6 . 3 1 ] 0 . 1 5 ( 0 . 8 8 )  =
Marrow Density 
(mg/cm^
2 4 . 3 5 [ 7 . 5 4 ] 2 5 . 3 5 [ 1 0 . 0 9 ] 14.42[8.79]*** 1 6 . 0 3  [ 1 2 . 8 8 ] 3 . 5 7 ( 0 . 0 0 )  =
Marrow Area 
(mm^)
1 5 0 . 2 4 [ 3 8 . 0 6 ] 1 4 8 . 0 0 [ 4 1 . 6 3 ] 1 0 1 . 2 7 [ 4 5 . 2 5 ] * * * 1 0 5 . 6 3 [ 5 9 . 6 3 ] 3 . 4 6 ( 0 . 0 0 )  =
Massl Mass3 
Ratio
1 . 0 8  [ 0 . 6 2 ] 0 . 9 2  [ 0 . 1 8 ] 1 . 1 0 [ 0 . 2 7 ] 1 . 0 3  [ 0 . 4 1 ] - 0 . 0 7 ( 0 . 9 4 )  =
* * * p < 0 . 0 0 1 ,  * * p < 0 . 0 1 ,  * p < 0 . 0 5
= N o r m a l l y  d i s t r i b u t e d  a n a l y s e s  b y  t  t e s t ; ’’ n o n - N o r m a l l y  d i s t r i b u t e d  a n a l y s e d  b y  M a n n - W i t n e y  U  
1 ,  s c a n  a t  t h e  4 %  s i t e ;  2 ,  s c a n  a t  1 4 %  s i t e ;  3 ,  s c a n  a t  3 8 %  s i t e
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Table 4.12 summarizes all the muscle and fat related variables. Caueasian women had a 
significantly higher muscle area than Asian women (p<0.05).
Table 4.12 Cross sectional muscle and subcutaneous fat at the tibia site separated by 
ethnicity
Ethnicity Caucasian n=21 Asian n=14 t-test (p) or 
Mann-
Mean[SD] Median[IQR] Mean[SD] Median[IQR] WhitneyU(P)
Muscle Tot Area 
1 (mm^)
6 6 5 4 . 2 5 [ 1 5 1 1 . 5 0 ] 6769.50[1231.88] 5653.09[1901.84] 6 3 0 7 . 3  8 [ 1 7 4 0 . 0 0 ] * 8 4 . 0 0 ( 0 . 0 3 ) ’’
Muscle Tot Area 
2 (mm^)
6 6 2 . 4 0 [ 7 6 . 7 5 ] 6 6 3 . 2 5  [ 9 3 . 0 0 ] 588.57[82.09]** 5 8 1 . 6 3 [ 1 1 8 . 6 3 ] 2 . 7 1 ( 0 . 0 1 ) =
Muscle Tot Area 
3 (mm^)
9 9 8 1 . 2 1  [ 1 5 2 9 . 5 9 ] 9925.50[2055.50] 9726.27[1833.37] 9 9 1 6 . 3 8 [ 2 9 8 5 . 8 1 ] 0 . 4 5 ( 0 . 6 6 )  =
Muscle Area 
(mm^)
5 9 9 1 . 8 5 [ 1 5 1 4 . 2 4 ] 6 1 3 0 . 2 5 [ 1 2 5 4 . 2 5 ] 5064.52[1909.07] 5718.75[1638.44]* 9 0 . 0 0 ( 0 . 0 5 ) ’’
Muscle CrtDeu2 
(mg/cm^)
1 1 3 8 . 2 9 [ 2 1 . 9 3 ] 1 1 3 8 . 1 0 [ 3 1 . 9 4 ] 1 1 3 1 . 5 2 [ 3 6 . 4 2 ] 1 1 2 9 . 7 6 [ 5 7 . 2 1 ] 0 . 6 9 ( 0 . 5 0 )  =
Bone Muscle 
Area Ratio %
8 . 9 3  [ 1 4 . 5 0 ] 5 . 8 8 [ 1 . 5 0 ] 5 . 4 6 [ 2 . 1 4 ] 5 . 3 4  [ 2 . 0 8 ] 1 2 6 . 5 0 ( 0 . 4 9 ) ’’
Fat Area (mm^) 3 3 2 6 . 9 6 [ 1 3 5 0 . 3 1 ] 2 9 7 4 . 2 5 [ 1 1 4 5 . 6 3 ] 4 0 7 3 . 1 8  [ 2 2 4 7 . 5 0 ] 3557.50[2203.63] 1 0 8 . 0 0 ( 0 . 1 9 ) ’’
Fat Muscle Area 
Ratio %
1 1 3 . 2 0 [ 2 8 7 . 3 1 ] 5 0 . 2 8 [ 2 1 . 2 2 ] 5 9 . 5 8  [ 2 2 . 2 3 ] 6 3 . 5 7 [ 2 4 . 4 9 ] 9 8 . 0 0 ( 0 . 1 0 ) ’’
Muscle Density 
(mg/cm^)
6 8 . 2 5 [ 2 5 . 8 1 ] 7 4 . 0 0 [ 3 . 1 3 ] 6 8 . 0 1  [ 1 9 . 7 2 ] 7 2 . 8 2 [ 4 . 0 8 ] 1 2 3 . 0 0 ( 0 . 4 2 ) ’’
Fat + Muscle 
Density 
(mg/cm^)
5 0 . 7 7 [ 5 . 9 5 ] 5 1 . 7 5  [ 7 . 4 3 ] 4 2 . 2 4 [ 1 3 . 0 8 ] * * 4 4 . 6 3  [ 1 0 . 3 0 ] 2 . 6 2 ( 0 . 0 1 ) =
***p<0.001, * * p < 0 . 0 1 ,  * p < 0 . 0 5
= N o r m a l l y  d i s t r i b u t e d  a n a l y s e s  b y  t  t e s t ; ’’ n o n - N o r m a l l y  d i s t r i b u t e d  a n a l y s e d  b y  M a n n - W i t n e y  U
1 ,  s c a n  a t  t h e  4 %  s i t e ;  2 ,  s c a n  a t  1 4 %  s i t e ;  3, s c a n  a t  3 8 %  s i t e ,  a l l  f a t  a n d  m u s c l e  m e a s u r e m e n t s  w e r e  f r o m  t h e  6 6 %  
p r o x i m a l  s i t e .
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4.4.3. Association between bone structure and vitamin D status
At the 66% radius site, 25(OH)D correlated negatively with total bone area (i=-0.72, p=0.02) and 
periosteal circumference (r=-0.73, p=0.02) in the South Asian group (i.e as vitamin D status went 
up, circumference and area went down). At the same site in the Caucasian women, there was a 
significant positive correlation between PTH and bone strength (as measured by SSIPOL;r=0.85, 
p=0.006), cortical area (r=0.79, p=0.01) and cortical density (r=0.76, p=0.02). All o f these 
correlations were adjusted for height and weight. There were no significant correlations between 
the 4% site variables and either vitamin D or PTH in either ethnic group.
Among Caucasian women, mean 25(OH)D level was significantly positively correlated with 
SSIPOL (r=0.76, p=0.05), SSIY (r=0.85, p=0.02), total area (r=0.80, p=0.03) and PERI C 
(r=0.80, p=0.03) at the mid shaft tibia 38% site. There was no correlation between 25(OH)D level 
and tibia bone pQCT measurements in the South Asian group. There was also no correlation 
between PTH and tibia pQCT bone parameters in either ethnic group.
4.4.4. Association between muscle strength and function with vitamin D status
Table 4.13 below displays the average muscle measurements for each ethnic group. There was a
significant difference between the mean grip strength and mean muscle pain score between South 
Asian and Caucasian groups (P<0.01), with the South Asian women having much lower values.
Table 4.13 Mean and SD o f muscle strength and function parameters
Mean [SD]
Grip strength right C, n=19 24.91 [5.36]**
hand (kg force)
A,n=16 20.21 [5.03]
Grip strength left hand C, n-19 22.32 [5.03]*
(kg force)
A,n=16 19.00 [5.82]
Sit to walk test C,n=19 6.17 [0.73]
(seconds)
A, n=15 6.63 [0.81]
Muscle pain score C,n=21 16.00[10.84]**
A, n=15 35.46[27.15]
**p<0.01, *p<0.05
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Table 4.14 shows the correlation analyses for vitamin D level and muscle strength variables. 
There was no significant correlation between vitamin D status and muscle strength variables 
including grip strength, sit-to-walk test, muscle pain score and exercise duration.Only biking 
duration per day was positively correlated with vitamin D in the Caucasian group.
Table 4.14 Associations between Vitamin D status and muscle strength and activity 
parameters in premenopausal Asian and Caucasian women
Ethnicity C a u c a s i a n A s l a n
2 5 ( O H ) D 2 5 ( O H ) D
r P n r  p n
Grip strength 
Right
- 0 . 2 0 . 4 3 1 8 - 0 . 0 1  0 . 9 7 1 6
Grip strength 
Left
- 0 . 1 9 0 . 4 5 1 8 - 0 . 0 9  0 . 7 5 1 6
Muscle pain 
score
0 . 3 3 0 . 3 5 10 - 0 . 0 4  0 . 9 3 8
Sit-to-walk-
test
0 . 0 6 0 . 8 1 1 8 0 . 0 8  0 . 7 9 1 4
Walk
duration/day
0 3 3 0 . 1 9 1 7 - 0 . 1  0 . 7 5 1 3
Biking
duration/day
0 . 5 9 0.02 1 5 11
G r i p  s t r e n g t h  r e p r e s e n t s  a n  a v e r a g e  o f  t h r e e  m e a s u r e m e n t s ;  s i t - t o - w a l k  t e s t  a n  a v e r a g e  o f  f i v e  m e a s u r e m e n t s  
r ,  c o r r e l a t i o n  v a l u e ;  p, s i g n i f i c a n t  v a l u e
4.4.5. Association between bone pain, bone structure and vitamin D status
Table 4.15 below summarizes the back pain and bone pain variables in each ethnic group. In 
general. South Asian women had significantly higher pain score than Caucasian group (refer to 
table 4.15 for p-values).
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Table 4.15 Self-reported bone pain separated in by ethnicity in pre menopausal Asian and
Caucasian women
Mean [SD]
B a c k  p a i n  s c o r e C ,  n = 1 5 2 3 . 6 6  [ 1 5 . 4 3 ] *
A , n = 1 2 4 8 . 0 0  [ 3 4 . 0 6 ]
B o n e  p a i n  s c o r e C ,  n = 2 1 3 2 . 5 7  [ 2 5 . 0 7 ] * *
A , n = 1 5 8 9 . 8 6 [ 7 6 . 5 3 ]
A l l  t y p e s  o f  p a i n  s c o r e C , n = 1 7 3 8 . 1 7  [ 3 1 . 7 8 ] *
A , n = 1 3 1 1 1 . 9 2  [ 9 2 . 7 1 ]
* * p < 0 . 0 1 ,  * p < 0 . 0 5  C ,  C a u c a s i a n ;  A ,  A s i a n
Statistical partial correlations, correcting for height and weight, were applied between all the 
radius and tibia bone scan measurements and measures o f body pain. There was no correlation 
between bone pain and any o f the radius and tibia bone measurements for the Caucasian group. 
However, there was a significant positive correlation between radius total area at the 66% 
diaphyseal radius with back pain (r=0.63, p=0.05), bone pain (r=0.60, p=0.05) and muscle pain 
(r= 0.72, p=0.02), and between radius PERI at the 66% diaphyseal radius with muscle pain 
(r=0.70, p=0.02) in Asian women.
At tibia sites, there was no correlation between any o f the bone parameters with classified pain 
categories in the Caucasian group. However, at the 14% diaphyseal tibia, there was a significant 
positive correlation between tibia mass and bone pain (r=0.79, p=0.04), and tibia mass and 
muscle pain (r=0.84, p=0.02). Tibia mass at the 38% site was also correlated with muscle pain 
(r=0.84, p=0.02) in South Asian women. Tibial polar strength strain index (SSIPOL) at the 14% 
diaphyseal site correlated positively with bone pain (r=0.75, p=0.05) and muscle pain (r=0.85, 
p=0.01) in the same group. At the 14% tibia site, further significant correlations were identified 
for South Asian women between muscle pain and SSIX (r=0.93, p=0.0), SSIY (r=0.84, p=0.02), 
cortical area (r=0.85, p=0.01) and cortical thickness (r=0.76, p=0.05). At the 38% tibia mid shaft
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site, muscle pain score was significantly positively correlated with total area (r=0.83, p=0.02) and 
with bone circumference (PERI) (r=0.81, p=0.03) in South Asian women.
None o f the body pain categories correlated significantly with 25(OH)D or PTH in either ethnic 
groups after controlling for weight and heigh t.
4.4.6. Vitamin D and cardiovascular disease risk
The analyses undertaken for this section included women o f all age groups who took part in the 
study, including those who were post- and pre-menopausal. Table 4.16 summarizes the 
descriptive statistics following the analysis o f cardiovascular risk variables. Both ethnic groups 
had glucose levels higher than the normal range. Mean cholesterol and HDL values were 
significantly lower among South Asians than Caucasians; whereas mean insulin level was higher 
in South Asians. Beta cell function (B%) and insulin resistance (IR) was higher among South 
Asians than Caucasians, whereas insulin sensitivity (S%) was lower among South Asians than 
Caucasians.
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Table 4.16 Mean and SD of cardiovascular risk- biochemistry measurements
Ethnicity Caucasian Asian
N Mean (SD) Median
(IQR)
N Mean(SD) Median (IQR) t-test (p) or
Mann-
WhitneyU(P)
TAG 73 1.33(0.58) 1.17(0.46) 34 1.55(0.70) 1.33(1.08) 1023(0.14)’’
(mmol/1)
Cholesterol 73 5.70(1.06) 5.70(1.30) 34 5.16(0.93)** 5.05(1.28) 2.56(0.01)=
(mmol/1)
LDL 73 3.53(0.88) 3.45(1.20) 34 326(0.87) 3.31(1.05) 1033(0.16)’’
(mmol/1)
HDL 73 1.91(0.48) 1.86(0.64) 34 1.59(0.32)*** 1.57(0.56) 3.48(0.00)=
(mmol/1)
Insulin 75 14.85(11.66) 13.20(6.30) 38 20.49(11.75) 17.25(11.75)*** 891(0.001)’’
(mU/L)
Glucose 73 5.83(0.51) 5.85(0.58) 34 6.35(1.40) 5.97(1.03) 957.5(0.06)’’
HOMA %B 72 103.78(29.96) 102.45(40.47) 32 127.04(45.82) 111.90(68.18)* 839(0.03)’’
HOMA %S 72 63.87(27.18) 57.65(27.82) 32 46.47(22.12) 43.75(2928)*** 684(0.001)’’
HOM AIR 72 1.81(0.69) 1.74(0.79) 32 2.77(1.60) 2.29(1.48)*** 683(0.001)’’
***p<0.001, **p<0.01, *p<0.05
= Normally distributed analyses by t test; non-Normally distributed analysed by Mann-Witney U
Mean levels o f 25(OH)D correlate positively with mean levels o f HDL among pre-menopausal 
and post-menopausal Caucasian women (Pearson correlation, r=0.29, p=0.01), however this 
correlation was lost after adjustment for BMI. Mean levels o f 25(OH)D mean did not correlate 
with any other lipid measurement, insulin, glucose or HOMA parameters in either ethnic group.
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4.4.7. UV exposure behaviour
Table 4.17 presents the mean and SD o f the standard eiythmal dose (SED) for both South Asian 
and Caucasian groups who wore dosimeters during the study. In summary, SED was lower in 
South Asian than in Caucasian women but not significantly so at any point.
Table 4.17 UVB exposure o f pre-menopausal Asian and Caucasian women as assessed by 
dosimeter badges.
Ethnicity N Mean (SD)
SED o f 2 days-Weekend Caucasian 11.00 1.21 (1.53)
Asian 3.00 0.63 (0.18)
SED o f 5 days- Weekdays Caucasian 11.00 2.12(2.18)
Asian 2.00 0.06 (1.26)
Average o f one day- Caucasian 11.00 0.61 (0.76)
Weekend
Asian 3.00 0.32 (0.09)
Average o f one day- Caucasian 11.00 0.42 (0.44)
Weekday
Asian 2.00 0.01 (0.25)
Average day for one week Caucasian 11.00 0.48 (0.47)
Asian 2.00 0.09(0.16)
SED, standard erythemal dose from dosimeters
Comparisons between South Asian (n=32) and Caucasian (n= 81) women were made in terms o f 
both natural (sunlight) and artificial UVB exposure following completion o f the questionnaire. 
More than 95% o f the respondents fi*om either ethnic group had never used a tanning sunbed and 
only 3 women had used one in the last year prior to the study. 77% percent (n=23) o f the South 
Asian group and 68% (n=52) o f the Caucasian group reported that their vocation did not involve 
exposure to the sunlight at any point. Outside o f work most o f the South Asian (62.5%, n=20) 
and Caucasian (84%, n=62) women reported that they spent more than 15 minutes a day exposed 
to sunlight.
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Table 4,18 illustrates the difference between the behaviour o f the two ethnic groups with respect 
to exposing their skin to sunlight during summer, as assessed by self-report questionnaires. The 
data indicate that South Asian women were less likely to expose their skin to sunlight than their 
Caucasian counterparts.
Table 4.18 Self-reported sun exposure for pre-menopausal Asian and Caucasian women
Percentage (n) reporting exposure
Exposure area South Asian (n=32) Caucasian (n=81)
Head 69 (22) 98 (79)
Hand 97(31) 99 (80)
Arm 63 (20) 99 (80)
Leg 1 6 0 ) 77 (62)
torso 3 0 ) 9(7)
South Asian women were less likely to sunbathe compared to Caucasians (17% and 59% 
respectively), and the majority o f Asians reported never having sunbathed (73% versus 33% o f 
Caucasian women).
O f the South Asian women, 33% (n=7) versus 71% (n=37) o f Caucasians,reported that they used 
sunscreen when they went outdoors. Amongst the sunscreen users, 56% o f South Asians (n=8) 
and 47% of Caucasians (n=33) used sun-protection factor (SPF) 30 or 50.
4.4.8. Bone density scan data and vitamin D values compared to the original D-FINES 
results
Partial correlations, adjusting for height and weight, were performed to investigate the 
relationships between data from the original D-FINES study (autumn and spring 2006-2007) and 
the vBMD measurements taken in summer 2010. Significant positive correlations between total 
density & trabecular density at the 4% distal radius DXA bone density measurements, correlation
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were more common in the Caucasian group than in the Asian group. Please refer to appendix A 
for more detail on the correlation data between longitudinal data of DXA and pQCT 
measurements.
Longitudinal vitamin D status was also investigated and is presented in Figure 4.6. There was a 
significant effect o f time on vitamin D status (Wilks’lambda, p=0.001) and a significant effect of 
ethnicity (Wilks’ lambda, p=0.01).
100 .0- E t h n i c i t y
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o
>0)
0
1 
I
Caucasian
A sian
40.0-
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Figure 4.6 Seasonal vitamin D levels for pre-menopausal women
South Asian (n=5) and Caucasian (n=12) women.
1, Summer 2007; 2, Autumn 2007; 3, Winter 2007; 4, Spring 2007; 5, Spring 2008, 6, Summer 
2010
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The vitamin D status o f Soutii Asian women remained relatively stable over time and did not 
appear to be season dependent. The vitamin D status o f Caucasian women varied according to 
season, with serum vitamin D levels at their highest during the summer and at their lowest during 
spring and winter (Figure 4.6).
4.5. DISCUSSION AND CONCLUSIONS
This study was carried out to investigate the interaction between vitamin D status and bone 
health, lifestyle and ethnicity in pre-menopausal women and was conducted in the summer o f 
2010. The study involved cross-sectional measurements o f vitamin D and vBMD and other bone 
parameters taken using a pQCT scanner. As expected, vitamin D levels were much lower among 
the South Asians than the Caucasian women, with the opposite being true for PTH levels. Asian 
women had a higher BMI, being shorter and heavier than Caucasian women and were more likely 
to have pain in the bone and muscle o f their backs than the Caucasian group. South Asian 
women tended to have lower bone mass, especially at the 4% distal radius and the 66% 
diaphyseal radius. Furthermore, South Asian women also had a lower total area, trabecular area, 
and cortical sub area at the 4% distal radius and the 4% distal tibia than Caucasian women.
This study involved scanning the tibia site, a site that has not previously been reported on in the 
literature for a pre-menopausal South Asian population. Surprisingly, in the tibia scan. South 
Asian women had a higher total bone density, higher trabecular bone density and higher cortical 
sub density at the 4% distal tibia. They had a lower total bone density, lower cortical bone 
density, and lower cortical thickness at the 14% diaphyseal tibia, and had a lower total density at 
the 38% tibia site than the Caucasian group. These inconsistent bone density findings may be 
related to the type o f physical activities undertaken in the Asian population. For instance, 
questionnaire data revealed that South Asian women were involved in limited types o f activities, 
where they more likely to walk than engage in cardio excercise like mnning and biking, which 
could potentially affect their bone density in some sites more than others. Another possible 
reason is that South Asian had smaller bone size (as it shown fi*om the current study’s pQCT 
results) than Caucasian where assessing bone density might not be in similar position. However,
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radius bone density (of any bone type) was not significantly difference between the ethnic group 
which was in agreement with other study finding done by Roy and colleagues (2005),
The pQCT scanner manual (Manual XCT2000), where bone measurements were on a cohort o f 
German subjects. There are no data on how these values might be in other ethnic groups. It is 
stated that the trabecular density o f radius and tibia should be higher than 200mg/cm, cortical 
density should be higher than 1050mg/cm3, and that values lower than these might be indicative 
o f osteomalacia. The bone densities at these sites for both ethnic groups were within the normal 
range. Moreover, the mass ratio data on the pQCT scanner are measured on a cohort o f  German 
subjects, however, the ratio o f radius bone mass at the 4% and 66% sites should be 1.2 on lower 
end range. This ratio was not observed in either ethnic group, where the radius ratio o f mass 1 
and mass 2 was 1.07 for both ethnic groups, and the tibia ratio o f mass 1 mass 3 was 1.08 and 
1.10 for Caucasians and Asians respectively. These low ratios indicate lower bone mass ratio o f 
both groups compared to the cohort German data set by the pQCT scanner
South Asian women had a lower polar stress-strain index, stress strain index X, and fi-acture load 
X at the radius site only. Moreover, these woman had lower stress strain index Y and fracture 
load Y in the radius and tibia compared to Caucasian subjects. These findings indicate that South 
Asian and Caucasian women have different bone geometry and bone strength and is in agreement 
with a study conducted by Ward and colleagues (2007). Ward et al, reported a difference in bone 
geometry and vBMD at the radius between UK-residing South Asians and Europeans, which was 
not explained by body size. However, they found no difference in bone strength, as polar stress 
strain data was similar in both groups. This study showed that South Asians also tended to have 
lower muscle total area in the radius and tibia and had weaker grip strength in both hands than 
Caucasian women. This study showed lower bone area in most radius and tibia sites, less cortical 
thickness at tibia site and lower bone density at some site in the tibia beside the deficient 
25(OH)D level among South Asian compared to Caucasian groups. All o f  these factors increase 
the risk for the South Asian groups o f suffering low bone quality and osteoporosis in later life 
compared to Caucasians group.
In general. South Asian women had less biologically desirable biochemical profiles (HDL, and 
insulin), %B, %S, and IR compared to standard reference ranges and Caucasian women. South
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Asians were less likely to expose their skin to sunlight and their SED was much lower than 
Caucasians. All o f the findings o f the current study put these Asian women at higher risk o f 
developing CVD and osteoporosis in later life.
Correlation between bone variables and body pain were observed in South Asian women but not 
in Caucasian women, and were more pronounced in tibia sites than in radius sites. The 
correlations suggest that a higher bone size or periosteal circumference in the circular ring at the 
radius site was associated with increased self-reported pain. At tibia sites, body pain was 
associated positively with bone mass; cortical area and thickness; total area; strength strain index 
and periosteal circumference in circular ring. All results suggested that higher bone mass and area 
was associated with greater back, bone and muscle pain.
That an association between vitamin D and muscle strength in the South Asian women was not 
observed may be because the majority o f the women in the study suffered with vitamin D 
deficiency, and an insufficient number with higher vitamin D levels were available to deduce a 
meaningful relationship. Further investigation o f the link between vitamin D and musculoskeletal 
health in younger women is highly recommended and is suggested to include subjects with a 
range o f vitamin D levels.
This study did not show any correlation between 25(OH)D and HOMA (homeostasis model 
assessment). This is contrary to the findings o f a larger cross-sectional study (n=441, including 
males and females) o f Asian Indians, that indicated a positive relationship between 25(OH)D and 
P-cell function (Majumdar et al., 2011). Failure to find a connection between HOMA variables 
and 25(OH)D might due to the small subjects number or due to the facts that most study’s 
subjects fall in the deficient groups where seeing correlation might be impossible.
The lack o f seasonal variation in vitamin D status in the South Asian group, as observed in the 
longitudinal analysis, indicated that they are at higher risk o f adverse health implications as a 
result o f their low vitamin D status throughout the year. This finding also sheds light on the 
behaviour o f these women in terms o f not regularly exposing themselves to sunlight even in the 
summertime. Whereas vitamin D levels increased during the summer months in Caucasians, 
reflecting time spent outside with exposed skin, levels remained constant in South Asians, 
highlighting cultural behavioural differences. Both UV exposure lifestyle data and the mean
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SED measured, confirm that South Asians are less likely to expose their skin to the sunlight. The 
vitamin D longitudinal analysis might also suggest that rather than limited sunlight exposure. 
South Asians could have different ability to produce vitamin D. Repeated measures o f bone 
density indicated that there is a relationship between DXA scan measurements and pQCT 
measurements at some bone sites, indicating that bone parameter have not changed between D- 
FINES I and D-FESIES II. However, age factors and bone analysis methods are two possible 
factors that may affect the validity o f this analysis.
Study Limitations
Recruiting participants from the original D-FINES study limited the maximum number o f women 
who would be available to take part in current study. This resulted in a relatively small number 
o f pre-menopausal women (Caucasian n=22, Asian n=19). As the study involved so many 
measurements and assessments, not all o f subjects provided complete datasets, reducing the 
power o f the analyses. The assessment o f bone pain was a subjective measure, open to mis- 
reporting, however it was the most available and fastest method available for this study. The 
questionnaires designed for the purpose o f this study did not undergo pilot testing prior to the 
study, which would have been a useful validation and improvement step. However, the 
questionnaires were designed to fit the study objective and were based on standard questions that 
are acceptable to most health professionals.
Study strengths
The longitudinal nature o f this study increased its power to detect changes in vitamin D, bone 
density and other health parameters over an extended period o f time, which is easily not 
achievable for independent researchers. This study also focussed on pre-menopausal women, 
specifically between the ages o f 19-48 years old. This group has not been extensively studied, so 
the findings reported herein are novel and useful for the healthcare community. It is well known 
that age decreases the capacity to produce vitamin D, so the population under study would be 
expected to have higher vitamin D levels compared with a similar group o f older people exposed 
to similar environmental factors. Similarly, vitamin D levels in the summer would be expected to 
be higher than in any other season. Thus, the combination o f optimal age and optimal season 
should allow an estimation o f the minimum risk o f vitamin D deficiency for South Asians and
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Caucasians. In another words, any adverse effects, such as back pain, bone pain and muscle pain 
measured in this study are likely to be magnified in the winter and in later life (MacLaughlin and 
Holick, 1985).
Conclusion
The findings o f this study indicate that South Asian women are at higher risk o f  osteoporosis due 
to their smaller bone size, and lower bone mass at some sites o f the radius and tibia. They have 
higher bone pain scores, and tended to be weaker in muscle strength tests. South Asian women 
are also at higher risk o f cardiovascular disease than Caucasian women because they have higher 
BMI and worse biochemistry measurements including vitamin D levels, insulin and HDL. 
Health-care providers assessing South Asian patients for osteoporosis should consider vitamin D 
deficiency as a possible and reversible risk factor contributing to bone loss.
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CHAPTER 5
DIFFERENCES IN VITAMIN D PRODUCTION IN CAUCASIAN AND 
ASIAN WOMEN FOLLOWING UVB EXPOSURE
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5.1. Introduction
5.1.1. Background
Sun exposure contributes significantly to the daily human production o f  vitamin D and as little as 
10 minutes o f daily exposure, in countries close to the equator in summer time, is thought to be 
enough to prevent deficiencies (Holick and Jemkins, 2004). However, controversy exists with 
respect to the paradoxical benefits and harmful effects o f ultra violet radiation (UVR) exposure 
and only a few studies have attempted to address this (Moan et al., 2008, Gilehrest, 2008, 
Reichrath, 2006). Solar radiation is the main source o f vitamin D; optimal levels o f  which are 
proactive against internal cancers and other diseases, yet long exposure to ultra violet (UV) may 
lead to skin cancer, non-melanoma or melanoma, in the event o f excessive UV exposure. 
Moderate exposure to solar radiation, with consideration given to multiple factors such as 
latitude, season and individual skin colour is recommended to receive health. Ramagopalan, 
(2001) explained the effect o f UV on the prevalence o f multiple sclerosis in the UK, where 
reliance on generating Vitamin D was the most likely candidate explaining the geographical 
relationship (Ramagopalan, 2011). However, in northern latitudes in winter solar UVB is 
insufficient to maintain adequate vitamin D levels and even if  UVB is available, the climate is too 
cold to facilitate skin exposure (Gozdzik et al., 2008). Studies have suggested that limiting skin 
exposure to UV by any means, e.g. limited time outdoors or excessive clothing, may lead to 
limited vitamin D synthesis and subsequently vitamin D deficiency may occur (Hollis et al.,
2007). There is therefore much concern about vitamin D deficiency within the northern countries 
o f the world, including the UK, where latitudes are between 50°N and 58°N.
Solar radiation is composed o f 90-99% UVA and 1-10% UVB (Norval et al., 2010). Solar UVB
radiation reaches the highest point at noon at the equator (Thieden et. a l,  2008). For successful
production o f vitamin D at a latitude close to the equator (11.5°N), an estimated sun exposure
time o f 9.5 minutes, at noon is suggested, regardless o f skin type and the time o f year (Webb and
Engelsen, 2006). According to current research by Action Spectra, it has been shown that only
UVB radiation (280-320 nm) causes cutaneous vitamin D synthesis, whereas UVA radiation
(320-400 nm) does not (Commission International on Illumination CIE, 2006) . With artificial
radiation (e.g. fi*om sunbeds), the proportion o f UVB could range from 0.5% to 4% and may emit
a similar emission spectrum to the sun, depending on the sunbed design (number and type o f
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fluorescent tubes, presence o f high pressure lamp, distance from eanopy to the skin and tube 
aging) (International Agency o f Research on Cancer lARC, 2006). However, sunbeds can reach 
values for UVA emission o f 10-15 times higher than the sun, but has no impact on vitamin D 
production (Gerber et al., 2002).
Both UVB and UVA cause prominent and aeute responses ineluding erythema and pigmentation, 
but UVA has a more prolonged effect than UVB (Suh et al., 2007). Gallagher et. al. (2005) also 
suggest tiiat both radiation types show a similar level o f  association with melanoma, but 
prolonged used o f artifieial radiation elevates the risk for cutaneous melanoma (Gallagher et al., 
2005). This study failed to indicate the exact risk o f low and moderate usage o f sunbeds, due to 
the fact that the research studies reviewed used different methods to record duration and/or 
frequency o f sunbed use. Furthermore, no study has collected information such as: years o f use, 
frequency o f exposure per year and duration o f each exposure (Gallagher et al., 2005) making 
definitive conclusions on the associated risks difficult to draw. Another systematic review was 
unable to provide evidence for an actual, increased association between melanoma and basal cell 
carcinoma (BCG) and long, latent periods o f sunbed usage. Again, this is because the 
epidemiological studies failed to distinguish between distant and recent exposure. Additionally, 
‘tanning’ has only recently become fashionable (lARC, 2006) so there is limited data on its 
longer term effects.
Studies that have been conducted in an attempt to recommend a safe UV exposure dose and 
duration have considered factors including season, latitude, skin-type and skin area exposed 
together with the associated risk o f eiythema. Recommended doses are expressed in terms o f  the 
minimum eiythema doses (MED) to prevent damage from UV exposure (Webb and Engelsen,
2008). MED is defined as the minimum UV dose necessary to elicit eiythema in the skin, used to 
measure erythemal radiation. The measure is based on individual sensitivity to UVR rather than a 
standard measure. Parameters taken into account include skin type, previous light exposure and 
other individual factors that affect the MED (Diffey et al., 1997).
It is known that skin pigmentation reduces the penetration o f  UVR and thus the extent o f light- 
dependent 25(OH)D synthesis. However, this has been proven only to be o f significance after a 
single exposure, since differences in skin pigmentation have little impact on circulating 25(OH)D
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upon multiple exposures (Young and Walker, 2005). A few studies in the literature have tested 
the body’s response to artificial UV exposure and, perhaps unsurprisingly, have identified health 
improvements due to the increase in vitamin D concentration. Chandra et al. (2007) showed an 
improvement in the vitamin D3 concentration o f five patients with cystic fibrosis and two with 
short bowel syndrome(suffering from vitamin D deficiency due to fat malabsorption) via UV 
lamps. UV therapy has also been used to improve psoriasis via an increase in 25(OH)D 
concentration (Osmancevic et al., 2007, Piystowsky et al., 1996). Cranney et al. (2008) undertook 
an extensive literature search o f multiple databases in order to examine the effect o f ultraviolet 
light, including solar and artificial, on circulating 25(OH)D concentration. They identified four 
studies that tested this objective but could not determine the potential impact o f effect modifiers 
such as race, ethnicity, age and latitude from the studies reviewed. However, their review did 
identify substantial evidence that UV exposure increased serum 25(OH)D concentration in 
participants with low or normal baseline 25(OH)D concentration. Moan et al. (2009) suggested 
considering moderate, non-eiythema sunbed exposure to maintain winter levels o f vitamin D 
when none is produced at northern latitudes.
To date, research has strongly indicated that Asian people living in the UK have a higher risk o f 
low vitamin D status compared to Caucasians. However, there is insufficient data to explain the 
reasons for this increased risk. Some predictors have been discussed and reviewed in previous 
research studies, including lifestyle factors such as covering most o f the body when going out, 
dark skin pigmentation, low dietary intakes o f vitamin D, and/or possible genetic differences. An 
intervention study by Daft et al (2002) determined the vitamin D status o f pregnant women from 
non-European ethnic minorities, supplemented the deficient group, and then re-checked their 
status at de lively. This study suggested that the factors that may influence vitamin D status, such 
as religion, fluency in English, and dress habit, did not appear to have any effect, although the 
women studied had lived in the UK for more than three years. The authors strongly suggested 
that ethnicity per se was associated with a high incidence o f sub-normal vitamin D level and 
consequently, their recommendations were for biochemical screening in early pregnancy, with 
subsequent supplementation where indicated (Datt et al., 2002).
A much earlier study, undertaken over 20 years ago by Clifford et. al. (1986), investigated
whether the high prevalence o f osteomalacia and rickets among Indian and Pakistani immigrants
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living in Great Britain was due to impaired capacity to produce vitamin D3 in their skin. The 
subjects were exposed to a whole-body dose o f UVR calculated at 1.5 times the MED in a walk- 
in irradiation chamber. Serial blood samples were obtained at 0, 1, 2, 3, 6, and 9 days after UV 
exposure. Six Asian subjects (Indians and Pakistani immigrants) aged between 18 and 30 years 
participated in the study; four age-matched Caucasian subjects served as controls. Figure 2.1 
shows the main findings o f the study. Maximum serum vitamin D concentration was seen at one 
day after UV irradiation. Serum vitamin D declined gradually back to baseline over the next 9 
days in both Asians and Caucasians. The UVR needed to produce an MED in Asians with darker 
skin, was greater (49-133 mJ/cm^) than that required in Caucasians (31-48 mJ/cm^). The authors 
concluded that Asians may need longer exposure to sunlight than Caucasians to give a 
comparable response, but the capacity to produce vitamin D is no different in Asian than 
Caucasian skin.
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Figure 5.1 Serum vitamin D concentrations after 1.5 MED whole body ultraviolet 
irradiation
©Adapted from Clifford, Paris, and Holick 1986
A further study used an artificial UV source and measured changes in 25(OH)D status, but only
among Caucasian volunteers. The purpose o f this study was to investigate whether the use o f
sunbeds with sunlamps, emitting mainly UVA and only 0.5% or 1.4% UVB, increases the level
o f serum 25(OH)D (Thieden et al., 2008). This was a controlled, open study with healthy,
Caucasian females (> 50 years) who were randomized to two different UV exposure regimes or a
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control group (n=21) who received no UV intervention. Sunbed radiation treatment was allocated 
as follows: Four 6-minute sunbed sessions (days 0, 2, 4 and 7) and four 12-minute sunbed 
sessions (days 9, 11, 14 and 16), with sunlamps emitting 0.5% UVB (n = 20), or with sunlamps 
emitting 1.4% UVB (n = 15) at the same timepoints. Serum levels o f 25(OH)D were measured 
on days 0, 9 and 18 in all three groups.
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Figure 5.2 Serum concentration o f 25-hydroxyvitamin D under the effect of two different 
dose of UV compared to control group
© adapted form Thieden et al. (2008)
Figure 2.2 above shows the main findings o f the study. The mean increase in serum 25(OH)D
from day 0 to day 9 was 12 nmoFL (SD 11 nmol/L, P = 0.0002) in the 0.5% UVB group and 27
nmol/L (SD 9 nmo/L, P < 0.0001) in the 1.4% UVB group. From day 9 to day 18, a ftirther but
non-significant increase in serum 25(OH)D was seen, specifically 3 nmol/L (SD 9 nmol/L, P =
0.2) in the 0.5% UVB group and 0.6 nmol/L (SD 18 nmol/L, P = 0.9) in the 1.4% UVB group.
This study shows that sunbeds emitting 0.5% and 1.4% UVB did effeetively increase the
25(OH)D serum level. The increases were dose-dependent but reached a plateau after a few
sessions. A side effeet o f mild to moderate erythema, or polymorphic light eruption and / or both
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were reported among more than 30% o f the subjects. This study used a standard dose and time o f 
artificial UV exposure, whereas Lo et. a l ,  1986, used 1.5 MED for each individual subject 
resulting in different exposure times.
Further studies have involved exposure to UV for different purposes but all have confirmed an 
increase in 25(OH)D concentration (please refer to appendix B for more details about these 
individual studies). Epstein et. a l  (2009) followed 29,508 women for an average o f 15.5 years, 
finding that women who used a sunbed more than three times per year reduced their hazard risk 
o f endometrial cancer (defined as cancer that forms in the tissue lining the uterus) by 40% (0.6, 
95% Cl 0.4-0.9) or by 50% when adjusted for BMI or physical activity (HR 0.5, 95% Cl 0.3-0.9). 
The reduced risk was associated to reaching the optimum level o f serum 25(OH)D (Epstein et ah,
2009). Another, indirect positive result was obtained by Tangpricha et. a l  (2004) who found that 
subjects who regularly exposed themselves to sunbeds (at least once a week) had 9% higher 
serum 25(OH)D, 18% lower PTH and higher BMD at total bone hip than control subjects. 
Another small study using subliminal artificial UVB for elderly residents found an improvement 
in vitamin D status at a lower cost than using oral vitamin D supplementation (Chuck et ah, 
2001). Finally a further study conducted among the elderly, found increased 25(OH)D fi*om 30 
nmol/l to 60 nmol/l after exposure to UVB irradiation at half the MED o f their lower back, three 
times per week, for a 12 week period. The study also concluded that UV exposure is as effective 
as oral vitamin D3 in increasing serum 25(OH)D and suppressing secondary hyperparathyroidism 
in the elderly (Chel et ah, 1998).
5.1.2. Justification for the study
This study aims to quantify the significant predictors o f low vitamin D status among South Asian 
women, in addition to comparing the reaction to UV in controlled environments between healthy 
(non-clinical) South Asian and Caucasian women subjects. Whilst data exists on the ability o f 
UV (solar and artificial) to raise 25(OH)D concentrations, the ethnic differences in 25(OH)D 
production remain to be fully elucidated. Specifically to control for the effects o f age and 
hormones, post-menopausal women aged 48 and older have been chosen for inclusion in the 
study, whilst any women taking HRT have been excluded.
148
Though the sample size and therefore the power o f the study o f Lo and colleagues (1986) was 
too low to make their conclusions more widely generalizable, it has informed the design o f the 
current study. The current study has been conducted to test the factors which may influence 
vitamin D status among the Asian population. This has been achieved by measuring the 
endogenous production o f vitamin D in Asian women, compared to that o f a Caucasian 
population, while controlling for skin color differences between the groups. If  no difference in 
vitamin D synthesis is found between these two groups for an identical stimulus, then genetics 
and biological ability o f vitamin D synthesis cannot be cited as factors responsible for low 
vitamin D status, among Asians. This study must be carried out between the months o f October 
to April, when the ambient UV radiation is negligible and the blood concentration o f vitamin 
25(OH)D is said to be at its lowest. By completing this research we hope to quantify significant 
predictors that To recruit cause low vitamin D status among Asians.
5.1.3. Aim and Objectives
This study aimed to investigate tiie differences in vitamin D production between Asian and 
Caucasian post-menopausal women, in response to a defined, controlled UVB exposure.
Objectives:
a representative sample o f healthy South Asian and Caucasian post-menopausal females >48 
years o f  age.
To implement a 9 day control period followed by a protocol o f 3 sunbed sessions over a 
period o f 9 days.
To collect blood samples prior to and after the UV sessions, for the two stages o f the study 
(control and intervention) in order to analyze the changes in vitamin D, PTH, and lipid 
profile.
To perform descriptive statistics to describe the mean change in serum 25(OH) D and PTH 
within each population group over the study period.
To investigate the difference in vitamin D production between South Asian and Caucasian 
post-menopausal women, within the periods o f the study.
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• To investigate whether vitamin D deficiency in Asian women is due to impaired capacity 
(genetic disability or disordered cutaneous production).
• To investigate the differences in vitamin D production between those who are deficient and 
sufficient at baseline (^25nmol/l and >25nmol/l respectively)
• To analyze the effect o f UV exposure on serum lipid, insulin, and glucose levels for the 
sample as a whole and for the individual ethnic subgroups.
5.2. METHODOLOGY:
5.2.1. Subject identification & recruitment strategy
Identification o f potential participants was via non-random sampling o f females over 48 years old 
and possibly post-menopausal who were willing to participate. Presentations o f the study 
proposal were made during D-FINES results meeting and advertisement brochures and flyers 
were placed in local Islamic centres to directly target the Asian population. Subjects o f both 
ethnicities were also recruited via email and poster advertisements to students and staff o f the 
University o f Surrey, to raise awareness o f the study and alert potential volunteers (see appendix 
B for a copy o f the study flyer). Power and sample size were calculated fi*om the Thieden et al. 
(2008) study; 1.0 SD size effect between control and intervention group at 80% power, n=14. 
As this protocol is very similar to that used in Thieden et. ah, (2008) publication, it is realistic to 
expect an increase in vitamin D levels in the intervention group, within the SD from this previous 
study, i.e. 21.5 nmol/l.
All interested subjects were asked to provide their contact information and, once ethical approval 
was obtained, interested subjects were contacted by telephone to undertake a short screening 
interview to check their eligibility to participate. Written letter, Information sheets and consent 
forms were sent to subjects prior to the study (please refer to appendix B for a copy o f the letter, 
information sheet and consent form). Subjects were free to withdraw from the study at any time, 
without giving a reason and without consequence. Participants were assigned to groups on the 
basis o f their availability to attend the Clinical Investigation Unit (CIU) at the University o f 
Surrey and the sunbed salon; with three groups allocated a different schedule o f visits.
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Each subject within each group was assigned six study visits, and each group was one week 
apart. Participants were contacted by telephone and email to arrange appointments and provide 
transportation or parking permits to attend the CIU and sunbed clinic. At the end o f the study 
small honorarium was made in appreciation o f their time and effort.
5.2.2. Criteria for participant selection
A one page self-completion screening questionnaire was designed to be filled in by participants 
prior to the study to ensure that they met the relevant inclusion and exclusion criteria (See 
appendix B for more detail on the inclusion/exclusion questionnaire). The important inclusion 
and exclusion criteria are provided below.
Inclusion:
Willing for skin colour to become darker as a result o f the UVB exposure 
Aged over 48 and / or post-menopausal
Able to understand and write English (in order to provide informed consent)
O f South Asian or Caucasian ethnicity 
Have no previous or current skin cancers
Exclusion:
• Suffering from any medical dermatology condition that may be worsened by sunbed 
exposure
• Any medication that would affect vitamin D production, such as HRT
• Any disorders that would affect vitamin D metabolism, e.g. liver disease
• Use o f vitamin D supplements in the 3 months prior to the study
• Visible tanning due to sunbed use or holidays in hot climates (at latitudes below 45°) in 
the last 12 months
• Any previous incidence o f serious sunburn
• Any previous use o f a UV-emitting tanning device
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• High risk skin pigmentation, e.g. Caucasian subjects with red hair and freckles who do not 
tan (but do bum if unprotected)
• Unable to travel to the sun-bed clinic on six occasions.
5.2.3. Participants and Procedures
The design o f the current study was driven by a similar study by Clifford et al. but has been 
adjusted by employing a different UV exposure method and a larger sample size (Lo et ah, 1986). 
This is a controlled intervention study designed to compare the vitamin D synthesis rate after UV 
(sunbed) exposure, in South Asian and Caucasian post-menopausal women in the UK, with a 
recmitment target o f 14 subjects per ethnic group. The study took place in the CIU at the 
University o f  Surrey, and a local sunbed salon between Febmaiy and mid March, 2011. These 
timelines were based on periods when the ambient UV radiation is deemed negligible and the 
blood concentration o f 25(OH)D is expected to be at its lowest levels during the year. In total, 19 
healthy women; 9 Caucasian, 8 South Asian and 2 o f mixed ethnicity took part in the study. 
Subjects lives in South East o f England, (ex. London’s latitude o f 51°N). Subjects acted as their 
own controls over a nine-day period, prior to the sunbed intervention study.
All subjects were asked to avoid using perfume, deodorant, make up or any cosmetics on their 
visits. They were also asked to remove all jewelry, accessories and watches during the session. 
All subjects had their own privacy in the sunbed room and were asked to wear only their 
underwear (resulting in approximately 82% body surface exposed). All subjects were provided 
with Wink-Ease, disposable eye protection, as is standard in the salon to protect their eyes during 
the session. The Wink-Ease eye protectors met the requirements and registered trademark o f 
EYE PRO (see appendix B for more details on the product registration). The sunbed room had a 
remote device to operate the sunbed, and subjects were guided on its use. All subjects were 
prescribed the same length o f time in the sunbed, independent o f their skin colour. Participants 
had no further involvement in the study after their sixth visit to the CIU. Following the study, 
subjects had the option to receive a written report o f their serum 25(OH)D levels and/ or a
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summaiy o f  the results o f the whole study when they become available. All travel expenses were 
reimbursed.
5.2.5. Study protocol (see Figure 5.3)
Visit 1
At the first visit, which took part in the CIU, participants completed a set o f  questionnaires 
(taking approximately 30 minutes), gave a fasted blood sample, had anthropometries 
measurements and had their skin tone assessed. At all visits subjects were given breakfast and 
drinks before leaving the CIU.
Visit 2
Visit 2 took place one week later, at which a fasted blood sample was taken.
Visit 3.
Four days later (day 12), the third visit took place in the sunbed salon with a fasted blood sample 
taken first. Skin tone was assessed again and a six minute sunbed session was undertaken.
Visit 4
Four days later (day 16), visit 4 was in the salon. An optional fasted blood sample was requested 
but since this was not designated in the study protocol nor detailed in the participant information 
leaflet, subjects were able to opt-out. All participants underwent a skin tone assessment and an 8 
minute sunbed session.
Visit 5
Four days later (day 20), participants visited the tanning salon a planned fasted blood sample, 
skin tone assessment and the last 8 minute sunbed session.
Visit 6
Two days later (day 22participants attended the CIU for a fasted blood sample, skin tone 
measurement and completion o f a short questionnaire on tanning skin reactions and skin colour 
change.
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Post study completion
Few months prior the study experiment, subjects received their vitamin D concentration results 
(please see appendix B for an example o f results letter).
Control period
Sunbed/ Vitamin D Study 
Intervention period
V i s i t  1  a t  C I U  ( d a y  
1)
• Blood sample 1
• Filling out 
questionnaires
V i s i t  2  a t  
C I U  ( d a y  8 )
• Blood 
sample 2
V i s i t  3  a t  
t a n n i n g  s a l o n  
( d a y  1 2 )
• Blood 
sample 3
• Sunbed 
session 1 (6 
minutes)
V i s i t  4  a t  t a n n i n g  
s a l o n  ( D a y  1 6 )
• Blood sample 
4 (optional) :
• Sunbed 
session 2 (8 
minutes)
V i s i t  5  a t  
t a n n i n g  s a l o n  
( D a y  2 0 )
• Blood 
sample 5
• Sunbed
, session 3 
(Bminutes)
V i s i t  6  a t  C I U  
( D a y  2 2 )
• Blood sample 
6
• Filling out 
s h o r t  0
questionnaire
Figure 5.3 study timescale with the details o f each visits
5.2.6. Measures and tools used:
5.2.6.1. Anthropometries
Anthropometric measures were taken in visit one. Weight was measured in light clothing 
(without shoes) using Seca dual scales, heavy duty model with a capacity o f 150kg/23 stone (to 
nearest 0.1 kg). Heights were measured using a wall-mounted stadiometer, with shoes removed 
(to nearest 0.1cm). Body mass index (BMI) was calculated using the equation:
BMI (kg/m^) = weight/ [height*height]
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5.2.6.2. Blood biochemistry
At each visit, a fasted blood sample o f  20 ml was taken from all subjects. Blood samples were 
collected by professional phlebotomist, and blood packing and processing was performed by the 
investigator under the supervision o f the phlebotomist.
The vitamin D and PTH analyses were undertaken under the supervision o f Dr Jacqueline Beny, 
University o f Manchester. Serum 250H)D3 and 25(OH)D2 were measured by mass spectrometry 
(Chromsystems reagent kit, 62000) (please refer to appendix B for more detail on the vitamin D 
analysis). Please refer to chapter 4 for more details about the analysis method o f PTH, lipids, 
glucose and insulin samples.
5.2.6.3. UV exposure behaviour
Natural and artificial UV exposure were assessed by administration o f a questionnaire that was 
designed for the purpose o f the study (refer to the appendix B for a copy o f the UV 
questionnaire). The questionnaire focused primarily on UVB exposure behaviour, recent travel, 
sunscreen use, and sunbed use. Subjects were also asked to wear dosimeter badges throughout the 
week to measure the amount o f natural UV that they were exposed to during the day.
5.2.6.4. Skin colour tone ^
An extensive search was undertaken to identify a suitable tool for assessment o f skin tone. 
Difficulty finding reliable equipment for this purpose was responsible for a delay in the 
commencement o f the study. Previous studies have used reflectance spectroscopy to measure the 
amounts o f melanin in the skin over time (Ravnbak et ah, 2008), however we could not gain 
access this meter for the current study. Other, non-mechanical options, include colour charts 
developed by cosmetic companies to identify skin tone. However, although a comprehensive 
chart was identified (de Rigal et ah, 2007) the owners were not willing to release it for use in this 
research study.
Therefore this study utilized a Chromotest meter, sourced from a local beauty clinic (permanent 
hair removing treatment clinic) made by Chromogenex Technologies Ltd. The Chromotest is a 
meter was designed to assist in the evaluation o f melanin content in a client’s skin prior to Intense 
Pulsed Light (IPL) treatment. Side effects from IPL treatment are more commonly reported in
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skins with high melanin content, due to increased light absorption and thermal trauma. The 
Chromotest meter can be used to support but not replace a trained operator’s assessment during 
treatment, and can be a means o f  monitoring a client’s skin at each consultation to ensure the 
treatment area has not tanned from sun exposure since the last visit. During IPL treatment, a skin 
tone number is used to assist in patch testing prior to treatment. The skin tone number can also be 
rechecked at future visits to ensure it hasn’t darkened, which would be a contraindication for 
treatment. The Chromotest works by evaluating the red, green and blue (RGB) colour 
components o f an area following calibration against white and black calibration charts. Each 
component is given a number between 0 and 333 based on its strength, the sum o f the three 
numbers giving a ‘skin tone’ number, see Table 5.1 for more detail. This skin tone number is 
purely a representation o f colour and does not assess skin fragility, sensitivities or damage that 
might also contraindicate a client from treatment.
The Chromotest works by evaluating the red, green and blue (RGB) colour components o f 
an area following calibration against white and black calibration charts. Each component is 
given a number between 0 and 333 based on its strength, the sum o f the three numbers 
giving a ‘skin tone’ numberTable 5.1 RGB numbers and how they compute to a skin tone 
number
Red Green Blue Skin
Tone
White 000 000 000
Black 333 333 333
Hypothetical 
Skin Tone
200 200 200 600
After Tanning 
(Flushed)
240 210 215 665
Next Day 210 210 215 635
(Not Flushed)
A d a p t e d  f r o m  ( C h r o m o g e n e x  T e c h n o l o g i e s  L t d ,  2 0 1 0 )
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When using the Chromotest, the skin area to be tested should first be cleaned. The tip of the 
meter is then pressed just firmly enough to contaet the skin and block out light, after which the 
reading is taken, see figure 5.5 for a pictorial demonstration. The machine can be tested for 
proficiency by taking multiple measurements without moving the tip. The skin tone numbers 
should be closely grouped, without more than a one or two point variance. If the numbers rise, 
the meter could be pressing too hard against the skin and if the numbers are inconsistent the 
meter may not be fitted w e ll . If the area is large or has a varied colouration, it was advisable to 
take measurements in several areas.
Figure 5.5 The Chromotest meter and its correct application to the skin
Skin tone readings were taken in this study on visit 1 as a baseline measurement and on visit 4, 5, 
and 6  as follow-up measures post-UV exposure. The skin parts tested were the dorsal forearm, 
ventral forearm, chest, upper back, and abdomen. Because the Chromotest is very sensitive, and 
may give different melanin readings within the same skin area, the investigator used a reference 
point to measure from and multiple readings were taken at each site. Other skin tone 
measurement tools used before and after the sunbed session were a skin colour chart and skin 
colour make up. These tools were helpftil for skin colour visualization to guide in skin type 
classification but no ftirther analyses have been considered in the study. Figure 5.6 provides more 
detail on the skin colour chart used in the study.
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Figure 5.6 skin tone cards and skin tone makeup
5.2.6.5. Skin colour type
A short questionnaire on skin color type was designed for the purpose o f the study to identify the 
subjects’ skin types (see appendix B for a copy of the questionnaire). Some o f the key questions 
included in the questionnaire were to assess the skin’s reaction to sun and the resulting skin 
colour. The design of the questionnaire took into consideration previously reported skin colour 
scales (Taylor et al., 2005, Roberts, 2009, Fitzpatrick, 1988b).
5.2.6.6. Sunbed cabin
The source o f UV radiation was a commercially available tanning sunbed. The tanning bed used 
was Ergo line 450- turbo power ultra; double sided lay-down (refer to figure 5.6). According to 
the Sun Ergo line Company, (Ergoline Inc, 2011), the tanning bed is 2 meters long, and has 42 
turbo powered UV lamps, 160/180 watt UV lamps with 4 high-pressure facial tanners. The total 
UV output was 81.4 kj/min; the intensity and specific percentages o f UVA, UVB and Irradiance 
is largely determined by the age and specification o f the lamps fitted to the sunbed. However, 
typical tanning bed devices have UV bulbs that emit 95% UVA and 5% UVB, +/-3% with the 
main purpose being to produce a cosmetic tan. The number o f sunbed sessions and duration o f 
each session were carefully chosen to be moderate and non-erythmic based on previous studies, 
tanning bed recommendations and the guidelines o f the tanning bed clinic. The investigator 
visited several local tanning salons to find a reliable machine and a salon owner willing to 
participate in the study. The final salon was selected because it had an up to date service histoiy, 
appropriate location and the agreement o f the owner to provide the seivice. The investigator
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contacted the sunbed company to obtain more detailed information on the specification o f the 
sunbed (please find the tanning bed manual in the appendix B for more detail).
Figure 5.6 Example of the model o f sunbed cabin used in the study
5.2.6.7. Food Diary
Food intake was assessed at the beginning o f the study by use o f a 4-day food questionnaire. 
Participants were given detailed instructions on how to complete the questionnaire and the 
responses were analyzed using Win Diets (Robert Gordon, Aberdeen). All participants were asked 
to avoid making any significant changes to their normal diet during the study period to minimize 
changes in vitamin D intakes.
5.2.7. Statistical analysis
Data were analyzed using SPSS (PAWS statistics 18). All variables were checked for normality 
using the Kolmogorov-Smirnov (K-S) test and to confinn that variables were normally 
distributed. Baseline characteristics were analyzed using unpaired /-tests for comparison o f South 
Asian and Caucasian groups. Data were fitted to a number o f statistic models, with mixed linear 
model providing the best fit where ethnicity and number o f sunbed visits were considered as 
fixed variables, and skin tone was used as a covariant. The changes in other biochemical 
measurements (lipids, glucose and insulin), between the time points within the two groups, were 
assessed by paired /-tests.
5.2.8. Ethical Issues:
The study received ethical approval from the University o f Surrey ethies committee (please see 
appendix B for more detail on the protocol and ethical committee approval). The final ethical 
approval was granted on 1 1 - 1 1 -2 0 1 0 .
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5.2.8.1. Risk assessment
Exposure to sunbed-emitted UV light could make the participants slightly tanned, which may be 
perceived as either a disadvantage or advantage depending on the subject’s personal beliefs. 
There was a possibility o f suffering from erythema, which is a redness o f  the skin caused by 
small blood vessel congestion, or polymorphic light eruption. This is a skin condition with 
symptoms like skin irritation, which may be itchy or painful. However, the exposure levels 
utilized in the current study were not sufficient to cause the skin to bum. Whilst UVB radiation is 
well-known for its carcinogenicity and associated with a high frequency o f acute side effects, 
these were not expected to occur in the present study, where exposure to UVB is transitory. 
Despite the recent confirmation that prolonged exposure to artificial UV radiation increases the 
risk o f melanoma, this study was designed to expose subjects for minimal duration and using low 
sunlamp strengths. These measures were instituted to reduce all possible long-term risks and 
acute, short-term effects, such as erythema and pigmentation.
In addition, the age group selected for the current study was chosen to be representative o f  an 
adult population with a lower risk from sunbed exposure, according to a study that reviewed by 
the International Agency for Research on Cancer (LARC) Working Group (2006). This group 
reported that exposure to sunbed radiation at an early age (before 35) increases the risk o f 
melanoma (summary relative risk, 1.75; 95% Cl, 1.35-2.26). However, taking all possible risks 
into account, this study will discourage participants from future exposure to artificial radiation. 
Verbal suggestions and a written letter have been given to the participants, advising them o f the 
dangers in order to reduce their overall risk to melanoma, fri addition, the inclusion and 
exclusion criteria had been carefully developed, in order to exclude potential participants thought 
to be at increased risk o f suffering negative side effects o f  sunbed exposure, e.g., those with very 
fair skin who bum easily and those with a previous histoiy o f  sunbed use and / or sunbum. The 
dose and duration proposed in the current study have been considered ‘moderate’ by those studies 
which endorse moderate usage o f sunbeds as beneficial. Blood samples were taken by trained 
professionals, causing no health risk. However, the drawing o f blood might cause some 
discomfort with a risk o f slight bruising. Provision o f study results, i.e. information on vitamin D 
status, was not expected to cause distress to participants.
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5.2.8.2. Potential benefits to participants
As a result o f participating in the study, subjects received an analysis o f their serum 25(OH)D 
level and were made aware o f the context o f their result in relation to normal or abnormal 
reference ranges for vitamin D status. Reasonable travel expenses to attend the sunbed salon and 
CIU were reimbursed, on production o f a valid receipt. To help encourage participants to 
complete the study, payment o f a small honorarium was made in appreciation o f their time and 
effort.
5.3. RESULTS
5.3.1. Subjects
All subjects were from Surrey in the South East o f England with a latitude o f 52.8°N. A total o f 
19 healthy participants completed the study with no subjects dropping out after recruitment. None 
o f the subjects had used a tanning sunbed before. All subjects completed the three required 
sunbed sessions.
5.3.2. Baseline characteristics
5.3.2.1. Ethnicity and age
Table 5.2 provides ftirther detail about participant numbers and ethnicity. The mean age o f the 
sample was 61.3 years [SD 9.1] with an age range o f 49-75. There was a significant difference in 
age (p<0.001) between the ethnic groups, where mean and (SD) for the Caucasian group was 
68.78 (4.79) and for the Asian group was 54.50 (5.26).
Table 5.2 Ethnicity o f post-menopansal women recruited to a sunbed study
C h a r a c t e r i s t i c s
E t h n i c i t y N ( % )
C a u c a s i a n 9  ( 4 7 . 4 )
S o u t h  A s i a n 8 ( 4 2 . 1 )
M i x e d  b a c k g r o u n d 2  ( 1 0 . 5 2 )
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S.3.2.2. Skin type
Caucasian participants were classified as skin type II or III based on the Fizpatric skin type 
classification, (Fitzpatrick, 1988a) and South Asian subjects were classified as skin types IV or 
V. No subjects with type I and VI skin took part in the study, where type I was excluded group 
and no black skin colour (type VI) took part in the study. Table 5.3 provides more detail on 
participant’s skin type classification.
Table 5.3 Skin type classification for post menopausal women recruited to the sunbed study
F i t z p a t r i c k  s k i n  t y p e * N ( % )
I I 8  ( 4 2 . 1 0 )
I I I 2  ( 1 0 . 5 2 )
I V 3 ( 1 5 . 7 8 )
V 6 ( 3 1 . 5 7 )
* (Fitzpatrick, 1988a)
5.3.2.3. Anthropometries
All data were found to be normally distributed. There was no difference in height between ethnic 
groups but Asian women were significantly heavier (p=0.03) and had a higher BMI (p=0.02) (see 
table 5.4).
Table 5.4 Anthropometric measurements for post menopausal women recruited to a 
sunbed study (mean (SD))
C a u c a s i a n
N = 9
S o u t h  A s i a n  
N = 8
M i x e d  e t h n i c i t y  
N = 2
T o t a l  s a m p l e  
N = 1 9
H e i g h t 1 5 9 . 1 1 ( 4 . 4 0 ) 1 5 9 . 3 8 1 6 6 . 7 5 ( 0 . 3 5 ) 1 6 0 . 0 3  ( 4 . 9 1 )
W e i g h t 6 2 . 7 7 ( 9 . 8 1 ) * 7 4 . 0 0 * 7 3 . 0 0 ( 1 8 . 3 8 ) 6 8 . 5 7  ( 1 1 . 4 3 )
B M I 2 4 . 7 7 ( 3 . 6 4 * 2 9 . 1 6 * 2 6 . 2 6 ( 6 . 7 2 ) 2 6 . 7 7  ( 4 . 2 8 )
^p<0.05
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5.3.3. Vitamin D concentrations
T a b l e  5 . 5  s u m m a r i z e s  t i i e  d a t a  o n  v i t a m i n  D  s t a t u s  i n  t h e  s t u d y  p o p u l a t i o n .
Table 5.5 Vitamin D levels among post-menopausal women recruited to a sunbed study, at 
baseline and after sunbed exposure
Ethnicity Caucasian Asian Mixed Total groups
N Mean(SD) N Mean(SD) N Mean(SD) N Mean (SD)
Vitamin D2 9 1.69(1.38) 8 1.20(1.08) 2 0.85 (0.92) 19 1.39(1.20)
' 1
Vitamin D3 9 43.58 (19.43) 8 27.04 (23.92) 2 20.65 (16.76) 19 34.20 (22.20)
>
Total vitamin D 9 45.23 (19.65) 8 28.24 (24.79) 2 (17.68) 19 35.58 (22.82)
Vitamin D2 7 1.16(0.83) 7 1.01 (0.87) 1 0 .2 0 (.) 15 1.03 (0.82)
1 Vitamin D3 7 41.53 (19.52) 7 21.66(23.20) 1 9.10Q 15 30.09 (22.94)>
T otal vitamin D 7 42.31 (19.43) 7 22.66 (23.94) 1 9.50(.) 15 30.95 (23.22)
Vitamin D2 8 1.85 (1.54) 7 1.09 (0.91) — 15 1.49(1.30)
cn
1 Vitamin D3 8 47.05 (21.41) 7 23.90(26.19) — 15 36.25 (25.81)>
Total vitamin D 8 48.69 (22.01) 7 24.94 (26.99) — 15 37.61 (26.55)
Vitamin D2 3 2.73 (2.69) 2 1.10(0.14) 2 0.90 (0.85) 7 1.74(1.84)
I Vitamin D3 3 47.63 (23.97) 2 35.95 (17.75) 2 29.45 (18.17) 7 39.10 (19.23)
>
Total vitamin D 3 50.27 (26.63) 2 37.15 (17.47) 2 30.40 (18.95) 7 40.84 (20.79)
Vitamin D2 9 1.69(1.67) 7 0.94 (0.83) 2 0.90 (0.85) 18 1.31 (1.32)
l O
1 Vitamin D3 9 55.52 (18.15) 7 3829 (19.88) 2 47.15 (21.43) 18 47.89 (19.76)>
Total vitamin D 9 57.19 (18.56) 7 39.21 (20.43) 2 48.05 (22.27) 18 49.18 (20.34)
Vitamin D2 9 1.70(1.72) 8 1.04 (0.71) 2 0.75 (1.06) 19 1.32(1.31)
'■O
1 Vitamin D3 9 57.50 (17.11) 8 44.73 (17.74) 2 56.30 (16.97) 19 51.99 (17.58)>
Total vitamin D 9 59.44 (17.77) 8 45.74 (18.03) 2 57.05 (18.03) 19 53.42 (18.18)
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Intervention period
Caucasian
- ■ “ Asian
S tu d y  v isits
Figure 5.7 Mean vitamin D3 synthesis over the course o f the study for post-menopausal 
women (Asian, n=8; Caucasian, n=9) enrolled in sunbed study
1, baseline measurement -  2, second control measurement -  3, third control measurement- 4, 
measurement after a 6 -minute sunbed session; 5, measurement after an 8 -minute sunbed session; 
6 , measurement after an 8 -minute sunbed session 
Error bars represent the calculated standard error o f the mean.
Both groups had a gradual increase in 25(OH)D with final levels significantly higher than 
baseline (p<0.01). Mean 25(OH)D concentration rose from a baseline o f 43.58 (19.65) to 57.80 
(17.11) nmol/1 in Caucasians and from 27.03 (23.92) to 44.73 (17.74) nmol/1 in Asian women. 
The baseline status o f vitamin D was classified as deficient among the Asian women and 
insufficient among the Caucasian women. The percentage increase in vitamin D3 among 
Caucasians was 39.86% (21.02) and 207.78% (286.02) in Asian subjects respectively. The 
increase in 25(OH)D3 level after UV exposure was significantly negatively correlated with 
baseline 25(OH)D3 level (p=0.01) in both ethnic groups. A mixed linear model analysis 
identified a significant effect o f duration o f UVR exposure on the production o f 25(OH)D 
(p<0.001 ). However, the model showed no significant effect o f ethnicity or skin tone on the 
production o f 25(OH)D.
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Table 5.6 illustrates the differences in vitamin D concentration between the study visits among 
Caucasian and Asian subjects. Despite an overall significant increase (baseline to visit 6 , t= - 
14.18, p<0.01) there was no significant increase in vitamin D3 between any o f the study visits for 
the Caucasian women. Among the Asian women, there were significant increases in vitamin D 3 
between visit 1 and visit 2, and between visit 5 and visit 6 . There was also a significant increase 
in vitamin D3 between baseline visit and the last visit (t= -6.09, p<0.01) among South Asian and 
(t=-14.18, p<0.001) among Caucasian.
Table 5.6 Differences in vitamin D3 level between study visits for post-menopausal women 
recruited to a sunbed study
E t h n i c i t y C a u c a s i a n  ( n = 9 ) S o u t h  A s i a n  ( n = 8 )
P a i r e d
D i f f e r e n c e s :
v i s i t  1  -  
v i s i t 2
v i s i t 2  -  
v i s i t s
v i s i t s  -  
v i s i t 4
v i s i t 4  -  
v i s i t s
v i s i t s  -  
v i s i t 6
v i s i t  1 
v i s i t 2
v i s i t 2  -  
v i s i t s
v i s i t s  -  
v i s i t 4
v i s i t s  -  
v i s i t 6
M e a n 1 . 2 1 - 2 . 6 2 - 5 . 3 - 7 . 5 7 - 1 . 9 8 2 . 9 1 - 0 . 9 - 6 . 0 5 - 4 . 3 3
S D 3 . 1 5 2 . 8 4 Z 8 3 1 0 . 8 3 . 5 4 1 . 8 5 2 . 7 2 0 . 9 2 3 . 9 9
t 1 . 0 2 - 2 . 2 6 - 2 . 6 5 - 1 . 2 1 - 1 . 6 7 4 . 1 6 - 0 . 8 1 - 9 . 3 1 - 2 . 8 7
p - v a l u e  ( 2 -  
t a i l e d )
0 . 3 5 0 . 0 7 0 . 2 3 0 . 3 5 0 . 1 3 0 . 0 1 0 . 4 6 0 . 0 7 0 . 0 3
5.3.4. PTH
Table 5.7 summarizes the changes in PTH (pmol/1) levels across the study visits for the study 
population, by ethnic group
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Table 5.7 PTH (pmol/1) levels (mean (SD)) for post menopausal women recruited to a 
sunbed study
Ethnicity Caucasian Asian M ixed Total groups
N M e a n ( S D ) N M e a n  ( S D ) N M e a n  ( S D ) N M e a n  ( S D )
V i s i t  1 9 2 8 1  ( E 4 7 ) 7 2 9 4 ( 1 2 1 ) 2 2 4 5 ( 0 2 1 ) 1 8 2 8 2 ( 1 2 8 )
V i s i t  2 7 2 0 7  ( E 2 9 ) 7 3 4 0 ( 0 . 9 7 ) 2 2 2 0 ( 0 4 0 ) 1 6 2 9 4 ( 1 4 5 )
V i s i t  3 7 2 . 5 1 ( 1 . 3 3 ) 7 2 . 8 3  ( 1 . 9 4 ) 1 2 4 0 ( J 1 5 2 4 5 ( 1 2 5 )
V i s i t  4 4 2 . 5 3  ( 1 . 8 1 ) 2 1 . 8 0  ( 0 . 2 8 ) 1 1 4 0 0 7 2 4 9 ( 1 2 5 )
V i s i t  5 9 2 . 1 2  ( 0 . 8 4 ) 7 2 1 3 ( 0 4 7 ) 1 1 2 0 6 ) 1 7 2 4 0 ( 0 2 3 )
V i s i t  6 9 2 . 4 0  ( 0 . 6 6 ) 8 2 . 5 6  ( 0 . 7 9 ) 2 1 . 7 5  ( 0 . 2 1 ) 1 9 2 . 4 0  ( 0 . 7 1 )
4 .0 Control period
ntersenticn period
3.5
3.0
2.5
2.0
1.5
1.0 Caucasian n=9
0.5
Asian n=lS u n b e d  s e s s i o n s
0.0
Study visits
Figure 5.8 Mean PTH (pmol/1) levels over the control and UVB exposure periods for 
postmenopausal women recruited to a sunbed study.
Error bars represent standard error of mean
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PTH levels decreased after the first UV session (after visit 3, 6  minutes sunbed session) as it is 
shown in figure 5.8., In the Asian group, PTH level decreased more dramatically after the third 
visit than it did in the Caucasian group. The large decrease in PTH in Asian women coincides 
with their large increase in vitamin D (see figure 5.8). After the first 6  minute exposure, PTH 
were increased and increased further following the next two UV sessions. The increase in 
25(OH)D3 level after the UV exposure was significantly positively correlated with baseline PTH 
level (p=0.02) among Asians but not Caucasians. There was no significant correlation between 
PTH and vitamin D either at baseline or at the last visit in either ethnic group. However, there 
was a significant positive correlation between PTH at baseline and the last visit (r=0.92, p=0.00) 
in the Caucasian group but not the Asian group.
5.3.5. Differences in vitamin D and PTH level between Vitamin D classification groups
Since a dramatic increase in vitamin D 3 was identified among subjects who were deficient at 
baseline, fiirther analysis by sub-groups o f vitamin D status was undertaken. The sub-groups 
were classified as deficient or sufficient (deficient ^5nm ol/l; sufficient >25nmol/l).
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Table 5.8 Vitamin D levels (nmol/1) according to baseline Vitamin D status in post­
menopausal women enrolled in a sunbed study.
Deficient Sufficient
n Mean(SD) n Mean(SD)
Vitamin Dz 5 0.88 (0.47) 1 2 1.70 (1.38)
"a Vitamin D3 5 12.20 (8.14) 1 2 45.63 (19.01)
>
Total Vitamin D 5 13.06 (8.40) 12 47.31 (19.52)
VitaminDz 5 0.76 (0.43) 9 1.27(0.95)
(N VitaminDs 5 10.16(7.13) 9 43.50 (19.75)
> Total Vitamin D 5 10.92 (7.57) 9 44.47 (20.03)
Vitamin D2 5 0.76 (0.42) 1 0 1.86 (1.45)
m Vitamin D3 5 10.00 (6.46) 1 0 49.37(21.06)
> Total Vitamin D 5 10.72 (6.77) 1 0 51.05 (21.76)
Vitamin D2 1 1 . 2 0  (.) 4 230 (2.36)
-Tf-
1
Vitamin D3 1 23.40 (.) 4 47.85 (19.57)
Total Vitamin D 1 24.80 (.) 4 50.08(21.75)
Vitamin D2 5 0.74 (0.44) 1 1 1.65 (1.58)
1
Vitamin D3 5 27.74 (5.11) 1 1 57.18 (17.59)
>
Total Vitamin D 5 2848(526) 1 1 58.80 (18.06)
VitaminD2 5 0.94 (0.62) 1 2 1.58 (1.54)
VitaminD3 5 3324(627) 1 2 59.09(15.65)
>
Total Vitamin D 5 34.16 (6.80) 1 2 60.84 (16.24)
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£ 40.00
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10.00 deficient  group 
sufficient group0.00
sunbed visits
Figure 5.9 Mean vitamin D3 concentrations over the course of a sunbed study for 
postmenopausal women classified as deficient and sufficient at baseline
Error bars represent standard error of mean
Figure 5.9 illustrates the vitamin D3 increase, stratified by baseline vitamin D status. Within the 
deficient group, vitamin D3 dramatically increased after the first UV session (visit 3, 6  minute 
exposure); with a ftirther gradual increase after sessions 4, 5 and 6 . Mean 25(OH)D3 
concentration rose from a baseline o f 12.20 (8.14) to 33.24 (6.77) nmol/1 in deficient individuals 
and from 45.63 (19.01) to 59.09 (15.65) nmol/1 in the sufficient group, representing a percentage 
increase o f 314.67% (323.71) and 37.31% (21.27) respectively. The increase in vitamin D levels 
from baseline to visit 6  was significantly different (t= -6.91, p=0.01) between the deficient and 
sufficient groups (t=-7.23 p=0.00).
Mean PTH levels in deficient women decreased from a baseline level o f 3.70 (1.21), to 2.98 
(0.62) (pmol/1) at the last visit, and from 2.59 (1.33) to 2.27 (0.65) (pmol/1) in sufficient women. 
There was no significant difference between the groups in baseline or final PTH or in change in 
PTH overtime.
169
5.3.6. Lipid profiles and other biochemistry measurements after UV sessions
Table 5.9 below presents the mean biochemical values for the separate ethnic groups and the total 
cohort before and after UV exposure. Mean TAG level in Caucasian women was classified as 
normal, whereas Asian women were classified as having a raised TAG level. Total cholesterol 
was classified as borderline-high and insulin was classified as elevated for both ethnic groups. 
Mean LDL levels in Caucasian women was classified as borderline high, whereas in Asian 
women it was classified as only slightly above the optimum. The mean HDL value for both 
ethnic groups was classified as a highly desirable level. Please refer to the standard classification 
levels for lipid profiles and insulin reported in chapter 2 to put these results into context. There 
was a significant difference between ethnic groups for TAG at baseline (t=-3.20, p=0.006), where 
Asians had a higher level. There was no other significant difference between ethnic groups at 
baseline for any other biochemistry parameters.
No significant differences were identified in the lipid, insulin and glucose levels between baseline 
and visit 6 after the exposure o f UV in the group as whole. However, there was a significant 
increase in insulin level at visit 6 compared to the baseline mean (t--2.83, p=0.03) in the Asian 
population, when analyzed independently.
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Table 5.9 Mean lipid, insulin and glucose levels at baseline and after UV exposure in 
Caucasian and Asian women recruited to a sunbed study
C a u c a s i a n A s i a n T o t a l g r o u p
n M e a n ( S D ) N M e a n ( S D ) N
T C  ( m m o P l ) 9 5 . 7 7  ( 1 . 3 1 ) 8 5 . 6 0  ( 0 . 8 5 ) 1 9 5 . 7 3 ( 1 . 0 4 )
T A G  ( m m o P l ) 9 1 . 2 9 ( 0 . 4 5 ) 8 2 . 4 6  ( 0 . 9 9 ) 1 9 1 . 7 3 ( 0 . 9 5 )
L D L  ( m m o l / 1 ) 9 3 . 8 9  ( 1 . 2 0 ) 8 3 . 2 1  ( 0 . 7 7 ) 1 9 3 . 6 2 ( 1 . 0 0 )
1 H D L  ( m m o P l ) 9 1 . 6 1  ( 0 . 3 7 ) 8 1 . 9 0 ( 0 . 3 8 ) 1 9 1 . 7 7 ( 0 . 4 0 )
I n s u l i n  ( m U / 1 ) 8 1 4 . 2 3  ( 4 . 9 6 ) 7 1 6 . 5 3  ( 6 . 4 7 ) 1 7 1 4 . 7 6 ( 5 . 5 1 )
G l u c o s e  ( m m o P l ) 9 5 . 7 1  ( 0 . 9 3 ) 8 5 . 7 6  ( 1 . 6 8 ) 1 9 5 . 7 0 ( 1 . 2 2 )
T C  ( m m o P l ) 9 5 . 7 1  ( 1 . 3 1 ) 8 5 . 3 0 ( 1 . 6 1 ) 1 9 5 . 3 5 ( 1 . 4 9 )
T A G  ( m m o l / 1 ) 9 1 . 4 9 ( 0 . 6 4 ) 8 1 . 9 1  ( 0 . 7 1 ) 1 9 1 . 6 0 ( 0 . 7 0 )
L D L  ( m m o P l ) 9 3 . 5 4  ( 1 . 0 9 ) 8 3 2 8  ( L 3 8 ) 1 9 3 . 3 4 ( 1 . 2 1 )
1 H D L  ( m m o P l ) 9 1 . 8 7 ( 0 . 4 4 ) 8 1 . 6 4 ( 0 . 4 4 ) 1 9 1 . 6 9 ( 0 . 4 7 )
I n s u l i n  ( m U / 1 ) 8 1 6 . 0 1  ( 7 . 7 7 ) 7 2 0 . 3 4  ( 5 . 5 0 ) 1 7 1 7 . 5 9 ( 7 . 0 2 )
G l u c o s e  ( m m o P l ) 9 6 . 1 4 ( 1 . 2 9 ) 8 5 . 0 9 ( 0 . 3 7 ) 1 9 5 . 6 6 ( 1 . 0 3 )
T C ,  t o t a l  c h o l e s t e r o l ;  T A G ,  t r i g l y c e r i d e ;  L D L ,  l o w  d e n s i t y  l i p o p r o t e i n ;  H D L ,  h i g h  d e n s i t y  l i p o p r o t e i n .
5.3.7. Association between lipid profiles and vitamin D concentration
When comparing ethnic groups, vitamin D level at baseline and after UV exposure correlated 
positively with HDL at baseline and after UV exposure in Caucasians but not in Asians. 
Surprisingly, vitamin D at baseline and after UV exposure correlated positively with baseline 
cholesterol level in Caucasian women. Baseline glucose level correlated negatively with the 
baseline vitamin D, and positively with baseline PTH level in the Caucasian group. Insulin level 
after UV exposure correlated positively with baseline PTH level in the Asian sub-group. The 
percent change in vitamin D level throughout the study correlated positively with the baseline 
glucose level (r=0.70, p=0.03). No other significant correlations were observed between percent 
change in vitamin D biochemistry measurements.
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Table 5.10 Pearson correlation between vitamin D and other biochemistry levels separated 
by ethnic groups
Total Vitamin D; visit 1 PTH; visit 1 Total Vitamin D visit 6 PTH; visit 6
C a u c a s i a n  ( n = 8 - 9 )
T A G - 0 . 1 6 0 . 2 - 0 . 1 9 0 . 1 3
I n s u l i n - 0 . 1 4 0 . 1 3 - 0 . 1 3 0 . 1 6
.ts T C 0 . 6 6 * - 0 . 4 3 0 . 6 9 * - 0 . 2 7
> G l u c o s e - 0 . 6 6 * 0 . 6 8 * - 0 . 6 4 0 . 6 5
H D L 0 . 7 5 * 0 . 0 2 0 . 7 6 * - 0 . 0 1
L D L 0 . 5 - 0 . 4 8 0 . 5 3 - 0 . 3
T A G 0 . 1 3 0 . 1 7 0 . 1 - 0 . 0 6
I n s u l i n 0 . 4 0 . 3 1 0 . 3 9 0 . 0 7
VO
.ts T C 0 . 3 8 0 . 4 5 0 . 4 0 . 5
G l u c o s e - 0 . 3 8 - 0 . 3 2 - 0 . 4 3 - 0 . 3 6
H D L 0 . 7 9 * * 0 . 2 5 0 . 8 3 * * 0 . 1 9
L D L 0 . 1 2 0 . 4 2 0 . 1 4 0 . 5 4
S o u t h  A s i a n  ( n = 7 - 8 )
T A G 0 . 6 9 - 0 . 5 9 0 . 6 9 - 0 . 5 7
I n s u l i n 0 . 0 9 0 . 4 9 0 . 0 8 0 . 6 9
tH
.ts T C 0 . 4 8 - 0 . 1 8 0 . 4 9 0 . 2 5
> G l u c o s e 0 . 1 1 - 0 . 3 9 0 . 0 9 - 0 . 2
H D L - 0 . 2 0 . 6 5 - 0 . 1 2 0 . 5
L D L 0 . 4 5 - 0 . 3 9 0 . 4 2 0 . 1 8
T A G 0 . 4 - 0 . 2 4 0 . 3 3 - 0 . 2 1
i n s u l i n - 0 . 3 7 0 . 8 5 * - 0 . 2 1 0 . 6 9
VO
.ts T C - 0 . 4 - 0 . 3 2 - 0 . 4 6 - 0 . 2 5
1 G l u c o s e 0 . 6 8 - 0 . 1 6 0 . 6 3 0 . 2 5
H D L - 0 . 4 4 - 0 . 0 7 - 0 . 6 0 . 3 3
L D L - 0 . 3 7 - 0 . 3 3 - 0 . 3 7 - 0 . 3 7
*p<0.05; **p<0.01; TC, total cholesterol; TAG, triglyceride; LDL, low density lipoprotein; HDL, 
high density lipoprotein.
The data in table 5.11 corresponds to the combined ethnic groups stratified by vitamin D status at 
baseline. In the total cohort, baseline cholesterol and LDL levels correlated positively with 
baseline vitamin D and vitamin D levels at visit 6. Baseline cholesterol also correlated positively 
with the vitamin D level measured at the last visit in those classified as deficient, and with both 
baseline vitamin D and vitamin D at visit 6 in those classified as sufficient. Baseline HDL level 
correlated positively with baseline vitamin D, and with the vitamin D at visit 6 in the sufficient
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group. TAG level correlated negatively with vitamin D in the deficient group following UV 
exposure.
Table 5.11 Pearson correlation between vitam in D and o ther biochem istry level separated 
by vitam in D status
Total vitamin D; visit 1 PTH; visit 1 Total vitamin D; visit 6 PTH; visit 6
Deficient group, n=5-6
T A G - 0 . 2 1 0 . 0 8 - 0 . 6 6 0 . 0 4
i n s u l i n 0 . 8 0 . 5 1 0 . 5 0 . 7 5
. t s T C 0 . 6 2 - 0 . 3 6 ( 1 8 2 * 0 . 1
g l u c o s e 0 . 7 6 - 0 . 4 2 0 . 1 8 0 . 4 7
H D L - 0 . 0 1 0 . 3 4 0 . 6 - 0 . 0 6
L D L 0 . 6 7 - 0 . 5 3 0 . 6 8 0 . 1 2
T A G - 0 . 6 3 0 . 1 5 - 0 . 8 6 * - 0 . 2 5
VO
. t s
i n s u l i n 0 . 4 3 0 . 7 8 0 . 7 0 . 4 4
T C - 0 . 3 - 0 . 5 5 - 0 . 5 1 - 0 . 3 5
f G l u c o s e 0 . 4 1 - 0 . 2 4 0 . 6 4 0 . 1 3
H D L 0 . 1 6 - 0 . 3 5 - 0 . 6 6 0 . 2 6
L D L - 0 . 3 8 - 0 . 5 6 - 0 . 3 2 - 0 . 5 1
Non deficient group, n= 11-13
T A G 0 . 2 4 - 0 . 1 4 0 . 0 6 - 0 . 1
I n s u l i n 0 . 1 7 0 . 0 4 0 0 . 2 1
. t s T C 0 . 5 8 * -037 0 . 6 3 * - 0 . 1 7
G l u c o s e - 0 . 3 0 . 2 - 0 . 3 3 0 . 0 5
H D L Q j g * 0 . 0 2 0 . 6 0 * 0 . 0 5
L D L 0 3 8 - 0 . 3 8 0 . 4 7 - 0 . 1 8
T A G 0 . 4 2 0 . 0 2 0 . 2 0 . 0 7
VO
. t s
i n s u l i n 0 . 4 4 0 . 2 8 0 . 3 0 . 1 2
T C 0 . 2 1 0 . 3 7 0 . 0 9 0 . 4 1
f G l u c o s e - 0 . 3 1 - 0 . 1 7 - 0 . 3 7 - 0 . 1 2
H D L 0 . 5 2 0 . 3 1 0 . 4 4 0 3 8
L D L - 0 . 0 1 0 . 3 2 - 0 . 0 9 0 . 3 4
Total sample,-17-19
T A G 0 . 1 2 - 0 . 1 2 - 0 . 0 2 - 0 . 0 5
i n s u l i n - 0 . 0 7 0 . 2 8 - 0 . 1 7 0 . 5 0 *
. t s T C 0 . 4 6 * - 0 . 3 6 0 . 5 4 * - 0 . 1 1
• a G l u c o s e - 0 . 1 1 0 . 0 8 - 0 . 1 7 0 . 1 1
H D L - 0 . 0 3 0 . 2 3 0 . 0 7 0 . 1 6
L D L 0 . 4 7 * - 0 . 4 5 0 . 5 3 * - 0 . 1 7
T A G 0 . 1 7 0 . 0 3 0 . 0 1 0 . 0 2
i n s u l i n - 0 . 1 0 . 4 4 - 0 . 1 1 0 . 3 3
VO T C 0 . 0 1 0 . 1 2 - 0 . 0 8 0 . 1 4
G l u c o s e 0 . 1 1 - 0 . 2 5 0 . 0 6 - 0 . 2 1
> H D L 0 . 2 8 0 . 1 3 0 . 1 5 0 . 3 3
L D L - 0 . 1 1 0 . 0 9 - 0 . 1 5 0 . 0 4
* p < 0 . 0 5 ;  T V D ,  t o t a l  v i t a m i n  D ;  P T H ,  p a r a t h y r o i d  h o r m o n e ;  T A G ,  t r i g l y c e r i d e ;  T C ,  t o t a l  c h o l e s t e r o l ;  H D L ,  h i g h  
d e n s i t y  l i p o p r o t e i n ;  L D L ,  l o w  d e n s i t y  l i p o p r o t e i n .
173
5.4. DISCUSSION AND CONCLUSIONS
This study was carried out to investigate the differences between vitamin D production in 
Caucasian and South Asian ethnic groups in a controlled environment, using artificial UVB 
exposure. Based on the findings o f previous studies, it was expeeted that Asian women would 
need longer exposure to UV to produee the same amount o f vitamin D eompared to Caucasians 
because o f their greater skin pigmentation. However, this study showed that they needed a mueh 
shorter time to make the same amount o f vitamin D as their Caueasian eounterparts. This was 
because Asian women were more deficient at the baseline and so had a relatively greater inerease 
in vitamin D over time. A total o f 22 minutes artifieial UV exposure (over 3 sessions) was 
enough to raise vitamin D from 43.58 (19.43) to 57.50 (17.11) in Caucasians and from 27.04 
(23.92) to 44.73 (17.74) in south Asian women. This greater response to UVR exposure among 
South Asin subject reflects the lower baseline levels o f vitamin D status. The study showed that 
there was no signifieant effect o f ethnicity and skin tone on vitamin D produetion rates. These 
novel findings indieate that people o f Asian ethnicity have the full capability to produce similar 
amounts o f vitamin D compared to Caueasians, but that initial vitamin D coneentration influenees 
the amount o f UVB needed to reaeh equal serum eoncentrations.
The observed dramatie increase in vitamin D among Asian women led to the requirement for a 
re-grouped analysis, whereby vitamin D production was compared between those classified as 
deficient versus those who were suffieient at baseline. Deficient women had a significantly 
higher pereentage inerease in vitamin D level compared to the suffieient group. These findings 
agree with those o f Clifford et al. (1986), who reported no significant difference in serum vitamin 
D between Asian and Caucasian subjects in response to 1.5 times their MED o f whole body UV. 
Since the ethnic groups in the current study were classified aceording to their skin type 
(Caueasian: types II and HI, Asian: types IV and V) these findings also agree with Bough et 
al.(2009), who found no e fleet o f melanin content to the production o f vitamin D.
Exposure to UV appears to have an effect on insulin levels, with a signifieant inerease in insulin
noted in the Asian group after UV exposure. This finding is opposite to what we expeeted but is
not neeessarily a result o f the inerease in vitamin D. The inerease observed eould be an artifact
caused by subjeets not fasting before their fasted blood test. Conversely, although a relationship
between higher vitamin D levels and redueed CVD risk has been reported, this study did not
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identify an effeet o f UV exposure on lipid profile. However, the relationship between vitamin D 
status and lipid profile is tenuous and many reports give eonflicting findings. The laek o f an 
association between the two faetors as seen here, is in agreement with the results o f Carbone, et 
al. (2008). Failure to find an effeet on lipid profiles from UV exposure (increase o f  vitamin D 
eoneentration) eould be a eonsequence o f the short-term nature o f this study.
Subjective assessments o f skin colour by the partieipants themselves and by the investigator 
showed that skin eolour did not ehange exeessively after three sunbed sessions. This was 
expected, as the study was designed to minimalise tanning and ethythema. However, pinkish and 
slight redness in the skin was notieed in a few partieipants usually in areas that are rarefy exposed 
to the sun like the abdominal area and thigh.
Some o f  the future analysis and investigation will be eonsidered out o f this study sueh as 
measuring ealeium and albumin levels, and observe inter- and intra-group differenees.
Caleulating the aetual radiation emitted by the tanning bed and calculate the individual exposure 
for each subject based on weight and height was also an area o f interest where radiation o f the 
tanning sunbed was already measured by the study investigator when the sunbed was in operation 
prior to and after the study experiment.
Strengths o f  the study
The highly controlled study design is one o f the predominant strengths o f this study, whereby 
subjeets were treated identically. UV dose and exposure time were kept constant and were 
applied during the same winter season, to avoid eonfounding faetors sueh as differential UV 
exposure due to seasonal and/ or climatic variations. The assigned subjeets have been assigned 
randomly in groups where both ethnie groups were mixed in the assigned experiments, to make 
ethnie groups treated equally regarding time o f the study assigned. Subjeet numbers o f  both 
ethnie groups were similar with age groups were also similar.
Study limitations
Incomplete blood sampling at visit 4 due to a study design error resulted in sub-optimal data 
eollection. The late request for a blood sample was declined by roughly half o f the participants, 
limiting the data available for analysis. The sensitivity o f the skin tone maehine also introdueed
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the potential for error as small changes in the loeation tested between visits eould give different 
readings. To minimize this variation the mean o f the readings from several readings taken at 
each visit was used. Another limitation o f  the study is that the ethnie groups did not start the 
study with similar vitamin D eoneentrations, with the Asian women being deficient and the 
Caueasian women insuffieient. Whilst this represents the real situation in these ethnie groups, it 
may have redueed our ability to make a true comparison o f production capability and it would be 
useful to repeat the study matehing for baseline levels. It is also not possible to assess the rate o f 
decline in vitamin D levels following eompletion o f the UV exposure regimen, as a follow up 
period was not ineluded in this study. Other studies have indicated that it takes to 2-4 weeks for 
vitamin D levels to return to baseline levels in the absence o f further UV exposure, and it would 
be interesting to investigate if these rates are similar between ethnic groups.
Conclusion
That ethnic differences in the synthesis o f vitamin D were not observed might due to the baseline 
differenees in vitamin D eoneentration or due to the small population size used in this study. To 
eonfirm that ethnieity and skin tone has no effeet on vitamin D produetion, a larger study is 
suggested that considers other ethnie groups with highly pigmented skin.
Based on these study results, we reeommend that the use o f tanning beds is considered as a 
means o f increasing vitamin D levels, espeeially in subjeets who are highly defieient. However, 
given the lack o f data regarding the effects o f moderate sunbed use, this method should only be 
used in people at low risk (for side effects o f artificial UV exposure) o f developing caneer e.g. 
older women with no previous sunbed use. In some cases, like those suffering from the 
malabsorption o f vitamin D, sunbed use could be a useful means o f increasing the vitamin D 
levels. This study proves that short exposures are sufficient to achieve a ‘summer’ vitamin D 
level. Using two speeific examples from the study, designated subjeet A and subjeet B, vitmain D 
levels started out at 8.8 and 16.3 nmol/1 respectively, increasing to 44.3 and 42.3 respectively by 
the end o f the study. However, based on the study findings, the human body synthesizes smaller 
quantities o f vitamin D if the baseline level is high. For example, subjeets C & D eommeneed the 
study with levels o f 66.0 and 75.5 nmol/1, inereasing to 78.0 and 86.0 nmol/1 over the 6 visits 
respeetively. Therefore, artifieial UV souree (sunbed) is unlikely to eonfer benefits for those with
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adequate vitamin D levels (vitamin D>40nmol/1) and in these eases the benefits in terms o f small 
inereases in vitamin D may be outweighed by the potential side effeets o f UV radiation. More 
elinical research on the use o f tanning sunbeds is needed to elearly determine the exposure 
required to achieve optimal vitamin D status while preventing aeute side effects.
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CHAPTER 6 
CONCLUSIONS AND FUTURE WORK
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6.1. Summary o f thesis projects
The projeets undertaken as part o f this thesis were carried to investigate the differenees in vitamin 
D status between south Asian and Caueasian women and to identify the implieations o f  this in 
terms o f osteoporosis and eardiovaseular disease risk. This type o f researeh is useful for a number 
o f reasons, one o f which being that it will eontribute to understanding the vitamin D status o f 
south Asian women residing in the UK, which is an under-researched area. Furthermore, this 
vitamin status is associated with other faetors sueh as bone health, and musele strength and 
general biochemical biomarkers o f health, to determine the broad health outcomes o f  vitamin D 
deficieney. The ability o f the skin o f this group o f women to produee vitamin D is also examined 
in an attempt to explain why vitamin D deficiency is becoming more eommon in the UK and is 
especially prominent in the south Asian population. An interesting dimension to this study is that 
is allows eomparison o f two genetieally and culturally different populations living elosely in 
similar environmental conditions and thus allows the impaet o f these faetors on vitamin D and 
health status to be examined. As previously mentioned, little data is available in the literature 
regarding the vitamin D status o f Asian women living in the UK and even less information is 
available regarding the associated risk o f developing osteoporosis or eardiovaseular disease 
When we undertook this study, we expected to see different heath risks arising in the Asian 
population due to the faet that south Asians may not fully adapt their behaviour and lifestyle from 
their own eultures to live in the UK. Finally, understanding factors associated with 25(OH)D 
level is important and can be key in diagnosis and treating vitamin deficieney.
The first projeet eonducted in this thesis aimed to find tiie differenees between eardiovaseular 
risk factors between South Asians and Caueasians in relation to 25(OH)D level. Data from the 
original D-FINES study, on which these projects are founded have been extraeted for further 
analysis. Analysis o f the personal eharacteristies o f the south Asian members o f the eohort 
showed that they had higher BMIs as a result o f being were lighter but shorter; had mueh lower 
vitamin D levels, classified as defieient; higher TAG, lower eholesterol, and lower HDL (though 
within the normal range) compared with Caucasians. Insulin was higher in the south Asian 
population and was classified as elevated; insulin sensitively was lower, with elevated beta eell 
function and higher insulin resistanee than the Caucasian group. All o f these parameters indieate 
that south Asians are at higher risk o f eardiovaseular disease than Caueasian groups. Even though
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the eurrent study involved a small number o f  women, the findings are in agreement with the 
British Heart Foundation, 2010 where it supplemented a statistieal series foeusing on deseribing 
ethnie inequalities in experieneing cardiovascular disease. One o f the main finding is that 
eoronary heart disease account for about quarter o f all death for South Asian population living in 
England and Wales. The findings highlight low level o f HDL eholesterol was observed among 
Bangladeshi women, where 8% o f them had low HDL eompared to 2% o f the general population. 
Insulin level was observed to be elevated among South Asian eompared to other ethnie groups. 
The study also highlight that south Asian are less likely to engage in heavy sport and exereise; 
one in ten women achieve the physieal aetivity recommendation (30 minutes or more o f at least 
moderate activity on at least five days a week) (Searborough et al., 2010). This current study 
found that in south Asians, HDL eorrelated positively with 25(OH)D level, and cholesterol and 
LDL eorrelated negatively with 25(OH)D. In Caueasians, on the other hand, LDL and TAG but 
not eholesterol eorrelated negatively with 25(OH)D level. Plotting equal 25(OH)D quartiles and 
tertiles against mean TAG, total eholesterol and LDL level showed signifieant differences 
between the lowest and highest sub-groups in the Caueasian group only. When grouping vitamin 
D level by defined cut-off values against bioehemistiy parameters, signifieant relationships were 
shown with total eholesterol and LDL in both ethnic groups..
Further investigations examined D-FMES data for bone quality (BUA, VOS, LS and FN BMD) 
differences between the ethnic groups in relation to lipid profiles, and insulin and glucose levels. 
In the Caucasian group, cholesterol and LDL eorrelated negatively with bone density o f the 
lumbar spine and femur neck in both seasons. Blunting equal cholesterol and LDL quartile 
groups against bone quality variables presented significant differences between the highest and 
lowest groups within Caueasian subjects. Lack o f a relationship between these variables in Asian 
subjects may have been due to the small population size and thus limited study power.
The third projeet involved recalling D-FINES subjects for repeated vitamin D and bone sean
measurements after the obtainment o f ethical approval to use a pQCT scaner. The study revealed
that south Asians tend to have lower bone mass and area than Caueasians but no differenee in
bone density was observed at radius sites. These findings suggest that South Asian women have
weaker bone in eompared with Caueasian women. However, there are differenees in bone
density at the tibia site, where Asians shown to have higher bone density at the distal tibia but
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lower bone density at the diaphyseal tibia. The ineonsistent bone densities observed between 
bone sites could be due to the types o f physical activity that south Asian women participate in. 
For example, it was observed that Asian women were more likely to walk, rather than eye le or 
involve themselves in team sports o f any kind. This was espeeially true for older women. 
Another explanation o f these ineonsistencies in bone density within tibia sites is that there are 
signifieant differences in bone size between the ethnie groups, the measurements point might be 
not exactly similar in both groups. South Asians also have different bone geometry, a lower 
strength strain index and lower fracture load in the radius and tibia. As expected. South Asians 
were shown to have a much lower vitamin D status than Caueasians, and were elassified as 
insufficient and hypovitaminosis respectively. Both ethnic groups had high levels o f insulin but 
the level in south Asians was mueh higher than in Caueasians.
The study revealed that the behaviour o f south Asians not only put them at high risk o f  vitamin D 
defieiency but that this population also needs a longer time in the sunlight compared to 
Caueasians in order to synthesise the same amount o f vitamin D. This requirement is due to the 
higher saturation o f skin pigmentation is Asians, which is exacerbated by the tendency o f  Asians 
protect themselves from sunlight. This was eonfirmed from the lower standard erythmal dose 
calculation than was seen in Caucasians and based on their response to the UV questionnaire, 
where they more likely to cover their skin parts when outside. A third o f the study partieipants 
reported wearing sun bloeks and half o f the sun bloek users used a high SPF factor (30-50) when 
they were outside. Volumetrie bone mineral density variables eorrelated positively with some 
DXA seaimed variables, indieating that the two measurement types were assoeiated despite there 
being a long time period between the two seans. This eonfirms that bone health had not ehanged 
significantly over the three years o f the study.
Longitudinal 25(OH)D measurements in pre-menopausal women indicated that no seasonal
variations occurred in South Asians living in the UK. In the Caueasian group, seasonal variation
was clear with the lowest concentrations o f 25(OH)D oceurring during the winter and spring and
the highest eoneentrations occurring in the summer. Repeated 25(OH)D measurements indieated
a slightly higher mean o f 25(OH)D during summer 2010 eompared with 2007. This inerease
might due raised awareness following partieipation in the D-FINES and eould be explained by
the faet that some o f the partieipants were taking vitamin D supplements. This researeh projeet
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indicated that south Asians are more likely to have smaller bone area and lower bone mass, less 
cortical thickness but with similar bone density to Caucasians. In general, these faetors indieate 
that south Asians living in the UK have weaker bones compared to Caueasians. It would be 
expected that smaller bone would have higher density, and therefore have a high fracture load 
and high stress strain index, however. South Asians do not display these faetors. South Asian is 
also at risk o f  cardiovascular disease where they have high BMI, elevated insulin, and low HDL. 
The eomparison o f variables between the ethnic groups showed that south Asians were at higher 
risk o f suffering from osteoporosis, as they tended to have higher bone pain scores, back & 
muscle pain and low muscle strength. The final project was conducted to uncover differenees in 
vitamin D produetion in south Asian and Caucasian women after exposure to artifieial UV in 
controlled environments. Baseline vitamin D levels (mean (SD)) were 28.24(24.79) and 
45.23(19.65) and rose to 45.74(18.03) and 59.44(17.77) among in south Asians and Caueasians 
respeetively. Number o f minutes significantly increased the produetion o f vitamin D but no effect 
o f ethnicity, skin tone; age and BMI were observed.
6.2. Overall thesis findings
The analysis o f data from the original D-FINES study along with the data collected for this thesis 
project confirmed that soutii Asian women are at higher risk o f cardiovascular disease and 
osteoporosis in addition to lower vitamin D levels than Caucasians. Asians also had higher 
triglyceride levels, BMI, insulin, a higher homeostasis model assessment o f insulin resistanee and 
lower HDL than Caueasians. These overall finding are in agreement with ftie findings o f the 
British Heart Association (2010) who indicated high factor risk prevalence among Indian, 
Pakistani and Bangladeshi people across the UK. The prevalence o f these risk factors explains the 
high incidence rate o f myocardial infarction and the high death rate among south Asians from 
coronary heart disease in England and Wales. Besides vitamin D deficieney, lower bone mass 
and lower bone area put south Asians at higher risk o f having weak bone and most likely 
inereases the risk o f bone problems later in life.
This study was able to show a connection between low vitamin D level and high levels o f
undesirable blood lipids and insulin. A further connection was observed between low bone
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quality and high lipid profile and insulin levels. This thesis presents a relationship between bone 
metabolism and lipid profiles that have never been investigated before in South Asian women 
groups. This is demonstrated by the positive relationship between parathyroid hormone levels and 
undesirable lipid profiles (LDL, TAG and total eholesterol). Furthermore a positive association 
between C terminal telopeptide o f  type I collagen (CTx) and eholesterol and LDL was observed. 
All o f these parameters confirm the association between cardiovascular disease and osteoporosis.
Even though this study failed to show correlation between insulin resistance and vitamin D level 
in sub study’s projects, higher insulin resistance among South Asian were observed in all the 
projeets analysis. Chaturved, 2003 have exploring insulin resistance in relation to heart disease in 
eohort studies where the finding were conflicting among non Asian population, however cross 
sectional analysis suggest that insulin resistanee may account o f enhanced ischaemic heart 
disease risk in o f South Asian population, and evidence in the form cohort data relating insulin 
resistance to ischemic heart disease is lacking (Chaturvedi, 2003).
A comparison o f south Asian and Caucasian groups regarding their UV exposure behaviour and 
the efficiency o f their skin at synthesising vitamin D under similar UV dose and duration has not 
previously been made. Investigation o f these two areas in this thesis has revealed that south 
Asians have lower vitamin D status mainly because o f their lack o f sun exposure. Either this 
population does not go out in the sunshine regularly enough or they cover up their body with 
clothing. Faetors including skin tone and ethnieity did not influence the production o f vitamin D. 
The key determinants o f greater vitamin D deficieney in Asians, eompared with Caueasian are 
the personal, cultural behaviours that lead to very limited exposure to natural sunlight.
O f the limited data already available on volumetrie bone density, almost none o f the tibia sites 
were eompared between the two ethnic groups under study in this thesis. Analysis o f the tibia 
sites herein showed a higher total and trabecular bone density at the distal tibia, lower total and 
cortical density with lower cortical thickness at the diaphyseal tibia and another lower total 
density at tibia mid shaft in south Asians eompared with Caucasians. The ineonsistent densities 
measured at the different tibia sites suggest the need for more researeh testing the tibia densities 
o f larger populations to look for an association with vitamin D level.
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6.3. Impact o f this thesis to research and the healthcare community
The data generated as a result o f  these projeets are helpful to both the nutrition field and the 
wider health community. Though this research forms a useful foundation, the information on the 
behaviour and health status o f south Asians cannot be generalised to the larger population 
because the sample size was small and studied women only. Despite this limitation, some useful 
insights were obtained, such as the amount (time and dose) o f UV exposure required to raise 
vitamin D levels, and the importance o f restricting natural exposure to sunlight through the use o f 
barriers such as clothes. Moreover, we have shown that these faetors are the most important and 
that other factors such as skin tone have little effeet on vitamin D synthesis capability. 
Understanding the major factors that increase the produetion o f vitamin D is important to help 
provide advice to the population on the best ways to inerease vitamin D synthesis. For example, it 
eould be suggested to women o f all ethnicities to walk in the sun and walking groups eould be 
arranged by community health organizers to alert populations to the health problems assoeiated 
with vitamin D deficieney, while avoiding over-exposure and skin burning during the spring and 
summer. Encouraging cross-ethnic community activities may also provide incentives to interact 
and be involved. Applying the idea o f the study experiment to real life, 6 minutes o f vitamin D 
dose in the tanning cabinets require 13 minutes in natural sunlight, considering exposing each 
side o f the bode which in faet require 26 minutes to get the same effeet (Berry et al., 2011). This 
study revealed that solving the problem o f deficiency eould be easy and rapid, since it appeared 
that vitamin D synthetic rates were much faster when starting from a lower baseline level. A 
bigger challenge may therefore be to reach optimum vitamin D levels from a higher but sub- 
optimal baseline. To do this requires higher UVB availability and exposed longer exposure time. 
Inereasing the surface area o f the skin exposed to UV would also inerease the effieieney o f 
synthesis during the summer. In the winter months, it may be necessary to recommend exposure 
to artificial UV sources to maintain beneficial vitamin D levels throughout the year.
Another outcome from the current sunbed project is that South Asian’s lifestyle behaviour in 
exposing themselves to natural sunlight along with the failure to spend appropriate time to the 
sunlight put them at high risk to have vitamin D deficieney. However, skin tone and ethnieity 
laek effeet on the vitamin D production might be disagreed in indirect way to Farrar et. al., 
(2011) study where they treated both groups with similar UV dose to determine the effect o f UK
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recommendations o f summer sunlight exposure on the vitamin D status on both ethnic group. The 
study concluded that the sun exposure recommendation is not appropriate for South Asian 
population where their vitamin D status have not improved as the other group did (Farrar et al., 
2011). This disagreement might due to the method that Farrar and colleagues used where they 
used two different UV sources in the study.
More research is required into the use o f sunbeds to ensure that it is a safe tool to inerease 
vitamin D synthesis, or at least that the benefits outweigh the risks. Sunbed use to increase 
vitamin D levels might also be more beneficial to some populations than others and this should 
be investigated further to maximize the beneficial effeets while limiting unnecessary exposure. 
Post-menopausal women for example would benefit from exposure, while being particularly 
refraetoiy to any adverse effeets o f prolonged UV exposure. Low to moderate sunbed use eveiy 
few weeks during the winter eould help to keep vitamin D levels stable throughout the whole 
year. More research is needed to define exactly what level o f sunbed use would be appropriate, as 
it is not elearly investigated in eurrent literature. One important consideration for this approach to 
be successful is that many Asian individuals avoid becoming tanned for social and cultural 
reasons. For example, many believe that being tanned reduces natural beauty and so would avoid 
natural and artificial UV exposure for these reasons. A possible solution to this problem is to 
raise awareness that Asian skin is classified as skin types 3-5, which indicates that their tanning 
response is medium to low. This could be useful in recommending skin-type specific UV 
exposure regimens that encourage vitamin D synthesis in the absence o f skin tanning. For Asians, 
sueh a regimen might be to use short exposure sessions at regular intervals that are separated by 
long breaks to avoid the build-up o f pigmentation. Sueh recommendations could be tested in 
clinical studies, to find the optimal exposure times and doses for each skin type.
In summary, the results o f this study should be helpfiil to health professionals and practitioners in 
convincing Asians that ethnic differences in lifestyle behavior put them at higher risk o f 
developing osteoporosis and cardiovascular disease. Considering these differenees are key to the 
prevention, diagnosis, and treatment o f these health problems, they should be recognized and 
acted upon.
185
6.4. Difficulties and limitations -  A personal perspective
Conducting this research project has progressively built-up knowledge and experience in 
conducting scientific research. An important lesson learnt was that ethnic differenees can 
determine the ways in which the researeh should be conducted. For instance, I learned that 
cultural differences affected the ways in which people were attracted to participate in the study 
and that differenee approaches were neeessaiy to encourage participation. One differenee was 
that south Asians were attracted from a health perspective and were eager to use sunbeds to 
inerease their vitamin D status and to receive die end report, whereas Caueasians were interested 
to participate in the study to get tanned skin. Another noticeable différence is that Caueasians 
preferred to book their appointment for a few weeks in advance, and although a reminder was 
suggested, it was not necessary as most used diaries or schedules. South Asians on the other hand 
don’t preferred to book appointment at short notice (two to three days ahead) and appointment 
reminders were suggested and neeessaiy.
It was not easy to recruit south Asian partieipants to the study, although having the original 
database information from D-FINES did make the process easier. The hardest group to re-reeruit 
were the pre-menopausal women, mainly because they had already had their bones scanned and 
had received their vitamin D analysis, causing them to lose interest. It was also harder for this 
age-group to attend early morning appointments for study measurements because o f family or 
work commitments. Many south Asian partieipants also failed to meet the inclusion criteria for 
the sunbed study, mainly because they viewed radiation and sunbeds as very dangerous and 
harmful even if  exposed for short periods. This group were also discouraged by the thought o f 
becoming tanned, as their beauty image is to have a light skin colour. In addition, for some 
women, their religious background discouraged them from getting undressed, even in a private 
place. These three faetors made it very difficult to recruit south Asian volunteers espeeially 
when they are not aware o f the importance and wider benefits o f such a research study. Another 
difficulty faced in this projeet was the drawn out ethical approval proeesse required prior to 
beginning any research, this process involved negotiation to make sure that it was safe, by 
minimizing the risks o f sunbed use. For the repeated D-FINES II measures (chapter 4), safety 
and training procedures also took a long time, since the PQCT was new maehine in the 
department and all safety regulations had to be met.
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It was also a challenge to ehoose the most applicable ways to measure study variables in this 
researeh. Bone and musele pain questionnaires for example were not the best way to assess bone 
pain, with elinieal assessment being a much more method for the obtainment o f accurate data. 
However, designing bone/ muscle pain questionnaires was the fastest and best way to achieve the 
outcome given the time restraints and equipment available for this study. A few errors in the 
questionnaires have been observed post-applieation and this data has therefore been excluded 
from the analyses. A pilot test o f the questionnaire would have been usefiil to minimize sueh 
errors and a review o f the questionnaire quality by professionals would have been a further 
advantage. The UV questionnaires used eould also be improved, by estimating the dose o f UV 
exposure from the daily duration and time o f the day that each subject reported sunlight exposure. 
Again there was no valid UV exposure data to be considered and designing one for the purpose o f 
the study would be ideal.
6.5. Future work
The inclusion o f more pre-menopausal subjects could have been achieved if  the participant 
selection wasn’t restricted to the original D-FINES population based on the ethics plan and on 
practical grounds. It also would have been possible to recruit more subjects for the sunbed study 
if  more time was spent recruiting. However, as the study had to be conducted in the winter, 
recruitment had to stop by mid March 2011. Larger studies investigating the effeet o f vitamin D 
on bone tibia measurements are recommended, espeeially in terms o f  its effeet on bone health in 
the Asian population. Larger eross-seetional studies investigating the association o f vitamin D 
level with cardiovascular disease risk are also recommended, with the inclusion o f other risk 
faetors sueh as blood pressure, smoking, physieal activity and lipid intake. Larger, interventional 
studies o f south Asian women with a broader range o f vitamin D levels at baseline are highly 
recommended to investigate the effeet o f UV exposure on synthesis rates and health outcomes. It 
would also be interesting to run a similar study including black African ethnic groups matched 
for baseline vitamin D level to investigate the effect o f a darker skin eolour on the produetion o f 
vitamin D. This would also present an opportunity to estimate the genetic involvement in vitamin 
D production. Regarding the bone analysis in relation to vitamin D level, it might be interesting
187
to run bigger study on wider ethnic populations and investigate the ethnie differences at wider 
range.
Further analysis may be possible to extract more data and find all possible interactions between 
the original D-FINES study and the sunbed study. One possibility is the investigation o f bone 
density differenees between deficient and sufficient vitamin D groups within both ethnic groups. 
It would also be interesting to examine the effeet o f vitamin D supplementation on bone and 
vitamin D status, by comparing supplemented versus non- supplemented groups, it would be 
interesting to determine if the UV emitted by the sunbed was the same prior to and after the 
study. Since there was no mueh work done on the premenopausal tibia pQCT seans, it might be 
interesting to investigate the association between the tibia and radius sites bone parameters. 
Finally, it is recommended that future work calculates the individual total UV dose received by 
each participant based on individual height and weight. Calculation o f the normalised dose may 
help to identify associations between UV dose and bioehemical/bone health measures that were 
not previously observed.
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Chapter 4
National Research Ethics Service
Surrey Research Ethics Committee
Education Centre 
Royal Surrey County Hospital 
Egerton Road 
GUILDFORD 
Surrey 
GU2 7XX
Telephone: 01483 406898  
Facsimile:
12 May 2010
Dear Dr Lanham-New
Study Title: interaction between vitamin D, ethnicity, bone health
and lifestyle: Follow up study to DFINES 
REG reference number: 10/H1109/25
Protocol number: 1
The Research Ethics Committee reviewed the above application at the meeting held on 11 
May 2010. Thank you for attending with Miss Darling and Mrs Hakim to discuss the study.
Ethical opinion
The following issues were discussed:
i. The Committee queried the actions should abnormal results be found on the 
scan. You explained that as with the previous study, the information would be 
collected and the GP would be informed-of the results.
ii. Members asked whether non-English speaking participants would be included. 
Miss Darling explained that participants were recruited through an Asian network 
and no one should be excluded. However, all participants would be adequately 
matched in order to avoid bias.
iii. The Committee pointed out that the Patient Information Sheet did not include a 
section explaining if there was a problem and the GP being made aware o f the 
participant’s inclusion in the study. You agreed to make the revisions.
The members o f the Committee present gave a favourable ethical opinion with additional 
conditions of the above research on the basis described in the application form, protocol 
and supporting documentation, subject to the conditions specified below.
Ethical review of research sites
The favourable opinion applies to all NHS sites taking part in the study, subject to 
management permission being obtained from the NHS/HSC R&D office prior to the start of 
the study (see "Conditions of the favourable opinion" below).
This Research Ethics Committee Is an advisory committee to  South East Coast Strategic Health Authority
The National Research Ethics Service (NRES) represents the NRES Directorate within 
the National Patient Safety Agency and Research Ethics Committees in England
Conditions of the favourable opinion
The favourable opinion is subject to the following conditions being met prior to the start of 
the study.
Management permission or approval must be obtained from each host organisation prior to 
the start of the study at the site concerned.
For NHS research sites only, management permission for research (“R&D approval) should 
be obtained from the relevant care organisation(s) in accordance with NHS research 
governance arrangements. Guidance on applying for NHS permission for research is 
available in the Integrated Research Application System or at http://www.rdforum.nhs.uk. 
Where the only involvement of the NHS organisation Is as a Participant Identification 
Centre, management permission for research Is not required but the R&D office should be 
notified of the study. Guidance should be sought from the R&D office where necessary.
Sponsors are not required to notify the Committee of approvals from host organisations.
Other conditions specified by the REG
i. The Patient Information Sheet needs a section covering ‘What if there is a 
problem?’
ii. The Patient Information Sheet needs to mention that the GP will be informed of 
the participation in the study.
It is responsibility of the sponsor to ensure that all the conditions are complied with 
before the start of the study or its initiation at a particular site (as applicable).
Approved documents
The documents reviewed and approved at the meeting were:
Document Version Date >
Covering Letter 29 March 2010
REG application 2.5 23 April 2010
Protocol 1 19 March 2010
Investigator CV 19 March 2010
Participant Information Sheet; Main Study 1 19 March 2010
Participant Information Sheet; Sub-Study 1 19 March 2010
Participant Consent Form: Main Study 1 19 March 2010
Participant Consent Form: Sub-Study 1 19 March 2010
Letter of invitation to participant 1 19 March 2010
Evidence of insurance or indemnity 08 July 2009
Summary/Synopsis 1 19 March 2010
Sample Diary/Patient Card 1 19 March 2010
Interview Schedules/Topic Guides 1 19 March 2010
Questionnaire; Lifestyle 1 19 March 2010
Questionnaire: Physical Activity 1 19 March 2010
Questionnaire: Bone and Muscle 1 19 March 2010
Questionnaire: UVB Exposure 1 19 March 2010
Questionnaire; Health 1 19 March 2010
An advisory committee to South East Coast Strategic Health Authority
A dvertisem ent..................... - , . , 1 19 March 2010
CV - Ms Andrea Darling 1 19 March 2010
CV - Ohood A Hakim 1 24 March 2010
Sum m ary of original D-Fines Study 1 19 March 2010
S leep  diary 1 19 March 2010
Risk A ssessm en t 1 19 March 2010
Invitation to Participant - Sub-Study 1 19 March 2010
Membership of the Committee
The members of the Ethics Committee who were present at the meeting are listed on the 
attached sheet.
Statement of compliance
The Committee is constituted in accordance with the Governance Arrangements for 
Research Ethics Committees (July 2001) and complies fully with the Standard Operating 
Procedures for Research Ethics Committees in the UK.
After ethical review
Now that you have completed the application process please visit the National Research 
Ethics Service website > After Review
You are invited to give your view of the service that you have received from the National 
Research Ethics Service and the application procedure. If you wish to make your views 
known please use the feedback form available on the website.
The attached document “After ethical review -  guidance for researchers" gives detailed 
guidance on reporting requirements for studies with a favourable opinion, including:
• Notifying substantial amendments
• Adding new sites and investigators
• Progress and safety reports
• Notifying the end of the study
The NRES website also provides guidance on these topics, which is updated in the light of 
changes in reporting requirements or procedures.
We would also like to inform you that we consult regularly with stakeholders to improve our 
service. If you would like to join our Reference Group please email 
referencegroup@nres.npsa.nhs.uk.
10/H1109/25 Please quote this number bn all correspondence
With the Committee’s best wishes for the success of this project 
Yours sincerely
An advisory committee to South East Coast Strategic Health Authority
Email; rsc-tr.ethicscommittée@nhs.net
Enclosures: List of names and professions of members who were present at the
meeting and those who submitted written comments 
“After ethical review -  guidance for researchers”
An advisory committee to  South East Coast Strategic Health Authority
Surrey Research Ethics Committee 
Attendance at Committee meeting on 11 May 2010
Committee Members:
W a m e y - : '  , - V  ■ .
Prof David R ussell-Jones Professor of Diabetes 
and Endocrinology
Y es Chair
Dr Clare Alexander Consultant Physician Y es
Miss M Ayton Infection Control Adviser Y es
R ev D Hobden Senior Chaplain Y es
Dr Stephen Houston Consultant Medical 
Oncologist
Y es
Mrs K ide Lay Member Y es
Mr Michael Morris Lay Member (Legal 
Expertise)
Y es
Mrs M Pryce Pharmacist Yes
Dr L Seiby General Practitioner Y es
Maria Robinson Regional Manager- 
NRES
Y es Observer
Dr Elizabeth Cheshire Consultant Physician Y es Observer
Also in attendance:
Mrs J Jackson Co-ordinator
Written comments received from:
Dr JHP Powell Consultant Physician Vice-Chatr
Gffi
National Research Ethics Service
Surrey Research Ethics Committee
Education Centre
................        -,....Royal Surrey County Hospital
Egerton Road 
GUILDFORD 
Surrey 
GU2 7XX
Telephone: 01483 406898 
Facsimile:
26 April 2010
Dr Susan Lanham-New
Divison of Nutritional Sciences
AY building
University of Surrey
Guildford
GU2 7XH
Dear Dr Lanham-New
Full title of study; Interaction between vitamin D, ethnicity, bone health and
lifestyle: Follow up study to DFINES 
REC reference number: 10/H 1109/25
Thank you for your application for ethical review, which was received on 26 April 2010. I 
can confirm that the application is valid and will be reviewed by the Committee at its next 
meeting
Meeting arrangements
The meeting wiil be held In Room B3, Education Centre, Royal Surrey County 
Hospital, Egerton Road, GUILDFORD, Surrey, GÜ2 7XX on 11 May 2010, The
Committee would find it helpful if you could attend the meeting to respond to any questions 
from members. Other key investigators and a representative of the sponsor are also 
welcome to attend. This may avoid the need to request further information after the 
meeting and enable the Committee to make a decision on the application more quickly.
If you have a disability and need any practical support when attending the REC meeting you 
may wish to contact the REC office so appropriate arrangements can be made if necessary.
If you are unable to attend the meeting the Committee will review the application in your 
absence.
The review of the application has been scheduled for 12.45pm. Would you please let 
me know whether or not you would be available to attend. Please note that it is difficult to be 
precise about the timing as it will depend on the progress of the meeting. We would kindly 
ask you to be prepared to wait beyond the allocated time if necessary.
Committee meetings are occasionally attended by observers, who will have no vested 
interest in the applications under review or take any part in discussion. All observers are 
required to sign a confidentiality agreement.
This Research Ethics Committee is an advisory committee to  South East Coast Strategic Health Authority
Thé National Research Ethics Service (NRES) represents the NRES Directorate within 
the National Patient Safety Agency and Research Ethics Committees in England
10/H1109/25 Page 2
Documents received
The documents to be reviewed are as follows:
Document ~ _ , Version '' Date
Covering Letter 29 March 2010
REC application 2.5 23 April 2010
Protocol 1 19 March 2010
Investigator CV 19 March 2010
Participant Information Sheet: Main Study 1 19 March 2010
Participant Information Sheet: Sub-Study 1 19 March 2010
Participant Consent Form: Main Study 1 19 March 2010
Participant Consent Form: Sub-Study 1 19 March 2010
Letter of Invitation to participant 1 19 March 2010
Evidence of insurance or indemnity 08 July 2009
Summary/Synopsis - Laymans 1 19 March 2010
Food Diary 1 19 March 2010
Interview Schedules/Topic Guides 1 19 March 2010
Questionnaire: Lifestyle 1 19 March 2010
Questionnaire: Physical Activity 1 19 March 2010
Questionnaire: Bone and Muscle 1 19 March 2010
Questionnaire: UVB Exposure 1 19 March 2010
Questionnaire: Health 1 19 March 2010
Advertisement/Flyer 1 19 March 2010
CV - Ms Andrea Darling 1 19 March 2010
CV - Ohood A Hakim 1 24 March 2010
Summary of original D-Flnes Study 1 19 March 2010
Sleep diary 1 19 March 2010
Risk Assessment 1 19 March 2010
invitation to Participant - Sub-Study 1 19 March 2010
No changes may be made to the application before the meeting. If you envisage that 
changes might be required, we would advise you to withdraw the application and re-submit 
it.
Notification of the Committee’s decision
You will receive written notification of the outcome of the review within 10 Working days of 
the meeting. The Committee will Issue a final ethical opinion on the application within a 
maximum of 60 days from the date of receipt, excluding any time taken by you to respond 
fully to one request for further information or clarification after the meeting.
R&D approval
All researchers and local research collaborators who intend to participate in this study at 
sites in the National Health Service (NHS) or Health and Social Care (HSC) in Northern 
Ireland should apply to the R&D office for the relevant care organisation. A copy of the Site- 
Specific Information (SSI) Form should be included with the application for R&D approval. 
You should advise researchers and local collaborators accordingly.
An advisory committee to South East Coast Strategic Health Authority
10/H1109/25 Pages
The R&D approval process may take place at the same time as the ethical review. Final 
R&D approval will not be confirmed until after a favourable ethical opinion has been given 
by this Committee.
Guidance on applying for R&D approval is available at http://www.rdforum.nhs.uk/rdform.
There is no requirement for separate Site-Specific Assessment as part of the ethical review 
of this research. The SSI Form should not be submitted to local RECs.
Communication with other bodies
All correspondence from the REC about the application will be copied to the research 
sponsor. It will be your responsibility to ensure that other investigators, research 
collaborators and NHS care organisation(s) involved in the study are kept informed of the 
progress of the review, as necessary.
10/H1109/25_____   Please quote this number on all correspondence
Yours sincerely
Email: rsc-tr.ethicscommittee@nhs.net
An advisory committee to  South East Coast Strategic Health Authority
UNIVERSITY OF
SURREY
Dr Susan Lanham-New 
Division of Nutritional Sciences 
FHMS
AY Building
Ethics Committee
02 June 2010 
Dear Dr Lanham-New
Interaction between Vitamin D, ethnicity bone health and lifestyle 
EC/2010/53/FHIVIS Fast-Track
On behalf of the Ethics Committee, I am pleased to confirm a favourable ethical 
opinion for the above research on the basis described in the submitted protocol and 
supporting documentation.
Date of confirmation of ethicai opinion: 2 June 2010.
The list of documents reviewed and approved by the Committee under its Fast Track 
procedure is as follows:-
pbcùmèht , , - . . . iDatè V
Appendix 1, 2 & 3 - CVs 2 June 10
Appendix 4 Summary of the purpose, design and methodology of the 
original D-FINES study
2 June 10
Appendix 5 Project summary 2 June 10
Appendix 6 Project protocol 2 June 10
Appendix 7, 8,9,10,11,12 & 13 Questionnaires/interview schedule 2 June 10
Appendix 14 Risk assessment 2 June 10
Appendix 15 Invitation letter to participants 2 June 10
Appendix 16 Information sheet for participants 2 June 10
Appendix 17 invitation to participate in the sub-study 2 June 10
Appendix 18 Health questionnaire 2 June 10
Appendix 19 Participant consent form 2 June 10
Appendix 20 Sub-study participant consent form 2 June 10
Appendix 21 Participant Information sheet 2 June 10
Appendix 22 Sub-study Participant Information sheet 2 June 10
Appendix 23 Instructions for wearing the Actiwatch-L monitors 2 June 10
Appendix 24 Instructions for diet diary 2 June 10
Appendix 25 Insurance confirmation 2 June 10
Appendix 26 NHS RRPS Assessment from Medical Physics expert 2 June 10
NHS REC form 2 June 10
NHS surrey REC favourable opinion with conditions 2 June 10
This opinion is given on the understanding that you will comply with the University's 
Ethical Guidelines for Teaching and Research.
The Committee should be notified of any amendments to the protocol, any adverse 
reactions suffered by research participants, and If the study is terminated earlier than 
expected with reasons. Please be advised that the Ethics Committee is able to audit
research to ensure that researchers are abiding by the University requirements and 
guidelines.
You are asked to note that a further submission to the Ethics Committee will be 
required in the event that the study is not completed within five years of the above 
date.
Please inform me when the research has been completed.
Yours sincerely
Glenn Moulton
Secretary, University Ethics Committee 
Registry
cc: Professor S Williamson, Chairman, Ethics Committee
UNIVERSITY OF
SURREY
Faculty of
Health and Medical Sciences
«Title» «First Name»
~  Susan Lanham-New
«Last_Name» ba, msc, Pho, RPHNutr
«Add 1 » Reader in Nutrition
. J_io Division of Nutritional Sciences
« A d d 2 »  AY Building
«Add3» Guildford, Surrey GU2 7XH UK
«Postcode» T:+44 (0)1483 686476
F; +44 (0)1483 686401
Email: s.lanham-new@surrey.ac.uk 
www.surrey.ac.uk
DATE
Study Title: Interaction between vitamin D, ethnicity, bone health and lifestyle: follow up to 
the D-FINES study NHS REC 10/H/1109/25
Dear «Title» «Last_Name»
We write to ask if you would consider helping us further with the research that we are undertaking 
here at the University of Surrey. We couldn’t be more grateful for all the time that you have given 
us to date and we hope that you don’t mind us writing to you further.
We would like to invite you back to the University for one further visit. The reason for this is we 
would like to take a further sample of your blood to compare the vitamin D levels of Summer 
2006 with those of Summer 2010. This will enable us to address, for the first time ever in the UK, 
what the long term change in vitamin D levels are over a period of years. We would also like to 
do a more detailed forearm and lower leg bone scan with our new bone scanner, some very 
basic muscle function tests and to ask you to fill out some questionnaires. As before we would 
also like you after the visit to keep a food diary for four days and wear a dosimeter badge for one 
week only. This data will be so informative for the nutritional science field. Unlike the original 
study there is only one visit required and all measurements are taken at the University.
There is also an option to participate in a sub study which would require one visit in addition for 
an interview and also the wearing of a pedometer like device called an Actiwatch for two weeks 
to measure sleep wake patterns.
We have enclosed Participant Information Sheets, which will provide you with all the details of 
what the further visit involves. If you are willing to come back for a further visit, then please 
complete the attached forms and post them back to us. We have provided a stamp addressed 
envelope for your reply. Even if you don’t want to take part, which we will fully understand, we 
would be grateful if you would return the forms. We will of course cover your travel expenses and 
will be able to arrange a time that is convenient to you. This further study is funded by in house 
University funds, and will be undertaken as part of the PhD programmes of Miss Andrea Darling 
and Mrs Ohood Hakim. This study has received a favourable ethical opinion from the University 
of Surrey Ethics Committee. Please do not hesitate to contact me if you would like any further 
information on any aspects of the study. We thank you very much indeed for all your help with 
our research to date and really hope that you will consider helping us further on this
With my very best wishes and sincerest of thanks,
Dr Susan Lanham-New 
P r i n c i p a l  I n v e s t i g a t o r
Date: 19/03/10 Version: 1.0
PARTICIPANT INFORMATION SHEET
Study Title: Interaction between vitamin D, ethnicity, bone health and lifestyle
You are invited to take part in a research study. Before you decide it is important for you 
to understand why the research is being done and what it will involve. Please take time to 
read the following information carefully. Please feel free to talk to others about the study if 
you wish.
Part 1 of this Participant Information Sheet tells you the purpose of the study and what will 
happen to you if you take part
Part 2 of this Participant Information Sheet gives you more detailed information about the 
conduct of the study
Please do not hesitate to ask us if there is anything that is not clear or if you would like 
more information. Take time to decide whether or not you wish to take part.
PART 1:
1. What is the purpose of the study?
There is a lack of data looking at vitamin D levels in the UK population over time. A recent 
analysis of a US survey showed a decline in vitamin D status from the 1998-2004 
However, there is little or no equivalent research in UK Caucasian and South Asian 
postmenopausal women. We aim to re-examine the vitamin D status of the DFINES 
women who had measurements taken at the University of Surrey in 2006/7. This will allow 
us to establish if vitamin D status has changed, and what factors may be of potential 
influence. We would also like to look more in detail at bone structure, to assess how 
common the problem of bone and muscle pain is, and investigate if there are age and 
ethnic differences. We also aim to find if out if there is a relationship between sun 
exposure and bone health.
The study is being undertaken as part of the PhD programmes of Miss Andrea Darling and 
Mrs Ohood Hakim, postgraduate students at the University of Surrey.
2. Why have I been chosen?
You previously took part in all or some of the D-FINES study run at the University of 
Surrey in 2006/2007. We would like to take some more measurements on the same 
women that came before so we can see if vitamin D status has changed since 2006/7.
3. Do I have to take part?
No. It is entirely up to you to decide whether or not to take part. If you do, you will be 
given this information sheet to keep and be asked to sign a consent form. You are still 
free to withdraw at any time and without giving a reason. A decision to withdraw at any 
time, or a decision not to take part, will not affect the standard of care you receive. You 
will not be able to participate in the study if you are currently pregnant or planning 
pregnancy, or if you are breastfeeding currently.
4. What will happen to me if I take part?
Participant Information Sheet Date: Version Number: 1
Study Titie:
You will be required to visit the Clinical Investigations Unit at the University of Surrey once. 
This visit will be in summer 2010. Upon agreement for participation in the study, you will 
be contacted by the researchers to book an appointment for your visit to the University.
You will be required to arrive at the University fasted (not having had anything to eat or 
drink [except water] on the morning. Your weight and height (with clothing on) will be 
taken. A small blood sample (25ml) will be collected from a trained phlebotomist. You will 
be provided with some refreshments and will then be asked to have a bone scan on your 
arm and leg, complete brief muscle function tests and complete physical activity, sun 
exposure, bone pain, lifestyle and medical questionnaires.
You will then be provided with a food diary (to record your food intake) and two dosimeter 
badges (to measure exposure to the suns rays). Instructions for completion and use of 
each of these (written and verbal) will be given. You will be asked to complete the food 
diary for four days, and wear the dosimeter badges for one week and to then post these 
back to us in the prepaid envelope provided. All travelling expenses will be reimbursed.
5. What do I have to do?
You will not be asked to follow any particular diet or lifestyle behaviour during this 
investigation. We just want you to continue your usual routine and collect information as 
detailed above with respect to the food that you eat and the level of outdoor exposure that 
you have. We just ask you to attend one visit at the University.
6. What are the possible disadvantages and risks of taking part?
The risks of this study to you are minimal. You may have some discomfort in your aim 
following the venepuncture in your arm to collect the blood sample. The pQCT scan is 
painless and the radiation dose is minimal.
7. Ionising Radiation
A peripheral Quantitative Computed Tomography (pQCT) scan of the forearm and lower 
leg will be performed at the University of Surrey. The procedure is painless and does not 
involve going through a tunnel of any kind. The radiation dose is considered negligible 
and is equivalent to around a half days natural background radiation that we are exposed 
to throughout our lives. You will be asked to sit on a seat where a scan of your forearm 
and lower leg will be performed. The procedure involves placing your forearm into the 
scanning machine where a X- ray beam moves across it. The procedure is then repeated 
with your lower leg in the scanning machine. The scans together take approximately 30 
minutes to complete and do not require removal of clothing. The exception is shoes which 
must be removed for the leg scan and wrist watches/jewellery which must be removed for 
the arm scan.
8. What are the possible benefits of taking part?
We cannot promise the study will help you specifically but the information that you provide 
in this study will be of value to science with respect to whether vitamin D deficiency is 
increasing or decreasing and what influences long term changes in vitamin D levels. The 
study will also give us valuable information about bone structure, bone pain and muscle 
function. It will also give evidence if there is a link between UVB exposure including sun 
and artificial sources and bone health.
You will receive information on your diet, as well as the results of your forearm and leg 
bone density measurements and your vitamin D status.
9. What happens when the research study stops?
At the end of the 6 month study period (October 2010) the analysis of the collected data 
will commence. We will keep you regularly updated on the University of Surrey Nutrition 
and Bone health website and then once all the data has been collected and analysed, we
Participant Information Sheet Date: Version Number: 2
Study Titie:
will send you a report of our findings as a whole, as well as your owned personalised 
results.
10. What are our plans to feed back clinically significant information from the 
tests?
We will provide you with a written report of your results for the study with respect to your 
dietary intake, your vitamin D levels and your bone mass once the study is complete and 
the analysis has been undertaken.
11. What if there is a problem?
Any complaint about the way you have been dealt with during the study or any possible 
harm you might suffer will be addressed. The detailed information on this is given in Part 
2 .
12. Will my taking part in the study be kept confidential?
Yes. All the information about your participation in this study will be kept strictly 
confidential. The details are included in Part 2.
13. Contact Details
Further information concerning the study can be obtained from either Miss Andrea Darling 
(a.darlinq@surrev.ac.uk) or Mrs Ohood Hakim (o.hakim@surrev.ac.uk) who can both be 
contacted on (01483) 689222. This phone has an answering machine that will pick up any 
calls made out of office hours. If you have any concerns about the study please contact 
Dr Susan Lanham-New (s.lanham-New@surrev.ac.uk) on (10483) 686476. The study e- 
mail is ...
This is Part 1 of the Information Sheet. If the information on Part 1 has interested you and 
you are considering participation, please continue to read the additional information in Part 
2 before making any decision.
Participant Information Sheet Date: Version Number:
Study Title:
Date: ; Version:
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S tu d y  T itle : Interaction betw een  vitam in D, ethnicity, bo n e  health  and  lifestyle
PART 2
14. What will happen if I don’t want to carry on with the study?
You can withdraw from the study at any time. Any stored blood or tissue samples that can 
still be identified as yours will be destroyed if you so wish.
15. What if there is a problem?
If you have a concern about any aspect of this study, you should ask to speak with Dr 
Susan Lanham-New who is the Principal Investigator for this study (Tel No. 01483 
686476; email: s.lanham-new@surrev.ac.uk).
16. Will my taking part in this study be kept confidential?
Your participation in this study will be kept confidential and you will be identified in the 
study with a unique study code.
17. What will happen to any samples I give?
The blood samples that you give will be frozen and stored in a -80oC freezer until the end 
of the study. Some of the blood from the samples will be sent to the University of 
Manchester for analysis of vitamin D metabolites.
18. What will happen to the results of the research study?
You will be kept fully informed throughout the study of the progress of our research work 
and we will provide you with the website details for our study. At the end of the study, we 
will provide you with the core research findings in a written report.
19. How long we propose to keep the samples?
We will keep the samples that you provide us in a secure -80oC freezer for a period of no 
less than 10 years
20. Who is organising and funding the research?
The Nutrition and Bone Health team at the University of Surrey are the researchers 
undertaking this project. A University of Surrey PhD Research Studentship is funding the 
project for Miss Andrea Darling and the Government of Saudi Arabia is funding the project 
for Mrs Ohood Hakim.
21. Who has reviewed the study?
This study has received a favourable ethical approval from the University of Surrey 
Research Ethics Committee.
Participant Information Sheet Date: Version Number:
Study Title:
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Follow up Study of D-FINES
Vitamin D a n d  b o n e  hea lth
Vitamin D is essential for healthy bones. There are two ways of getting sufficient vitamin D 
either via your skin when it is exposed  to sunlight or in your diet. However, vitamin D is found in 
only a few  foods such as margarine, eg g s and oily fish.
W hat Is th e  University of Surrey study  a b o u t?
This is follow on study from the D-FINES research that was run in 2006-2007 that investigated  
scientific data  on vitamin D levels in different a g e  and ethnic groups and it's effect on b one  
health. This is a  further investigation study that will focuses on a comparison of the vitamin D 
levels of summer 2006 with those of summer 2010. This will enab le us to address, for the first time 
ever in the UK, what the long term ch a n g e  in vitamin D levels are over a period of years. It will 
also provide us with more information regarding the relation b etw een  vitamin D level and b on e  
health & muscle function.
W hat will I h a v e  to  d o ?
If you d ec id e  to take part, you would b e  required to attend the University of Surrey Clinical 
Investigation Unit o n ce . You would b e  asked to:
• Fill in short questionnaires about your bone pain, lifestyle habits, sun exposure behaviour, and  
physical activity levels.
• Have a scan d on e of the forearm and lower leg b one with our new  bone scanner. This is 
painless, involves a  very low radiation dose, does not require removal of clothing and d oes not 
involve going through a tunnel of any kind. It is d on e at the University at the sam e visit you have  
your blood taken.
• Undertake basic muscle function tests
• Give a small amount of blood (to b e  taken by trained staff).
How will I benefit?
• You will b e  provided with your personal test and scan results
• All your travel costs will b e  refunded.
Has th e  study  b e e n  a p p ro v e d  by  a n  Ethical C o m m ittee?
Yes, the study has b een  fully approved by the Surrey Research Ethics Committee 
(Reference No. ???????)
W hom  d o  I n e e d  to  c o n ta c t  if i h a v e  a n y  q uestions?
If you have any questions you can  telephone either Ms. Andrea Darling or Mrs. O hood Hakim 
on (01483 689222) or email a.darlina@surrev.ac.uk or o.hakim@surrev.oc.uk
Thankyou very much for your time
Participant ID number: ______  Date: Version:
PARTICIPANT CONSENT FORM
Study Title: In teraction betw een  Vitamin D, ethnicity  b o n e  health  and  lifestyle 
CONSENT FORM
• I (name)________________________________________ voluntarily agree to take part in
the above named research study conducted by the University of Surrey.
• I have read and understood the Participant Information Sheet provided (Date, 19/03/10 
VersionI.O). I have been given a full explanation by the investigators of the nature and 
purpose of the study. I have been given the opportunity to ask questions on all aspects of 
the study and have understood the advice and information given as a result.
• I understand that all personal data is held and processed in the strictest confidence, and in 
accordance with the Data Protection Act (1998). I agree that I will not seek to restrict the 
use of the results of the study on the understanding that my anonymity is preserved.
• I understand that I am free to withdraw from the study at any time without needing to justify 
my decision and without prejudice to me. I agree to my GP being informed of my 
participation in this study
• I understand that the University of Surrey holds insurance, which covers claims for injury or 
deterioration in health, which arise directly from participation in clinical trials but that it 
applies only in those situations where the University can be shown to be legally liable.
• I confirm that I have read and understood the above and freely consent to participating in 
this study. I have been given adequate time to consider my participation and agree to 
comply with the instructions and restrictions of the study.
Name of volunteer (BLOCK CAPITALS)
Signed
Address
Date
Name of w itness (BLOCK CAPITALS)
Signed
Date
i U
■ Cj
■•M.\
d
%
. 1
This is to certify that
Has attended
at
School of Oriental and African Studies 
London
on
1 9 / 0 5 / 2 0 1 0
UNIVERSITY OF
University of Surrey
Health and Safety Departm ent
This is to certify that
Ohood
has attended the 
Radiation Protection Induction Course 
Held at the University of Surrey on 
6th May 2010 
Presented by the Radiation Protection Adviser
Topics covered:
Working safely with Radioisotopes 
Radioactivity 
Radiobiology 
Radiological Quantities, Units and Prefixes 
Regulations; IRR and RSA 
Risk Assessment
Signed
Penny Giorgio, RPA 
University of Surrey 
Guildford, Surrey, GU2 7XH
PROJECT PROTOCOL
Study Title: Interaction between vitamin D, ethnicity, bone health and lifestyle 
Brief Study Background
Vitamin D deficiency is a problem of growing concern in the UK and abroad, being linked to an increasing 
number of chronic diseases including osteoporosis, coronary heart disease, cancer, diabetes mellitus, 
infectious disease and multiple sclerosis. The economic implications of vitamin D deficiency are not clearly 
defined but Grant et al (2009)  ^ estimated that if vitamin D status in Western Europe alone could be raised 
From deficient to sufficient, then the estimated economic burden could be reduced by at least 187,000 
million Euros per year. Vitamin D deficiency is therefore of large public health importance.
In 2006-2007, 373 Asian and Caucasian women took part in the D-FINES (Vitamin D, Food Intake, 
Nutrition and Exposure to Sunlight in Southern England) study in the Faculty of Health and Medical 
Sciences at the University of Surrey. The 373 women visited the Clinical Investigation Unit (CIU) four times 
in 2006-2007 (summer, autumn, winter and spring). At each CIU visit, blood samples were taken for 
measurements of vitamin D status and blood biochemistry. Also physical activity was assessed by 
questionnaire and anthropometric variables were measured. After each visit, dietary intake of nutrients was 
assessed by completion of a diet diary for 4 days, and UVB exposure by the wearing of dosimeter badges 
For a week and also completing a sun exposure diary for one week. The participants also undertook whole 
body DEXA (Dual-Energy X-Ray absorptiometry) scans at the Nuffield Hospital, Guildford, in autumn and 
spring to assess bone density. Lower vitamin D status and UVB exposure were found in Asian compared 
to Caucasian subjects. This data is currently being used to inform public health policy via the Food 
Standards Agency who funded the project (FSA project N05064).
In spring/summer 2010 we propose to invite back the D-FINES cohort (n=279 Caucasian women - 144 
postmenopausal and 135 premenopausal) and n=94 Asian women - 44 postmenopausal and 50 
premenopausal) for a repeat measurement of vitamin D status, UVB exposure, nutrient intake, bone 
density and lifestyle and anthropometric variables. This will enable longitudinal analysis of these variables 
over the past four year period and elucidate the factors affecting change in vitamin D status over a time 
period of years in the UK. At present there is a lack of such data.
Ethnicity is an important issue with respect to vitamin D status and bone health. There is an ongoing 
debate as to whether Asians and Caucasians differ in volumetric bone density and lower extremity muscle 
Function and whether this is related to differences in vitamin D status. Little is known about the prevalence 
of vitamin D deficiency bone pain. In the proposed study, a peripheral Computed Tomography bone scan, 
sit to stand tests and bone pain questionnaires in the D-FINES women will investigate these issues further. 
In addition we will look more in detail about UVB exposure behaviour (including sun and artificial sources) 
n South Asian and Caucasian populations, and explore the association between UVB exposure and bone 
lealth.
There are potential links between vitamin D, musculoskeletal health and sleep. This is because vitamin D 
deficiency causes musculoskeletal pain, and all pain can potentially affect sleep. It is unknown whether 
;here is a direct link between vitamin D status and sleep quality. Therefore, a sub-study in a subset of the 
Darticipants would also be conducted to assess sleep quality, and its relationship to light exposure, activity 
and vitamin D status. It would be of great interest to see if there is an ethnic difference in sleep quality, and 
f so if this is due to ethnic differences in light exposure and/or physical activity. This subset of participants 
/vould also take part in an interview to assess sociological influences on vitamin D status, attitudes to sun 
exposure and vitamin D supplements and perceptions of personal sleep quality. This analysis will be hugely 
/aluable as there is no research in the UK that has examined social and cultural influences on vitamin D 
status and sleep in South Asian compared to Caucasian women. This would be very useful for producing 
effective public health campaigns to improve vitamin D status in South Asian women and provide core 
sociological information on experiences of sleep disruption in South Asian compared to Caucasian women.
Mms and Hvpotheses
VIAIN STUDY
[1) To assess change in vitamin D status over 3 years (2007-2010) and to determine which factors (UVB, 
dietary vitamin D intake, lifestyle, anthropometric) determine change in vitamin D status
[2) To assess whether there are differences between South Asian and Caucasian women in volumetric 
Done density, lower extremity muscle function and bone pain.
• Alternative Hypothesis: South Asian women will have lower volumetric bone density, poorer lower 
extremity muscle function and higher pain scores than Caucasian women
• Null Hypothesis: There will be no difference in volumetric bone density, lower extremity muscle 
function and pain scores by ethnic group
[3) To assess whether there is difference between South Asian and Caucasian in UVB exposure dose and 
/vhether there is an association between UVB exposure and bone health
• Alternative Hypothesis: South Asian women have different UVB exposure behaviour and bone
health than Caucasian women
• Null Hypothesis: there is no significant difference in UVB exposure behaviour and bone health by 
ethnicity
SUB STUDY
[4) To assess whether South Asian women have different sleep-wake cycles than Caucasian women
• Alternative Hypothesis: South Asian women will have different sleep-wake cycles than Caucasian 
women
• Null Hypothesis: There will be no significant difference in sleep-wake cycles by ethnicity.
[5) To assess whether there is a link, (independent of light exposure, lifestyle, personal factors and
Tiusculo-skeletal pain), between vitamin D and sleep quality
• Alternative Hypothesis: There will be a significant association between vitamin D status and 
objective and subjective sleep quality
• Null Hypothesis: There will be no significant association between vitamin D status and objective and 
subjective sleep quality
[6) To assess qualitatively the attitudes, beliefs, perceptions and behaviours surrounding sun exposure, 
consumption of vitamin D rich foods and consumption of vitamin D supplements in UK South Asian and 
Caucasian women.
7) To assess qualitatively similarities and differences in subjective experiences of sleep disruption in UK 
South Asian and Caucasian women.
Criteria for participant selection
Ml women who are willing to return from the original D-FINES cohort will be included in the study if they still 
emain eligible. Eligibility will be defined as in the original study (see below).
inclusion criteria:
• Women who have not suffered any condition or taken any medication likely to affect their bone 
metabolism.
• These criteria will be assessed using the health questionnaire, and will apply to both the main study 
and the sub study.
Exclusion criteria:
Coronary heart disease or has a pacemaker in situ
Known Type 1 or Type 2 diabetes
Renal failure or evidence of renal impairment
Liver disease
Gout
Pregnancy- confirmed pregnancy or planning pregnancy 
Given birth in the previous 3 months and/or currently breastfeeding 
Eating disorders including anorexia or bulimia nervosa 
Obesity of known cause e.g. Cushings disease 
Alcohol abuse within the last 2 years
Uncontrolled thyroid disease or an abnormal TSH level based on GP opinion 
Respiratory disease (except stable asthma)
Treatment for a malignancy 
Rheumatoid arthritis 
Osteoporosis or osteomalacia
Use of the following medications: Hormone Replacement Therapy (for greater than 6 months) 
Glucocorticoids, Weight loss drug/ preparations including orlistat (Xenical) or sibutramine (Reductil) 
Lipid lowering or anti-hypertensive drugs 
Anti-depressant medication
Number of participants to be recruited
We already have contact details for (n=373) women who took part in the original D-FINES study in summer 
2006-spring 2007. We can be confident from the attendance in the original study that we can obtain 
enough women who are willing to return for another visit. Therefore there is no need to go through 
ecruitment procedures. See table for attendance numbers from original study. We seek ethical approval 
:o re-contact these women for this new study.
Ml women taking part in the main study will be asked during their CIU visit if they would also like to take 
Dart in the sub study (sleep diary, Actigraphy and interview). For the sub study 15 Asian and 15 Caucasian 
A/omen are required. Thirty participants is a sufficient number to generate enough data for the interview and 
\ctigraphy and also small enough to enable enough in-depth analysis of each participants data.
TABLE OF ATTENDANCE DURING ORIGINAL DFINES STUDY
Summer Autumn Winter Spring
2007
Caucasian
Postmenopausal
144 138 133 133
Caucasian
Premenopausal
135 109 91 90
Asian
Postmenopausal
40 38 36 35
Asian
Premenopausal
46 39 35 35
All Caucasian 279 247 224 223
All Asian 86 77 71 70
All women 365 324 295 293
Summary of experimental design and m ethods used
This is an observational study which requires a visit to the CIU at the University of Surrey for a blood 
sample, grip strength test, a timed sit-to stand test, a pQCT bone scan, anthropometric measurements. It 
will also require completion of lifestyle, sun exposure and bone pain questionnaires during the visit. See 
figure for a flow chart of summary of activities undertaken during the main study visit to the Clinical 
Investigation unit. All participants will receive instructions on how to use the dosimeters and complete the 
food diaries which they will use at home for 4 days (food diary) and one week (dosimeter). They will be 
instructed to send these back to the Investigators using the freepost envelopes provided.
The protocol for individual participants (one time visit 
to CIU, University of Surrey)
Breakfast
break
Blood
sam ples (20  
ml) for 
analysis of:
1. Vitamin D
2. PTH
3. Calcium
4. Albumin
About 10 min
Anthropometric pQCT scan
m easure including
include height forearm and
and w eight, grip lower leg
strength
About 30 min
About 10 min
Sit-to 
stand test
About 10 
min
Filling out
questionnaire:
1. Lifestyle 
survey
2. Dietary 
survey 
(optional)
3. Bone pain 
survey
4. UVB 
exposure 
survey
About 20 min
During the CIU visit, the sub group of participants participating in the sub-study will in addition receive 
nstruction in how to use the Actiwatches and how to complete the sleep diaries. At home, the subjects will 
jse these as instructed for two weeks. As with the main study, the participants will be required to return 
:hese items to the University using freepost envelopes provided. Within the next few months, they will also 
:ake part in one separate audio-recorded interview of around 1 hour to investigate subjective attitudes and 
oeliefs towards sun exposure and vitamin D and of subjective sleep disruption. If not already posted back 
Defore the interview, they can return the Actiwatches and sleep diaries at this visit to the investigator
VIeasures:
The total blood sample required is 25 ml for vitamin D, PTH, calcium and albumin measure. Blood samples 
/vill be collected by a trained phlebotomist.
Sit-to-walk (STW) and Sit-to-stand (STS) test: subjects will be asked to sit in comfortable wooden chair with 
heir back in contact with the backrest of the chair and feet resting on the ground in front of the chair 
standardised position). From the initial seated position, subjects will asked to stand and walk to another 
:hair 6 meter directly in front. Time will be recorded by stopwatch. This test will be repeated five times.
Statistical Analysis
Multiple regression, using Statistical Packages for the Social Sciences (SPSS), will be used to 
assess the predictive ability of relevant variables (UVB exposure, dietary intake of vitamin D and 
calcium, physical activity. Body Mass Index, sunscreen use, holiday frequency or duration, ethnicity) 
on change in vitamin D status over three years.
• Differences in volumetric BMD indices and bone pain by ethnicity will be assessed via T-tests or 
Mann-Whitney tests as appropriate.
• Differences in sun exposure by ethnicity will be analysed by T-test and correlation after it is checked 
for normality.
• In SPSS, Analysis of Covariance (ANCOVA) will be used to test ethnic differences in sleep variables 
(e.g. total sleep time, sleep onset latency, sleep efficiency, number of night awakenings). We will 
control for light exposure, physical activity, bone pain, and other relevant personal and lifestyle 
variables.
• Partial correlations (controlling for light, bone pain and activity) will be used to assess whether there 
is a statistically significant correlation between vitamin D status and indices of sleep quality.
• The interview data transcripts will be analysed using qualitative analysis software and by a mixture 
of analysis methods including grounded theory or other suitable inductive methods.
Study Evaluation 
Benefits to participants
Ml subjects will be offered a summary of their results, including bone density, dietary analysis, as well as 
vitamin D status and if taking part in the sub study an actigraphic representation of their sleep wake cycles. 
These will be of interest to the subjects. We will also stress the importance of the the data collected to the 
scientific community at large, particularly with respect to establishing whether vitamin D levels in the UK are 
changing and the importance of understanding social influences of vitamin D intake in order to produce 
effective public health campaigns. Subjects will be reimbursed for all travel expenses but will not receive 
formal payment for participation.
Risks to participants
MAIN STUDY
• Subjects will require only one visit for the main study and only one more in addition if taking part in 
the sub study. This may be of minimal inconvenience to the participants.
• The peripheral Computed Tomography (pQCT) measurements (for assessment of bone mineral 
density) are painless and involve a very low total radiation dose (total dose=3 pSv. This is 
equivalent to approximately half a days natural background radiation- see appendix 26 for 
assessment from Medical Physics Expert). If the participant moves during the scan it will need to be 
repeated (the total x-ray dose in this case would still be minimal). Therefore the risks/adverse 
effects of the pQCT radiation are minimal.
• The venepuncture may cause some minor discomfort, although will be taken by an experienced 
phlebotomist to minimise any adverse effects.
• The questionnaires are unlikely to cause inconvenience to women as they are brief and focused. 
The bone pain questionnaire is unlikely to cause distress as it involves only superficial answers 
regarding pain experienced. The food diaries can be monotonous to complete but we have limited 
the days for completion to 4 days. There were no significant problems with use of the food diary, 
bone scanning, dosimeter badges, anthropometries and questionnaires in the previous D-FINES 
study.
3UBSTUDY
• The Actigraphy watches and sleep diaries require little work by the participants and these 
techniques have not been found to be a problem for the participants in previous studies undertaken 
in the Faculty of Health and Medical Sciences at the University of Surrey.
The interviews will be kept reasonably brief of around one hour in length and will only require one 
visit.
Benefits to scientific knowledge and public health policy
This work will enable the longitudinal analysis of changes in vitamin D status in the UK and what factors 
predict change. This will be of benefit to the vitamin D research field and in informing public health policy on 
vitamin D. This work will also help to bridge gaps in knowledge concerning bone pain, bone density and 
lower extremity muscle function in Asian and Caucasian individuals. It will aim to assess whether a link 
between vitamin D status and sleep exists which could potentially have therapeutic implications. It also 
gives crucial data on light exposure, activity and sleep wake cycles in the South Asian population which has 
never been done before in the literature. The study will give important insights into the sociological 
influences on vitamin D status and related lifestyle behaviours which will help inform public policy about 
effective ways to improve vitamin D status. It will provide core sociological analysis of the differences in 
subjective experiences of sleep between South Asian and Caucasian women in the UK which has also not 
been done to date.
References
1 Grant, W. B., H. S. Cross, et al. (2009). "Estimated benefit of increased vitamin D status in reducing the 
economic burden of disease in western Europe." Progress in Biophysics & Molecular Biology 99(2-3): 104- 
113.
SUMMARY OF THE PURPOSE, DESIGN AND METHODOLOGY OF THE ORIGINAL 
D-FINES STUDY (NHS REC Ref: 06/01909/1)
1. Purpose: This research study aimed to quantify the percentage contribution of diet and 
sunlight exposure on vitamin D status and functional markers of calcium metabolism and 
bone health in Caucasian and Asian premenopausal and postmenopausal women living in 
Southern England.
2. Design: This was an observational study where we collected information on subjects four 
times (in each of the four seasons) in a single 12-month period starting from June 2006 to 
May 2007. We assessed subjects at 3 monthly intervals over a 12 month period:
SUMMER STAGE: June-August 2006;
AUTUMN STAGE: September-November 2006;
WINTER STAGE: December 2006-February 2007;
SPRING STAGE: March-May 2007.
In each of these four stages we measured: (1) vitamin D status (25 OHD); (2) parathyroid 
hormone (PTH), serum calcium and albumin; (3) bone turnover markers; (4) body fat (by 
DXA and skin-fold thickness); (5) dietary intake of vitamin D using 4d food diaries [including 
one weekend day]; (6) sunlight exposure by questionnaire and dosimeter; (7) critical lifestyle 
factors (e.g. physical activity {using questionnaire], smoking habits etc); (8) frequency of 
falls; and (9) grip strength. In autumn and spring: whole body, lumbar spine and femoral 
neck BMD were assessed by Dual X-ray Absorptiometry (D)Ù\) and in a subset of subjects 
(30%) by Broadband Ultrasound Attention.
3. Methodology:
(i)Subject recruitment
The study recruited 365 women at baseline in each of the following categories
GROUP 1: Premenopausal Caucasian (19-40 years): n=144 
GROUP 2: Premenopausal Asian (19-40 years): n=135 
GROUP 3: Postmenopausal Caucasian (55-70 years): n=40 
GROUP 4: Postmenopausal Asian (55-70 years: n=46
373 willing volunteers were recruited from GP surgery patient lists within Surrey. Women 
who were currently on steroids or other medication likely to affect vitamin D metabolism or 
have a history of any disorder of calcium homeostasis were excluded. Women who were 
currently taking vitamin D supplements or cod liver oil supplements were excluded or asked 
to refrain from use 3 months prior to the start of the study or during the 12 months of the 
study investigation. Those women who were housebound or who are likely to travel abroad 
extensively over the coming year were also excluded from the study.
Women who met the inclusion criteria and who are willing to participate in the study were 
invited to attend the Clinical Research Unit at the University of Surrey. On the first visit, 
weight and height were recorded and a fasting blood sample was taken for analysis of 
vitamin D status, parathyroid hormone, serum calcium and albumin as well as routine 
biochemistry to detect any abnormalities. After a light breakfast, women were given full 
instructions on the correct procedures for collection of a 4-d estimated food record. For 
these purposes, women were given a food diary (as used in the EPIC study). Progress of 
women was monitored during the 4-d recording period and diaries were sent back to Surrey 
at the end of the study period using a freepost envelope. Use of estimated food records, as 
opposed to the weighed technique allowed the monotony of dietary recording to be reduced 
to the minimum and has been shown to be a valid tool for estimating dietary intake.
We also measured sunlight exposure using a dosimeter. Subjects used the dosimeter for 
one week. Other lifestyle variables including smoking, physical activity, alcohol, 
socio-economic status etc were collected by questionnaire. Last, the women were asked to 
perform a grip strength test at each visit and asked to complete a falls questionnaire which 
enabled identification of incidence and frequency of falls in the past year.
(iii) Assessment of bone health in AUTUMN STAGE AND SPRING STAGE
In the AUTUMN STAGE data collection period (September-November 2006) and the 
SPRING STAGE data collection period (March-May 2007) lumbar spine, femoral neck and 
whole body bone mineral density (BMD) were measured using Dual X-ray Absorptiometry 
(DXA). This was undertaken in the bone centre within the Guildford Nuffield Hospital. We 
also assessed body composition in subjects using the whole body BMD measurements. 
Measurements were performed by a Senior Radiographer at the Nuffield Hospital. We also 
measured calcaneal bone mass using broadband ultrasound attenuation (BUA). This was 
undertaken in the Clinical Investigation Unit at the University of Surrey.
(iv) Analysis of vitamin D status and functional markers of calcium metabolism
The stored serum samples were sent frozen to the Department of Medicine, University of 
Manchester for analysis of 25(OH)D3, PTH, Ca and albumin. Sample analysis was 
undertaken under the supervisor of Dr Jacqueline Berry (JB) who is Deputy Director of the 
Supra-Regional Assay Centre and a recognized authority on vitamin D metabolism.
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B one and M uscle Pain Q uestionnaire
The purpose of this questionnaire is to assess bone and muscle pain and their effects 
on everyday living. This data will provide us with important information about how 
common bone and muscle pain is and how it impacts on women's everyday lives. 
Therefore it is important that you answer it as fully as possible. Unless instructed 
otherwise, please mark only one answer for each question.
Section 1- Fractures
1a) Have you ever had a wrist fracture?
Yes □ (go to question 1b) No □ (go to question 2a)
1 b) Was your wrist fracture due to
A fall □
Lifting a heavy load □
Bending to pick up something □
Sneezing □
Playing sport □
Other, please specify________
2a) Have you ever had a hip fracture?
Yes □ (go to question 2b) No □ (go to question 3a)
2b) Was your hip fracture due to
A fall □
Lifting a heavy load □
Bending to pick up something □
Sneezing □
Playing sport □
Other, please specify________
3a) Have you ever had a spine fracture (vertebrae)
Yes □ (go to question 3b) No □ (go to question 4)
3b) Was your spine fracture due to
A fall □
Lifting a heavy load □
Bending to pick up something □
Sneezing □
Playing sport □
Other, please specify_________
S ectio n  2- B ack pain
4. In the past 6 months, have you had any back pain?
a. Yes □ (go to question 5) b. No □ (go to question 15)
5. What are the causes of this back pain?
(Please give details in the space provided below)
6. How bad is the back pain on average?
Mild □
Moderate □
Severe □
7. In what part of the back is the pain usually located?
Please use the chart as your guide
Upper back (Area 1) □
Mid area of back (Area 2) □
Lower back (Area 3) □
8. How frequently have you experienced this back pain?
Less than once a month □
One to three times a month □
One to three times per week □
Daily □
9. How would you describe the type of back pain? (circle a//that apply)
‘Shooting’ □
Dull □
Tender □
Spasmodic □
Aching □
Sharp □
Prickly □
Sore □
10. Do you do anything to relieve this pain?
Yes □ (go to question 11)
No □ (go to question 14)
11. What do you do to relieve this pain?
(Please circle all answers which apply)
Nothing □
Rest (lie down, sit down, sleep etc) □
Home remedies (heat pad, heat lamp, cold compresses etc) □
Medication (i.e.' pain killers’, analgesics) □
12. If you use medication, please the name/s of the medication/s here_____
13. How often do you use this pain medication?
Less than once a month □
One to three times per month □
One to three times per week □
Daily □
14. Have you ever consulted your GP (Doctor) about the pain? Yes □ No o 
Section 3- Dailv living
Please circle the letter which best describes your experience of the following tasks in 
the last 6 months:
15. (a) Bending down to pick up lightweight objects (like clothing) from the floor
No difficulty- □ go to question 16
Some difficulty □
Much difficulty □
Unable to do □
(b) Is this due to back pain?
Yes □ No o Don’t know □
16. (a) Lifting a ten-pound object (such as a bag of potatoes) from the floor
No difficulty- ago to question 17
Some difficulty □
Much difficulty □
Unable to do □
(b) Is this due to back pain?
Yes □ No o Don’t know □
17. (a) Reaching for an object just above your head, such as a jar on the shelf
No difficulty- a go to question 18
Some difficulty □
Much difficulty □
Unable to do □
(b)ls this due to back pain?
Yes □ No o Don’t know □
18. (a) Putting on socks or stockings on either foot
No difficulty- □ go to question 19
Some difficulty □
Much difficulty □
Unable to do □
(b) Is this due to back pain?
Yes □ No □ Don’t know □
19. (a) Getting in and out of an automobile
No difficulty- □ go to question 20
Some difficulty □
Much difficulty □
Unable to do □
(b) Is this due to back pain?
Yes □ No o Don’t know □
20. (a) Standing on your feet for 30 minutes
No difficulty- □ go to question 21
Some difficulty □
Much difficulty □
Unable to do □
(b) Is this due to back pain?
Yes □ No o Don’t know □
21. (a) Climbing stairs at a moderate pace
No difficulty- □ go to question 22
Some difficulty □
Much difficulty □
Unable to do □
(b) Is this due to back pain?
Yes □ No o Don’t know □
22. (a) Walking at a moderate pace on flat ground
No difficulty- ngoto question 23
Some difficulty □
Much difficulty □
Unable to do □
(b) Is this due to back pain?
Yes □ No o Don’t know
S ection  4- B on e and m u sc le  pain
The foilowing questions relate to the past 6 months
PART A-BONE PAIN
23. (a) Have you had any pain in your bones?
Yes □ No □ (go to question 25)
(b) On the table below, please tick the box on the area point where you have pain in the 
bones, please also rate how severe is the pain from scale 1 to 10 (1 no pain and 10 for severe 
pain):
Location of 
the pain
The severity of the pain Location of 
the pain
The severity of the pain
1. collar 1 r
no pain
t  10
severe
pain
2. shoulder(s)
1 f
no pain
”V 10
severe
pain
3. rib(s)
1 r
no pain
10
severe
pain
4. back
1 r
no pain
“V 10
severe
pain
5. Arm(s)
1 f
no pain
t  10
severe
pain
6. hand(s) 1 r
no pain
T  10
severe
pain
7. wrist(s)
1 r
no pain
”V 10
severe
pain
8. hip
1 f
no pain
I f  10
severe
pain
9. leg
1 r
no pain
T 10
severe
pain
10. knee(s)
1 f
no pain
T  10
severe
pain
11. ankle(s)
1 f
no pain
t  10
severe
pain
12. foot/feet
1 f
no pain
"T 10
severe
pain
13. thighs
1 r
no pain
T  10
severe
pain
14. other 
(specify 1 fno pain
T  10
severe
pain
24. Have you had pain in the back of your thighs?
Yes □ (go to question 26) No □ (go to question 27)
25. How would you describe this thigh pain? (circle all that apply)
‘Shooting’ □
Dull □
Tender □
Spasmodic □
Aching □
Sharp □
Prickly □
Sore □
26. Have you had symptoms of pain, aching, or stiffness in or around a joint?
Yes □ No □ Don’t know □
PART B- MUSCLE PAIN
The following questions relate to the past 6 months
27. (a) Have you had any pain in your muscles?
Yes □ No □ (go to question 31)
(b) On the table below, please tick the box on the area point where you have pain in the 
muscles, please also rate how severe is the pain from scale 1 to 10 (1 no pain and 10 for 
severe pain):
Location of 
the pain
The severity of the pain Location of 
the pain
The severity of the pain
1. collar
1 f
no pain
T 10
severe
pain
2. shoulder(s)
1 r
no pain
"T 10
severe
pain
3. rib(s)
1 I
no pain
T  10
severe
pain
4. back
1 f
no pain
"T 10
severe
pain
5. Arm(s)
1 r
no pain
T  10
severe
pain
6. hand(s)
1 f
no pain
"V 10
severe
pain
7. wrist(s) 1 r
no pain
10
severe
pain
8. hip
1 r
no pain
t  10
severe
pain
9. leg
1 f
no pain
T  10
severe
pain
10. knee(s)
1 r
no pain
t  10
severe
pain
11. ankle(s)
1 f
no pain
"V  10
severe
pain
12. foot/feet
1 f
no pain
▼ 10
severe
pain
13. thighs
1 f
no pain
T  10
severe
pain
14. other 
(specify 1 rno pain
> 10
severe
pain
28. How would you describe the type of muscle pain? (circle all that apply)
a. ‘Shooting’
b. Dull
c. Tender
d. Spasmodic
0. Aching
f. Sharp
g- Prickly
h. Sore
I. Burning
29. In the last 6 months have you had any feelings of muscle weakness in the back of 
the thighs?
Yes □ No □ Don’t know □
Thank you for answ ering  ou r  ques tionnaire
DVB Exposure Questionnaire
The purpose of this questionnaire is to assess your exposure to UVB light including 
from sun and artificial sources. The results of this questionnaire will allow us to compare 
exposure between women of different ages and ethnicities and to relate light exposure 
to bone health.
Section 1 -  sunbed exposure 
1 a) Within the past 12 months, have you used a sunbed?
Yes □ No □
1 b) How often do you use a sunbed?
Never (go to question 2a) □
Once a year □
3 times a year □
4-6 times a year □
Once a month □
More than one a month □
1 c) What is the purpose of your sunbed usage?(p/ease c h o s e  t h e  b e s t  r e a s o n )
Cosmetic reason (to get tan) □
For health benefit □
To enjoy with friends □
Other please specify----------- -
Section 2 -  sun exposure
2 a) Does your work involve being outside in the sun at any point?
Yes □ No □
2 b) Currently how many minutes are you out in the sunlight? ( p l e a s e  t i c k  t h e  
b o x  t h a t  b e s t  r e p r e s e n t  h o w  m a n y  m i n u t e s  y o u  a r e  e x p o s e d  t o  s u n l i g h t  d a i l y )
Never (go to question 2e) □
Few minutes a week □
2-5 minutes a day □
6-10 minutes a day □
11-15 minutes a day □
More than 15 minutes a day □
2 c) 'Are you ever out in the sun between the hours of 12:00 and 4:00 p.m.?
Yes □ No o
2 d) How often are you usually outdoors and which parts of your body do you 
usually expose? Please tick the boxes which best describe your behavior.
To help you answer this think about the following questions:
If it is sunny, are you generally inside or outside, e.g. walking, shopping, gardening, 
sitting in the sun etc
If it is sunny but cool/windy, do you muffle up (hat/ gloves/ tights)?
If it is sunny and warm do you usually go outside with short-sleeves/ bare legs/ a hat?
Always Often O ccasionally Seldom /N ever Skin Exposure
Spring
March-May
□
Head Hand Arms Legs Torso  
□  □  □  □  □
Sum m er
June-Aug
□  □  □  □  □
Autumn
Sept-N ov
□ □  □  □  □  □
Winter
D ec-Feb
□ □  □  □  □  □
3 e) Within the past 12 month, have you ever sunbathed?
Yes □ No □
f) How often do you sunbathe
Never (go to question 3a) □
Once a year □
3 times a year □
4-6 times a year □
every month □
more than one a month □
g) What are your main reasons for sunbathing
Cosmetic reason-to get tan □
For health benefit □
Socializing with friends □
Other please specify-------------
Section 3 -  holiday
3 a) Please list, with details, all your visits aboard within the last 12 months:
Date/mo
nth
location Number 
of days
How 
many 
minutes 
in the 
sun per 
day
Did you use 
sunscreen 
when you 
went outside?
Skin exposure 
Head Hand Arms Legs Torso
Example
20 /08 /09
Turkey 10 days 20  per 
day
Y es^
N o d
K □ □
Yeso
N od
□ □ □ □ □
YesD
N od
□ □ □ □ □
YesD
N od
□ □ □ □ □
YesD
N od
□ □ □ □ □
YesD
N o d
□ □ □ □ □
Section 4 -  other related behavior
4 a) In the UK, do you use sunscreen when you go outside? If yes, how often 
do you apply it (circle one answer form the table below). Please specify in 
the table below for each season:
Yes No How often do you use the 
sunscreen? (Please circle one 
answer for each season)
Spring
March-May
Always, sometimes, never
Sum m er
June-Aug
Always, sometimes, never
Autumn
Sept-N ov
Always, sometimes, never
Winter
D ec-Feb
Always, sometimes, never
4 b) What sunscreen factor do you use, e.g. Factor 8, Factor 30?
4 c) In the past 12 months, how many times have you had a red OR painful 
sunburn that lasted a day or more?
Zero □
One □
Two □
Three □
Four □
Five or more □
4 d) Have you ever had a cancer before, if yes please specify the type in the 
space below?
Yes □ Tvoe:
No □ Don’t know □
4 e) Have you had melanoma or any other type of skin cancer?
Yes □ No o Don’t know □
4 f) Do you have family history of skin cancer?
Yes □ No o Don’t know □
4 g) have you had an excessive exposure to chemicals, such as environmental 
toxins like asbestos?
Yes □ No a Don’t know □
4 h) have you had radiotherapy treatment?
Yes □ No o Don’t know □
th c m h y o w fo r  ifU pportlvx^ otAr y tu d y
Participant number.
LIFESTYLE SURVEY
What is your Date of Birth? I
Day Month Year
How many years have you lived in Southern England?
What is your postcode?
In which country were you born?
What is your ethnicity?
□W hite DChinese
□  Indian □Pakistani
□O ther (Please describe)
□ S ri Lankan 
□Bangladeshi
□M iddle Eastern
What is the highest level of education you have completed?
□  Secondary School (up to 16 years of age)
□  Further education, e.g. A levels or college (up to 18 years of age)
□  Higher education, e.g. University Degree Course
□  Other Qualification (please give details)
(a) Do you smoke?
If yes please give details; 
Number of cigarettes per day 
Number of years smoking 
Age at which started smoking
□Y es □ N o
(b) How much alcohol (units) do you drink on average per week?
(1 pint o f beer/cicler= 2 units; 1 pub m easu re of spirits = 1 unit, 1 sm all g la s s  of w ine= 1 unit, 1 large g la s s  of 
w ine= Sunits)
None □ 1-4 units □ 5-14units 1 Sunits or more □
(c) How many cups of caffeinated tea do you drink a day (not including herba l, fruit or decaff 
tea )?__________
How many cups of caffeinated coffee do you drink a day?
Lifestyle survey
3. Have you ever broken or fractured any bones?
□Y es □ N o  □ N o t sure
Has your natural mother or father ever suffered a fractured or broken hip?
Natural Mother □Y es □ N o  □ N o t sure
Natural Father □Yes □ N o  □ N o t sure
Lifestyle survey
How much milk do you have per day?
□none □ less than 1/2 pint ^ 1 /2  pint □ I  pint □m ore than 1 pint
How much margarine/spread do you have on bread per day?
□none □ less than one slice □one slice □ 2-5  slices □m ore than 5 slices
If you use margarine/spread how do you spread it on bread? □ thickly □ th in ly
How often do you eat the following per week?
Eggs □never □ less than once □once □2-5  times □m ore than 5
Oily fish* □never □ less than once □once ^2 -5  times □m ore than 5
*such as sardines, tuna, salmon, mackerel, herring, kippers, trout and pilchards
Have you taken cod liver oil or fish oil supplements at any □Yes □ N o
point in the past three years?
If yes please list the brands.
Have you taken vitamin or mineral supplements at any □Yes □ N o
point in the past three years?
If yes, please list brands taken
Have you taken a vitamin D supplement at any point in the past three years? YES N0_
If yes:
If you know the brand of the supplement please state here _______________________
If you know the strength (dose) of the supplement please state here 
How long have you been taking the supplement?_________ months
PTO
Lifestyle survey
1. PITTSBURGH SLEEP QUALITY INDEX
Instructions;
The following questions relate to your usual sleep habits during the past month only. Your 
answers should indicate the most accurate reply for the majority of days and nights in the 
past month. Please answer all the questions.
1) During the past month, when have you usually gone to bed at night?
Usual bed time (clock time, e.g. 11pm); _____
2) During the past month, how long (in minutes) has it usually take you to fall asleep
each night?
Number of minutes;
3) During the past month, when have you usually got up in the morning?
Usual getting up time (clock time, e.g. 7am );_____
4) During the past month, how many hours of actual sleep did you get at night? (This
may be different from the number of hours spent in bed.)
Hours of sleep per night;_____
For each of the remaining questions, check the one best response. Please answer all 
questions.
5) During the past month, how often have you had trouble sleeping because you.
a) Cannot get to sleep within 30 minutes
Not during the Less than Once or twice Three or more
past month  once a week______ a week____ times a week______
b) Wake up in the middle of the night or early morning
Not during the Less than Once or twice Three or more
past month  once a week   a week____ times a week______
Lifestyle survey
c) Have to get up to use the bathroom
Not during the Less than Once or twice
past month  once a week_____  a week_
d) Cannot breathe comfortably
Not during the Less than Once or twice
past month  once a week_____  a week_
e) Cough or snore loudly
Not during the Less than Once or twice
past month  once a week_____  a week
f) Feel too cold 
Not during the 
past month___
Less than Once or twice 
once a week a week
g) Feel too hot 
Not during the 
past month___
Less than Once or twice 
once a week a week
h) Had bad dreams
Not during the Less than Once or twice
past month  once a week_____  a week_
i) Have pain 
Not during the 
past month___
Less than Once or twice 
once a week a week
j)Other reason(s), please describe
Three or more 
times a week
Three or more 
times a week
Three or more 
times a week
Three or more 
times a week
Three or more 
times a week
Three or more 
times a week
Three or more 
times a week
Lifestyle survey
How often during the past month have you had trouble sleeping because of this?
Not during the Less than Once or twice Three or more
past month  once a week a week____ times a week______
6) During the past month, how would you rate your sleep quality overall?
Very good _____
Fairly good___________
Fairly bad_____________
Very bad_____________ _
7) During the past month, how often have you taken medicine (prescribed or “over the 
counter”) to help you sleep?
Not during the Less than Once or twice Three or more
past month  once a week______ a week____ times a week_
8) During the past month, how often have you had trouble staying awake while driving, 
eating meals, or engaging in social activity?
Not during the Less than Once or twice Three or more
past month  once a week_____  a week____ times a week______
9) During the past month, how much of a problem has it been for you to show enthusiasm to 
get things done?
Not during the Less than Once or twice Three or more
past month  once a week______ a week____ times a week______
Lifestyle survey
10) During the past month, how would you rate your sleep quality overall? 
Very good Fairly good Fairly bad  Very bad  _
IF YOU HAVE ANY QUESTIONS, PLEASE CONTACT:
-ifestyle survey
y 1 1 H ours
/ 1 1 H ours
□ H ours a DAY
□ H ours a DAY
□ Days a WEEK
□ Days a WEEK
Participant num ber..........................................
Present Physical Activities
1. Do you usually  walk and/or cycle each day?
(Please tick two boxes if necessary).
1. □  No
2. I I W alk Total time walked each day I I rs M inutes
3. I I Cycle Total time cycled each day I__ 1 rs M inutes
2 a) How many h o u rs  a day  do you do paid work?
b) How many h o u rs  a day do you do housework?
c) How many d ay s  a w eek do you do paid work?
d) How many d ay s  a w eek do you do housework?
3.a) When working (including housework), for how long are you usually physically 
1) Very active, 2) Moderately active and 3) Inactive each day?
Please circle an answer in each section.
To help, try to think how much time you spend on different activities during your working day.
For example, if you do very little strenuous activity, spend one and a half hours walking between 
shops or offices, and spend most of your time sitting or driving, you would circle: <1 hours a DAY for 
very active, 1-2 hours a DAY for moderately active, and 5-6 hours a DAY for inactive.
1) Very active Hours a DAY
(For example, fast walking, heavy housework, going <1 1-2 3-4 5-6 7-8 >a
up and down stairs, heavy lifting or carrying)
2) Moderately active Hours a DAY
(For example, moderate walking, light housework, <1 1-2 3-4 5-6 7-8 >8
shopping, light lifting or carrying)
3) Inactive Hours a DAY
(For example, slow walking, light arm movements, <1 1-2 3-4 5-6 7-8 >8
sitting, standing, driving)
3.b) When working (including housework), how often are you physically active for at
least 20 minutes during which time you become short of breath and sweat?
1. □ more than 3 times a week
2. □ 2-3 times a week
3. □ once a week
4. □ less than once a week
P l e a s e  T u r n  o v e r
4.a) During your non-w orking tim e (including going to and from work), for how long are you usually  
physically 1) very active, 2) moderately active and 3) inactive each week? Please answer each 
section.
To help, try to think of how many hours you spend on different activities during 
your non-working time.
1) Very active Hours a WEEK
(For example, aerobics, jogging, bicycling, swimming, <1 1-2 3-4 5-6 7-8 >8
hill walking, heavy gardening, competitive sports 
- squash, badminton, tennis, running)
(PLEASE NOTE, THIS QUESTION ASKS ‘ HOURS A WEEK’ AND THE REST ‘HOURS A DAY )
2) Moderately active Hours a DAY
(For example, moderate walking, shopping, light <1 1-2 3-4 5-6 7-8 >8
gardening, taking a shower or bath, getting dressed, 
dancing, golf)
3) Inactive Hours a DAY
(For example, sitting, standing, watching TV, listening to <1 1-2 3-4 5-6 7-8 >8
music, cooking, drinking, eating, visiting pub, piano 
playing, driving).
(Do no t co u n t tim e in bed).
4.b) During your non-w orking time, how often are you physically active for at least 20 minutes during 
which time you become short of breath and sweat?
1. I I m ore than  3 tim es a w eek
2. I I 2-3 tim es a w eek
3. I I o n ce  a w eek
4. I I le ss  th an  o n ce  a w eek
5. Since you last filled in this questionnaire would you say that your level of physical activity has
1. in creased  I I 2. s tay ed  th e  sa m e  I I 3. d e c re a se d  | |
If it has changed, for how long has it been at its current level?
Y ears ______  M onths
6. How many hours a day do you usually spend in bed?
(This includes time reading in bed and also short sleeps during the day)
On w ork day s 
On non-w ork d ay s
H ours
H ours
Participant num ber................................
HEALTH QUESTIONNAIRE
We would be grateful If you would answer the following questions.
In the p ast three years have you suffered from any of the following?
Yes No
Osteoporosis □ □
Asthma □ □
Breast Cancer □ □
Thyroid Disease □ □
Liver Disease □ □
Severe Rheumatoid Arthritis □ □
Any other bone disease (excluding osteoarthritis) □ □
Severe Crohns disease or Coeliac disease □ □
Any other disease (if yes give details) □ □
Have you ever suffered from skin cancer? □ □
Do you or have you ever taken any of the following over the last year?
Yes No
Hormone Replacement Therapy (HRT) □ □
Steroids (tablets or inhalers) □ □
Diuretics □ □
Tamoxifen □ □
Bone medications □ □
Are you currently taking sleep medications? (if yes: give detaiis of □  
name, dose, time of administration, and how often)
□
Any other medication (if yes give details) □ □
Further information
Please answer the fo llow ing
Yes No
Are you or might you be pregnant? □ □
Are you intending to become pregnant in the next year? □ □
Have you had a baby in the last 3 months? □ □
Are you breastfeeding? □ □
Have you had your ovaries removed? □ □
Have you had your womb removed? □ □
We are planning to see participants in the morning between 8.00am and 12.00 noon. Are 
there any particular day or days which would be best for you?
Thank you for taking the time to answer our questionnaire. 
Your help is greatiy appreciated.
IF YOU HAVE ANY QUESTIONS, PLEASE CONTACT:
Further information
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Did you know that vitamin D is essential for skeletal health and has been 
related to protection from multiple chronic diseases?
Did you know that women living in Britain are at high risk o f having 
vitamin D deficiency because o f low exposure to the sunlight?
Are you Caucasian or South Asian Females aged over 48 years old? 
Would you like to know your vitamin D Status?
I f  so we need YOUR help for a study at the University o f Surrey 
investigating the relationship between light exposure [use o f Sunbed) and
vitamin D levels
All travel expenses will be paid!
An Honorarium o f £50 well be paid on completion o f all the visits o f the
study
Study has been given a favourable ethical opinion by the University o f  
Surrey Research Ethics Committee
For more information please contact: Mrs. Hakim
UN IVERSITY OF
Faculty of
Health and Medical Sciences  
S u s a n  L an h am -N ew
N a m e  ba, kisc, Pho, RPHNutr
.  , . R ead er in Nutrition
A Q u r 6 S S  D iv is io n  o f  N utritional S c ie n c e s
AY Building
Guildford, Surrey GU 2 7XH UK 
T: +44 (0 )1483  6 8 6 4 7 6  
F: + 44 (0 )1483  686401
Email: s .ianham -new @ surrey.ac.uk  
w w w .surrey.ac.uk
Study Title: Differences in vitamin D status in Caucasians and Asian Women 
Following UVB
Dear....
Thank you very much for accepting our invitation to participate further in our Sunbed- 
Vitamin D research. It was a great pleasure to see you and to welcome you back to 
the University of Surrey.
We would like to invite you to attend the Enalion Beauty Salon (location: 54High 
Street Knaphill, Woking, Surrey GU21 2PY) for few sunbed light exposure. We also 
would like to invite you to visit the CIU (Clinical Investigating Unit) at Surrey 
University for few times for fasted blood sampling collection (we are enclosing maps 
of both locations). All your visits will not require more than half hour except the first 
one for the questionnaire filling up and to explain the study routine.
We attach a participant information sheet with further details of the schedules. The 
reason for study, we would like to take samples of blood and compare the vitamin D 
levels in Asian and Caucasian women after the exposure to the same amount and 
length to UVB light. Once the study is completed, we may be able to understand 
why Asian women are more common to have vitamin D deficiency. This data will be 
so informative for the nutritional science field.
We have enclosed the Participant Information Sheet, which will provide you with all 
the details of what the further visit involves. We are having two set of times in the 
enclosed small slip. Please tick the most appropriate time to you and return the slips 
back to us in the enclosed prepaid addressed envelope. Even if you don’t want to 
take part, which we will fully understand, we would be grateful if you would return 
the form. We will of course cover your travel expenses and will be able to arrange a 
time that is convenient to you. An Honorarium of £50 well be paid o completion of all 
the visits of the study
This further study is funded by the University of Surrey, with the intention of 
determining whether vitamin D is produced in similar amount among different 
ethnicity.
Please do not hesitate to ring us if you have any queries: If you have any general 
question or if you would like any further information on any aspects of the study 
please do not hesitate to contact my PhD student Noor Hakim or
, email o.hakim@surrev.ac.uk. We thank you very much indeed for all 
your help with our research to date and really hope that you will consider helping us 
further on this research.
With my very best wishes and sincerest of thanks.
Yours sincerely
Dr. Sue Lanham-New Dr. Kath Hart Mrs Noor Hakim
Reader in Nutrition Lecturer in Nutrition PhD Student
MATERIAL REDACTED AT REQUEST OF UNIVERSITY
U N IV E R S IT Y  O F
SURREY
Consent Form
I the undersigned voluntarily agree to take p a rt in  the study on Differences in  vitamin D  sta tus in 
Caucasians versus Asian Women Following UVB Exposure.
I have read  and understood the Information Sheet provided. I have been given a full explanation by the 
investigators of the nature, purpose, location and likely duration of the study, and of w hat I will be 
expected to do. I have been advised about any discomfort and possible ill-effects on my health  and well­
being which m ay result. 1 have been given the opportunity to ask questions on all aspects of the study and 
have understood the advice and information given as a result.
1 agree to comply w ith any instruction given to me during the study and to co-operate fully w ith the 
investigators. 1 shall inform them  immediately if 1 suffer any deterioration of any kind in my health  or 
well-being, or experience any unexpected or unusual symptoms.
1 agree to the investigators contacting my general practitioner about my participation in  the study, and 1 
authorise my GP to disclose details of my relevant medical or drug history, in confidence.
1 consent to my personal data, as outlined in  the accompanying information sheet, being used for the 
research project detailed in  the information sheet, and agree th a t data collected may be shared w ith other 
researchers or interested parties. 1 understand th a t all personal data relating to volunteers is held and 
processed in  the strictest confidence, and in  accordance with the D ata Protection Act (1998).
1 understand th a t I am free to withdraw from the study a t any time without needing to justify my decision 
and w ithout prejudice.
1 acknowledge th a t my participation in  the project as a whole is voluntary.
1 understand th a t in  the event of my suffering a  significant and enduring injury (including illness or 
disease) as a  direct result of my participation in  the study, compensation will be paid to me by the 
University (or sponsor where a clinical trial is  sponsored b y  a pharmaceutical company), subject to certain 
provisos and Hmitations. The am ount of compensation will be appropriate to the nature, severity and 
persistence of the injury and will, in  general term s, be consistent with the am ount of damages commonly 
awarded for sim ilar injury by an  English court in  cases where the liability has been adm itted
1 confirm th a t 1 have read and understood the above and freely consent to participating in  th is study. 1 
have been given adequate time to consider my participation and agree to comply w ith the instructions and 
restrictions of the study.
Name of volunteer (BLOCK CAPITALS)
Signed
Date
Name of researcher/person taking consent (BLOCK CAPITALS)
Signed
Date
ID Number
We would be grateful if you would answer the following questions. Thank you for your time
1. What is your date o f birth?__________
2. What is your ethnicity
□White Caucasian □ Indian DPakistani nBangladeshi nSri Lanka
□Chinese □Middle Eastern □Other (please describe)__________
3. How long have you lived in England?______
4. Have you EVER been told by a doctor, nurse, or other health professional that you are in the 
menopause period? □Yes □No
5. Have you had the end o f your last menstrual? □Yes □ N o
6. When did you have the last menstrual cycle?____________
7. How old were you when your first menstrual period started
8. Have you ever had skin cancer? □Yes □ No
9. Do you know if  you have risk o f skin cancer? □Yes □ No
S o m e  o f  t h e  r i s k  f a c t o r  o f  s k i n  c a n c e r  l i k e  h i s t o r y  o f  e x c e s s i v e  e x p o s u r e  t o  u l t r a v i o l e t  r a d i a t i o n  U V  ( m a i n l y  t h e  s u n ) ,  
e x c e s s i v e  e x p o s u r e  t o  c h e m i c a l s ,  p r e v i o u s  r a d i o t h e r a p y  t r e a t m e n t  a n d  f a m i l y  h i s t o r y  o f  s k i n  c a n c e r .
10. Within the past 6 month, have you had a sunbed tanning, excessive exposure to sun, or/and 
holiday in sunny country such as India, Turkey, Iran, and Pakistan (at latitudes below 45)?
□Yes □No
11. Do you take any prescribed medication?
Please list_________________________________________________ ___________
12. Do you take hormone replacement therapy HRT? □Yes □No
13. Do you take dietary supplements (vitamin/minerals tablets, cod liver oil, fish oil, herbal or other 
‘natural medicine’? □Yes □No
14. Do you take any vitamin D supplements? □Yes □No
If you answer ‘Yes’ in question 13 or 14, please answer question 15 otherwise go to question 16
Name o f the product Frequency (dose/day or week) Since when?
16. Have you ever had your vitamin D status measured? oY es d N o  
If yes do you remember what it was?______
17. Do you know if  you have vitamin D deficiency? oY es oNo
Please tick any of the following which apply:
□ I would like to know my vitamin D status at the end o f the study
□ I am interested in the study and would like to receive a summary o f the result information at the 
end
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EC TYPE-EXAMINATION CERTIFICATE: 1926
Product description: -
Product identification: -
Manufacturer: -
Solaria Protective Eyewear 
Disposable for Indoor Use
WINK EASE
Eye Pro inc.
10H 9 pri^water Road 
Suite 100 
Fort Wayne 
Indiana 46845 
USA.
When assessed and examined % a i i^  R technical specification based on 
EN166:2001 and EN170:2002 is found ^  be in conformity with 
Council Directive 89/686/EEC and associated amendments, relating to 
personal protective equipment
Authorised EU Representative: - John Cracknell
IBIS Integrated Bindery Systems Ltd. 
High Wycombe 
HP12 3PY 
United Kingdom
Signed * Date: 24 th April 2009
K J Warren, Manager, Certification Services
For and on behalf oflNSPEC International Ltd.
(Notified Body No: 0194)
For terms and conditions o f  issue, see page 2
certificate Invalid 
if not embossed
EC Certificate: 1926 Page 1 o f3 Revision: 090424
Terms and Conditions
Reference Documents: -
i) Test Reports -IN S P E C 06.ll.il
ii) Technical File - Reference INSPEC TF 1615
iii) Test and Inspection Plan - Eye Pro Inc.
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Instruction M anual for LGMS/MS Analysis
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25-OH-Vitamin D3/D 2 
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CHROMSYSTEMS
Vitamin D, (animais and human)
7-Dehydro-
cholesterol
Cholecalciferol (Vitamin D3] 
(inactive)
UV irradiation
(ring decomposition)
HO' Liver
(Hydroxylation)HO''
H( np
25-OH-Cholecalciferol
(2 5 -OH-D3}1,25-Dihydroxy- 
cholecalciferol 
(active) |
Kidney
Main metabolite in 
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HO OH HO
Vitamin Dg (plants and fungi)
Ergosterol
UV irradiation
(ring decomposition) Ergocalciferol (Vitamin Dg)
HO'
HO
Metobolisation 
analogous to Vitamin Dg
Figure 1 : Biosynthesis und metabolism of vitamin D
Principle of the reagent kit:
This Chromsystems reagent kit allows for the specific analysis of 25-OH-vitamin Da and 25-OH-vitamin D2 in 
serum and plasma by LC-tandem mass spectrometry. Manual sample preparation is limited to simple and 
effective protein precipitation. A trap column concentrates the analytes and separates interfering 
substances. A two position six-port valve connects the trap column to an HPLC column where the 
chromatographic separation takes place. The use of atmospheric pressure chemical ionisation (APCI) and a 
deuterated internal standard assures precision and robustness and minimises ion suppression effects.
P a g o  5  IM 62000 25-OH-vitamin D3/D2 E Mai 2011 R3
CHROMSYSTEMS
3 LGMS/MS-System
Caution: When using the reagents, please note the recommended hazard information in annex II.
The analysis of 25-OH-vitamin D3/D 2 in serum/plasma requires an HPLC pump system, an autosampler, a 
software-controlled valve, and a tandem mass spectrometer (triple quadrupole instrument} with sufficient 
sensitivity. The mobile phases should be kept capped, even during use. Use Rinsing Solution (order no. 
62009) for the autosampler. The prepared samples are purified using a trap column (order no. 62110). 
Subsequently, the analytes are separated on an analytical column (order no. 62100).
Two possible HPLC configurations are described below which differ in the respective solvent delivery 
systems and valves. The configuration using two isocratic HPLC pumps (see chapter 3.1) is virtually 
independent of void volume. The use of a binary gradient HPLC system (see chapter 3,2) will show 
variation in retention times due to different void volumes. Extension of the run time may be necessary if the 
void volume is high.
3.1 HPLC param eters using two isocratic HPLC pumps
These HPLC param eters are  tested with mass spectrometers from AB Sciex and Thermo Scientific. Two 
isocratic pumps and a  2-po5ition-6-port-valve are necessary.
Instrument settings; 
Injection volume:
Run time:
Column temperature;
1 0 -5 0  pi (mass spectrometer dependent) 
5 .0  min
Ambient temperature (25 ®C)
Needle rinsing solution for the injector: Rinsing Solution (order no. 62009)
Flow gradient:
Time 
1 [min.]
Mobile Phase A* Time 
Flow rate [mi/min] | [min.]
Mobile Phase B 
Flow rate [ml/min]
0.00 1.00 0 .00 0.60
1.00 1.00 2 .60 0.60
1.01 0.02 2.61 1.00
3.00 0 .02  4 .98 1.00
3.01
* Option:
1.00 4 .99
Mobile phase A con be pumped constantly at a  
Increased in this case.
0.60
low rate of 1.0 ml/min. The consumption is
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Skin type questionnaire
The purpose of this questionnaire is to identify skin type and skin reactivity to sun 
and UV. Question 4 and 5 might be interviewed because sunburning has different 
meaning to different persons and can only be correctly elicited by personal 
interview,
1. W hat is your skin colour?
a. Very light: pale white or freckled
b. Fair: white
c. White to light brown
d. Olive: moderate brown
e. Brown: dark brown
f. Black: very dark brown to black
2. W hat is your hair colour?
a. Blond
b. Red
c. Brown
d. Black
3. W hat is your eye colour?
a. Blue
b. Hazel
c. Green
d. Brown
e. Black
4. W hat is your initial response to sun exposure after 45 to 60 minutes of noon 
exposure in northern latitudes (20° to 45) in early summer?
a. Always bum
b. Usually bum
c. Sometimes mild bum
d. Rarely bum
5. W hat is your initial response to sun exposure after 15 to 25 minutes of noon 
exposure in northern latitudes (20° to 45) in early summer?
a. Never tan
b. Tan less than average (with difficulty)
c. Tan about average
d. Tan more than average (with ease)
6. How much o f a tan would you develop after a w eek if  you have same exposure in 
question 5?
a. I will have a painful bum after 24 hours and no tan at seven days
b. No bum after 24 hours and a good tan after seven days
c. A  painful bum after 24 hours and light tan after seven days
d. A  slightly tender bum after 24 hours and a moderate tan after seven days
7. I f  you get sunburnt, how painful is your sunburn after 24 hours? (please cheek  
all that apply)
a. Pinkness
b. redness
c. Skin feels warm or hot to the touch
d. Pain or tenderness
e. Swelling
f. Small fluid-filled blisters, which may break
g. Headache, fever and fatigue if  sunburn covers a large area
h. Discomfort
i. Have never been sunburnt
ID number
1) Please choose th e  closest colour to  th e  skin on the  top of your hand area from either the 
fair, medium or dark colour group
Fair colour group Medium colour group
W m â
-r: I *
. i '
Î I
1
Dark colour group
i)Wi
I'.I
in
ID number
1. Please chose the  closest colour to  your top  hand area from group fair, medium or dark 
colour
Fair colour group Medium colour group
#
I % i l '
» ;
Dark colour group
Dm ■  m
2. Have you noticed any skin colour changes after the last sunbed session?
a. Not at all
b. Lightly tanned, hardly notice it
c. Lightly tanned, easily notice it
d. Medium tanned
e. Very much tanned
f. Excessively tanned
3. Have you noticed any redness on your skin?
a. Lightly
b. Medium
c. Heavily
d. Erythematic; redness with pain
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1. Oral presentation in the IGF Regionals -  2nd Middle East & Africa Osteoporosis Meeting & 
6th Pan Arab Osteoporosis Congress PAOC’6 was held in Jordan on September 27 -  
October 1,2012: Differences in vitamin D production in Caucasian and Asian women 
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Group, University o f Manchester. M13 9WL.S
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M anchester. M l 3 9W L.
4. Poster presentation in 15* Vitamin D workshop. Houston, Texas from 19-22 Jun2 2012: 
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McCabe^, J. Berry^, L. E. Rhodes"^, N. Spyrou^ A. Alfuraih^’ ,^ S. Lanham-New\ ^Nutrition 
and Metabolism Department, Faculty o f Health and Medical Sciences, University o f Surrey 
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Department o f Medicine, University of Manchester M l 3 9WL; "^Experimental 
Dermatological Sciences, University o f Manchester M6 8HD. ^Department o f Physics, 
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O. Hakim % A. Darling^ K. H art\ J. Berry^ and S. Lanham-New\
^Nutritional Sciences Division, Faculty of Health and Medical Sciences, University o f 
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UVR exposure. O. Hakim*, K. Hart*, P. McCabe^, J. Berry^’L. E. Rhodes"*, N. 
Spyrou^, A. Alfuraih^’ ,^ S. Lanham-New* *Nutritional Sciences Division, Faculty o f 
Health and Medical Sciences, University o f Surrey; ^Clinical Research Centre, 
University o f Surrey; ^Vitamin D Research Group, Department o f Medicine, 
University o f Manchester; "*Experimental Dermatological Sciences, University o f 
Manchester. ^Department of Physics, University o f Surrey; ^Department o f 
Radiology Sciences, King Saud University.
7. Poster presentation in European Congress on Osteoporosis & Osteoarthritis (lOF- 
ECCE012), Palais des Congrès de Bordeaux, France, March 21-24,2012: Volumetric bone 
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asian and Caucasian women.O. Hakim*, A. Darling*, K. Hart*, J. Berry^ and S. Lanham- 
New*.
*Nutritional Sciences Division, Faculty o f Health and Medical Sciences, University o f 
Surrey, Guildford; ^Vitamin D Research Group, Department o f Medicine, University o f 
Manchester.
8. Poster presentation in 1st lOF Middle East and Africa Osteoporosis Meeting, Dubai, UAE 
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radius and tibia in premenopausal Caucasian and Asian women
O. Hakim*, A. Darling*, K. Hart*, J. Berry^ and S. Lanham-New*.
*Nutritional Sciences Division, Faculty o f Health and Medical Sciences, University o f 
Surrey, Guildford; ^Vitamin D Research Group, Department o f Medicine, University o f 
Manchester.
9. Poster presentation in Festival o f Research July 5* 2011, University o f Surrey
Differences in volumetric bone mineral density (vBMD) at the radius and tibia in 
premenopausal Caucasian and Asian women
O. Hakim*. A. Darling*, K. Hart*, J. Berry^ and S. Lanham-New* *Faculty o f Health and 
Medical Sciences, ^Postgraduate Medical School, University o f Surrey, Guildford.
10. Poster presentation in 2011 joint meeting o f the Bone research Society & the British 
Orthopaedic Research Society. 27-29 June 2011, Cambridge, UK: Vitamin D deficiency 
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Hakim. F Shojaee-Moradie, K Hart, JL Berry, R Eastell, F Gossiel, R Hannon, AM 
Umpleby, BA Griffin and SA Lanham-New
11. Poster presentation Athens Greece 7-11 May 2011 :Evidence of a link between poor bone 
health, low vitamin D status and CVD risk in Caucasian and Asian women
O A . HAKIM*. F. SHOJAEE-MORADIE^ K. HART*, J.L. BERRY \ R. EASTELL"*, F. 
GOSSIEL"*, R. HANNON"*, A.M. UMPLEBY^ B.A. GRIFFIN* AND S.A. LANHAM- 
NEW* ^Faculty o f  Health and Medical Sciences, Postgraduate Medical School, University 
o f  Surrey, Guildford. ^Vitamin D Research Group, University o f  Manchester. "*Department 
o f Human Metabolism, University o f Sheffield
12. Poster presentation Athens Greece 7-11 May 2011 : Differences in volumetric bone 
mineral density (vBMD) at the radius and tibia in premenopausal Caucasian and Asian 
women
O. Hakim*, A. Darling*, K. Hart*, J. Berry^ and S. Lanham-New*.
*Nutritional Sciences Division, Faculty o f Health and Medical Sciences, University o f 
Surrey, Guildford; ^Vitamin D Research Group, Department o f Medicine, University o f 
Manchester.
13. Oral presentation to the 2011 Irish Section meeting Cork, Islands
Vitamin D deficiency, poor bone health and the risk of cardiovascular disease in 
Caucasian and South Asian women
O.A. HAKIM*, F. SHOJAEE-MORADIE^ K. HART*, J.L. BERRY^ R. EASTELL"*, F. 
GOSSIEL"*, R. HANNON"*, A.M. UMPLEBY^ B.A. GRIFFIN* AND S.A. LANHAM- 
NEW* ^Faculty o f  Health and Medical Sciences, Postgraduate Medical School, University 
o f  Surrey, Guildford. ^Vitamin D Research Group, University o f  Manchester. "*Department 
of Human Metabolism, University o f Sheffield
14. Poster presentation in Osteoporosis Conference, National Osteoporosis Society, Liverpool. 
Poorer lipid Profile are Associated with Increased Bone Resorption and Parathyroid 
Hormone: Preliminary Results of the D-FINES Study (Date 28 N ovem ber-1 December 
2010)
O.A. HAKIM*, F. SHOJAEE-MORADIE^ R. EASTELL^ F. GOSSIEL^ R. HANNON^
K. HART*, L.M. MORGAN*, J.L. BERRY"*, A.M. UMPLEBY^ B.A. GRIFFIN* AND
S.A. LANHAM-NEW* *Faculty o f Health and Medical Sciences, University o f Surrey, 
Guildford GU2 7XH. ^Postgraduate Medical School, University o f Surrey, Guildford GU2 
7XH. ^University o f Sheffield, Sheffield. "*Vitamin D Research Group, University o f 
Manchester M13 9WL.
15. POSTER AWARD: PREMIER POSTER. Poster presentation in Osteoporosis 
Conference, National Osteoporosis Society, Liverpool. Evidence of a link between 
osteoporosis risk and CVD in Caucasian but not Asian women : Results of the D- 
FINES study (Date 28 Novem ber-1 December 2010)
O.A. HAKIM*. F. SHOJAEE-MORADIE^ K. HART*, J.L. BERRY^ R. EASTELL"*, F. 
GOSSIEL"*, R. HANNON"*, A.M. UMPLEBY^ B.A. GRIFFIN* AND S.A. LANHAM- 
NEW* ^Faculty o f  Health and Medical Sciences, Postgraduate Medical School, University 
o f  Surrey, Guildford. ^Vitamin D Research Group, University o f  Manchester. "*Department 
o f Human Metabolism, University o f Sheffield
16. Poster presentation Cardiovascular research Symposium, University o f Surrey: Poorer 
Lipids Profiles are associated with Increased Bone Resorption and Parathroid 
Hormone: Preliminary Results of the D-FIENS Study (2-3 September 2010)
O.A. HAKIM*, F. SHOJAEE-MORADIE^ R. EASTELL^ F. GOSSIEL^ R. HANNON^
K. HART*, L.M. MORGAN*, J.L. BERRY"*, A.M. UMPLEBY^ B.A. GRIFFIN* AND
S.A. LANHAM-NEW* *Faculty o f Health and Medical Sciences, University o f Surrey, 
Guildford GU2 7XH. ^Postgraduate Medical School, University o f Surrey, Guildford GU2 
7XH. ^University of Sheffield, Sheffield. "*Vitamin D Research Group, University of 
Manchester M l3 9WL.
17. Oral presentation, 2"^ * Cardiovascular research Symposium, University o f Surrey: 
Suboptimal levels of 25(OH)D are associated with poorer indices of cardiovascular 
health: further analysis of D-FINES study (2-3 September 2010)
18. Poster presentation. Faculty o f Health and Medical Sciences Festival of Research, University 
o f surrey: Poor bone health and increased cardiovascular disease risk: evidence of a 
link in the d-fines study population 6th July 2010
19. Oral presentation. Nutrition Society- Edinburgh: Suboptimal levels of 25(OH)D are 
associated with poorer indices of cardiovascular health: further analysis of D-FINES 
study (Date 28 june-1 July 2010)
O.A. HAKIMl. A.L. DARLINGl, S. STARKEYl, M.C.Y. W ONGl, W. FOSTERl, F. 
SH0JAEE-M0RADIE2, K. HARTl, L.M. MORGANl, J.L. BERRY3, A.M.
UMPLEBY2, B.A. GRIFFINl AND S.A. LANHAM-NEWl IFaculty o f  Health and  
Medical Sciences, University o f  Surrey, Guildford GU2 7XH 2Postgraduate Medical 
School, University o f  Surrey, Guildford GU2 7XH. 3 Vitamin D Research Group, University 
o f  Manchester. M13 9WL.
20. Poster presentation IGF World Congress on Osteoporosis & Tenth European Congress on 
Clinical and Economic Aspect of Osteoporosis and osteoarthritis, Florence, Italy: Poor 
Bone Health and Increased Cardiovascular Disease Risk: Evidence of a Link in the D- 
FINES Study population (5-8 May 2010)
O.A. HAKIMl. A.L. DARLINGl, S. STARKEYl, M.C.Y. W ONGl, W. FOSTERl, F. 
SH0JAEE-M0RADIE2, K. HARTl, L.M. M ORGANl, J.L. BERRY3, A.M.
UMPLEBY2, B.A. GRIFFINl AND S.A. LANHAM-NEWl IFaculty o f  Health and  
Medical Sciences, University o f  Surrey, Guildford GU2 7XH. 2Postgraduate Medical 
School, University o f  Surrey, Guildford GU2 7XH. 3 Vitamin D Research Group, University 
o f  Manchester. M13 9WL.
21. Poster presentation in 14* Vitamin D workshop, Bruges Belgium: Evidence of a 
detrimental Effect of Low Vitamin D Status on Markers of Cardiovascular Health in 
the D-FINES Study Population: Ethnic Influences (Date 4-8 Oct 2009).
O.A. HAKIMl. A.L. DARLINGl, S. STARKEYl, M.C.Y. W ONGl, W. FOSTERl, F. 
SH0JAEE-M0RADIE2, K. HARTl, L.M. M ORGANl, J.L. BERRY3, A.M. UMPLEBY2, 
B.A. GRIFFINl AND S.A. LANHAM-NEWl IFaculty o f  Health and Medical Sciences, 
University o f  Surrey, Guildford GU2 7XH. 2Postgraduate Medical School, University o f  
Surrey, Guildford GU2 7XH. 3 Vitamin D Research Group, University o f  Manchester. M l 3 
9WL.
22. Oral presentation. Nutrition Society Summer meeting, university of Surrey: Evidence of 
detrimental Effect of low Vitamin D Status on markers of cardiovascular Health in the 
D-FINES study Population: Ethic Influences (Date 30-7-2009)
23. Poster presentation, Festival of Research; University of Surrey: Evidence of a detrimental 
Effect of Low Vitamin D Status on Markers of Cardiovascular health in the D-FINES 
Study Population: ethnic Influence. (Date 09-06-2009)
1. & 6b. Differences in vitamin D status in Caucasian and Asian women following UVR 
exposure
O. Hakim*, K. Hart*, P. McCabe^, J. Berry^’L. E. Rhodes"*, N. Spyrou^ A. Alfuraih^' S. Lanham- 
New*
*Nutritional Sciences Division, Faculty o f Health and Medical Sciences, University o f Surrey; 
^Clinical Research Center, University o f Surrey; ^Vitamin D Research Group, Department of 
Medicine, University o f Manchester; "*Experimental Dermatological Sciences, University o f 
Manchester. ^Department of Physics, University o f Surrey; ^Department of Radiology Sciences,
King Saud University.
It is known that skin pigmentation reduces the penetration o f UVR and thus photosynthesis o f 
25(OH)D. However the ethnic differences in 25(OH)D production remain to be fully elucidated. 
This study aimed to investigate the differences in vitamin D production between Asian and 
Caucasian postmenopausal women, in response to a defined, controlled UVB exposure. Seventeen 
women; 9 white Caucasian(skin phototype II and III), 8 South Asian women (skin phototype IV and 
V) participated in the study, acting as their own controls. Three blood samples were taken for 
measurement o f 25(OH)D during the run in period (9 days, no sunbed exposure) after which all 
subjects underwent an identical UVR exposure protocol irrespective of skin colour (9 days, 3 sun 
bed sessions, 6, 8 and 8 minutes respectively with approximately 80% body surface exposed) . Skin 
tone was measured four times during the study.
Both groups showed a gradual increase in 25(OH)D with final levels significantly higher than 
baseline (p<0.01). 25(OH)D concentration mean rose from a baseline of 43.58(19.65) to 
57.80(17.11) nmol/1 among Caucasian and from 27.03(23.92) to 44.73(17.74) nmol/1 among Asian 
women. The baseline status o f vitamin D was classified as deficient among the Asian women and 
insufficient among the Caucasian women. The percentage increase in vitamin Dg among Caucasians 
was 39.86% (21.02) and 207.78% (286.02) in Asian subjects respectively. This greater response to 
UVR exposure reflects the lower baseline levels o f the Asian subjects. Mixed linear model analysis 
identified a significant effect of duration of UVR exposure on the production o f 25(OH)D.
However, the model shows no significant effect o f ethnicity and skin tone on the production o f 
25(OH)D.
These novel findings indicate that people of Asian ethnicity have the full capability to produce 
similar amount o f vitamin D compared to Caucasian group; initial vitamin D concentration 
influences the amount o f UVB needed to reach equal serum concentrations.
2. Homeostatic model assessment (HOMA) in relation to lipid profiles and vitamin D 
status in South Asian and Caucasian women: preliminary results from D-FINES. By
0 .A . Hakim \ K. Hart, ^A.L. Darling\ F. Shojaee-Moradie^ J.L. Berry^, A.M. Um pleby\ 
B.A. Griffin^ and S.A. Lanham-New^ ^Nutrition and Metabolism Department, Faculty o f  
Health and Medical Sciences, University o f Surrey, Guildford GU2 7XH. ^Vitamin D 
Research Group, University o f  Manchester. M l 3 9WL.
It is well recognised that populations with the most insulin resistance are at greater risk o f  
developing cardiovascular disease and metabolic syndrome However little is known 
about the UK-based South Asian population in comparison to their Caucasian counterparts. 
This subsidiary study is part o f the D-FINES study (Vitamin D, Food Intake, Nutrition and 
Exposure to Sunlight in Southern England). This secondary analysis aimed to quantify 
insulin resistance (IR), beta cell function(%B), and insulin sensitivity (%S) using the 
homeostatic model assessment (HOMA) in both ethnic groups and to investigate if  they 
were any associations with vitamin D status 25(OH)D and lipid profiles.
The HOMA calculator from the University o f Oxford (Diabetes Trails Unit, 2004) was used 
to estimate IR, %B and %S using fasting glucose and insulin level^^l The analysis was from 
summer 2008 and included 185 Caucasian and 52 South Asian women aged 19-70 years 
old. We have previously shown that South Asian women had a significantly lower 
25(OH)D status (p<0.001) and a significantly higher BMI than the Caucasian group
(p<0.01).
Table 1 below presents the %B, %S and IR means for both ethnic groups. South Asian were 
shown to have significantly higher beta cell function and lower insulin sensitivity (p<0.05, 
P<0.001 respectively) than the Caucasian group. South Asians were significantly more 
insulin resistant than the Caucasian group (p<0.001).
Table 1: HOM A model among Caucasian and South Asian women
_________________________ Caucasian________ Asian__________
beta cell function (%B) 103.18(33.48)* 121.02(50.68) :
insulin sensitivity (%S) 72.06(35.24)*** 54.12(25.16)
m ............................... 1.65(0:69)*** 2.29(1.42)
***p<0.001, **p<0.01, *p<0.05, all variables were not normally distributed analysed by Mann-Witney U
HOMA variables did not correlate with 25(OH)D status for either ethnic groups. However, 
beta cell function correlated positively vdth mean total cholesterol and low density 
lipoprotein (LDL) among South Asian females (p<0.001). In this group there was also a 
significant positive correlation between insulin resistance and mean triglyceride (TAG) 
(p<0.01). All correlations were adjusted for B M I .
Lack o f association between the HOMA model and 25(OH)D status among the South 
Asian populations may due to the year-long, severe vitamin D deficiency in this group. 
However the lipid correlation findings indicate that South Asian women are at high risk o f  
cardiovascular disease with respect to the lipid profile associations with the HOMA model. 
Further investigations are certainly warranted.
1. McFarlane et.al. J Clin Endocrinol Metab. 2001; 86:713-718
2. HOMA calculator. Oxford: diabetes trail unit. University o f Oxford
3 .25(OH)D CONCENTRATION AND MUSCLE FUNCTION IN PREMENOPAUSAL 
SOUTH ASIAN AND CAUCASIAN WOMEN
Introduction: It has been shown that hypovitaminosis is associated with poor muscle strength and 
performance among elderly women*. Little is known in literature about middle age women and if 
there is an ethnic difference in muscle performance.
Materials and Methods: As part of the D-FINES (Vitamin D, Food Intake, Nutrition and Exposure 
to Sunlight in Southern England) study, we aimed to determine if there was an association between 
serum 25(OH)D, and muscle function. Forty healthy premenopausal women (21 C and 19 SA), age 
ranges 18-55 yrs took part in the study. Fasted blood samples were collected for vitamin D. Muscle 
pain were assessed via a questionnaire. Grip strength and the sit-to-walk test were measured to 
reflect muscle strength and performance.
Results and Discussion: 25(OH)D status was significantly different between SA and C groups
(p<0.001)
The Table below shows the mean value of the muscle function measurements according to ethnicity
Mean fSD]
Grip strength Right hand C, n=19 24.91 [5.36]**
A, n=16 20.21 [5.03]
Grip strength Left hand C, n-19 22.32 [5.03]*
A, n=16 19.00 [5.82]
Sit to walk test (seconds) C, n=19 6.17 [0.73]
A, n=15 6.63 [0.81]
Muscle pain score C, n=21 16.00[10.84]**
A, n=15 35.46[27.15]
**p<0.01, *p<0.05; Values were analysed by t-test
There was a significant difference between grip strength mean and muscle pain score between SA 
and C groups (P<0.01), with the SA women having much lower values. There was however, no 
significant correlation between vitamin D and muscle strength variables. Inability to observe 
association between vitamin D and muscle strength in the SA women may be due to widespread 
vitamin D deficiency in this group. Further investigation of the link between vitamin D and 
musculoskeletal health in younger women is underway.
*Mastaglia et al (2011) J Nutr Health Aging 15(5):349-54
4.
DIFFERENCES IN VITAMIN D STATUS AND LIPID PROFILE IN CAUCASIAN AND ASIAN WOMEN FOLLOWING 
ULTRAVIOLET RADIATION (UVR) EXPOSURE. By 0 . Hakim \ K. HarP. F. Robertson^ P. McCabel J. Berrv^'L.
E. Rhodes'*. N. Spvrou^. A. Alfuraih^'^. S. Lanham-New\ ^Nutrition and Metabolism Department, Faculty of 
Health and Medical Sciences, University of Surrey GÜ2 7XH; ^Clinical Research Centre, University of Surrey; 
Vitam in D Research Group, Department of Medicine, University of Manchester M13 9WL; "^Experimental 
Dermatological Sciences, University of Manchester M 6 8 HD. ^Department of Physics, University of Surrey; 
^Department of Radiology, King Saud University.
It is known that skin pigmentation reduces the penetration of UVR and thus photosynthesis of 25(OH)D. 
However the ethnic differences in 25(OH)D production remain to be fully elucidated, particularly in older 
South Asian (SA) women. This study aimed to investigate the differences in vitamin D production between 
SA and Caucasian (C) postmenopausal women, in response to a defined, controlled UVR exposure. 
Seventeen women; 9 white C (skin phototype II and III) and 8 SA women (skin phototype IV and V) 
participated, acting as their own controls. Three blood samples were taken for measurement of 25{OH)D 
during the run in period (9 days, no sunbed exposure) after which all subjects underwent an identical UVR 
exposure protocol, irrespective of skin colour (9 days, 3 sun bed sessions, 6, 8 and 8 minutes respectively 
with 80% body surface exposed). Lipid profiles were analyzed at baseline and at the end of the study and 
skin tone was measured at 4 timepoints. Both groups showed a gradual increase in 25{OH)D with final levels 
significantly higher than baseline (p<0.01). Mean 25(OH)D concentration rose from a baseline of 
43.58(19.65) to 57.80(17.11)nmol/l among C and from 27.03(23.92) to 44.73(17.74)nmol/l among SA 
women. The percentage increase in vitamin D3 among C and SA was 39.86(21.02)% and 207.78(286.02)%  
respectively. This greater response to UVR exposure in the SA subjects reflects their lower baseline levels.
5. Volumetric bone mineral density (vBMD) at tibia site and vitamin D status in
premenopausal South Asian and Caucasian women
O. Hakim*, A. Darling*, K. Hart*, J. Berry  ^and S. Lanham-New*.
*Nutritional Sciences Division, Faculty of Health and Medical Sciences, University of Surrey, 
Guildford; Vitamin D Research Group, Department of Medicine, University of Manchester.
Recent studies indicate that women of European origin have higher areal bone mineral density 
(BMD) than South Asian women. However this has been explained by ethnic variation in bone 
size*. Few data exist on true volumetric BMD in premenopausal South Asian women and no data is 
available at the tibia site. As part of the D-FINES (Vitamin D, Food Intake, Nutrition and 
Exposure to Sunlight in Southern England) study, which investigates the interaction between diet 
and sunlight exposure and vitamin D status, we aimed to investigate differences in volumetric bone 
mineral density (vBMD) between South Asian (SA) and Caucasian (C) women at the tibia and 
determine if there is an association between vBMD and serum 25(OH)D. Thirty five healthy 
premenopausal women (21 C and 14 SA), age ranges 18-55 yrs, were scanned by peripheral 
Quantitative Computed Tomography (pQCT) at the tibia (non-dominant) using a Stratec XCT 2000 
pQCT machine. Fasted blood samples were collected for vitamin D analysis.
SA women were significantly shorter (p<0.001), and slightly heavier than C women; Therefore SA 
had significantly higher BMI (p<0.05) than C women. SA women had significantly lower 25(OH)D 
concentration than C women (p<0.001) with mean values of 31.53[16.32] and 80.91 [20.08] (nmol/1) 
respectively.
SA women had significantly smaller bone size and higher vBMD than C women (p<0.05) for total, 
trabecular, and cortical bone at the 4% site. SA women had significantly lower total vBMD at 14% 
site (p<0.05) and the 38% site (p<0.01) than Caucasians. SA had significantly lower cortical density 
at site 14% than Caucasians (p<0.05).This was also lower at the 38% site but this was not 
statistically significant. There was a trend for a negative association between 25(OH)D and total 
area, trabecular area, and cortical area at the 4% site in the Asian group only (p=0.06). There was 
no correlation between 25(OH)D and vBMD at any site in either ethnic group. Our finding of 
differences in vBMD at the tibia for SA and C premenopausal women is novel and now requires 
further investigation.
1 Roy et al (2005) Osteoporosis Int41: 117-121
6a. BONE PAIN, 25(GH)D CONCENTRATION, VOLUMETRIC BONE MINERAL 
DENSITY (VBMD) AT RADIUS AND TIBIA SITES IN PREMENOPAUSAL SOUTH 
ASIAN AND CAUCASIAN WOMEN
O. Hakim*, A. Darling*, S. Lanham-New*, J. Berry  ^and K. Hart*.
*Nutrition and Metabolism Department,, Faculty of Health and Medical Sciences, University of 
Surrey, Guildford; ^Vitamin D Research Group, Department of Medicine, University of 
Manchester.
Little data are available on the extent of bone pain in South Asian populations, particularly in 
women of child-bearing age. Findings from an earlier study in older women suggested wide spread 
bone pain among the Asian population * whilst Macfarlane et al., (2005) reported that low vitamin 
D levels were more common among those with widespread pain .^
As part of the D-FINES (Vitamin D, Food Intake, Nutrition and Exposure to Sunlight in Southern 
England) study, we aimed to determine if there was an association between bone pain, serum 
25(OH)D, and volumetric bone mineral density (vBMD) at radial and tibial sites. Forty healthy pre­
menopausal women (21 Caucasian (C) and 19 South Asian (SA)), aged between 18 and 55 yrs took 
part in the study. Fasted blood samples were collected for vitamin D, bone pain was assessed via a 
questionnaire and sit-to-walk test and subjects were scanned by peripheral Quantitative Computed 
Tomography (pQCT) at the radius and tibia (non-dominant) using a Stratec XCT 2000 pQCT 
machine.
SA had significantly higher BMI (p<0.05) than G women, with a mean BMI of 24.5[SD3.9)kg/m^ 
and 27.9[5.5]kg/m^ respectively. 25(OH)D concentration was significantly lower among SA women 
than C women (p<0.001) (mean 25(OH)D 31.53 [16.32] and 80.91 [20.08]nmol/l respectively). Bone 
pain and back pain scores were significantly higher in SA subjects than Caucasian (p<0.05). There 
was no significant difference in sit-to-walk test results between ethnic groups. Bone pain correlated 
positively with total bone area at the 66% radius site and with bone mass at the 14% tibia 
site(p<0.05) in the Asian group after adjustment for weight and height. A trend towards a negative 
correlation between back pain and vitamin D status (p=0.10) was observed, but no associations 
were identified between bone pain and vitamin D in either specific ethnic group.
The current study confirms that bone pain and back pain are prevalent amongst premenopausal 
Asian women. Any association between bone pain and vitamin D concentrations may have been 
masked by the consistently low vitamin D levels within the Asian sub-group and so further 
investigations in a larger sample is warranted.
*Allisson et al. Ann Rheum Dis, 2002
 ^Macfarlane et al. Ann Rheum Dis 2005
7. VOLUMETRIC BONE MINERAL DENSITY (VBMD) AT RADIUS SITE AND 
VITAMIN D STATUS IN PREMENOPAUSAL SOUTH ASIAN AND CAUCASIAN 
WOMEN
O. Hakim*, A. Darling*, K. Hart*, J. Berry  ^and S. Lanham-New*.
*Nutritional Sciences Division, Faculty of Health and Medical Sciences, University of Surrey, 
Guildford; Vitamin D Research Group, Department of Medicine, University of Manchester.
Recent studies indicate that women of European origin have higher areal bone mineral density 
(BMD) than South Asian women. However this has been explained by ethnic variation in 
differences in bone size*. Few data exist on true volumetric BMD in premenopausal South Asian at 
the radius site. As part of the D-FINES (Vitamin D, Food Intake, Nutrition and Exposure to 
Sunlight in Southern England) study, we aimed to investigate differences in trabecular and cortical 
volumetric bone mineral density (vBMD) between Caucasian (C) and South Asian (SA) women at 
the radius site and determine if it associate with serum 25(OH)D.
SA had significantly higher BMI (p<0.05) than C women. SA women had significantly lower 
vitamin D status than C women (p<0.001) with mean values of 31.53[16.32] and 80.91 [20.08] 
(nmol/1) respectively.
pQCT variables measured at 4% distal radius in SA and C women
Ethnicity Mean[SD] 
SA n=14
Mean[SD]
Cn=19
‘ Total area (mm^) 340.95[37.00]** 374.81[43.29]
Total Density mg/cm^) 312.14[45.61] 315.66[45.35]
: Tubercular area (mm^) " T53.30[16.62]** 168.51[19.46]
Tubercular Density 
(mg/cm^)
175.40[37.21] 178.98[35.54]
Cortical Sub Area (mm^) 187.64[20.38]** 206.30[2L83]
Cortical Sub Density 
(mg/cm^)
^ ^ L 8 ^ 2 .4 9 ] 427.32[60.03]
All data were at 4% site;*p<0.05, **p<0.01 
Values were analysed by t-test analysis
At the 4% radius site, SA has significant lower mean value for total area, trabecular area, and 
cortical sub area than C women (P<0.01). SA group has slightly lower mean for total bone density, 
trabecular density and cortical sub density than C but differences were not significant. Total bone 
area is significantly negatively correlated with 25(OH)D among SA group but not with C(p<0.001). 
SA women tend to has lower bone size at 4% distal radius than C women but no association exist 
with bone density.
1 Roy et al (2005) Osteoporosis Int 41: 117-121
8. Vitamin D status and volumetric bone mineral density (vBMD) at tbe radius and tibia in
premenopausal Caucasian and Asian women
O. Hakim*, A. Darling*, K. Hart*, J. Berry  ^and S. Lanham-New*.
*Nutritional Sciences Division, Faculty of Health and Medical Sciences, University of Surrey, 
Guildford; Vitamin D Research Group, Department of Medicine, University of Manchester.
Current studies indicate that women of European origin have higher bone mineral density (BMD) 
than Far-East Asian women but few data exist on South Asian women. Roy et al (2005) explained 
differences in BMD between Caucasian and Asian women by differences in bone size*. Current data 
from our group show extensive vitamin D deficiency amongst UK population, particularly Asian 
women .^ As part of the D-FE<fES (Vitamin D, Food Intake, Nutrition and Exposure to Sunlight in 
Southern England), which is longitudinal study investigating the interaction between diet and 
sunlight exposure on vitamin D status, we now aim to investigate differences between volumetric 
bone mineral density (vBMD) between Caucasian (C) and Asian (A) women. Forty healthy 
premenopausal women (21 C and 19 A), age ranges 18-55 yrs, were studied. Peripheral Quantitative 
Computed Tomography (pQCT) measurements were taken at the radius and tibia (non-dominant) 
using a Stratec XCT 2000 pQCT scanner. Blood samples have been collected for vitamin D 
analysis.
Caucasian were slightly lighter and taller than Asian women, with an average BMI of 24.9 (4.12) 
and 27.7(5.8) respectively. The table below shows the results of vBMD at 4% and 66% radius; 4%, 
14%, and 38% tibia in C and A women. Asian women had significantly higher total density and 
trabecular density at 4% tibia than C women; but they had significantly lower cortical density at 
14% and 38% tibia sites. Asian women had also significant lower total area and trabecular area 
(p<0.05) at 4% tibia site. There were no significant differences in vBMD between C and A in radius 
sites. However, at the 4% radius, Asian had significantly lower bone mass (p<0.05), total area 
(p<0.01) and trabecular area (p<0.01) than the Caucasian women. Further analysis is on-going 
examining vitamin D status; with the expectation of ethnic differences in vitamin D status as 
observed earlier in this study in 2006  ^and concomitant vitamin D/BMD examinations. Our finding 
supports the results of Ward et al (2007) where there was no difference in vBMD at the radius 
between A and C women"*. Our novel findings for differences in the tibia sites for A and C women 
require further investigations as there are no data examining this bone site in ethnic groups.
References:
1 Roy et. al. Osteoporosis Int. 2007; 41: 117-121 
2. Hakim et al Proc Nutr Soc 2011 (in press)
3 Macdonald et. Al. Osteoporos Int. 2011 (in press)
4 Ward et. al. Bone. 2005; 16; 1254-1262
9. Differences in volumetric bone density at the radius and tibia in premenopausal Caucasian
and Asian women
O. Hakim, A. Darling, K. Hart, S. Lanham-New, Nutritional Sciences Division. Faculty of Health 
and Medical Sciences. University of Surrey.
Current studies indicate that women of European origin have higher bone mineral density (BMD) 
than Far-East Asian women but few data exist on South Asian women. A current study explained 
differences in BMD density between Caucasian and Asian women by differences in bone size*. The 
aim of this study was to investigate differences between volumetric bone density (vBMD) between 
Caucasian (C) and Asian (A) women. Thirty-five healthy premenopausal women (19 C and 16 A), 
age range 18-55 years took part in the study. Peripheral Quantitative Computed Tomography 
(pQCT) measurements were taken at the radius and tibia (non-dominant) using a Stratec XCT 2000 
pQCT scanner.
Caucasian were slightly lighter and taller than Asian women with average BMI of 24.9 (4.12) and 
27.7(5.8) respectively. The table below shows the results of bone density at 4% and 66% radius; 
4%, 14%, and 38% tibia in C and A women
U .2
TOT_DEN (mg/cm3) 319.0(45.8) 313.7(44.5)
TRAB_DEN (mg/cm3) 181.8(36.6) 176.7(39.9)
TOTDEN (mg/cm3) 745.7(90.1) 774.5(87.0)
CORT_DEN (mg/cm3) 1134.7(38.0) 1125.5(39.6)
TOTDEN (mg/cm3) 304.3(34.3) 350.4(58.7)**
TRABDEN (mg/cm3) 230.2(30.9) 280.8(73.6)*
TOT_DEN (mg/cm3) 570.7(124.1) 488.7(97.1)
CORT_DEN (mg/cm3) 1133.3(25.5) 1086.1(68.2)**
TOTDEN (mg/cm3) 906.3(81.9) 852.1(91.8)
111 CORTDEN (mg/cm3) 1182.7(19.3) 1153.3(57.2)*
*p<0.05, **p<0.01 for 2 sample Mest. Data expressed as the mean (SD); Abbreviations: TOT_DEN, total density; TRAB_DEN, 
trabecular density; TOT_A, total area; TRAB_A, trabecular area; CORT_DEN, cortical density; CORT_A, cortical area.
Table above shows that A women had significantly higher total density and trabecular density at 4% 
tibia than C women; but they had significantly lower cortical density at 14% and 38% tibia sites. 
Asian women had also significant lower total area and trabecular area (p<0.05) at 4% tibia site. 
There are no significant differences in vBMD between C and A in radius sites. However, at the 4% 
radius, Asian have significant lower bone mass (p<0.05), total area (p<0.01) and trabecular area 
(p<0.01) than Caucasian. Out finding support the results of Ward et al where there is no difference 
in vBMD at the radius between A and C women. The interesting finding shows that tibia 
measurements require further investigation as no data is available.
References:
* Roy et al 2005 Osteoporosis Int.
 ^Ward et al 2007 Bone
10. Vitamin D deficiency and poor bone health are associated with CVD risk in Caucasian and 
Asian women
O.A. HAKIM*. F. SHOJAEE-MORADIE^ K. HART*, J.L. BERRY\ R. EASTELL"*, F. 
GOSSIEL"*, R. HANNON*, A.M. UMPLEBY^ B.A. GRIFFIN* AND S.A. LANHAM-NEW* 
^Faculty of Health and Medical Sciences, Postgraduate Medical School, University o f Surrey, 
Guildford. ^Vitamin D Research Group, University o f Manchester. "*Department of Human 
Metabolism, University of Sheffield,
Osteoporosis has been linked to CVD risk, suggesting that there may be an association between a 
poor serum lipid profile and increased bone resorption/lower bone mass. There are also data linking 
vitamin D ‘insufficiency’ with increased CVD. The aim of this study was to examine the 
association between bone health, low vitamin D status and CVD lipid profiles.
The D-FINES study (Vitamin D, Food Intake, Nutrition and Exposure to Sunlight in Southern 
England) was a longitudinal study that investigated the interaction between diet and sunlight 
exposure on vitamin D status. Total of 279 Caucasian (C) and 94 Asian (A) women aged 19-70 
years living in Southern England were included in the study. Fasted blood samples were collected at 
three monthly intervals from Summer 2006 to Spring 2007. Serum CTx was assessed and 
parathyroid hormone (PTH) was measured. Bone quality including broadband ultrasound 
attenuation (BUA), velocity of sound (VOS), lumbar spine (LS) BMD, and femoral neck (FN) 
BMD in Autumn 2006 and Spring of 2007 were assessed
The aim of the present subsidiary study was to examine the association between bone health (bone 
quality, bone resorption and PTH), vitamin D status, and CVD. Correlation analysis between serum 
lipid profiles (serum triglyceride (TAG), total cholesterol, high density lipoprotein (HDL), low 
density lipoprotein (LDL)) and bone health parameters and vitamin D status have been measured.
Negative correlations were apparent in most of the bone measures with lipid profiles in the C 
women but not A women. LS and FN bone density was associated negatively with cholesterol and 
LDL in both seasons. A significant negative correlation between BUA, VOS and cholesterol was 
found in Autumn only. Higher CTx was associated with higher cholesterol and LDL. A significant 
correlation was found between PTH, TAG, cholesterol, LDL consistently in both seasons. These 
correlations remained significant after adjustment for BMI and vitamin D status. Significant 
negative correlations were found between markers of CVD and 250HD status in all groups 
combined and then specifically in the C women but not A women (p<0.001).
These data indicate a link between poor bone health and increased CVD risk in Caucasian 
population. It also indicates a link between higher bone resorption and increase risk of CVD in the 
Caucasian population. The present findings are a cause for concern and warrant further 
investigation.
11. EVIDENCE OF A LINK BETW EEN POOR BONE HEALTH, LOW  VITAM IN  
D STATUS AND CVD RISK IN CAUCASIAN AND ASIAN W OM EN
0 . Hakim F. Shojaee-Moradie K. Hart \  J. Berry R. Eastell F. Gossiel R. 
Harmon M. Umpleby B. Griffin \  S.Lanham-New ^
^Nutritional Sciences Division, ^Postgraduate Medical School, University o f  Surrey, 
Guildford, ^Department o f Medicine, University o f Manchester, Manchester, "^Department 
of Human Metabolism, University o f Sheffield, Sheffield, United Kingdom
Abstract: Osteoporosis has been linked to CVD risk, suggesting that there may be an 
association between a poor serum lipid profile and increased bone resorption/lower bone 
mass. There are also data linking vitamin D ‘insufficiency’ with increased CVD. The aim 
of this study was to examine the association between bone health, low vitamin D status and 
CVD lipid profiles. The D-FFNES study (Vitamin D, Food Intake, Nutrition and Exposure 
to Sunlight in Southern England) investigated the interaction between diet and sunlight 
exposure on vitamin D status. Fasted blood sample were collected at three monthly 
intervals from Summer 2006 to Spring 2007 on a total o f 223 Caucasian (C) and 70 Asian 
(A) women aged 19-70 years living in Southern England. Serum CTx was assessed and 
parathyroid hormone (PTH) was measured. Bone quality including broadband ultrasound 
attenuation (BUA), velocity o f sound (VOS), lumbar spine (LS) BMD, and femoral neck 
(FN) BMD in Autumn 2006 and Spring o f 2007 were assessed. The aim o f  the present 
subsidiary study was to examine the association between bone health (bone quality, bone 
resorption and PTH), vitamin D status, and CVD. Correlation analysis between serum lipid 
profiles (serum triglyceride (TAG), total cholesterol, high density lipoprotein (HDL), low  
density lipoprotein (LDL)) and bone health parameters and vitamin D status have been 
measured. Negative correlations were apparent in most o f the bone measures with lipid 
profiles in the C women but not A women. LS and FN bone density was associated 
negatively with cholesterol and LDL in both seasons. A significant negative 
correlation between BUA, VOS and cholesterol was found in Autumn only. A  significant 
negative association was found between CTx and insulin level for both seasons. Higher 
CTx was associated with higher cholesterol and LDL. A significant correlation was found 
between PTH, TAG, cholesterol, LDL consistently in both seasons. These correlations 
remained significant after adjustment for BMI and vitamin D status. Significant negative 
correlations were found between markers o f CVD and 250H D  status in all groups 
combined and then specifically in the C women but not A  women (p<0.001 ).
These data indicate a link between poor bone health and increased CVD risk in Caucasian 
population. It also indicates a link between higher bone resorption and increase risk o f  
CVD in the Caucasian population. The present findings are a cause for concern and warrant 
further investigation.
12. Differences in volumetric bone mineral density (vBMD) at the radius and tibia in
premenopausal Caucasian and Asian women
O. Hakim*, A. Darling*, K. Hart*, J. Berry  ^and S. Lanham-New*.
*Nutritional Sciences Division, Faculty of Health and Medical Sciences, University of Surrey, 
Guildford; ^Vitamin D Research Group, Department of Medicine, University of Manchester.
Current studies indicate that women of European origin have higher bone mineral density (BMD) 
than Far-East Asian women but few data exist on South Asian women. Roy et al (2005) explained 
differences in BMD between Caucasian and Asian women by differences in bone size*. The aim of 
this study was to investigate differences between volumetric bone mineral density (vBMD) between 
Caucasian (C) and Asian (A) women. Thirty-five healthy premenopausal women (19 C and 16 A), 
age range 18-55 yrs, were studied.. Peripheral Quantitative Computed Tomography (pQCT) 
measurements were taken at the radius and tibia (non-dominant) using a Stratec XCT 2000 pQCT 
scanner.
Caucasian were slightly lighter and taller than Asian women, with an average BMI of 24.9 (4.12) 
and 27.7(5.8) respectively. The table below shows the results of vBMD at 4% and 66% radius; 4%, 
14%, and 38% tibia in C and A women
G s
TOT_DEN (mg/cm3) 319.0(45.8) 313.7(44.5)
TRABDEN (mg/cm3) 181.8(36.6) 176.7(39.9)
TOTDEN (mg/cm3) 745.7(90.1) 774.5(87.0)
^ î i CORTDEN (mg/cm3) 1134.7(38.0) 1125.5(39.6)
TOTDEN (mg/cm3) 304.3(34.3) 350.4(58.7)**
TRABDEN (mg/cm3) 230.2(30.9) 280.8(73.6)*
TOT_DEN (mg/cm3) 570.7(124.1) 488.7(97.1)
« i CORT_DEN (mg/cm3) 1133.3(25.5) 1086.1(68.2)**
TOT_DEN (mg/cm3) 906.3(81.9) 852.1(91.8)
I S i
CORTDEN (mg/cm3) 1182.7(19.3) 1153.3(57.2)*
*p<0.05, **p<0.01 for 2 sample Mest. Data expressed as the mean (SD); Abbreviations: TOT_DEN, total density; TRAB_DEN, 
trabecular density; TOT_A, total area; TRAB_A, trabecular area; CORT DEN, cortical density; CORT A, cortical area.
Asian women had significantly higher total density and trabecular density at 4% tibia than C 
women; but they had significantly lower cortical density at 14% and 38% tibia sites. Asian women 
had also significant lower total area and trabecular area (p<0.05) at 4% tibia site. There were no 
significant differences in vBMD between C and A in radius sites. (Not shown in the table) however, 
at the 4% radius, Asian have significant lower bone mass (p<0.05), total area (p<0.01) and 
trabecular area (p<0.01) than Caucasian. Our finding supports the results of Ward et al (2007) 
where there was no difference in vBMD at the radius between A and C women. Our novel findings 
for differences in the tibia sites for A and C women require further investigations as there are no 
data examining this bone site in ethnic groups.
1 Roy et. al. Osteoporosis Int. 2007; 41: 117-121
2 Ward et. al. Bone. 2005; 16; 1254-1262
13. Vitamin D deficiency, poor bone health and the risk of cardiovascular disease in 
Caucasian and South Asian women: analysis from the D-FINES Study
By O.A. HAKIM*, F. SHOJAEE-MORADIE^ K. HART*, J.L. BERRY\ R. EASTELL"*, F. 
GOSSIEL"*, R. HANNON"*, A.M. UMPLEBY^ B.A. GRIFFIN* AND S.A. LANHAM-NEW* 
^Faculty o f Health and Medical Sciences, Postgraduate Medical School, University of Surrey, 
Guildford. ^Vitamin D Research Group, University o f Manchester. Department of Human 
Metabolism, University o f Sheffield.
Bone health has been linked to CVD risk, suggesting that there may be an association between a 
poor serum lipid profile and increased bone resorption/lower bone mass. There are also data linking 
vitamin D ‘insufficiency’ with increased CVD. The D-FINES study (Vitamin D, Food Intake, 
Nutrition and Exposure to Sunlight in Southern England) investigated the interaction between diet 
and sunlight exposure on vitamin D status. Fasted blood sample were collected at three monthly 
intervals from Summer 2006 to Spring 2007 on a total of 223 Caucasian (C) and 70 Asian (A) 
women aged 19-70 years. Bone quality including broadband ultrasound attenuation (BUA), velocity 
of sound (VOS), lumbar spine (LS) BMD, and femoral neck (FN) BMD in Autumn 2006 and 
Spring of 2007 were assessed. The aim of the present subsidiary study was to examine the 
association between bone health (bone quality, bone resorption and PTH), vitamin D status, and 
CVD. The table below shows correlations (r) between markers of CVD and BUA, VOS, FN, and 
LS in Autumn season.
TAG
(mmol/1)
Cholesterol
(mmol/1)
LDL (mmol/1) HDL
(mmol/1)
Insulin
(mU/1)
BUA mHz
C (n=68) -0.11 -0.24* (-0.24*) -0.22 -0.17 0.19
A (n=32) 0.15 0.02 0.02 -0.05 -0.02
VOS
C (n=68) -0.19 -0.27* (-0.28*) -0.23 -0.19 -0.06
. C '  
. E A (n = 32) 0.29 0.17 0.08 0.17 0.01
1 LS gicwP
< C (n=194) -0.04 -0.21** (-0.19**) -0.21** (- -0.09 0.08
A (n=50) 0.17 -0.07 0.21**) -0.19 -0.14
-0.01
FN g/cm^
C (n=193) -0.05 -0.21** (-0.19**) -0.18* (-0.19**) -0.15* (-0.07) 0.15* (-0.02)
A  (n=50) 0.29* (0.18) 0.01 0.11 -0.28* (-0.22) 0.01
Asian
; at the 0.01 level, () partial correlation for BMI, C Caucasian, A
Negative correlations were apparent in most of the bone measures with lipid profiles in the C 
women but not A women. LS and FN bone density was associated negatively with cholesterol and 
LDL in both seasons. A significant negative correlation between BUA, VOS and cholesterol was 
found in Autumn only. A significant negative association was found between CTx and insulin level 
for both seasons. Higher CTx was associated with higher cholesterol and LDL. A significant 
correlation was found between PTH, TAG, cholesterol, LDL consistently in both seasons. These 
correlations remained significant after adjustment for BMI and vitamin D status. Significant 
negative correlations were found between markers of CVD and 250HD status in all groups 
combined and then specifically in the C women but not A women (p<0.001). These data indicate a 
link between poor bone health and increased CVD risk in Caucasian population. The present 
findings are a cause for concern and warrant further investigation.
The D-FINES Study was funded by the FSA (NO5064)
14 . P oorer lipid profiie are a sso c ia ted  w ith  in creased  b o n e  resorp tion  and parathyroid  
h orm on e: preiim inary resu lts  o f  th e  D-FINES stu d y
Early experimental studies have suggested that serum cholesterol may be a common 
pathogenic factor in the development of bone loss and osteoporosis. Only a fe w  stu d ies  
have in vestigated  th e  relation b e tw e en  lipids and b on e turnover. The D-FINES study  
(Vitamin D, Food Intake, Nutrition and Exposure to  Sunlight in Southern  England) is a 
longitudinal stud y in vestigated  th e  interaction  b e tw e en  d iet and sunlight exp osu re on  
vitam in D sta tu s. The aim o f  th e  p resen t subsidiary study w as to  exam in e th e  assoc ia tion  
b e tw e e n  serum  lipids w ith  b on e turnover and parathyroid h orm one (PTH), in A utum n  
2 0 0 6  and Spring 2 0 0 7 . C oncom itantly, w e  have also  exam in ed  th e  association  b e tw e en  
lipid profile and b on e d en sity  (Hakim e t  al 2010). Fasted b lood sam ple w ere  co llected  
from  279  Caucasian and 94  Asian w o m en  aged  1 9 -70  years living in Southern England. 
Serum  CTx w as a ssessed  using e lec troch em ilu m in escen t im m u n oassay  during A utum n  
2 0 0 6  and Spring o f  2 0 0 7  and parathyroid h orm on e (PTH) w as m easured  using th e  OCTEIA 
im m u n oen zym om etric assay (Im m unodianostic System  Ltd, Boldon, Tyne and W ear, UK). 
The tab le  b e low  sh o w s th e  correlations (r) b e tw e en  m arkers o f  CVD, CTx and PTH.
TAG (m m o i/i) C h o les tero l
(m m o l/ l)
LDL (m m o l/ l) HDL (m m o l/l) Insulin (m U /l)
1:
c
Ctx (n gm l)
C (n = 35)  
A (n = 2 8 )
-0 .1 5
-0 .0 8
0 .2 3
0 .1 5
0 .2 1
0 .0 9
0 .2 0
0 .2 3
- 5 2 * * (
0 .0 6
-0 .4 7 * * )
1
PTH
C (n = 1 8 8 )  
A (n = 5 5 )
0 .1 9 * * (0 .1 0 )
-0 .2 6 * (-0 .2 S )
0 .1 9 * * (0 .2 0 * * )
0 .0 0 1
0 .2 3 * * (0 .2 2 * * )
-0 .0 3
-0 .0 4
0 .1 5
0 .0 7
0 .0 8
1
g,
c  . 
a .
«0
Ctx (n gm l)
C (n = 35)  
A (n = 2 8 )
0 .0 2
-0 .0 7
0 .3 3 * (0 .3 8 * )
0 .2 1
0 .3 4 * (0 .4 5 * )
0 .1 5
0 .1 4
0 .2 5
-0 .5 6 * '
0 .1 4
'(-0 .5 6 * * )
PTH
C (n = 1 9 1 )  
A (n = 5 5 )
0 .1 9 * * (0 .1 0 )
-0 .0 0 4
0 .2 1 * * (0 .2 1 * * )
-0 .0 8
0 .2 4 * * (0 .2 2 * * )
-0 .0 3
-0 .0 1
-0 .1 3
0 .0 9
0 .1 8
*correlation  is significant at th e  0 .0 5  level, ** correlation  is sign ificant at th e  0 .0 1  level, () 
partial correlation  for BMI, C Caucasian, A Asian
A significant n egative association  w as found b e tw e e n  CTx and insulin levels for both  
se a so n s . Higher Ctx w as a ssoc ia ted  w ith  higher ch o lestero l and LDL. A significant 
correlation  w as found b e tw e en  PTH, TAG, ch o lestero l, and LDL con sisten tly  in both  
se a so n s . T h ese correlations w ere  rem ained significant after ad ju stm en t for BMI and  
vitam in D sta tu s, but w ere  co n sis ten t in th e  Caucasian population  only.
T h ese data indicate a link b e tw e en  higher b on e resorption  and in crease risk o f  
cardiovascular d isea se  in th e  Caucasian population  and certainly warrant further  
investigation .
 ^Hakim e t  al su bm itted  to  NOS co n feren ce  2 0 1 0  Liverpool.
The D-FINES Study is funded  by th e  Food Standards A gency (Project no. N O 5064).
0 . A. H. is grateful to the Royal Embassy o f Saudi Arabia for PhD funding
15 . E vidence o f  a link b e tw e e n  o s te o p o r o s is  risk and CVD in C aucasian b ut n o t Asian  
w o m e n  : R esu lts o f  th e  D-FINES stu d y
O steop orosis  has b een  linked to  CVD, su ggestin g  th a t it m ight be due to  th e  association  
b etw e en  serum  lipids and b on e health  indices. W e are currently exam ining lip id/ b on e  
relationship  as part to  our D-FINES study (Vitamin D, Food Intake, Nutrition and Exposure 
to  Sunlight in Southern  England). W e have sh ow n  a link b e tw e e n  poor lipid profile and an 
in crease in b o n e  resorption  and PTH .^ W e exp lore further in th is abstract th e  lip id/ b on e  
d en sity  results. The aim o f  th e  p resen t subsidiary study w a s to  exam in e th e  association  
b etw e en  serum  lipids and b on e quality including broadband ultrasound a tten u ation  
(BUA), velocity  o f  sound  (VOS), lum bar sp ine (LS) BMD, and fem oral neck (FN) BMD in 
A utum n 2 0 0 6  and Spring 2 0 0 7 . The tab le  b e lo w  sh o w s correlations (r) b e tw e en  m arkers 
o f  CVD and BUA, VOS, FN, and LS.
TAG
(m m o l/ l)
C h o lestero l
(m m o l/ l)
LDL (m m o l/ l) HDL (m m o l/l) Insulin  (m U /l)
BUA mHz
C (n = 68) -0 .1 1 -0 .2 4 *  (-0 .24* ) -0 .2 2 -0 .1 7 0 .1 9
A (n = 3 2 ) 0 .1 5 0 .0 2 0 .0 2 -0 .0 5 -0 .0 2
c
VOS
C (n = 68) -0 .1 9 -0 .2 7 *  (-0 .28* ) -0 .2 3 -0 .1 9 -0 .0 6
I A (n = 3 2 ) 0 .2 9 0 .1 7 0 .0 8 0 .1 7 0 .0 1
J LS g/cm ^C (n = 194) -0 .0 4 -0 .2 1 * *  (-0 .19** ) -0 .2 1 * *  (-0 .2 1 * * ) -0 .0 9 0 .0 8
A (n=50) 0 .1 7 -0 .0 7 -0 .0 1 -0 .1 9 -0 .1 4
FN g/cm ^
C (n =193) -0 .0 5 -0 .2 1 * *  (-0 .19** ) -0 .1 8 *  (-0 .1 9 * * ) -0 .1 5 *  (-0 .07) 0 .1 5 *  (-0 .0 2 )
A (n = 5 0 ) 0 .2 9 *  (0 .18 ) 0 .0 1 0 .1 1 -0 .2 8 *  (-0 .22) 0 .0 1
BUA mHz
C (n = 41) -0 .2 3 -0 .1 9 -0 .1 5 -0 .1 3 0 .3 8 *  (0 .3 5 * )
A (n=15) 0 .1 9 -0 .0 3 0 .0 0 2 -0 .1 1 0 .0 0 2
M
VOS
C (n = 41) -0 .3 0 -0 .1 1 -0 .0 8 -0 .0 6 0 .2 9
A (n=15) 0 .2 6 2 0 .0 3 0 .1 5 -0 .2 7 0 .2 1
g- LS g /c tv l 
C (n =191) -0 .0 4 -0 .2 2 * *  (-0 .21** ) -0 .2 2 * *  (-0 .2 2 * * ) -0 .0 8 0 .0 8
A (n = 5 0 ) 0 .1 6 -0 .0 8 -0 .0 2 -0 .1 9 -0 .1 5
FN g /c w l 
C (n = 189) -0 .0 5 -0 .2 2 * *  (-0 .20** ) -0 .1 9 * *  (-0 .2 0 * * ) -0 .1 3 0 .1 0
A (n = 5 0 ) 0 .3 2 *  (0 .2 9 * ) -0 .0 5 0 .0 4 -0 .2 8 *  (-0 .27* ) 0 .0 0 2
*correlation is significant at the 0.05 level, ** correlation is significant at the 0.01 level, () partial correlation 
for BMI, C Caucasian, A Asian
N egative correlations w ere  ap paren t in a lm ost all th e  b on e m ea su res w ith lipid profiles in 
th e  Caucasian w o m en  but n ot th e  Asian w o m en . LS and FN b o n e d en sity  w as a ssoc ia ted  
n egatively  w ith ch o lestero l and LDL in both se a so n s . A sign ificant n egative  correlation  
b etw e en  BUA, VOS and ch o lestero l w as found in A utum n only. Interestingly, insulin w as  
associa ted  positively  w ith  FN BMD and BUA in Caucasian w o m e n . T h ese correlations  
rem ained significant after ad ju stm ent for BMI and vitam in D sta tu s. T h ese data indicate a 
link b e tw e en  poor b on e health  and increased  CVD risk in Caucasian p opu lations. A 
p ossib le p otentia l m echanism  o f  th e se  CVD/ o steo p o ro sis  findings is that a d ip ocy tes  and  
o steo b la sts  share a com m on  progen itor from  th e  strom al cell in th e  b one m arrow . T h ese  
finding certainly w arrant further investigation
 ^Hakim e t  al su bm itted  to  NOS con feren ce  2 0 1 0  Liverpool.
The D-FINES Study is funded  by th e  Food Standards A gency (Project no. N O 5064).
0 . A. H. is grateful to  the Royal Embassy o f Saudi Arabia for PhD funding
16. P oorer lipid p rofile are a sso c ia ted  w ith  in creased  b o n e  resorp tion  and parathyroid  h orm on e:  
p relim inary resu lts o f  th e  D-FINES stu d y , BY O A  HAKIM\ F. SHOJAEE-MORADIE^ R. EASTELL^ F. 
GOSSIEL^ R. HANNON^ K. HART\ L.M. MORGAN^ J.L. BERRY ,^ A.M. UMPLEBY^ B.A. GRIFFIN^ AND 
S.A. LANHAM-NEW^ ^Faculty o f  Health and M edical S cien ces, University o f  Surrey, Guildford GU2 
7XH. ^Postgraduate M edical School, University o f  Surrey, Guildford GU2 7XH. ^University o f  
Sheffield , Sheffield . V itam in  D Research Group, University o f  M an ch ester M 13 9WL.
Early experimental studies have suggested that serum cholesterol may be a common pathogenic 
factor in the development of bone loss and osteoporosis. Only a few  stu d ies have in vestigated  th e  
relation b e tw e en  lipids and b on e turnover. The D-FINES stud y (Vitamin ^  Food Intake, N utrition  
and Exposure to  Sunlight in Southern  England) is a longitudinal stu d y  in vestigated  th e  in teraction  
b e tw e e n  d iet and sunlight exp osu re on vitam in D sta tu s. The aim o f  th e  p resen t subsidiary stud y  
w as to  exam in e th e  association  b e tw e en  serum  lipids w ith  b on e turnover and parathyroid  
h orm on e (PTH), in Autum n 2 0 0 6  and Spring 2 0 0 7 . C oncom itantly, w e  have also exam in ed  th e  
associa tion  b e tw e en  lipid profile and b on e d en sity  (Hakim e t  al 2010). Fasted b lood  sam p le w ere  
co llec ted  from  279  Caucasian and 94  Asian w o m e n  aged  19 -70  years living in Southern  England. 
Serum  CTx w as a sse sse d  using e lec troch em ilu m in escen t im m u n oassay  during A utum n 2 0 0 6  and  
Spring o f  2 0 0 7  and parathyroid h orm one (PTH) w as m easu red  using th e  OCTEIA 
im m u n oen zym om etric assay (Im m unodianostic System  Ltd, Boldon, Tyne and W ear, UK). The tab le  
b elo w  sh o w s th e  correlations (r) b e tw e en  m arkers o f  CVD, CTx and PTH.
TAG
(m mol/l)
Cholesterol
(m mol/l)
LDL (m mol/l) HDL
(m mol/l)
Insulin (m U/l)
i s
Ctx (ngml)
C aucasian (n=35) 
Asian (n=28)
-0.15
-0.08
0.23
0.15
0.21
0.09
0.20
0.23
-.52**(-0.47**)
0.06
s  s  
<
PTH
C aucasian (n = 188) 
Asian (n=55)
0.19**{0.10)
-0.26*(-0.25)
0.19**(0.20**)
0.001
0.23**(0.22**)
-0.03
-0.04
0.15
0.07
0.08
8
St
Ctx (ngml)
C aucasian (n=35) 
Asian (n =28)
0.02
-0.07
0.33*(0.38*)
0.21
0.34*(0.45*)
0.15
0.14
0.25
-0.56**{-0.56**)
0.14
PTH
C aucasian (n = 191) 
Asian (n=5S)
0.19**(0.10)
-0.004
0.21* * (0.21**)
-0.08
0.24**(0.22**)
-0.03
-0.01
-0.13
0.09
0.18
* cor re ation is significant at th e  0 .0 5  leve , ** correlation  is significant at th e  0 .0 1  level
0  partial correlation for BMI
A significant n egative association  w as found b e tw e e n  CTx and insulin levels for both  se a so n s . 
Higher Ctx w as a ssoc ia ted  w ith higher ch o lestero l and LDL. A significant correlation  w a s foun d  
b e tw e e n  PTH, TAG, ch o lestero l, and LDL con sisten tly  in both  se a so n s . T hese correlations w ere  
rem ained significant after ad ju stm ent for BMI and vitam in D sta tu s, but w ere  co n sis te n t in th e  
Caucasian population  only. T h ese data indicate a link b e tw e e n  higher b on e resorption  and  
in crease risk o f  cardiovascular d isea se  in th e  Caucasian p opulation  and certainly w arrant further  
in vestigation .
 ^Hakim e t  al su bm itted  to  NOS con feren ce  2 0 1 0  Liverpool.
The D-FINES Study is funded  by th e  Food Standards A gency (Project no. N O 5064).
0 . A. H. is grateful to the Royal Embassy o f Saudi Arabia for PhD funding
17. Sub optim al le v e ls  o f  25(OH)D are a sso c ia ted  w ith  p oorer in d ices o f  card iovascu lar health :  
furth er an a lysis  o f  D-FINES stu d y , By O.A. H aklm \ A .L Darling^ S. Starkey^ M.C.Y. W o n g \ F. 
Shojaee-M orad ie^  K.H. H art\ L.M. M organ^ J.L. Berry^ A.M. U m pleby^ B.A. Griffin^ and S.A. 
Lanham-New^ ^Faculty o f Health and Medical Sciences, University o f Surrey, Guildford GU2 7XH. 
^Postgraduate Medical School, University o f Surrey, Guildford GU2 7XH. ^Vitamin D Research 
Group, University o f Manchester. M 13 9W L
A significant link b e tw e en  vitam in D and cardiovascular d isea se  (CVD) risk has b een  su g g ested , 
w ith strong assoc ia tion s being foun d  b e tw e en  poor vitam in D sta tu s and CVD risk factors such as 
dyslip idaem ia and hyperten sion . The aim o f  th is subsidiary study w as to  further in vestigate  th e  
association  b e tw e e n  su m m er vitam in D sta tu s (25 hydroxyvitam in D 250H D ) and CVD risk factors, 
as d efined  by serum  lipid profiles and insulin levels w ith  sp ecific 250H D  cu t-o ff va lu es^  The D- 
FINES study (Vitamin D, Food Intake, Nutrition and Exposure to  Sunlight in S outhern  England) w as  
a longitudinal stud y th at in vestigated  th e  in teraction  b e tw e en  d iet and sunlight exp osu re on  
250H D  sta tu s. A to ta l o f  27 9  Caucasian (C) and 94  Asian (A) w o m e n  aged  19-70  years living in 
Southern  England participated in th e  study, providing fa sted  b lood sam p les for th e  a sse ssm e n t o f  
250H D ) and lipid profile. The Table b elow  com p ares lipid levels  b e tw e en  Vitamin D sta tu s groups, 
d efined  according to  differing leve ls  o f  250H D  cut-offs.
Vitamin D status
'Deficient' 
<25 nmol/l 
(0=0, A=29)
'Insufficient' 
25-40 nmol/l 
(0=13, A=15)
'Inadequate' 
40-75 nmol/l 
(0=87, A=10)
'Optimal' 
>75 nmol/l 
(0=62, A=0)
TAG (mmol/L)
Caucasian
Asian 1.45(0.59]
1.56(0.88]'
1.25(0.49]
1.09(0.44]*’
1.14(0.63]
0.99(0.78]*’
Total-C (mmol/L)
Caucasian
Asian 4.90(0.84]
4.93(1.44]
4.78(0.71]
5.25(1.17]'
4.15(0.92]
4.75(1.12]*’
LDL-C (mmol/L)
Caucasian
Asian 3.16(0.67]'
3.11(1.14]
3.09(0.61]'
3.30(.99]'
2.38(0.74]*’
2.92(.87]*’
HDL-C (mmol/L)
Caucasian
Asian 1.44(0.35]
1.51(0.49]
1.43(0.30]
1.73(0.50]
1.54(0.45]
1.63(0.44]
Insulin (mU/L)
Caucasian
Asian 17.17(7.45]
13.60(8.58]
14.18(5.46]
12.67(4.47]
16.12(4.12]
11.46(4.69]
Cells within a row with different superscript letters are significantly different. AN OVA p<0.05. Mean [SD] given
D ifferences in plasm a lipids b e tw e e n  vitam in D sub-groups w ere  m ore pron oun ced  in 'C  th an  W  
w o m en . 'C  w o m en  w ith optim al vitam in D sta tu s had low er TAG, to ta l and LDL ch o le stero l than  
groups o f  insufficient or in ad eq u ate  statu s. In 'A' w o m en , only LDL ch o lestero l w a s sign ificantly  
n egatively  assoc ia ted  w ith vitam in D level. All resu lts rem ained  significant a fter  ad ju sted  for BMI, 
ex cep t for TAG am ong 'C  w o m e n . The lack o f  an association  b e tw e e n  25  OHD sta tu s and CVD 
m arkers in Asian w o m en  m ay be reflective o f  th e  a lm ost co m p lete  250H D  'd efic ien cy' in th is  
en tire group T hese data provide n ew  ev id en ce  for significant a ssoc ia tion s b e tw e e n  p oor 25  OHD 
sta tu s and m arkers o f  CVD risk, especia lly  in Caucasian w o m en .
1. Hakim, OA e t  al (2010): Proceedings o f the Nutrition Society (in Press)
The D-FINES Study is funded by the Food Standards Agency (Project No. NO5064).
O.A. Hakim is grateful to the Royal Embassy of Saudi Arabia for PhD funding
18. POOR BONE HEALTH AND INCREASED CARDIOVASCULAR DISEASE RISK; EVIDENCE OF A LINK IN THE D- 
FINES STUDY POPULATION
By O.A. Hakim^. A.L. Darling^ S. Starkey^ M.C.Y. W ong \ F. Shojaee-Moradie^, K. H a rt\ L.M. Morgan^ J.L. 
Berry\ A.M. Umpleby^ B.A. Griffin^ and S.A. Lanham-New\ ^Faculty o f Health and Medical Sciences and 
^Postgraduate Medical School, University o f Surrey, Guildford GU2 7XH, UK and ^Vitamin D Research 
Group, University o f Manchester. Manchester M 13 9WL, UK
Early experimental studies have suggested that serum cholesterol may be a common pathogenic factor in the 
development o f  bone loss and osteoporosis. Only a few studies have investigated the relation between lipids 
and bone mineral density.
The D-FINES study (Vitamin D, Food Intake, Nutrition and Exposure to Sunlight in Southern England) is 
currently investigating the interaction between diet and sunlight exposure on vitamin D status in Caucasian 
(n=279) and Asian (n=86) women aged 19-70 years living in Southern England. Bone quality was assessed 
using broadband ultrasound attenuation (BUA; MHz) during Autumn and Spring seasons of 2007 (BUA, Cuba 
Clinical UK). The aim of the present subsidiary study was to examine the association between serum lipids 
and bone quality in Autumn and Spring 2007.
There was a significant negative correlation between cholesterol, insulin and BUA in Caucasian women but 
not Asian women. These finding remained significant after adjustment for BMI and vitamin D status. Velocity 
of sound (VOS; m/s) was also examined. Only significant negative correlation was found between VOS and 
cholesterol level (r=-0.27 p<0.05) in Autumn among the Caucasian women but not Asian women. This 
finding remained significant after adjustment for BMI and vitamin D status. These data indicate a link 
between poor bone health and increased CVD risk in Caucasian populations and certainly warrant further 
investigations.
The D-FINES Study is funded by the Food Standards Agency (Project no. NO5064).
0 . A. H. is grateful to the Royal Embassy of Saudi Arabia for PhD funding
19 . S ub optim al le v e ls  o f  25(OH)D are a sso c ia ted  w ith  p oorer  in d ices o f  card iovascu lar health :  
fu rth er an a lysis o f  D-FINES stu d y , By O.A. H akim \ A.L. Darling^ S. Star key \  M.C.Y. W o n g \ F. 
S h ojaee-M orad ie^  K.H. H art\ L.M. M organ^ J.L. Berry^ A.M. U m pleby^ B.A. Griffin^ and S.A. 
Lanham-New^ ^Faculty o f Health and Medical Sciences, University o f Surrey, Guildford GU2 7XH. 
^Postgraduate Medical School, University o f Surrey, Guildford GU2 7XH. ^Vitamin D Research 
Group, University o f Manchester. M 13 9WL.
A significant link b e tw e en  vitam in D and cardiovascular d isea se  (CVD) risk has b een  su g g ested , 
w ith  stron g assoc ia tion s being found b e tw e en  poor vitam in D sta tu s and CVD risk factors such  as  
d yslip idaem ia and hyperten sion . The aim  o f  th is subsidiary stu d y  w as to  further in vestiga te  th e  
associa tion  b e tw e en  su m m er vitam in D sta tu s (25 hydroxyvitam in D 250H D ) and CVD risk factors, 
as d efin ed  by serum  lipid profiles and insulin levels w ith  sp ecific  250H D  cu t-o ff va lu es^
The D-FINES stud y (Vitamin D, Food Intake, Nutrition and Exposure to  Sunlight in Southern  
England) w as a longitudinal stud y th a t in vestigated  th e  interaction  b e tw e en  d iet and sunlight 
exp osu re on  250H D  statu s. A to ta l o f  279  Caucasian (C) and 9 4  Asian (A) w o m en  aged  1 9 -70  years  
living in Southern  England participated in th e  study, providing fa sted  b lood sa m p les  for th e  
a sse ssm e n t o f  250H D ) and lipid profile. The Table b e lo w  com p ares lipid levels b e tw e e n  Vitam in D 
sta tu s groups, d efined  according to  differing levels o f  250H D  cu t-offs .
V itam in  D sta tu s
'D efic ien t' 
<25 n m o l/l 
(C=0, A=29)
'Insufficien t' 
2 5 -4 0  n m o l/l 
(C=13, A=15)
'In ad eq u ate' 
4 0 -7 5  n m o i/i 
(C=87, A=10)
'O ptim al' 
>75 n m o l/l  
(C=62, A=0)
TAG (m m ol/L )
Caucasian
Asian 1.45(0 .59]
1 .5 6 (0 .8 8 ]'
1 .25(0 .49]
1.09(0.44]*’
1 .14(0 .63]
0.99(0.78]*’
Total-C (m m ol/L )
Caucasian
Asian 4 .9 0 (0 .8 4 ]
4 .9 3 (1 .4 4 ]
4 .7 8 (0 .7 1 ]
5 .2 5 (1 .1 7 ]'
4 .15 (0 .92 ]
4.75(1 .12]*’
LDL-C (m m ol/L )
Caucasian
Asian 3 .1 6 (0 .6 7 ]'
3 .11 (1 .14 ]
3 .0 9 (0 .6 1 ]'
3 .3 0 (.9 9 ]'
2.38(0.74]*’
2.92[.87]*’
HDL-C (m m ol/L )
Caucasian
Asian 1 .44(0 .35]
1 .51 (0 .49 ]
1 .43 (0 .30 ]
1 .73(0 .50]
1 .54(0 .45]
1 .6 3 (0 .4 4 ]
Insulin (m U/L)
Caucasian
Asian 17 .17 (7 .45 ]
13 .60 (8 .58 ]
14 .18 (5 .46 ]
12 .67 (4 .47 ]
16 .12 (4 .12 ]
1 1 .4 6 (4 .6 9 ]
Cells within a row with different superscript letters are significantly different. AN OVA p<0.05. Mean [SD] given
D ifferences in plasm a lipids b e tw e en  vitam in D su b-groups w ere  m ore p ron oun ced  in 'C  th an  'A' 
w o m en . 'C  w o m en  w ith  optim al vitam in D sta tu s had low er TAG, to ta l and LDL ch o lestero l than  
groups o f  insufficient or in ad eq u ate sta tu s. In W  w o m e n , on ly LDL ch o lestero l w a s sign ificantly  
negatively  a ssoc ia ted  w ith vitam in D level. All resu lts rem ained  significant a fter  ad ju sted  for BMI, 
ex c ep t for TAG am on g 'C' w o m en . The lack o f  an assoc ia tion  b e tw e en  25  OHD sta tu s and CVD 
m arkers in Asian w o m en  m ay be reflective o f  th e  a lm ost co m p lete  250H D  'd efic ien cy' in th is  
en tire group T h ese data provide n ew  ev id en ce  for significant a ssoc ia tion s b e tw e e n  p oor 25  OHD 
sta tu s and m arkers o f  CVD risk, especia lly  in Caucasian w o m en .
1. Hakim, OA e t  al (2010): Proceedings o f the Nutrition Society (in Press)
The D-FINES Study is funded by the Food Standards Agency (Project No. NO5064).
O.A. Hakim is grateful to the Royal Embassy of Saudi Arabia for PhD funding
20. Poor b o n e  h ea lth  and Increased  card iovascu lar d ise a se  risk: ev id e n c e  o f  a link in th e  D-FINES 
stu d y  p op u lation
By O A  H akim \ A.L Darling^ S. Starkey^ M.C.Y. W o n g \ F. S hojaee-M orad ie^  K. H art\ LM . M organ^  
J.L. Berry^ A.M . U m pleby^ B.A. Griffin^ and S.A. L an h am -N ew \ ^Faculty o f Health and Medical 
Sciences and ^Postgraduate Medical School, University o f Surrey, Guildford GU2 7XH, UK and ^Vitamin 
D Research Group, University o f Manchester. Manchester M 13 9WL, UK
Early Experimental studies have suggested that serum cholesterol play an important pathogenic 
factor in the development of bone loss and osteoporosis. Only a fe w  stu d ies have in vestigated  th e  
relation b e tw e en  lipids and b on e m ineral d en sity
M eth od s: The D-FINES stud y (Vitamin D, Food Intake, N utrition and Exposure to  Sunlight in 
Southern  England) is currently investigating th e  interaction  b e tw e e n  d iet and sunlight exp osu re on  
vitam in D sta tu s in Caucasian and Asian w o m en  aged  1 9 -7 0  years living in Southern  England. 
Fasted blood sam p les w ere  co llec ted  from  a to ta l o f  279  Caucasian and 94  Asian w o m e n  in each  
se a so n . Bone quality w as a sse sse d  using broadband ultrasound a tten u ation  BUA during A utum n  
and Spring se a so n s  o f  2 007 .
Aim: The aim o f  th e  p resen t subsidiary study w as to  exam ine: 1) th e  association  b e tw e e n  serum  
lipids and b on e quality in A utum n and Spring 2007; 2) th e  assoc ia tion  b e tw e en  vitam in D sta tu s  
and BUA according to  eth n icity  groups.
R esults: As is sh ow n  in th e  Table b elow , th ere  w as a significant n egative  correlation  b e tw e e n  lipid 
profiles and BUA in Caucasian w o m e n  but n ot Asian w o m en , w ith  e ffec t  g re a test  in th e  Spring. 
T h ese finding rem ained  significant for ch o lestero l, TAG and LDL after ad ju stm en t for BMI and  
vitam in D sta tu s..
T able. Pearson correlation  (rva lu es) b e tw e en  serum  lipid and BUA in Caucasian and Asian w o m e n
Autum n 07 Spring 07
All groups  
n=86
Caucasian
n=58
Asian
n=28
All groups  
n=47
Caucasian
n=34
Asian
n=13
TAG (m m ol/l) -0 .0 5 -0 .11 0 .1 5 -0 .1 9 -0 .32*
(-0 .36*)
0 .1 9
C holesterol
(m m ol/l)
-0 .19 -0 .24*
(-0.17)
0 .0 2 -0 .33*
(-0 .33*)
-0 .41**
(-0 .39**)
-0 .0 2
LDL (m m ol/l) -0 .1 6 -0 .22 0 .0 2 -0 .33*
(-0 .36*)
-0 .41**
(-0 .41**)
0 .0 0
HDL (m m ol/l) -0 .1 5 -0 .17 -0 .0 5 -0 .13 -0 .13 -0 .1 1
Insulin (m U /l) 0 .1 4 0 .1 9 -0 .0 2 0 .2 1 0.30*
(0 .28)
0 .0 0 4
T < 0 .0 5  **p <0.01  (partial correlation) Adjusted for BM ; vitam in D sta tu s
There w ere  no statistical d ifferen ces in m ean  BUA b etw e en  eth n ic  groups but a trend  for low er  
level in Caucasian w o m en  (Caucasian 7 1 .4 3 (1 5 .8 5 ] versu s Asian 7 3 .1 7 (1 4 .6 7 ] in Autum n; Caucasian  
68 .3 1 (1 8 .1 0 ] versu s Asian 7 2 .8 9 (1 9 .2 4 ] in Spring). No correlations w ere  found b e tw e e n  vitam in  D 
sta tu s and BUA in e ith er  o f  th e  eth n ic  groups.
C onclusions: T h ese data indicate a link b etw e en  poor b on e health  and in creased  CVD risk in 
Caucasian popu lations and certainly warrant further in vestigation s.
The D-FINES Study is fun ded  by th e  Food Standards A gency (Project no. N 0 5 0 6 4 ).
0 .  A. H. is grateful to  th e  Royal Em bassy o f  Saudi Arabia for PhD funding
2 1 -2 3  E vidence o f  a d etrim en ta l e f fe c t  o f  lo w  v itam in  D s ta tu s  on  m arkers o f  card iovascu lar h ealth  
in th e  D-FINES stu d y  p opulation: e th n ic  and a g e  in flu en ces. BY O.A. HAKIM^ A.L DARLING^ S. 
STARKEY^ M.C.Y. WONG% W. FOSTER^ F. SHOJAEE-MORADIE^ K. H A R l\ LM . MORGAN^ J.L. BERRY^ 
A.M. UMPLEBY^ B.A. GRIFFIN  ^ AND S.A. LANHAM-NEW^ ^Faculty o f Health and Medical Sciences, 
University o f Surrey, Guildford GU2 7XH. ^Postgraduate Medical School, University o f Surrey, Guildford 
GU2 7XH. ^Vitamin D Research Group, University o f Manchester. M 13 9WL.
There are clear associa tion s b e tw e en  vitam in D deficien cy , and insulin resistan ce , b eta-cell 
dysfunction  and reduced insulin secretion . There are also  data linking vitam in D 'insufficiency' as a 
risk factor for m etabolic  syn drom e, h yperten sion  and d ia b e tes , all o f  w hich m ay clarify its 
associa tion  w ith  increased  cardiovascular d isea se . T h ese assoc ia tion s are particularly ap paren t in 
Asian groups and m ay underlie th e  con sid erab le p red isp osition  to  CVD in th is group. Poor vitam in  
D sta tu s m ay h en ce  be assoc ia ted  w ith  raised to ta l ch o lestero l and inversely related  to  th e  serum  
con cen tration  o f  cardio-protective HDL, although lim ited data on  UK p opu lations are available.
The D-FINES stud y (Vitamin Food Intake, Nutrition and Exposure to  Sunlight in S outhern  
England) is currently investigating th e  interaction  b e tw e en  d iet and sunlight exp osu re on vitam in D 
sta tu s in Caucasian and Asian w o m en  aged  1 9 -70  years (m ean  4 8 .0 , SD 14 .33) living in Southern  
England. Fasted b lood sam p les have b een  co llec ted  at th ree  m onthly  intervals from  Sum m er 2 0 0 6  
to  Spring 2 0 0 7  on  a to ta l o f  279  Caucasian and 9 4  Asian w o m e n  and d ietary intake a sse sse d  during 
th e se  periods using 4-day estim ated  food  records. W om en  w ere  recruited through G eneral 
Practice or through Asian com m unity  netw orks in W oking, Kingston and Thornton H ealth. For lipid 
analysis, data w ere  checked  for norm ality using K-S te s t . Variable found to  be n ot norm ally  
distributed , non-param etric analysis w ere  applied. The aim o f  th is subsidiary study w a s to  exam in e  
th e  relationship  b e tw e en  su m m er vitam in D sta tu s and serum  lipid profiles, (serum  triacylglycerol 
(TAG), and high d en sity  lipoprotein  (HDL)), and insulin. Descriptive data and spearman correlation (r 
values) between markers of cardiovascular health and 25 -0HD in Caucasian and Asian women from D-FINES
All groups 
N=373
Caucasian
N=279
Asian
N=94
All groups Caucasian Asian
Vitamin D status 
(nmol/L)
58.36126.96] 67.86" [23.06] 28.63 "[13.06]
TAG (mmol/L) 1.17 [0.64] 1.12"[0.65 ] 1.34" [0.57 ] -0.29***
(-0.16)**
-0.25***
(-0.13)+
-0.19
(-0 .1 2 )
Cholesterol
(mmol/L)
5.03 [1.19] 5.12" [1.26] 4.72" [0.84] -0.008(-0.04) -0 .1 2 +
(-0.15)*
-0.18
(-0.24)+
LDL
(mmol/L)
3.18[0.98] 3.23[1.05] 2.99[0.71] -0.08
(-0.09)
-0.14*
(-0.17)*
-0.25+
(-0.37)**
HDL (mmol/L) 1.62 [0.45] 1.67" [0.46] 1.46" [0.34] 0.19**
(0.15)*
0.08
(0.04)
0 .14
(0.19)
Insulin (mU/L) 13.23 [5.66] 12.33" [5.14 ] 16.33" [6.28] -0.24***
(-0 .2 0 )***
-0 . 1 0
(-0 .0 1 )
-0.13
(-0 .1 1 )
Values are means [SD]; *** P<0.001; ** P<0.01; *P<0.05, tp<0.1 Unlike superscripts are significantly different (M-W- 
U test P=0.016- 0.001)
OPartial correlation adjusted for BMI
As sh ow n  in th e  Table ab ove, th e  m ean  serum  vitam in D level w as significantly low er in Asian 
w o m en  com pared  to  Caucasian w o m e n  (P<0.0001). The m ean  BMI w as 2 5 .98  [4.77] for Caucasian  
w o m en  and 2 7 .83  [5.70] for Asian w o m en . There w as a h igher TAG in Asian w o m en  com pared  to  
Caucasian w o m en  (P<0.001) and higher HDL in Caucasian than  Asian w o m en  (P<0.002). Insulin 
leve ls w ere significantly higher in th e  Asian w o m en  {P<0.001). Significant n egative  correlations  
w ere  found b e tw e en  m arkers o f  cardiovascular health  and 250H D  sta tu s in all groups com b ined  
and th en  specifically  in th e  Caucasian w o m en  but n ot th e  Asian w o m en . Partial correlation  w as  
calcu lated  adjusting for BMI, and results rem ained  significant. Blunting o f  250H D  levels i.e. sev ere  
vitam in D deficien cy  has b een  identified  in th e se  Asian w o m e n , w ith  75% having a 250H D  b elow  
25 n m o l/l (depend ing  on  sea so n s) (Darling et al., 2 0 09 ), and m ay explain th e  lack o f  assoc ia tion  
b e tw e e n  250H D  and m arkers o f  CV health . The p resen t findings are a cau se  for concern  and  
w arrant further investigation .
The D-FINES Study is funded by the Food Standards Agency (Project No. NO5064)
O.A. Hakim is grateful to the Royal Embassy of Saudi Arabia for PhD funding 
A.L. Darling, P.A. Lee., D.Lovell, W.T.K. Lee, J.L. Berry, and S.A. Lanham-New (2009). Interaction between 
diet and sunlight exposure on vitamin D status in premenopausal women living in southern England: 
Proceedings of the Nutrition Society {In Press)
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